"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34195465","10.18502/cmm.6.4.5442","Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis.","The world is involved with a pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations of reported COVID-19-associated pulmonary impairments range from asymptomatic infections to a pneumonia-induced acute respiratory distress syndrome that requires mechanical ventilation. Fungal superinfections complicating the clinical course remain underexplored. Angiotensin-converting enzyme 2, the receptor for COVID-19 that is mainly e","2021","07","02","Curr Med Mycol","Current medical mycology"," Aspergillosis;  Immune responses;  SARS-CoV-2; Aspergillus fumigatus","Tavakoli","Mahin","Invasive Fungi Center, Communicable Diseases Research Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"2","34195465","10.18502/cmm.6.4.5442","Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis.","The world is involved with a pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations of reported COVID-19-associated pulmonary impairments range from asymptomatic infections to a pneumonia-induced acute respiratory distress syndrome that requires mechanical ventilation. Fungal superinfections complicating the clinical course remain underexplored. Angiotensin-converting enzyme 2, the receptor for COVID-19 that is mainly e","2021","07","02","Curr Med Mycol","Current medical mycology"," Aspergillosis;  Immune responses;  SARS-CoV-2; Aspergillus fumigatus","Shokohi","Tahereh","Invasive Fungi Center, Communicable Diseases Research Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"3","34195465","10.18502/cmm.6.4.5442","Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis.","The world is involved with a pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations of reported COVID-19-associated pulmonary impairments range from asymptomatic infections to a pneumonia-induced acute respiratory distress syndrome that requires mechanical ventilation. Fungal superinfections complicating the clinical course remain underexplored. Angiotensin-converting enzyme 2, the receptor for COVID-19 that is mainly e","2021","07","02","Curr Med Mycol","Current medical mycology"," Aspergillosis;  Immune responses;  SARS-CoV-2; Aspergillus fumigatus","Lass Flörl","Cornelia","nstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"4","34195465","10.18502/cmm.6.4.5442","Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis.","The world is involved with a pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations of reported COVID-19-associated pulmonary impairments range from asymptomatic infections to a pneumonia-induced acute respiratory distress syndrome that requires mechanical ventilation. Fungal superinfections complicating the clinical course remain underexplored. Angiotensin-converting enzyme 2, the receptor for COVID-19 that is mainly e","2021","07","02","Curr Med Mycol","Current medical mycology"," Aspergillosis;  Immune responses;  SARS-CoV-2; Aspergillus fumigatus","Hedayati","Mohammad Taghi","Invasive Fungi Center, Communicable Diseases Research Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"5","34195465","10.18502/cmm.6.4.5442","Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis.","The world is involved with a pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2. The clinical manifestations of reported COVID-19-associated pulmonary impairments range from asymptomatic infections to a pneumonia-induced acute respiratory distress syndrome that requires mechanical ventilation. Fungal superinfections complicating the clinical course remain underexplored. Angiotensin-converting enzyme 2, the receptor for COVID-19 that is mainly e","2021","07","02","Curr Med Mycol","Current medical mycology"," Aspergillosis;  Immune responses;  SARS-CoV-2; Aspergillus fumigatus","Hoenigl","Martin","Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, California, USA",NA
"6","34195441","10.1016/j.heliyon.2021.e07343","Research investigating individual device preference and e-learning quality perception: can a one-solution-fits-all e-learning solution work?","COVID-19 caused a paradigm shift for educators, and raised many questions about the future of technology in the delivery of educational content. Literature highlights numerous benefits of using e-learning solutions, yet many still consider 'online learning' as the cheap/'low-quality' alternative to traditional 'face-to-face' models. In this research we ask two questions that are critical to the effective development of future e-learning solutions: Do students prefer face-to-face (traditional) le","2021","07","02","Heliyon","Heliyon","Culture value dimensions; E-learning; Face-to-Face learning; HE services quality indicators; Quality indicators; Quality perception","Ali","Samnan","GC University, Lahore, Pakistan",NA
"7","34195441","10.1016/j.heliyon.2021.e07343","Research investigating individual device preference and e-learning quality perception: can a one-solution-fits-all e-learning solution work?","COVID-19 caused a paradigm shift for educators, and raised many questions about the future of technology in the delivery of educational content. Literature highlights numerous benefits of using e-learning solutions, yet many still consider 'online learning' as the cheap/'low-quality' alternative to traditional 'face-to-face' models. In this research we ask two questions that are critical to the effective development of future e-learning solutions: Do students prefer face-to-face (traditional) le","2021","07","02","Heliyon","Heliyon","Culture value dimensions; E-learning; Face-to-Face learning; HE services quality indicators; Quality indicators; Quality perception","Gulliver","Stephen R","University of Reading, Reading, UK",NA
"8","34195441","10.1016/j.heliyon.2021.e07343","Research investigating individual device preference and e-learning quality perception: can a one-solution-fits-all e-learning solution work?","COVID-19 caused a paradigm shift for educators, and raised many questions about the future of technology in the delivery of educational content. Literature highlights numerous benefits of using e-learning solutions, yet many still consider 'online learning' as the cheap/'low-quality' alternative to traditional 'face-to-face' models. In this research we ask two questions that are critical to the effective development of future e-learning solutions: Do students prefer face-to-face (traditional) le","2021","07","02","Heliyon","Heliyon","Culture value dimensions; E-learning; Face-to-Face learning; HE services quality indicators; Quality indicators; Quality perception","Uppal","M Amaad","GC University, Lahore, Pakistan",NA
"9","34195441","10.1016/j.heliyon.2021.e07343","Research investigating individual device preference and e-learning quality perception: can a one-solution-fits-all e-learning solution work?","COVID-19 caused a paradigm shift for educators, and raised many questions about the future of technology in the delivery of educational content. Literature highlights numerous benefits of using e-learning solutions, yet many still consider 'online learning' as the cheap/'low-quality' alternative to traditional 'face-to-face' models. In this research we ask two questions that are critical to the effective development of future e-learning solutions: Do students prefer face-to-face (traditional) le","2021","07","02","Heliyon","Heliyon","Culture value dimensions; E-learning; Face-to-Face learning; HE services quality indicators; Quality indicators; Quality perception","Basir","Muhammad","GC University, Lahore, Pakistan",NA
"10","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Mohammadkhah","Fatemeh","Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran",NA
"11","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Shamsalinia","Abbas","Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran",NA
"12","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Shirinkam","Fatemeh","Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran",NA
"13","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Daneshnia","Mahboubeh","Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran",NA
"14","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Mahmoudian","Amaneh","Golestan University of Medical Sciences, Iran",NA
"15","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Rafiei","Nastaran","Mazandaran University of Medical Sciences, Ramsar Health Network, Health Education Department, Ramsar, Iran",NA
"16","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Atashpoosh","Abolfazl","Department of Psychology, Lahijan Branch, Islamic Azad University, Lahijan, Iran",NA
"17","34195437","10.1016/j.heliyon.2021.e07336","Exploring COVID-19 anxiety in Iranian adult based on health literacy by moderating demographic variables: A structural equation model.","The COVID-19 (coronavirus disease 2019) pandemic is associated with far-reaching psychological consequences, such as anxiety. The incidence and severity of this anxiety depend on several individual, family and social factors that need to be identified and planned for effective interventions. One of these factors is health literacy (HL). The aim of this study was to determine the relationship between HL and demographic characteristics with COVID-19 anxiety in adults living in Iran at the time of ","2021","07","02","Heliyon","Heliyon","Adult population; Coronavirus anxiety; Coronavirus disease 2019; Coronavirus outbreak; Health literacy; Structural equation modeling","Ghaffari","Fatemeh","Nursing Care Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran",NA
"18","34195381","10.1002/lio2.557","Attend anywhere clinic: A virtual outpatient clinic experience in otolaryngology during the COVID-19 pandemic.","Numerous technological advances have been made during the COVID-19 pandemic. There has been a growing body of evidence highlighting the value of virtual consultations as an adjunct to physical appointments. This study presents the virtual clinic experiences of one ENT department in the UK. Retrospective review of all virtual consultations undertaken at a single ENT department during the COVID-19 pandemic. A total of 556 virtual consultations took place during the study period across all ENT sub-","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; appointments and schedules; otolaryngology; referral and consultation; telemedicine","Puttasiddaiah","Paramesh Mankunda","Department of Otolaryngology Morriston Hospital Swansea UK",NA
"19","34195381","10.1002/lio2.557","Attend anywhere clinic: A virtual outpatient clinic experience in otolaryngology during the COVID-19 pandemic.","Numerous technological advances have been made during the COVID-19 pandemic. There has been a growing body of evidence highlighting the value of virtual consultations as an adjunct to physical appointments. This study presents the virtual clinic experiences of one ENT department in the UK. Retrospective review of all virtual consultations undertaken at a single ENT department during the COVID-19 pandemic. A total of 556 virtual consultations took place during the study period across all ENT sub-","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; appointments and schedules; otolaryngology; referral and consultation; telemedicine","Morris","Simon","Department of Otolaryngology Morriston Hospital Swansea UK",NA
"20","34195381","10.1002/lio2.557","Attend anywhere clinic: A virtual outpatient clinic experience in otolaryngology during the COVID-19 pandemic.","Numerous technological advances have been made during the COVID-19 pandemic. There has been a growing body of evidence highlighting the value of virtual consultations as an adjunct to physical appointments. This study presents the virtual clinic experiences of one ENT department in the UK. Retrospective review of all virtual consultations undertaken at a single ENT department during the COVID-19 pandemic. A total of 556 virtual consultations took place during the study period across all ENT sub-","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; appointments and schedules; otolaryngology; referral and consultation; telemedicine","Dwamena","Sam","Department of Otolaryngology Morriston Hospital Swansea UK",NA
"21","34195381","10.1002/lio2.557","Attend anywhere clinic: A virtual outpatient clinic experience in otolaryngology during the COVID-19 pandemic.","Numerous technological advances have been made during the COVID-19 pandemic. There has been a growing body of evidence highlighting the value of virtual consultations as an adjunct to physical appointments. This study presents the virtual clinic experiences of one ENT department in the UK. Retrospective review of all virtual consultations undertaken at a single ENT department during the COVID-19 pandemic. A total of 556 virtual consultations took place during the study period across all ENT sub-","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; appointments and schedules; otolaryngology; referral and consultation; telemedicine","Sanu","Ameeth","Department of Otolaryngology Morriston Hospital Swansea UK",NA
"22","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Ashoor","Mona Mohammedsaleh","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"23","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Almulhem","Noorah Jamal","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"24","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","AlMubarak","Zaid Abdulrahman","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"25","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Alrahim","Ahmed Abdulrahman","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"26","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Alshammari","Saad Mohammed","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"27","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Alzahrani","Fahad Saleh","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"28","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Alhayek","Ali Radi","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"29","34195380","10.1002/lio2.556","The psychological impact of the COVID-19 pandemic on otolaryngologists: Should we be concerned?","Physicians on the frontline of the COVID-19 pandemic are at increased risk of contracting the disease. Otolaryngologists are amongst the high-risk practitioners, as they are in close proximity to patient's upper airway, which may induce their psychological stress. A cross-sectional survey study, conducted among otolaryngologists in Saudi Arabia from June 11 to June 22. Survey consisted of sociodemographic questionnaire, Coronavirus Anxiety Scale (CAS), Obsession with COVID-19 Scale (OCS) and Pat","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; SARS-CoV-2; mental wellness; otolaryngologist; pandemic; psychiatric distress","Alardhi","Abdullah","Department of Otolaryngology Head and Neck Surgery, King Fahad Hospital of the University, College of Medicine Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia",NA
"30","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","Huntley","Colin","Thomas Jefferson University Department of Otolaryngology-Head &amp",NA
"31","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","Boon","Maurits","Thomas Jefferson University Department of Otolaryngology-Head &amp",NA
"32","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","Ishman","Stacey","Division of Pediatric Otolaryngology-Head &amp",NA
"33","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","Capasso","Robson","Department of Otolaryngology, Head and Neck Surgery, Sleep Surgery Division Stanford University Medical Center Stanford California USA",NA
"34","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","Crawford","Julia","Department of Otolaryngology-Head &amp",NA
"35","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","D'Agostino","Mark A","Southern New England ENT New Haven Connecticut USA",NA
"36","34195378","10.1002/lio2.562","Virtual otolaryngologic management of sleep apnea patients: Lessons learned from COVID-19 pandemic.","To discuss the virtual management options and strategies learned during the COVID-19 pandemic for treatment of patients with sleep complaints and sleep disordered breathing presenting to the otolaryngologist. The addition of a virtual evaluation can be beneficial in assessing the patient presenting to the otolaryngologist with sleep complaints. With the implementation of telemedicine, validated subjective assessment tools, and a limited physical exam, patients can be triaged for the need for tre","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; obstructive sleep apnea; pandemic; telemedicine; virtual","Hoff","Paul","Department of Otolaryngology-Head and Neck Surgery University of Michigan Ann Arbor Michigan USA",NA
"37","34195375","10.1002/lio2.578","Impact of face masks in public spaces during COVID-19 pandemic on daily life communication of cochlear implant users.","Investigate potential problems in the daily life communication of cochlear implant (CI) patients due to the widespread use of face masks in public places during the COVID-19 pandemic. Prospective survey study. This study used an online questionnaire about the effects of face masks on daily life communication of adult CI users. The questionnaire consists of three parts: (a) A face mask questionnaire, (b) loneliness question (c) three subdomains of the Nijmegen Cochlear Implant Questionnaire to as","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","Covid19; cochlear implants; facemasks; hearing loss; quality of life","Homans","Nienke C","Department of Otorhinolaryngology and Head and Neck Surgery Erasmus MC Rotterdam The Netherlands",NA
"38","34195375","10.1002/lio2.578","Impact of face masks in public spaces during COVID-19 pandemic on daily life communication of cochlear implant users.","Investigate potential problems in the daily life communication of cochlear implant (CI) patients due to the widespread use of face masks in public places during the COVID-19 pandemic. Prospective survey study. This study used an online questionnaire about the effects of face masks on daily life communication of adult CI users. The questionnaire consists of three parts: (a) A face mask questionnaire, (b) loneliness question (c) three subdomains of the Nijmegen Cochlear Implant Questionnaire to as","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","Covid19; cochlear implants; facemasks; hearing loss; quality of life","Vroegop","Jantien L","Department of Otorhinolaryngology and Head and Neck Surgery Erasmus MC Rotterdam The Netherlands",NA
"39","34195366","10.1002/lio2.560","Tracheotomy in COVID-19 patients: A retrospective study on complications and timing.","The aim of this study was to analyze the timing of tracheotomy and the duration of mechanical ventilation and stay in the intensive care unit (ICU) in patients with COVID-19 infection. Furthermore, we aimed to investigate tracheotomy complications and mortality. Consecutive patients with COVID-19 infection admitted to the Department of Infectious Diseases in Gothenburg, Sweden were identified. Medical records were retrieved and retrospectively assessed. One hundred eighty-eight patients with COV","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; intensive care unit; pandemic; tracheotomy","Pauli","Nina","Department of Otorhinolaryngology Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital Gothenburg Sweden",NA
"40","34195366","10.1002/lio2.560","Tracheotomy in COVID-19 patients: A retrospective study on complications and timing.","The aim of this study was to analyze the timing of tracheotomy and the duration of mechanical ventilation and stay in the intensive care unit (ICU) in patients with COVID-19 infection. Furthermore, we aimed to investigate tracheotomy complications and mortality. Consecutive patients with COVID-19 infection admitted to the Department of Infectious Diseases in Gothenburg, Sweden were identified. Medical records were retrieved and retrospectively assessed. One hundred eighty-eight patients with COV","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; intensive care unit; pandemic; tracheotomy","Eeg-Olofsson","Måns","Department of Otorhinolaryngology Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital Gothenburg Sweden",NA
"41","34195366","10.1002/lio2.560","Tracheotomy in COVID-19 patients: A retrospective study on complications and timing.","The aim of this study was to analyze the timing of tracheotomy and the duration of mechanical ventilation and stay in the intensive care unit (ICU) in patients with COVID-19 infection. Furthermore, we aimed to investigate tracheotomy complications and mortality. Consecutive patients with COVID-19 infection admitted to the Department of Infectious Diseases in Gothenburg, Sweden were identified. Medical records were retrieved and retrospectively assessed. One hundred eighty-eight patients with COV","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; coronavirus; intensive care unit; pandemic; tracheotomy","Bergquist","Henrik","Department of Otorhinolaryngology Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital Gothenburg Sweden",NA
"42","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Sharma","Arun","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"43","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Bowman","Ryan","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"44","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Ettema","Sandra L","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"45","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Gregory","Stacie R","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"46","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Javadi","Pardis","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"47","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Johnson","Matthew D","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"48","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Butcher","Marissa L","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"49","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Mutua","Evans","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"50","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Stack","Brendan C","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"51","34195358","10.1002/lio2.552","Rapid telehealth implementation into an otolaryngology practice during the COVID-19 pandemic.","Report outcomes of rapid implementation of telehealth across an academic otolaryngology-head and neck surgery department during the COVID-19 pandemic. This is a retrospective, single-institution study of rapid deployment of telehealth during the COVID-19 pandemic. Characteristics of patients were compared between those who agreed and those who declined telehealth care. Reasons for declining telehealth visits were ascertained. Characteristics of telehealth visits were collected and patients were ","2021","07","02","Laryngoscope Investig Otolaryngol","Laryngoscope investigative otolaryngology","COVID-19; novel coronavirus; otolaryngology; telehealth","Crosby","Dana L","Department of Otolaryngology - Head and Neck Surgery Southern Illinois University School of Medicine Springfield Illinois USA",NA
"52","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Wikramanayake","Eric","WWF Asia-Pacific Counter-Illegal Wildlife Trade Hub (IWT Hub), WWF-Hong Kong, Kwai Chung, New Territories, Hong Kong SAR, PR China",NA
"53","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Pfeiffer","Dirk U","Centre for Applied One Health Research and Policy Advice, City University of Hong Kong, Kowloon, Hong Kong SAR, PR China",NA
"54","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Magouras","Ioannis","Centre for Applied One Health Research and Policy Advice, City University of Hong Kong, Kowloon, Hong Kong SAR, PR China",NA
"55","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Conan","Anne","Centre for Applied One Health Research and Policy Advice, City University of Hong Kong, Kowloon, Hong Kong SAR, PR China",NA
"56","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Ziegler","Stefan","WWF-Germany, Taunusanlage 8, 60329 Frankfurt/Main, Germany",NA
"57","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Bonebrake","Timothy C","Division for Ecology &amp",NA
"58","34195344","10.1016/j.onehlt.2021.100279","A tool for rapid assessment of wildlife markets in the Asia-Pacific Region for risk of future zoonotic disease outbreaks.","Decades of warnings that the trade and consumption of wildlife could result in serious zoonotic pandemics have gone largely unheeded. Now the world is ravaged by COVID-19, with tremendous loss of life, economic and societal disruption, and dire predictions of more destructive and frequent pandemics. There are now calls to tightly regulate and even enact complete wildlife trade bans, while others call for more nuanced approaches since many rural communities rely on wildlife for sustenance. Given ","2021","07","02","One Health","One health (Amsterdam, Netherlands)","Asia-Pacific; Ecology; OneHealth; Pandemic; Wildlife trade; Zoonoses","Olson","David","WWF Asia-Pacific Counter-Illegal Wildlife Trade Hub (IWT Hub), WWF-Hong Kong, Kwai Chung, New Territories, Hong Kong SAR, PR China",NA
"59","34195311","10.1016/j.dib.2021.107238","The dataset for the assessment of the inflammatory potential of the overall diet consumed by women of childbearing age.","The data presented in this article is related to the research article titled ""Racial differences in dietary choices and their relationship to inflammatory potential in childbearing age women at risk for exposure to COVID-19"". This data article provides details of dietary intake data from 509 women (African American, n = 327 and Caucasian American, n = 182) who are residents of Birmingham, AL. All women were characterized for demographic and lifestyle factors and indicators of exces","2021","07","02","Data Brief","Data in brief","Anti-inflammatory; Block food frequency questionnaire; Childbearing age; Dietary inflammatory score; Pro-inflammatory food items","Piyathilake","Chandrika J","Department of Nutrition Sciences, The University of Alabama at Birmingham, Birmingham, AL 35294, USA",NA
"60","34195311","10.1016/j.dib.2021.107238","The dataset for the assessment of the inflammatory potential of the overall diet consumed by women of childbearing age.","The data presented in this article is related to the research article titled ""Racial differences in dietary choices and their relationship to inflammatory potential in childbearing age women at risk for exposure to COVID-19"". This data article provides details of dietary intake data from 509 women (African American, n = 327 and Caucasian American, n = 182) who are residents of Birmingham, AL. All women were characterized for demographic and lifestyle factors and indicators of exces","2021","07","02","Data Brief","Data in brief","Anti-inflammatory; Block food frequency questionnaire; Childbearing age; Dietary inflammatory score; Pro-inflammatory food items","Badiga","Suguna","Department of Nutrition Sciences, The University of Alabama at Birmingham, Birmingham, AL 35294, USA",NA
"61","34195311","10.1016/j.dib.2021.107238","The dataset for the assessment of the inflammatory potential of the overall diet consumed by women of childbearing age.","The data presented in this article is related to the research article titled ""Racial differences in dietary choices and their relationship to inflammatory potential in childbearing age women at risk for exposure to COVID-19"". This data article provides details of dietary intake data from 509 women (African American, n = 327 and Caucasian American, n = 182) who are residents of Birmingham, AL. All women were characterized for demographic and lifestyle factors and indicators of exces","2021","07","02","Data Brief","Data in brief","Anti-inflammatory; Block food frequency questionnaire; Childbearing age; Dietary inflammatory score; Pro-inflammatory food items","Chappell","Ashley R","Department of Epidemiology, The University of Alabama at Birmingham, Birmingham, Al 35294, USA",NA
"62","34195311","10.1016/j.dib.2021.107238","The dataset for the assessment of the inflammatory potential of the overall diet consumed by women of childbearing age.","The data presented in this article is related to the research article titled ""Racial differences in dietary choices and their relationship to inflammatory potential in childbearing age women at risk for exposure to COVID-19"". This data article provides details of dietary intake data from 509 women (African American, n = 327 and Caucasian American, n = 182) who are residents of Birmingham, AL. All women were characterized for demographic and lifestyle factors and indicators of exces","2021","07","02","Data Brief","Data in brief","Anti-inflammatory; Block food frequency questionnaire; Childbearing age; Dietary inflammatory score; Pro-inflammatory food items","Johanning","Gary L","SunnyBay Biotech, Inc. Fremont, CA 94539, USA",NA
"63","34195311","10.1016/j.dib.2021.107238","The dataset for the assessment of the inflammatory potential of the overall diet consumed by women of childbearing age.","The data presented in this article is related to the research article titled ""Racial differences in dietary choices and their relationship to inflammatory potential in childbearing age women at risk for exposure to COVID-19"". This data article provides details of dietary intake data from 509 women (African American, n = 327 and Caucasian American, n = 182) who are residents of Birmingham, AL. All women were characterized for demographic and lifestyle factors and indicators of exces","2021","07","02","Data Brief","Data in brief","Anti-inflammatory; Block food frequency questionnaire; Childbearing age; Dietary inflammatory score; Pro-inflammatory food items","Jolly","Pauline E","Department of Epidemiology, The University of Alabama at Birmingham, Birmingham, Al 35294, USA",NA
"64","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Minhas","Anum S","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"65","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Gilotra","Nisha A","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"66","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Goerlich","Erin","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"67","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Metkus","Thomas","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"68","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Garibaldi","Brian T","Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"69","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Sharma","Garima","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"70","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Bavaro","Nicole","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"71","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Phillip","Susan","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"72","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Michos","Erin D","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"73","34195234","10.3389/fcvm.2021.667721","Myocardial Work Efficiency, A Novel Measure of Myocardial Dysfunction, Is Reduced in COVID-19 Patients and Associated With In-Hospital Mortality.","Background: Although troponin elevation is common in COVID-19, the extent of myocardial dysfunction and its contributors to dysfunction are less well-characterized. We aimed to determine the prevalence of subclinical myocardial dysfunction and its association with mortality using speckle tracking echocardiography (STE), specifically global longitudinal strain (GLS) and myocardial work efficiency (MWE). We also tested the hypothesis that reduced myocardial function was associated with incr","2021","07","02","Front Cardiovasc Med","Frontiers in cardiovascular medicine","COVID-19; echo; non-invasive; strain; ultrasoud diagnosis","Hays","Allison G","Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States",NA
"74","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Ma","Huijing","Imaging Center, Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Huazhong University of Science &amp",NA
"75","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Ye","Qinghao","Hangzhou Ocean's Smart Boya Co., Ltd, Hangzhou, China",NA
"76","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Ding","Weiping","School of Information Science and Technology, Nantong University, Nantong, China",NA
"77","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Jiang","Yinghui","Hangzhou Ocean's Smart Boya Co., Ltd, Hangzhou, China",NA
"78","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Wang","Minhao","Hangzhou Ocean's Smart Boya Co., Ltd, Hangzhou, China",NA
"79","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Niu","Zhangming","Mind Rank Ltd, Hong Kong, China",NA
"80","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Zhou","Xi","Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom",NA
"81","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Gao","Yuan","Department of Radiology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China",NA
"82","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Wang","Chengjia","British Heart Foundation (BHF) Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom",NA
"83","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Menpes-Smith","Wade","Aladdin Healthcare Technologies Ltd, London, United Kingdom",NA
"84","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Fang","Evandro Fei","Department of Clinical Molecular Biology, University of Oslo, Oslo, Norway",NA
"85","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Shao","Jianbo","COVID-19 Specialist Team, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science &amp",NA
"86","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Xia","Jun","Department of Radiology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China",NA
"87","34195215","10.3389/fmed.2021.699984","Can Clinical Symptoms and Laboratory Results Predict CT Abnormality? Initial Findings Using Novel Machine Learning Techniques in Children With COVID-19 Infections.","The rapid spread of coronavirus 2019 disease (COVID-19) has manifested a global public health crisis, and chest CT has been proven to be a powerful tool for screening, triage, evaluation and prognosis in COVID-19 patients. However, CT is not only costly but also associated with an increased incidence of cancer, in particular for children. This study will question whether clinical symptoms and laboratory results can predict the CT outcomes for the pediatric patients with positive RT-PCR testing r","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; RT-PCRpolymerase chain reaction with reverse transcription; artificial intelligence; decision trees; machine learning; pediatric","Yang","Guang","Cardiovascular Research Centre, Royal Brompton Hospital, London, United Kingdom",NA
"88","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Solanich","Xavier","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"89","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Antolí","Arnau","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"90","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Rocamora-Blanch","Gemma","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"91","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Padullés","Núria","Department of Pharmacy, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"92","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Fanlo-Maresma","Marta","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"93","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Iriarte","Adriana","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"94","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Mitjavila","Francesca","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"95","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Capdevila","Olga","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"96","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Riera-Mestre","Antoni","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"97","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Bas","Jordi","Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain",NA
"98","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Vicens-Zygmunt","Vanesa","Department of Pneumology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"99","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Niubó","Jordi","Department of Microbiology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"100","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Calvo","Nahum","Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"101","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Bolivar","Santiago","Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"102","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Rigo-Bonnin","Raúl","Department of Clinical Laboratory, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"103","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Mensa-Vilaró","Anna","Department of Immunology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain",NA
"104","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Arregui","Laura","HUB-ICO-IDIBELL Biobank, Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"105","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Tebe","Cristian","Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain",NA
"106","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Videla","Sebastià","Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain",NA
"107","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Hereu","Pilar","Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain",NA
"108","34195214","10.3389/fmed.2021.691712","Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.","Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, open-label, phase II trial with the aim to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus plus standard of care (SoC) vs. SoC alone, in hospitalized patients with severe COVID-19. The primary outcome was time to clinical stability within 56 days after randomi","2021","07","20","Front Med (Lausanne)","Frontiers in medicine","COVID-19; SARS-CoV-2; inflammation; lung injury; methylprednisolone; tacrolimus","Corbella","Xavier","Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain",NA
"109","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Long","Wei","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"110","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Yang","Jie","Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China",NA
"111","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Li","Zhengwei","Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"112","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Li","Jinpeng","Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"113","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Chen","Sichao","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"114","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Chen","Danyang","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"115","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Wang","Shipei","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"116","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Li","Qianqian","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"117","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Hu","Di","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"118","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Huang","Jianglong","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"119","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Zeng","Wen","Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"120","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Guo","Liang","Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"121","34195213","10.3389/fmed.2021.687220","Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study.","Purpose: The coronavirus disease (COVID-19) pandemic poses a global threat, and identification of its prognostic biomarkers could prove invaluable. Fibrinogen (FIB) could be one such indicator as coagulation and fibrinolysis abnormalities are common among COVID-19 patients. We examined the role of FIB levels in the prognosis of COVID-19. Methods: This retrospective cohort study enrolled 1,643 COVID-19 patients from the Leishenshan Hospital in Wuhan, China. The follow-up was conduct","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","COVID-19; clinical management; fibrinogen; prognostic indicators; retrospective study","Wu","Xiaohui","Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"122","34195209","10.3389/fmed.2021.666949","The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.","Background: This meta-analysis aimed to assess the prognostic value of hyponatremia in patients with COVID-19. Methods: We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Wiley up until January 26, 2021. The key exposure was hyponatremia, defined as sodium level below the reference level. The outcome of interest was poor outcome, which was a composite of mortality, severe COVID-19, and prolonged hospitalization. Severe COVID-19 was defined severe CAP ","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","coronavirusCOVID-19; critical; hyponatremia; mortality; severe; sodium","Akbar","Mohammad Rizki","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"123","34195209","10.3389/fmed.2021.666949","The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.","Background: This meta-analysis aimed to assess the prognostic value of hyponatremia in patients with COVID-19. Methods: We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Wiley up until January 26, 2021. The key exposure was hyponatremia, defined as sodium level below the reference level. The outcome of interest was poor outcome, which was a composite of mortality, severe COVID-19, and prolonged hospitalization. Severe COVID-19 was defined severe CAP ","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","coronavirusCOVID-19; critical; hyponatremia; mortality; severe; sodium","Pranata","Raymond","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"124","34195209","10.3389/fmed.2021.666949","The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.","Background: This meta-analysis aimed to assess the prognostic value of hyponatremia in patients with COVID-19. Methods: We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Wiley up until January 26, 2021. The key exposure was hyponatremia, defined as sodium level below the reference level. The outcome of interest was poor outcome, which was a composite of mortality, severe COVID-19, and prolonged hospitalization. Severe COVID-19 was defined severe CAP ","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","coronavirusCOVID-19; critical; hyponatremia; mortality; severe; sodium","Wibowo","Arief","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"125","34195209","10.3389/fmed.2021.666949","The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.","Background: This meta-analysis aimed to assess the prognostic value of hyponatremia in patients with COVID-19. Methods: We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Wiley up until January 26, 2021. The key exposure was hyponatremia, defined as sodium level below the reference level. The outcome of interest was poor outcome, which was a composite of mortality, severe COVID-19, and prolonged hospitalization. Severe COVID-19 was defined severe CAP ","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","coronavirusCOVID-19; critical; hyponatremia; mortality; severe; sodium","Irvan","Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia","34195209"
"126","34195209","10.3389/fmed.2021.666949","The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.","Background: This meta-analysis aimed to assess the prognostic value of hyponatremia in patients with COVID-19. Methods: We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Wiley up until January 26, 2021. The key exposure was hyponatremia, defined as sodium level below the reference level. The outcome of interest was poor outcome, which was a composite of mortality, severe COVID-19, and prolonged hospitalization. Severe COVID-19 was defined severe CAP ","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","coronavirusCOVID-19; critical; hyponatremia; mortality; severe; sodium","Sihite","Teddy Arnold","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"127","34195209","10.3389/fmed.2021.666949","The Prognostic Value of Hyponatremia for Predicting Poor Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.","Background: This meta-analysis aimed to assess the prognostic value of hyponatremia in patients with COVID-19. Methods: We performed a systematic literature search on PubMed, Scopus, ScienceDirect, and Wiley up until January 26, 2021. The key exposure was hyponatremia, defined as sodium level below the reference level. The outcome of interest was poor outcome, which was a composite of mortality, severe COVID-19, and prolonged hospitalization. Severe COVID-19 was defined severe CAP ","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","coronavirusCOVID-19; critical; hyponatremia; mortality; severe; sodium","Martha","Januar Wibawa","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"128","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Ghazanfari","Mona","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"129","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Arastehfar","Amir","Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, United States",NA
"130","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Davoodi","Lotfollah","Antimicrobial Resistance Research Center/Department of Infectious Diseases, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran",NA
"131","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Yazdani Charati","Jamshid","Department of Biostatistics, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran",NA
"132","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Moazeni","Maryam","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"133","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Abastabar","Mahdi","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"134","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Haghani","Iman","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"135","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Mirzakhani","Roghayeh","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"136","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Mayahi","Sabah","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"137","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Fang","Wenjie","Medical Mycology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China",NA
"138","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Liao","Wanqing","Medical Mycology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China",NA
"139","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Nguyen","M Hong","Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States",NA
"140","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Perlin","David S","Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, United States",NA
"141","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Hoenigl","Martin","Clinical and Translational Fungal-Working Group, University of California, San Diego, La Jolla, CA, United States",NA
"142","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Pan","Weihua","Medical Mycology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China",NA
"143","34195207","10.3389/fmed.2021.649675","Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.","Background: Recent studies from multiple countries have shown a high prevalence of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) among severely ill patients. Despite providing valuable insight into the clinical management of CAPA, large-scale prospective studies are limited. Here, we report on one of the largest multicenter epidemiological studies to explore the clinical features and prevalence of COVID-19-associated pulmonary mold infections (CAPMIs) among","2021","07","02","Front Med (Lausanne)","Frontiers in medicine","Aspergillus; COVID-19-associated pulmonary mold infections; Fusarium; galactomannan; mechanically ventilation","Hedayati","Mohammad T","Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran",NA
"144","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Arjmand","Babak","Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran",NA
"145","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Alavi-Moghadam","Sepideh","Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran",NA
"146","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Parhizkar Roudsari","Peyvand","Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran",NA
"147","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Rezaei-Tavirani","Mostafa","Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"148","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Rahim","Fakher","Health Research Institute, Thalassemia and Hemoglobinopathies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran",NA
"149","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Gilany","Kambiz","Reproductive Immunology Research Center, Avicenna Research Institute, The Academic Center for Education, Culture and Research (ACECR), Tehran, Iran",NA
"150","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Mohamadi-Jahani","Fereshteh","Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran",NA
"151","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Adibi","Hossein","Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran",NA
"152","34195193","10.3389/fcell.2021.675310","COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.","Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the diseas","2021","07","02","Front Cell Dev Biol","Frontiers in cell and developmental biology","coronavirus disease 2019; cytokine storm; mesenchymal stem cells; multi-organ failure; severe acute respiratory syndrome-coronavirus 2","Larijani","Bagher","Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran",NA
"153","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","Byrd-Williams","Courtney","Health Promotion and Behavioral Sciences, Michael &amp",NA
"154","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","Ewing","Mollie","Michael &amp",NA
"155","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","Rosenthal","E Lee","Department of Medical Education, Paul L. Foster School of Medicine, Texas Tech University Health Science Center, El Paso, TX, United States",NA
"156","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","St John","Julie Ann","Julia Jones Matthews Department of Public Health, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Abilene, TX, United States",NA
"157","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","Menking","Paige","University of New Mexico School of Medicine, Albuquerque, NM, United States",NA
"158","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","Redondo","Floribella","Arizona Community Health Workers Association, Yuma, AZ, United States",NA
"159","34195172","10.3389/fpubh.2021.689946","Training Needs of Community Health Workers Facing the COVID-19 Pandemic in Texas: A Cross-Sectional Study.","The COVID-19 pandemic has required the professional healthcare workforce not only to adjust methods of delivering care safely but also act as a trusted sources of information during a time of uncertainty and rapid research and discovery. The Community Health Worker COVID-19 Impact Survey is a cross-sectional study developed to better understand the impact of COVID-19 on this sector of the healthcare workforce, including training needs of those working through the pandemic. The survey was distrib","2021","07","05","Front Public Health","Frontiers in public health","COVID-19 pandemic response; Infectious disease preparedness; community health worker; education; workforce training needs; Arizona; COVID-19; Community Health Workers; Cross-Sectional Studies; Humans; New Mexico; Pandemics; SARS-CoV-2; Texas","Sieswerda","Stephanie","Michael &amp",NA
"160","34195171","10.3389/fpubh.2021.676750","So Few COVID-19 Cases in Taiwan: Has Population Immune Health Played a Role?",NA,"2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Taiwan; heath promotion; pandemic; public health; COVID-19; Humans; Population Health; SARS-CoV-2; Taiwan","Chiu","Wen-Ta","AHMC Health System, Alhambra, CA, United States",NA
"161","34195171","10.3389/fpubh.2021.676750","So Few COVID-19 Cases in Taiwan: Has Population Immune Health Played a Role?",NA,"2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Taiwan; heath promotion; pandemic; public health; COVID-19; Humans; Population Health; SARS-CoV-2; Taiwan","Scholl","Jeremiah","AESOP Technology, San Francisco, CA, United States",NA
"162","34195171","10.3389/fpubh.2021.676750","So Few COVID-19 Cases in Taiwan: Has Population Immune Health Played a Role?",NA,"2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Taiwan; heath promotion; pandemic; public health; COVID-19; Humans; Population Health; SARS-CoV-2; Taiwan","Li","Yu-Chuan Jack","College of Medical Science and Technology, Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei, Taiwan",NA
"163","34195171","10.3389/fpubh.2021.676750","So Few COVID-19 Cases in Taiwan: Has Population Immune Health Played a Role?",NA,"2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Taiwan; heath promotion; pandemic; public health; COVID-19; Humans; Population Health; SARS-CoV-2; Taiwan","Wu","Jonathan","AHMC Health System, Alhambra, CA, United States",NA
"164","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Assefa","Nega","College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"165","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Hassen","Jemal Yousuf","College of Agriculture and Environmental Sciences, Haramaya University, East Hararghe, Ethiopia",NA
"166","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Admassu","Desalegn","College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"167","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Brhane","Mussie","Hararghe Health Research Partnerships, Haramaya University, Harar, Ethiopia",NA
"168","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Deressa","Mersen","Hararghe Health Research Partnerships, Haramaya University, Harar, Ethiopia",NA
"169","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Marami","Dadi","College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"170","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Teklemariam","Zelalem","College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"171","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Dessie","Yadeta","College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia",NA
"172","34195170","10.3389/fpubh.2021.675553","COVID-19 Testing Experience in a Resource-Limited Setting: The Use of Existing Facilities in Public Health Emergency Management.","Introduction: Coronavirus disease 2019 (COVID-19) is a public health emergency with little testing and treatment experiences at its occurrence. Diagnostic and treatment rapidly changed in the world including Ethiopia. Haramaya University has strived to change its diagnostic capacity using existing facilities in response to the national call to the pandemic. Objective: This summary aims to detail experiences of setting up COVID-19 testing in Haramaya University laboratories, Eastern","2021","07","05","Front Public Health","Frontiers in public health","CAGED; COVID-19 testing; Ethiopia; HHR; Haramaya University; coronavirus; COVID-19; COVID-19 Testing; Ethiopia; Humans; Public Health; SARS-CoV-2","Oundo","Joseph","Hararghe Health Research Partnerships, Haramaya University, Harar, Ethiopia",NA
"173","34195169","10.3389/fpubh.2021.667729","Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems.","Background: The outbreak of COVID-19 has had a major impact on people's daily life. This study aimed to examine use of alcohol and addictive drugs during the COVID-19 outbreak in Norway and examine their association with mental health problems and problems related to the pandemic. Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and addictive drugs were cross-tabulated with sociodemographic variables, mental health problems, and problems related to COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; alcohol; pandemic; population survey; substance use; COVID-19; Depression; Disease Outbreaks; Humans; Mental Health; Norway; Pandemics; Pharmaceutical Preparations; SARS-CoV-2","Bonsaksen","Tore","Department of Health and Nursing Sciences, Faculty of Social and Health Sciences, Inland Norway University of Applied Sciences, Elverum, Norway",NA
"174","34195169","10.3389/fpubh.2021.667729","Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems.","Background: The outbreak of COVID-19 has had a major impact on people's daily life. This study aimed to examine use of alcohol and addictive drugs during the COVID-19 outbreak in Norway and examine their association with mental health problems and problems related to the pandemic. Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and addictive drugs were cross-tabulated with sociodemographic variables, mental health problems, and problems related to COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; alcohol; pandemic; population survey; substance use; COVID-19; Depression; Disease Outbreaks; Humans; Mental Health; Norway; Pandemics; Pharmaceutical Preparations; SARS-CoV-2","Ekeberg","Øivind","Psychosomatic and Consultation-Liaison Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway",NA
"175","34195169","10.3389/fpubh.2021.667729","Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems.","Background: The outbreak of COVID-19 has had a major impact on people's daily life. This study aimed to examine use of alcohol and addictive drugs during the COVID-19 outbreak in Norway and examine their association with mental health problems and problems related to the pandemic. Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and addictive drugs were cross-tabulated with sociodemographic variables, mental health problems, and problems related to COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; alcohol; pandemic; population survey; substance use; COVID-19; Depression; Disease Outbreaks; Humans; Mental Health; Norway; Pandemics; Pharmaceutical Preparations; SARS-CoV-2","Schou-Bredal","Inger","Faculty of Medicine, University of Oslo, Oslo, Norway",NA
"176","34195169","10.3389/fpubh.2021.667729","Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems.","Background: The outbreak of COVID-19 has had a major impact on people's daily life. This study aimed to examine use of alcohol and addictive drugs during the COVID-19 outbreak in Norway and examine their association with mental health problems and problems related to the pandemic. Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and addictive drugs were cross-tabulated with sociodemographic variables, mental health problems, and problems related to COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; alcohol; pandemic; population survey; substance use; COVID-19; Depression; Disease Outbreaks; Humans; Mental Health; Norway; Pandemics; Pharmaceutical Preparations; SARS-CoV-2","Skogstad","Laila","Department of Research, Sunnaas Rehabilitation Hospital HF, Bjørnemyr, Norway",NA
"177","34195169","10.3389/fpubh.2021.667729","Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems.","Background: The outbreak of COVID-19 has had a major impact on people's daily life. This study aimed to examine use of alcohol and addictive drugs during the COVID-19 outbreak in Norway and examine their association with mental health problems and problems related to the pandemic. Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and addictive drugs were cross-tabulated with sociodemographic variables, mental health problems, and problems related to COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; alcohol; pandemic; population survey; substance use; COVID-19; Depression; Disease Outbreaks; Humans; Mental Health; Norway; Pandemics; Pharmaceutical Preparations; SARS-CoV-2","Heir","Trond","Norwegian Center for Violence and Traumatic Stress Studies, Oslo, Norway",NA
"178","34195169","10.3389/fpubh.2021.667729","Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems.","Background: The outbreak of COVID-19 has had a major impact on people's daily life. This study aimed to examine use of alcohol and addictive drugs during the COVID-19 outbreak in Norway and examine their association with mental health problems and problems related to the pandemic. Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and addictive drugs were cross-tabulated with sociodemographic variables, mental health problems, and problems related to COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; alcohol; pandemic; population survey; substance use; COVID-19; Depression; Disease Outbreaks; Humans; Mental Health; Norway; Pandemics; Pharmaceutical Preparations; SARS-CoV-2","Grimholt","Tine K","Faculty of Health Studies, VID Specialized University, Oslo, Norway",NA
"179","34195168","10.3389/fpubh.2021.628211","The Epidemiological and Spatiotemporal Characteristics of the 2019 Novel Coronavirus Disease (COVID-19) in Libya.","COVID-19 is a global pandemic that has affected all aspects of life. Understanding its geographical and epidemiological characteristics has become particularly important in controlling the spread of the pandemic. Such studies are lacking in North African countries, particularly in Libya, which has the second largest area of any country in Africa and the longest coast facing Europe. The objectives of this study are to determine the epidemiological parameters and spatiotemporal patterns of COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Libya; dynamics; epidemiology; geography; spatiotemporal analysis; Adolescent; Adult; Africa; Africa, Northern; Aged; COVID-19; Child; Child, Preschool; Europe; Female; Humans; Libya; Male; Middle Aged; Pandemics; SARS-CoV-2; Young Adult","Daw","Mohamed A","Department of Medical Microbiology &amp",NA
"180","34195168","10.3389/fpubh.2021.628211","The Epidemiological and Spatiotemporal Characteristics of the 2019 Novel Coronavirus Disease (COVID-19) in Libya.","COVID-19 is a global pandemic that has affected all aspects of life. Understanding its geographical and epidemiological characteristics has become particularly important in controlling the spread of the pandemic. Such studies are lacking in North African countries, particularly in Libya, which has the second largest area of any country in Africa and the longest coast facing Europe. The objectives of this study are to determine the epidemiological parameters and spatiotemporal patterns of COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Libya; dynamics; epidemiology; geography; spatiotemporal analysis; Adolescent; Adult; Africa; Africa, Northern; Aged; COVID-19; Child; Child, Preschool; Europe; Female; Humans; Libya; Male; Middle Aged; Pandemics; SARS-CoV-2; Young Adult","El-Bouzedi","Abdallah H","Faculty of Biotechnology, University of Tripoli, Tripoli, Libya",NA
"181","34195168","10.3389/fpubh.2021.628211","The Epidemiological and Spatiotemporal Characteristics of the 2019 Novel Coronavirus Disease (COVID-19) in Libya.","COVID-19 is a global pandemic that has affected all aspects of life. Understanding its geographical and epidemiological characteristics has become particularly important in controlling the spread of the pandemic. Such studies are lacking in North African countries, particularly in Libya, which has the second largest area of any country in Africa and the longest coast facing Europe. The objectives of this study are to determine the epidemiological parameters and spatiotemporal patterns of COVID-1","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; Libya; dynamics; epidemiology; geography; spatiotemporal analysis; Adolescent; Adult; Africa; Africa, Northern; Aged; COVID-19; Child; Child, Preschool; Europe; Female; Humans; Libya; Male; Middle Aged; Pandemics; SARS-CoV-2; Young Adult","Ahmed","Mohamed O","Department of Medical Microbiology &amp",NA
"182","34195166","10.3389/fpubh.2021.604093","Short-Term Forecasting of Daily Confirmed COVID-19 Cases in Malaysia Using RF-SSA Model.","Novel coronavirus (COVID-19) was discovered in Wuhan, China in December 2019, and has affected millions of lives worldwide. On 29th April 2020, Malaysia reported more than 5,000 COVID-19 cases; the second highest in the Southeast Asian region after Singapore. Recently, a forecasting model was developed to measure and predict COVID-19 cases in Malaysia on daily basis for the next 10 days using previously-confirmed cases. A Recurrent Forecasting-Singular Spectrum Analysis (RF-SSA) is proposed by e","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; eigentriples; forecasting; recurrent forecasting; singular spectrum analysis; trend; window length; COVID-19; China; Humans; Malaysia; SARS-CoV-2; Singapore; Spectrum Analysis","Shaharudin","Shazlyn Milleana","Department of Mathematics, Faculty of Science and Mathematics, Universiti Pendidikan Sultan Idris, Tanjung Malim, Malaysia",NA
"183","34195166","10.3389/fpubh.2021.604093","Short-Term Forecasting of Daily Confirmed COVID-19 Cases in Malaysia Using RF-SSA Model.","Novel coronavirus (COVID-19) was discovered in Wuhan, China in December 2019, and has affected millions of lives worldwide. On 29th April 2020, Malaysia reported more than 5,000 COVID-19 cases; the second highest in the Southeast Asian region after Singapore. Recently, a forecasting model was developed to measure and predict COVID-19 cases in Malaysia on daily basis for the next 10 days using previously-confirmed cases. A Recurrent Forecasting-Singular Spectrum Analysis (RF-SSA) is proposed by e","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; eigentriples; forecasting; recurrent forecasting; singular spectrum analysis; trend; window length; COVID-19; China; Humans; Malaysia; SARS-CoV-2; Singapore; Spectrum Analysis","Ismail","Shuhaida","Data Analytics, Sciences &amp",NA
"184","34195166","10.3389/fpubh.2021.604093","Short-Term Forecasting of Daily Confirmed COVID-19 Cases in Malaysia Using RF-SSA Model.","Novel coronavirus (COVID-19) was discovered in Wuhan, China in December 2019, and has affected millions of lives worldwide. On 29th April 2020, Malaysia reported more than 5,000 COVID-19 cases; the second highest in the Southeast Asian region after Singapore. Recently, a forecasting model was developed to measure and predict COVID-19 cases in Malaysia on daily basis for the next 10 days using previously-confirmed cases. A Recurrent Forecasting-Singular Spectrum Analysis (RF-SSA) is proposed by e","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; eigentriples; forecasting; recurrent forecasting; singular spectrum analysis; trend; window length; COVID-19; China; Humans; Malaysia; SARS-CoV-2; Singapore; Spectrum Analysis","Hassan","Noor Artika","Department of Community Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, Malaysia",NA
"185","34195166","10.3389/fpubh.2021.604093","Short-Term Forecasting of Daily Confirmed COVID-19 Cases in Malaysia Using RF-SSA Model.","Novel coronavirus (COVID-19) was discovered in Wuhan, China in December 2019, and has affected millions of lives worldwide. On 29th April 2020, Malaysia reported more than 5,000 COVID-19 cases; the second highest in the Southeast Asian region after Singapore. Recently, a forecasting model was developed to measure and predict COVID-19 cases in Malaysia on daily basis for the next 10 days using previously-confirmed cases. A Recurrent Forecasting-Singular Spectrum Analysis (RF-SSA) is proposed by e","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; eigentriples; forecasting; recurrent forecasting; singular spectrum analysis; trend; window length; COVID-19; China; Humans; Malaysia; SARS-CoV-2; Singapore; Spectrum Analysis","Tan","Mou Leong","Geoinformatic Unit, Geography Section, School of Humanities, Universiti Sains Malaysia, Gelugor, Malaysia",NA
"186","34195166","10.3389/fpubh.2021.604093","Short-Term Forecasting of Daily Confirmed COVID-19 Cases in Malaysia Using RF-SSA Model.","Novel coronavirus (COVID-19) was discovered in Wuhan, China in December 2019, and has affected millions of lives worldwide. On 29th April 2020, Malaysia reported more than 5,000 COVID-19 cases; the second highest in the Southeast Asian region after Singapore. Recently, a forecasting model was developed to measure and predict COVID-19 cases in Malaysia on daily basis for the next 10 days using previously-confirmed cases. A Recurrent Forecasting-Singular Spectrum Analysis (RF-SSA) is proposed by e","2021","07","05","Front Public Health","Frontiers in public health","COVID-19; eigentriples; forecasting; recurrent forecasting; singular spectrum analysis; trend; window length; COVID-19; China; Humans; Malaysia; SARS-CoV-2; Singapore; Spectrum Analysis","Sulaiman","Nurul Ainina Filza","Department of Mathematics, Faculty of Science and Mathematics, Universiti Pendidikan Sultan Idris, Tanjung Malim, Malaysia",NA
"187","34195152","10.4103/jfmpc.jfmpc_2373_20","Essential role of communication to alleviate the COVID-19 Pandemic fear.",NA,"2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care",NA,"Singh","Ruchi","Department of Physiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India",NA
"188","34195152","10.4103/jfmpc.jfmpc_2373_20","Essential role of communication to alleviate the COVID-19 Pandemic fear.",NA,"2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care",NA,"Chouhan","Sunil","Department of Physiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India",NA
"189","34195152","10.4103/jfmpc.jfmpc_2373_20","Essential role of communication to alleviate the COVID-19 Pandemic fear.",NA,"2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care",NA,"Rai","Nirendra K","Department of Neurology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India",NA
"190","34195149","10.4103/jfmpc.jfmpc_2229_20","Dental nurse role in operatory during and post pandemic outbreak of COVID-19.",NA,"2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care",NA,"Sajja","Rishitha","Data Manager, Department of Research and Development, Bristol Myers Squibb, New Jersey, USA",NA
"191","34195147","10.4103/jfmpc.jfmpc_2271_20","Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: A case series.","Three independent cases of adult patients are described who had relative control of their type 2 diabetes prior to infection with COVID-19. Each of the described patients had different levels of severity of COVID-19 but all experienced significant and prolonged hyperglycemia for at least 1-2 months after resolution of their COVID-19 infection. Two of the three patients required intensifying insulin regimens for two months after COVID-19 infection. The case study helps to inform primary care prov","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; hyperglycemia; inflammation; type 2 diabetes","Downes","Jessica M","Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, OneWorld Community Health Centers, Inc., Omaha, Nebraska, USA",NA
"192","34195147","10.4103/jfmpc.jfmpc_2271_20","Prolonged hyperglycemia in three patients with type 2 diabetes after COVID-19 infection: A case series.","Three independent cases of adult patients are described who had relative control of their type 2 diabetes prior to infection with COVID-19. Each of the described patients had different levels of severity of COVID-19 but all experienced significant and prolonged hyperglycemia for at least 1-2 months after resolution of their COVID-19 infection. Two of the three patients required intensifying insulin regimens for two months after COVID-19 infection. The case study helps to inform primary care prov","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; hyperglycemia; inflammation; type 2 diabetes","Foster","Jennifer A","Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, OneWorld Community Health Centers, Inc., Omaha, Nebraska, USA",NA
"193","34195145","10.4103/jfmpc.jfmpc_2396_20","Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report.","Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease (COVID-19) pandemic has become the most important health-care crisis globally, having spread to millions of people worldwide. Patients who recover from COVID-19 are still susceptible to reinfection. In this report, we present the case of a patient who had recovered from COVID-19. Recovery was defined as the resolution of symptoms accompanied by two consecutive SARS-CoV-2-negative real-tim","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Duhok City; Kurdistan; reinfection case","Hussein","Nawfal R","College of Medicine, University of Zakho, Kurdistan Region, Iraq",NA
"194","34195145","10.4103/jfmpc.jfmpc_2396_20","Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report.","Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease (COVID-19) pandemic has become the most important health-care crisis globally, having spread to millions of people worldwide. Patients who recover from COVID-19 are still susceptible to reinfection. In this report, we present the case of a patient who had recovered from COVID-19. Recovery was defined as the resolution of symptoms accompanied by two consecutive SARS-CoV-2-negative real-tim","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Duhok City; Kurdistan; reinfection case","Musa","Dildar H","College of Medicine, University of Duhok, Kurdistan Region, Iraq",NA
"195","34195145","10.4103/jfmpc.jfmpc_2396_20","Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report.","Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease (COVID-19) pandemic has become the most important health-care crisis globally, having spread to millions of people worldwide. Patients who recover from COVID-19 are still susceptible to reinfection. In this report, we present the case of a patient who had recovered from COVID-19. Recovery was defined as the resolution of symptoms accompanied by two consecutive SARS-CoV-2-negative real-tim","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Duhok City; Kurdistan; reinfection case","Saleem","Zana Sidiq M","College of Medicine, University of Duhok, Kurdistan Region, Iraq",NA
"196","34195145","10.4103/jfmpc.jfmpc_2396_20","Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report.","Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease (COVID-19) pandemic has become the most important health-care crisis globally, having spread to millions of people worldwide. Patients who recover from COVID-19 are still susceptible to reinfection. In this report, we present the case of a patient who had recovered from COVID-19. Recovery was defined as the resolution of symptoms accompanied by two consecutive SARS-CoV-2-negative real-tim","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Duhok City; Kurdistan; reinfection case","Naqid","Ibrahim A","College of Medicine, University of Zakho, Kurdistan Region, Iraq",NA
"197","34195145","10.4103/jfmpc.jfmpc_2396_20","Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report.","Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease (COVID-19) pandemic has become the most important health-care crisis globally, having spread to millions of people worldwide. Patients who recover from COVID-19 are still susceptible to reinfection. In this report, we present the case of a patient who had recovered from COVID-19. Recovery was defined as the resolution of symptoms accompanied by two consecutive SARS-CoV-2-negative real-tim","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Duhok City; Kurdistan; reinfection case","Ibrahim","Nashwan","College of Medicine, University of Duhok, Kurdistan Region, Iraq",NA
"198","34195143","10.4103/jfmpc.jfmpc_2126_20","Post-COVID-19 pulmonary fibrosis: A case series and review of literature.","The most common lung problem faced by a post-COVID patient is lung fibrosis. Clinical recovery is generally complete in mild-to-moderately severe COVID-19 cases but a small proportion of patients with severe disease may go on to develop lung fibrosis. Patient groups at the highest risk to develop lung fibrosis are the elderly, especially those requiring ICU stay and mechanical ventilation. No definitive therapy for managing this pulmonary fibrosis exists as of date, even though various options a","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","ARDS; COVID-19; antifibrotic; lung fibrosis","Rai","Deependra K","Department of Pulmonary Medicine, AIIMS, Patna, Bihar, India",NA
"199","34195143","10.4103/jfmpc.jfmpc_2126_20","Post-COVID-19 pulmonary fibrosis: A case series and review of literature.","The most common lung problem faced by a post-COVID patient is lung fibrosis. Clinical recovery is generally complete in mild-to-moderately severe COVID-19 cases but a small proportion of patients with severe disease may go on to develop lung fibrosis. Patient groups at the highest risk to develop lung fibrosis are the elderly, especially those requiring ICU stay and mechanical ventilation. No definitive therapy for managing this pulmonary fibrosis exists as of date, even though various options a","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","ARDS; COVID-19; antifibrotic; lung fibrosis","Kumar","Subhash","Department of Radiology, AIIMS, Patna, Bihar, India",NA
"200","34195143","10.4103/jfmpc.jfmpc_2126_20","Post-COVID-19 pulmonary fibrosis: A case series and review of literature.","The most common lung problem faced by a post-COVID patient is lung fibrosis. Clinical recovery is generally complete in mild-to-moderately severe COVID-19 cases but a small proportion of patients with severe disease may go on to develop lung fibrosis. Patient groups at the highest risk to develop lung fibrosis are the elderly, especially those requiring ICU stay and mechanical ventilation. No definitive therapy for managing this pulmonary fibrosis exists as of date, even though various options a","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","ARDS; COVID-19; antifibrotic; lung fibrosis","Sahay","Nishant","Department of Anaesthesia, AIIMS, Patna, Bihar, India",NA
"201","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Menon","Unnikrishnan K","Department of Otorhinolaryngology, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"202","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Gopalakrishnan","Suja","Department of Physiology, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"203","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","N Unni","C Sumithra","Department of Biochemistry, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"204","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Ramachandran","Riju","Department of General Surgery, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"205","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Poornima","B","Department of Microbiology, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"206","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Sasidharan","Anu","Department of Forensic Medicine and Toxicology, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"207","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Ashika","M S","Department of Biochemistry, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"208","34195141","10.4103/jfmpc.jfmpc_2141_20","Pilot of a questionnaire study regarding perception of undergraduate medical students towards online classes: Process and perspectives.","The COVID-19 pandemic situation has forced a shift in medical education from physical classroom to virtual online teaching. However, students and teachers perceive this differently. It is important to study these perceptions to improve the teaching-learning process, and thus to validate the role of online learning in the country. To document the process of a pilot for a questionnaire-based study regarding perception of undergraduate medical students towards on-going online classes. Medical Educa","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Content validity; online learning; pilot study; questionnaire; sample size; undergraduate students","Radhakrishnan","Natasha","Department of Ophthalmology, All are Faculty of the Medical Education Department (MEU) of Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwavidyapeetham, Kerala, India",NA
"209","34195126","10.4103/jfmpc.jfmpc_2459_20","Knowledge, attitude and practice of health care professionals on laboratory diagnosis of COVID-19.","Coronavirus disease-2019 (COVID-19) is currently a global public health concern. Thorough knowledge of diagnostics of COVID-19 amongst health care professionals (HCPs) is critical for timely and accurate diagnosis. The aim of the study was to assess the knowledge, attitude, and practice among HCPs related to the laboratory diagnosis of COVID-19. In this cross-sectional study, participants completed a self-administered questionnaire on KAPs regarding COVID-19 laboratory diagnosis. Knowledge and p","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; SARS-CoV-2; healthcare worker; laboratory medicine; pandemic; public health","Mukhopadhyay","Tapasyapreeti","Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Centre, New Delhi, India",NA
"210","34195126","10.4103/jfmpc.jfmpc_2459_20","Knowledge, attitude and practice of health care professionals on laboratory diagnosis of COVID-19.","Coronavirus disease-2019 (COVID-19) is currently a global public health concern. Thorough knowledge of diagnostics of COVID-19 amongst health care professionals (HCPs) is critical for timely and accurate diagnosis. The aim of the study was to assess the knowledge, attitude, and practice among HCPs related to the laboratory diagnosis of COVID-19. In this cross-sectional study, participants completed a self-administered questionnaire on KAPs regarding COVID-19 laboratory diagnosis. Knowledge and p","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; SARS-CoV-2; healthcare worker; laboratory medicine; pandemic; public health","Relan","Jay","Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India",NA
"211","34195126","10.4103/jfmpc.jfmpc_2459_20","Knowledge, attitude and practice of health care professionals on laboratory diagnosis of COVID-19.","Coronavirus disease-2019 (COVID-19) is currently a global public health concern. Thorough knowledge of diagnostics of COVID-19 amongst health care professionals (HCPs) is critical for timely and accurate diagnosis. The aim of the study was to assess the knowledge, attitude, and practice among HCPs related to the laboratory diagnosis of COVID-19. In this cross-sectional study, participants completed a self-administered questionnaire on KAPs regarding COVID-19 laboratory diagnosis. Knowledge and p","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; SARS-CoV-2; healthcare worker; laboratory medicine; pandemic; public health","Subramanian","Arulselvi","Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Centre, New Delhi, India",NA
"212","34195126","10.4103/jfmpc.jfmpc_2459_20","Knowledge, attitude and practice of health care professionals on laboratory diagnosis of COVID-19.","Coronavirus disease-2019 (COVID-19) is currently a global public health concern. Thorough knowledge of diagnostics of COVID-19 amongst health care professionals (HCPs) is critical for timely and accurate diagnosis. The aim of the study was to assess the knowledge, attitude, and practice among HCPs related to the laboratory diagnosis of COVID-19. In this cross-sectional study, participants completed a self-administered questionnaire on KAPs regarding COVID-19 laboratory diagnosis. Knowledge and p","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; SARS-CoV-2; healthcare worker; laboratory medicine; pandemic; public health","Lathwal","Amit","Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India",NA
"213","34195115","10.4103/jfmpc.jfmpc_2252_20","Study to identify predictor of hypoxia in COVID-19 infection: A single-center, retrospective study.","Given the limited availability of critical care resources in our country, it is important to identify reliable predictors of hypoxia in patients with COVID-19 infection. We thus sought to compare differential predictive values of demographic, clinical, and laboratory measures and identify predictor for hypoxia in COVID-19 infection. This is single-center retrospective analysis of patient admitted at AIIMS Patna between 15<sup>th</sup> June and 15<sup>th</sup> Aug. All the patients who had oxygen","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Comorbidity; hypoxia; inflammatory marker","Rai","Deependra K","Department of Pulmonary Medicine, AIIMS Patna, Bihar, India",NA
"214","34195115","10.4103/jfmpc.jfmpc_2252_20","Study to identify predictor of hypoxia in COVID-19 infection: A single-center, retrospective study.","Given the limited availability of critical care resources in our country, it is important to identify reliable predictors of hypoxia in patients with COVID-19 infection. We thus sought to compare differential predictive values of demographic, clinical, and laboratory measures and identify predictor for hypoxia in COVID-19 infection. This is single-center retrospective analysis of patient admitted at AIIMS Patna between 15<sup>th</sup> June and 15<sup>th</sup> Aug. All the patients who had oxygen","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; Comorbidity; hypoxia; inflammatory marker","Thakur","Somesh","Department of Pulmonary Medicine, AIIMS Patna, Bihar, India",NA
"215","34195109","10.4103/jfmpc.jfmpc_2382_20","COVID-19 appropriate behavior in India: Time to invest for the benefits in future.","The COVID-19 pandemic gave an opportunity to adopt many appropriate changes in the behavior of the people in India. The major gears of those behavior changes were the enforcement by the government, fear, motivation (self and induced), and self-experiences or realizations with time. If those changes are fitted in the Trans-Theoretical Model, Indian people have passed through the ""Pre-Contemplation"" to ""Action"" stage of behavior changes during different phases of this pandemic. Frequent hand hygie","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Behavior; COVID-19; cough etiquettes; hand hygiene; physical distancing","Gupta","Manoj Kumar","Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India",NA
"216","34195109","10.4103/jfmpc.jfmpc_2382_20","COVID-19 appropriate behavior in India: Time to invest for the benefits in future.","The COVID-19 pandemic gave an opportunity to adopt many appropriate changes in the behavior of the people in India. The major gears of those behavior changes were the enforcement by the government, fear, motivation (self and induced), and self-experiences or realizations with time. If those changes are fitted in the Trans-Theoretical Model, Indian people have passed through the ""Pre-Contemplation"" to ""Action"" stage of behavior changes during different phases of this pandemic. Frequent hand hygie","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Behavior; COVID-19; cough etiquettes; hand hygiene; physical distancing","Bhardwaj","P","Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India",NA
"217","34195109","10.4103/jfmpc.jfmpc_2382_20","COVID-19 appropriate behavior in India: Time to invest for the benefits in future.","The COVID-19 pandemic gave an opportunity to adopt many appropriate changes in the behavior of the people in India. The major gears of those behavior changes were the enforcement by the government, fear, motivation (self and induced), and self-experiences or realizations with time. If those changes are fitted in the Trans-Theoretical Model, Indian people have passed through the ""Pre-Contemplation"" to ""Action"" stage of behavior changes during different phases of this pandemic. Frequent hand hygie","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Behavior; COVID-19; cough etiquettes; hand hygiene; physical distancing","Goel","A","Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India",NA
"218","34195109","10.4103/jfmpc.jfmpc_2382_20","COVID-19 appropriate behavior in India: Time to invest for the benefits in future.","The COVID-19 pandemic gave an opportunity to adopt many appropriate changes in the behavior of the people in India. The major gears of those behavior changes were the enforcement by the government, fear, motivation (self and induced), and self-experiences or realizations with time. If those changes are fitted in the Trans-Theoretical Model, Indian people have passed through the ""Pre-Contemplation"" to ""Action"" stage of behavior changes during different phases of this pandemic. Frequent hand hygie","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Behavior; COVID-19; cough etiquettes; hand hygiene; physical distancing","Saurabh","S","Department of Community Medicine and Family Medicine, AIIMS, Jodhpur, Rajasthan, India",NA
"219","34195109","10.4103/jfmpc.jfmpc_2382_20","COVID-19 appropriate behavior in India: Time to invest for the benefits in future.","The COVID-19 pandemic gave an opportunity to adopt many appropriate changes in the behavior of the people in India. The major gears of those behavior changes were the enforcement by the government, fear, motivation (self and induced), and self-experiences or realizations with time. If those changes are fitted in the Trans-Theoretical Model, Indian people have passed through the ""Pre-Contemplation"" to ""Action"" stage of behavior changes during different phases of this pandemic. Frequent hand hygie","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Behavior; COVID-19; cough etiquettes; hand hygiene; physical distancing","Misra","S","Department of Director and CEO, AIIMS, Jodhpur, Rajasthan, India",NA
"220","34195108","10.4103/jfmpc.jfmpc_2108_20","Role of radiology in RT-PCR negative COVID-19 pneumonia: Review and recommendations.","Currently, RT-PCR is the gold standard for diagnosing SARS-CoV-2 infection. However, due to the time-consuming laboratory tests and the low positivity rate of RT-PCR, it cannot be an ideal screening tool for infected population. In this review article, we have reviewed studies related to RT-PCR and CT chest and we would like to give our recommendations. Depending upon the patient's clinical symptoms and radiology imaging typical of viral pneumonia compatible with COVID-19 infection, clinicians n","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; CT; RT-PCR; negative","Sureka","Binit","Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, Rajasthan, India",NA
"221","34195108","10.4103/jfmpc.jfmpc_2108_20","Role of radiology in RT-PCR negative COVID-19 pneumonia: Review and recommendations.","Currently, RT-PCR is the gold standard for diagnosing SARS-CoV-2 infection. However, due to the time-consuming laboratory tests and the low positivity rate of RT-PCR, it cannot be an ideal screening tool for infected population. In this review article, we have reviewed studies related to RT-PCR and CT chest and we would like to give our recommendations. Depending upon the patient's clinical symptoms and radiology imaging typical of viral pneumonia compatible with COVID-19 infection, clinicians n","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; CT; RT-PCR; negative","Garg","Pawan Kumar","Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, Rajasthan, India",NA
"222","34195108","10.4103/jfmpc.jfmpc_2108_20","Role of radiology in RT-PCR negative COVID-19 pneumonia: Review and recommendations.","Currently, RT-PCR is the gold standard for diagnosing SARS-CoV-2 infection. However, due to the time-consuming laboratory tests and the low positivity rate of RT-PCR, it cannot be an ideal screening tool for infected population. In this review article, we have reviewed studies related to RT-PCR and CT chest and we would like to give our recommendations. Depending upon the patient's clinical symptoms and radiology imaging typical of viral pneumonia compatible with COVID-19 infection, clinicians n","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; CT; RT-PCR; negative","Saxena","Suvinay","Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, Rajasthan, India",NA
"223","34195108","10.4103/jfmpc.jfmpc_2108_20","Role of radiology in RT-PCR negative COVID-19 pneumonia: Review and recommendations.","Currently, RT-PCR is the gold standard for diagnosing SARS-CoV-2 infection. However, due to the time-consuming laboratory tests and the low positivity rate of RT-PCR, it cannot be an ideal screening tool for infected population. In this review article, we have reviewed studies related to RT-PCR and CT chest and we would like to give our recommendations. Depending upon the patient's clinical symptoms and radiology imaging typical of viral pneumonia compatible with COVID-19 infection, clinicians n","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; CT; RT-PCR; negative","Garg","Mahendra Kumar","Department of General Medicine, All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, Rajasthan, India",NA
"224","34195108","10.4103/jfmpc.jfmpc_2108_20","Role of radiology in RT-PCR negative COVID-19 pneumonia: Review and recommendations.","Currently, RT-PCR is the gold standard for diagnosing SARS-CoV-2 infection. However, due to the time-consuming laboratory tests and the low positivity rate of RT-PCR, it cannot be an ideal screening tool for infected population. In this review article, we have reviewed studies related to RT-PCR and CT chest and we would like to give our recommendations. Depending upon the patient's clinical symptoms and radiology imaging typical of viral pneumonia compatible with COVID-19 infection, clinicians n","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","COVID-19; CT; RT-PCR; negative","Misra","Sanjeev","Department of Director and Professor Surgical Oncology, All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, Rajasthan, India",NA
"225","34195107","10.4103/jfmpc.jfmpc_1754_20","Remdesivir - Current evidence &amp; perspective in management of COVID-19 infection.","Coronavirus infection or COVID 19 was first reported in December 2019 in Wuhan, China, and has rapidly spread to more than 200 countries. The pandemic has also taken a toll of over 2.2 million. But the elusive search for an effective antidote is still on. Pending multiple and robust randomized controlled studies, some drugs are being used globally based on in-vitro studies, in -vivo evidence, observational studies, and small nonrandomized studies. Remdesivir is a nucleotide analog. It inhibits v","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; pneumonia; remdesivir; severe disease; simple study","Bajpai","Jyoti","Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"226","34195107","10.4103/jfmpc.jfmpc_1754_20","Remdesivir - Current evidence &amp; perspective in management of COVID-19 infection.","Coronavirus infection or COVID 19 was first reported in December 2019 in Wuhan, China, and has rapidly spread to more than 200 countries. The pandemic has also taken a toll of over 2.2 million. But the elusive search for an effective antidote is still on. Pending multiple and robust randomized controlled studies, some drugs are being used globally based on in-vitro studies, in -vivo evidence, observational studies, and small nonrandomized studies. Remdesivir is a nucleotide analog. It inhibits v","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; pneumonia; remdesivir; severe disease; simple study","Kant","Surya","Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"227","34195107","10.4103/jfmpc.jfmpc_1754_20","Remdesivir - Current evidence &amp; perspective in management of COVID-19 infection.","Coronavirus infection or COVID 19 was first reported in December 2019 in Wuhan, China, and has rapidly spread to more than 200 countries. The pandemic has also taken a toll of over 2.2 million. But the elusive search for an effective antidote is still on. Pending multiple and robust randomized controlled studies, some drugs are being used globally based on in-vitro studies, in -vivo evidence, observational studies, and small nonrandomized studies. Remdesivir is a nucleotide analog. It inhibits v","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; pneumonia; remdesivir; severe disease; simple study","Pradhan","Akshyaya","Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"228","34195107","10.4103/jfmpc.jfmpc_1754_20","Remdesivir - Current evidence &amp; perspective in management of COVID-19 infection.","Coronavirus infection or COVID 19 was first reported in December 2019 in Wuhan, China, and has rapidly spread to more than 200 countries. The pandemic has also taken a toll of over 2.2 million. But the elusive search for an effective antidote is still on. Pending multiple and robust randomized controlled studies, some drugs are being used globally based on in-vitro studies, in -vivo evidence, observational studies, and small nonrandomized studies. Remdesivir is a nucleotide analog. It inhibits v","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","Coronavirus; pneumonia; remdesivir; severe disease; simple study","Verma","Ajay K","Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh, India",NA
"229","34195106","10.4103/jfmpc.jfmpc_1397_20","Exposure of second hand smoke in women and children: A narrative review.","Second-hand smoke is a neglected public health issue. Every year 1.2 million people die due to this exposure. Second-hand smoke is also related to various other diseases like cardiovascular diseases, lung diseases, low birth weight, maternal depression, etc. The purpose of this review is to look over various studies and to gain an understanding of existing research about second-hand smoke and its adverse effects. In addition, we tried to identify the barriers behind creating a smoke-free environ","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","<CopyrightInformation>Copyright: © 2021 Journal of Family Medicine and Primary Care.</CopyrightInformation></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Sharma</LastName><ForeName>Twinkle</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, AIIMS Rishikesh, Uttarakhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Khapre</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, AIIMS Rishikesh, Uttarakhand, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Family Med Prim Care</MedlineTA><NlmUniqueID>101610082</NlmUniqueID><ISSNLinking>2249-4863</ISSNLinking></MedlineJournalInfo><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">COVID-19; pregnancy; second-hand smoke; tobacco smokeCOVID-19","Sharma","Twinkle","Department of Community and Family Medicine, AIIMS Rishikesh, Uttarakhand, India",NA
"230","34195106","10.4103/jfmpc.jfmpc_1397_20","Exposure of second hand smoke in women and children: A narrative review.","Second-hand smoke is a neglected public health issue. Every year 1.2 million people die due to this exposure. Second-hand smoke is also related to various other diseases like cardiovascular diseases, lung diseases, low birth weight, maternal depression, etc. The purpose of this review is to look over various studies and to gain an understanding of existing research about second-hand smoke and its adverse effects. In addition, we tried to identify the barriers behind creating a smoke-free environ","2021","07","02","J Family Med Prim Care","Journal of family medicine and primary care","<CopyrightInformation>Copyright: © 2021 Journal of Family Medicine and Primary Care.</CopyrightInformation></Abstract><AuthorList CompleteYN=""Y""><Author ValidYN=""Y""><LastName>Sharma</LastName><ForeName>Twinkle</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, AIIMS Rishikesh, Uttarakhand, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=""Y""><LastName>Khapre</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community and Family Medicine, AIIMS Rishikesh, Uttarakhand, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=""D016428"">Journal Article</PublicationType><PublicationType UI=""D016454"">Review</PublicationType></PublicationTypeList><ArticleDate DateType=""Electronic""><Year>2021</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Family Med Prim Care</MedlineTA><NlmUniqueID>101610082</NlmUniqueID><ISSNLinking>2249-4863</ISSNLinking></MedlineJournalInfo><KeywordList Owner=""NOTNLM""><Keyword MajorTopicYN=""N"">COVID-19; pregnancy; second-hand smoke; tobacco smokeCOVID-19","Khapre","Meenakshi","Department of Community and Family Medicine, AIIMS Rishikesh, Uttarakhand, India",NA
"231","34195105","10.4103/jfmpc.jfmpc_950_21","Protecting national interest through public health policy - Why does India need to shift from selective primary health care (disease focused vertical programs) to a comprehensive health care model; lessons from COVID 19 pandemic!","The COVID virus and the pandemic are defying the general laws of epidemiology and virology. The pandemic shows how the economy can be crippled due to health care. Health is a key area which directly drives the economy. Incapacity in health policy leaves us vulnerable as a country. Global organizations and development partners have been too keen to lend technical help, policies, and procedures to India. Gone are the days when India used to receive any international funding in the health sector bu","2021","07","01","J Family Med Prim Care","Journal of family medicine and primary care","COVID I9; Comprehensive Primary Care; Health policy; National Interest of India; National Security; Selective Primary Care; Vertical Health Programs","Kumar","Raman","National President, Academy of Family Physicians of India",NA
"232","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","El Cheikh","Jean","Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon",NA
"233","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","El Warrak","Samantha","Cancer Research Institute, Department of Internal medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon",NA
"234","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Ghaoui","Nohra","Cancer Research Institute, Department of Internal medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon",NA
"235","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Al Chami","Farouk","Cancer Research Institute, Department of Internal medicine, Hematology/Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon",NA
"236","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Shahbaz","Maya","Faculty of Sciences, Lebanese University, Beirut, Lebanon",NA
"237","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Chehayeb","Sarah","Department of Nursing, Naef. K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon",NA
"238","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Saghir","Nagi","Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon",NA
"239","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Bazarbachi","Ali","Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon",NA
"240","34195088","10.3389/fonc.2021.685107","Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction.","The Coronavirus Disease 2019 (COVID-19) was declared a pandemic by WHO in March 2020. The first case of COVID-19 was identified in Lebanon on the 21<sup>st</sup> of February 2020, amid a national economic crisis. As the numbers of cases increased, ICU admissions and mortality rose, which led hospitals across Lebanon to take certain safety measures to contain the virus. The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center handles oncology outpatient visi","2021","07","02","Front Oncol","Frontiers in oncology","AUBMC; COVID-19; NKBCI; interventions; oncology; satisfaction","Taher","Ali","Division of Hematology/Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon",NA
"241","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Guha","Subhasish Kamal","Department of Tropical Medicine, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"242","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Biswas","Malabika","Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"243","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Gupta","Bishal","Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"244","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Acharya","Alisha","Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"245","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Halder","Supriya","Protozoology Unit, Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"246","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Saha","Bibhuti","Department of Tropical Medicine, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"247","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Chatterjee","Moytrey","Protozoology Unit, Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"248","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Kundu","Pratip Kumar","Director and Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"249","34195059","10.4103/tp.TP_105_20","A report on incidence of COVID-19 among febrile patients attending a malaria clinic.","Screening for malaria and coronavirus disease (COVID-19) in all patients with acute febrile illness is necessary in malaria-endemic areas to reduce malaria-related mortality and to prevent the transmission of COVID-19 by isolation. A pilot study was undertaken to determine the incidence of SARS-CoV-2 infection among febrile patients attending a malaria clinic. All patients were tested for malaria parasite by examining thick and thin blood smears as well as by rapid malaria antigen tests. COVID-1","2021","07","02","Trop Parasitol","Tropical parasitology","COVID-19; COVID-malaria coinfection; India; Plasmodium falciparum; Plasmodium vivax","Maji","Ardhendu Kumar","Protozoology Unit, Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India",NA
"250","34195053","10.4103/tp.tp_12_21","Molecular diagnosis of infectious parasites in the post-COVID-19 era.","The endemicity of several parasitic diseases across the globe and recent evidence of distress among COVID-19 patients with preexisting parasitic infections requires strengthening One Health framework and advanced strategies for parasitic detection. Owing to the greater sensitivity and accuracy, molecular technologies such as conventional polymerase chain reaction (PCR), reverse transcription (RT)-PCR, nested PCR, loop-mediated isothermal amplification (LAMP), and xMAP technology have been extens","2021","07","02","Trop Parasitol","Tropical parasitology","Molecular diagnosis; parasites; post-COVID-19; zoonotic disease","Parija","Subhash Chandra","Vice Chancellor, Sri Balaji Vidyapeeth University, Puducherry, India",NA
"251","34195053","10.4103/tp.tp_12_21","Molecular diagnosis of infectious parasites in the post-COVID-19 era.","The endemicity of several parasitic diseases across the globe and recent evidence of distress among COVID-19 patients with preexisting parasitic infections requires strengthening One Health framework and advanced strategies for parasitic detection. Owing to the greater sensitivity and accuracy, molecular technologies such as conventional polymerase chain reaction (PCR), reverse transcription (RT)-PCR, nested PCR, loop-mediated isothermal amplification (LAMP), and xMAP technology have been extens","2021","07","02","Trop Parasitol","Tropical parasitology","Molecular diagnosis; parasites; post-COVID-19; zoonotic disease","Poddar","Abhijit","Scientist, Sri Balaji Vidyapeeth University, Puducherry, India",NA
"252","34195051","10.34172/hpp.2021.32","A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.","CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythr","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID; CoronoVac; Psoriasis","Onsun","Nahide","Department of Dermatology and Venereology, Bezmialem Vakif University, Istanbul, Turkey",NA
"253","34195051","10.34172/hpp.2021.32","A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.","CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythr","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID; CoronoVac; Psoriasis","Kaya","Gökhan","Department of Dermatology and Venereology, Bezmialem Vakif University, Istanbul, Turkey",NA
"254","34195051","10.34172/hpp.2021.32","A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.","CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythr","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID; CoronoVac; Psoriasis","Isik","Bengisu Güçkan","Department of Dermatology and Venereology, Bezmialem Vakif University, Istanbul, Turkey",NA
"255","34195051","10.34172/hpp.2021.32","A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report.","CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythr","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID; CoronoVac; Psoriasis","Günes","Begüm","Department of Dermatology and Venereology, Bezmialem Vakif University, Istanbul, Turkey",NA
"256","34195049","10.34172/hpp.2021.30","A remotely-delivered community action project to promote a diabetes lifestyle intervention programme in northwest London: basis, process and outcomes.","Background : The prevalence of type 2 diabetes mellitus (T2DM) in London is rising, obesity being a major driver. As part of a primary care placement, the authors (two medical students and a lead general practitioner) directly promoted the Reducing Weight with Intensive Dietary Support (REWIND) programme to patients in Northwest London and collected feedback on the promotion. Methods : The team developed and delivered three remote interventions: a redesigned patient-facing informat","2021","07","02","Health Promot Perspect","Health promotion perspectives","Community medicine; Health education; Health promotion; Type 2 diabetes mellitus","Kapadia","Sharan J","Imperial College School of Medicine, London, UK",NA
"257","34195049","10.34172/hpp.2021.30","A remotely-delivered community action project to promote a diabetes lifestyle intervention programme in northwest London: basis, process and outcomes.","Background : The prevalence of type 2 diabetes mellitus (T2DM) in London is rising, obesity being a major driver. As part of a primary care placement, the authors (two medical students and a lead general practitioner) directly promoted the Reducing Weight with Intensive Dietary Support (REWIND) programme to patients in Northwest London and collected feedback on the promotion. Methods : The team developed and delivered three remote interventions: a redesigned patient-facing informat","2021","07","02","Health Promot Perspect","Health promotion perspectives","Community medicine; Health education; Health promotion; Type 2 diabetes mellitus","Gao","Yu","Imperial College School of Medicine, London, UK",NA
"258","34195049","10.34172/hpp.2021.30","A remotely-delivered community action project to promote a diabetes lifestyle intervention programme in northwest London: basis, process and outcomes.","Background : The prevalence of type 2 diabetes mellitus (T2DM) in London is rising, obesity being a major driver. As part of a primary care placement, the authors (two medical students and a lead general practitioner) directly promoted the Reducing Weight with Intensive Dietary Support (REWIND) programme to patients in Northwest London and collected feedback on the promotion. Methods : The team developed and delivered three remote interventions: a redesigned patient-facing informat","2021","07","02","Health Promot Perspect","Health promotion perspectives","Community medicine; Health education; Health promotion; Type 2 diabetes mellitus","Cumming","Ewa","Eastbury Surgery, Northwood, London, UK",NA
"259","34195047","10.34172/hpp.2021.28","Online assessment of the perception of loneliness and associated factors in Colombian climacteric women during the COVID-19 pandemic: A cross-sectional study.","Background: The coronavirus disease 2019 (COVID-19) pandemic has generated changes due to confinement, this measure can increase the perception of loneliness. The objective was to estimate the frequencies of emotional, social and general loneliness and their association with fear and anxiety with COVID-19, religiosity and severe deterioration of quality of life in middle-aged women. Methods: A cross-sectional study in Colombian women (40-59 y, n=984) surveyed with an electronic for","2021","07","02","Health Promot Perspect","Health promotion perspectives","Anxiety; COVID-19; Climacteric; Fear; Loneliness; Mental health; Middle aged; Pandemics; Quality of life","Monterrosa-Blanco","Angélica","Health Sciences University Foundation (FUCS), Women's Health Research Group, Faculty of Medicine, University of Cartagena, Cartagena, Colombia",NA
"260","34195047","10.34172/hpp.2021.28","Online assessment of the perception of loneliness and associated factors in Colombian climacteric women during the COVID-19 pandemic: A cross-sectional study.","Background: The coronavirus disease 2019 (COVID-19) pandemic has generated changes due to confinement, this measure can increase the perception of loneliness. The objective was to estimate the frequencies of emotional, social and general loneliness and their association with fear and anxiety with COVID-19, religiosity and severe deterioration of quality of life in middle-aged women. Methods: A cross-sectional study in Colombian women (40-59 y, n=984) surveyed with an electronic for","2021","07","02","Health Promot Perspect","Health promotion perspectives","Anxiety; COVID-19; Climacteric; Fear; Loneliness; Mental health; Middle aged; Pandemics; Quality of life","Monterrosa-Castro","Álvaro","Research Department, Women's Health Research Group. Faculty of Medicine, University of Cartagena, Cartagena, Colombia",NA
"261","34195047","10.34172/hpp.2021.28","Online assessment of the perception of loneliness and associated factors in Colombian climacteric women during the COVID-19 pandemic: A cross-sectional study.","Background: The coronavirus disease 2019 (COVID-19) pandemic has generated changes due to confinement, this measure can increase the perception of loneliness. The objective was to estimate the frequencies of emotional, social and general loneliness and their association with fear and anxiety with COVID-19, religiosity and severe deterioration of quality of life in middle-aged women. Methods: A cross-sectional study in Colombian women (40-59 y, n=984) surveyed with an electronic for","2021","07","02","Health Promot Perspect","Health promotion perspectives","Anxiety; COVID-19; Climacteric; Fear; Loneliness; Mental health; Middle aged; Pandemics; Quality of life","González-Sequeda","Andrea","Women's Health Research Group, Faculty of Medicine, University of Cartagena, Cartagena, Colombia",NA
"262","34195043","10.34172/hpp.2021.24","Conceptualization of college students' COVID-19 related mask-wearing behaviors using the Multi-Theory Model of health behavior change.","Background: Recommendations and policies, regarding the use of face coverings, have been instituted to control transmission of coronavirus disease 2019 (COVID-19). Understanding of psychosocial factors related to the use of face coverings within the context of COVID-19 is needed. This study aimed to conceptualize mask-wearing behavior among students using the Multi-theory Model (MTM) of behavior change. Methods: In October 2020, students (n = 595) enrolled in a large public southea","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Face mask guidelines; Policy; Social environment; University","Davis","Robert E","Substance Use and Mental Health Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, 155 N Stadium Drive, HPER 308, Fayetteville, AR 72701, USA",NA
"263","34195043","10.34172/hpp.2021.24","Conceptualization of college students' COVID-19 related mask-wearing behaviors using the Multi-Theory Model of health behavior change.","Background: Recommendations and policies, regarding the use of face coverings, have been instituted to control transmission of coronavirus disease 2019 (COVID-19). Understanding of psychosocial factors related to the use of face coverings within the context of COVID-19 is needed. This study aimed to conceptualize mask-wearing behavior among students using the Multi-theory Model (MTM) of behavior change. Methods: In October 2020, students (n = 595) enrolled in a large public southea","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Face mask guidelines; Policy; Social environment; University","Sharma","Manoj","Social and Behavioral Health, Department of Environmental &amp",NA
"264","34195043","10.34172/hpp.2021.24","Conceptualization of college students' COVID-19 related mask-wearing behaviors using the Multi-Theory Model of health behavior change.","Background: Recommendations and policies, regarding the use of face coverings, have been instituted to control transmission of coronavirus disease 2019 (COVID-19). Understanding of psychosocial factors related to the use of face coverings within the context of COVID-19 is needed. This study aimed to conceptualize mask-wearing behavior among students using the Multi-theory Model (MTM) of behavior change. Methods: In October 2020, students (n = 595) enrolled in a large public southea","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Face mask guidelines; Policy; Social environment; University","Simon","Kayla E","Substance Use and Mental Health Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, 155 N Stadium Drive, HPER 308, Fayetteville, AR 72701, USA",NA
"265","34195043","10.34172/hpp.2021.24","Conceptualization of college students' COVID-19 related mask-wearing behaviors using the Multi-Theory Model of health behavior change.","Background: Recommendations and policies, regarding the use of face coverings, have been instituted to control transmission of coronavirus disease 2019 (COVID-19). Understanding of psychosocial factors related to the use of face coverings within the context of COVID-19 is needed. This study aimed to conceptualize mask-wearing behavior among students using the Multi-theory Model (MTM) of behavior change. Methods: In October 2020, students (n = 595) enrolled in a large public southea","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Face mask guidelines; Policy; Social environment; University","Wilkerson","Amanda H","Department of Human Environmental Sciences, University of Alabama, 481 Russell Hall, Box 8 70311, Tuscaloosa, AL, 35487, USA",NA
"266","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Johnson","Kemmian D","Department of Internal Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Ave Suite 436 New Orleans, LA 70112, USA",NA
"267","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Akingbola","Oluwatomi","School of Medicine, Tulane University, 1430 Tulane Ave, New Orleans, LA 70112",NA
"268","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Anderson","Jessica","School of Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Ave Suite 436 New Orleans, LA 70112, USA",NA
"269","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Hart","Jennifer","Department of Internal Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Ave Suite 436 New Orleans, LA 70112, USA",NA
"270","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Chapple","Andrew","School of Public Health, Biostatistics, Louisiana State University Health Sciences Center, 1542 Tulane Ave Suite 436 New Orleans, LA 70112, USA",NA
"271","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Woods","Che'la","Rosalind Franklin University of Medicine and Science- Chicago Medical School, 3333 Green Bay Rd, North Chicago, IL 60064, USA",NA
"272","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","Yeary","Karen","Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets Buffalo, NY 14263",NA
"273","34195041","10.34172/hpp.2021.22","Combatting a ""Twin-demic"": A quantitative assessment of COVID-19 and influenza vaccine hesitancy in primary care patients.","Background: Public health officials anticipate severe health outcomes amidst the circulation of two major viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza. This study investigated intent to be vaccinated against COVID-19 and influenza, and sought to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: This observational cross-sectional study was conducted in the Louisiana State University Medicine Clinic from September","2021","07","02","Health Promot Perspect","Health promotion perspectives","2019 Novel coronavirus vaccine; COVID-19; COVID-19 vaccines; Influenza vaccine; Public health","McLean","Angela","Department of Internal Medicine, Louisiana State University Health Sciences Center, 1542 Tulane Ave Suite 436 New Orleans, LA 70112, USA",NA
"274","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Asadi Faezi","Nasim","Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"275","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Gholizadeh","Pourya","Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"276","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Sanogo","Moussa","Faculty of Pharmacy USTTB, Faculty of Medicine and Odonto Stomatology, University of Science, Technics and Technology of Bamako, Bamako, Mali",NA
"277","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Oumarou","Amadou","Faculte des sciences la santé de l universite Dan Dicko DanKoulodo de Maradi, Niger",NA
"278","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Mohamed","Maad Nasser","Service des maladies infectieuses et tropicales de l'hôpital général peltier, Djibouti",NA
"279","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Cissoko","Yacouba","Faculty of Medicine and Odonto Stomatology (FMOS), USTTB, University of Science, Technics and Technology of Bamako, Bamako, Mali",NA
"280","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Saliou Sow","Mamadou","Service des Maladies Infectieuses, Hôpital National Donka, CHU Conakry, Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Guinea",NA
"281","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Keita","Bakary Sayon","Department of Medicine and Medical Specialities/Infectious Disease Unit of Fousseyni Daou Hospital, Kayes, Mali",NA
"282","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Baye","Youssouf Ag Mohamed","Faculty of Medicine and Odonto Stomatology (FMOS), USTTB, University of Science, Technics and Technology of Bamako, Bamako, Mali",NA
"283","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Pagliano","Pasquale","Departement of Medicine, University of Salerno, Salerno, Italy",NA
"284","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Akouda","Patassi","CHU Sylvanus Olympio, Universitie delome, Togo",NA
"285","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Soufiane","Sid'Ahmed","Faculte de Medecine de Nouakchott, Muritanie",NA
"286","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Iknane","Akory Ag","Faculty of Medicine and Odonto Stomatology (FMOS), USTTB, University of Science, Technics and Technology of Bamako, Bamako, Mali",NA
"287","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Safiatou Diallo","Mamadou Oury","Service des Maladies Infectieuses, Hôpital National Donka, CHU Conakry, Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Guinea",NA
"288","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Gansane","Zakaria","Burkinabé Observatory for Healthcare Quality and Safety, Ouagadougou, Burkina Faso",NA
"289","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Ali Khan","Barkat","Department of Pharmaceutics, Faculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan",NA
"290","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Köse","Sükran","Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Tepecik Training and Research Hospital, Izmir, Turkey",NA
"291","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Allahverdipour","Hamid","Research Center of Psychiatry and Behavioural Sciences and Department of Health Education and Promotion, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"292","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Ganvarov","Khudaverdi","Department of Microbiology, Baku State University, Baku, Azerbaijan",NA
"293","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Soumaré","Mariam","Faculty of Medicine and Odonto Stomatology (FMOS), USTTB, University of Science, Technics and Technology of Bamako, Bamako, Mali",NA
"294","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Asgharzadeh","Mohammad","Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"295","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Dao","Sounkalo","Faculty of Medicine and Odonto Stomatology (FMOS), USTTB, University of Science, Technics and Technology of Bamako, Bamako, Mali",NA
"296","34195040","10.34172/hpp.2021.21","Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.","Background: To end the COVID-19 pandemic, a large part of the world must be immune to the virus by vaccination. Therefore, this study aimed to gauge intent to be vaccinated against COVID-19 among ordinary people and to identify attitudes towards vaccines and barriers for vaccine acceptance. Methods: The study population comprises 1880 people residing in different countries that answer a prepared questionnaire. The questionnaire topics are demographics, historical issues, participan","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; SARS-CoV-2; Surveys and Questionnaires; Vaccination","Samadi Kafil","Hossein","Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"297","34195037","10.34172/hpp.2021.18","Risk communication and community engagement strategies for COVID-19 in 13 African countries.","Background: Coronavirus disease 2019 (COVID-19) outbreak is a major threat facing health systems globally and African countries are not an exception. Stakeholders, governments, and national authorities have mounted responses to contain the pandemic. This study aimed to catalogue the risk communication and community engagement (RCCE) strategies as well as the challenges facing RCCE in 13 African countries. Methods: We conducted a narrative review of evidence to answer the aim of the","2021","07","02","Health Promot Perspect","Health promotion perspectives","Africa; COVID-19; Community engagement; Responses; Risk communication","Adebisi","Yusuff Adebayo","Global Health Focus, London, United Kingdom",NA
"298","34195037","10.34172/hpp.2021.18","Risk communication and community engagement strategies for COVID-19 in 13 African countries.","Background: Coronavirus disease 2019 (COVID-19) outbreak is a major threat facing health systems globally and African countries are not an exception. Stakeholders, governments, and national authorities have mounted responses to contain the pandemic. This study aimed to catalogue the risk communication and community engagement (RCCE) strategies as well as the challenges facing RCCE in 13 African countries. Methods: We conducted a narrative review of evidence to answer the aim of the","2021","07","02","Health Promot Perspect","Health promotion perspectives","Africa; COVID-19; Community engagement; Responses; Risk communication","Rabe","Adrian","Global Health Focus, London, United Kingdom",NA
"299","34195037","10.34172/hpp.2021.18","Risk communication and community engagement strategies for COVID-19 in 13 African countries.","Background: Coronavirus disease 2019 (COVID-19) outbreak is a major threat facing health systems globally and African countries are not an exception. Stakeholders, governments, and national authorities have mounted responses to contain the pandemic. This study aimed to catalogue the risk communication and community engagement (RCCE) strategies as well as the challenges facing RCCE in 13 African countries. Methods: We conducted a narrative review of evidence to answer the aim of the","2021","07","02","Health Promot Perspect","Health promotion perspectives","Africa; COVID-19; Community engagement; Responses; Risk communication","Lucero-Prisno Iii","Don Eliseo","Global Health Focus, London, United Kingdom",NA
"300","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Ebrahimzadeh-Attari","Vahideh","Department of Nutrition and Food Sciences, Maragheh University of Medical Sciences, Margheh, Iran",NA
"301","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Panahi","Ghodratollah","Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran",NA
"302","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Hebert","James R","Department of Epidemiology &amp",NA
"303","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Ostadrahimi","Alireza","Nutrition Research Center, Department of Clinical Nutrition, Faculty of Nutrition &amp",NA
"304","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Saghafi-Asl","Maryam","Nutrition Research Center, Department of Clinical Nutrition, Faculty of Nutrition &amp",NA
"305","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Lotfi-Yaghin","Neda","Student Research Committee, Department of Clinical Nutrition, Faculty of Nutrition &amp",NA
"306","34195036","10.34172/hpp.2021.17","Nutritional approach for increasing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.","Background: The novel coronavirus (COVID-19) is considered as the most life-threatening pandemic disease during the last decade. The individual nutritional status, though usually ignored in the management of COVID-19, plays a critical role in the immune function and pathogenesis of infection. Accordingly, the present review article aimed to report the effects of nutrients and nutraceuticals on respiratory viral infections including COVID-19, with a focus on their mechanisms of action. ","2021","07","02","Health Promot Perspect","Health promotion perspectives","COVID-19; Coronavirus; Electrolytes; Energy intake; Fatty acids; Immunity; Minerals; Omega-3 Vitamins; Proteins; Vitamins","Baradaran","Behzad","Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran",NA
"307","34195034","10.34172/hpp.2021.15","COVID-19 highlights health inequalities in individuals from black and minority ethnic backgrounds within the United Kingdom.",NA,"2021","07","02","Health Promot Perspect","Health promotion perspectives",NA,"Wheatle","Monique","Birmingham Medical School, University of Birmingham, Birmingham, UK",NA
"308","34194998","10.1016/j.idcr.2021.e01179","A curious case of Lyme carditis in an urban hospital.","Lyme carditis (LC), a manifestation of early disseminated Lyme disease, most commonly presents with cardiac conduction abnormalities. It is a transient condition with good prognosis but in extremely rare cases may be life-threatening. We describe a 42-year-old man who presented with progressively worsening generalized weakness, presyncope and dyspnea on exertion for 2 weeks after sustaining a tick bite. He subsequently developed a 'bull's eye rash' on his flank 2 days before his presentation. He","2021","07","02","IDCases","IDCases","AV, atrioventricular; Cardiology; ECG, electrocardiogram; High-grade AV block; IV, intravenous; Infectious diseases; LC, Lyme carditis; LD, Lyme disease; Lyme carditis; MS, millisecond; Transvenous pacemaker","Brissett","Shantel","Department of Internal Medicine, NYC Health &amp",NA
"309","34194998","10.1016/j.idcr.2021.e01179","A curious case of Lyme carditis in an urban hospital.","Lyme carditis (LC), a manifestation of early disseminated Lyme disease, most commonly presents with cardiac conduction abnormalities. It is a transient condition with good prognosis but in extremely rare cases may be life-threatening. We describe a 42-year-old man who presented with progressively worsening generalized weakness, presyncope and dyspnea on exertion for 2 weeks after sustaining a tick bite. He subsequently developed a 'bull's eye rash' on his flank 2 days before his presentation. He","2021","07","02","IDCases","IDCases","AV, atrioventricular; Cardiology; ECG, electrocardiogram; High-grade AV block; IV, intravenous; Infectious diseases; LC, Lyme carditis; LD, Lyme disease; Lyme carditis; MS, millisecond; Transvenous pacemaker","Myint","Khaing T","Division of Infectious Diseases, NYC Health &amp",NA
"310","34194998","10.1016/j.idcr.2021.e01179","A curious case of Lyme carditis in an urban hospital.","Lyme carditis (LC), a manifestation of early disseminated Lyme disease, most commonly presents with cardiac conduction abnormalities. It is a transient condition with good prognosis but in extremely rare cases may be life-threatening. We describe a 42-year-old man who presented with progressively worsening generalized weakness, presyncope and dyspnea on exertion for 2 weeks after sustaining a tick bite. He subsequently developed a 'bull's eye rash' on his flank 2 days before his presentation. He","2021","07","02","IDCases","IDCases","AV, atrioventricular; Cardiology; ECG, electrocardiogram; High-grade AV block; IV, intravenous; Infectious diseases; LC, Lyme carditis; LD, Lyme disease; Lyme carditis; MS, millisecond; Transvenous pacemaker","Lopez","Yanira","Department of Emergency Medicine, NYC Health &amp",NA
"311","34194998","10.1016/j.idcr.2021.e01179","A curious case of Lyme carditis in an urban hospital.","Lyme carditis (LC), a manifestation of early disseminated Lyme disease, most commonly presents with cardiac conduction abnormalities. It is a transient condition with good prognosis but in extremely rare cases may be life-threatening. We describe a 42-year-old man who presented with progressively worsening generalized weakness, presyncope and dyspnea on exertion for 2 weeks after sustaining a tick bite. He subsequently developed a 'bull's eye rash' on his flank 2 days before his presentation. He","2021","07","02","IDCases","IDCases","AV, atrioventricular; Cardiology; ECG, electrocardiogram; High-grade AV block; IV, intravenous; Infectious diseases; LC, Lyme carditis; LD, Lyme disease; Lyme carditis; MS, millisecond; Transvenous pacemaker","Raiszadeh","Farbod","Division of Cardiology, NYC Health &amp",NA
"312","34194998","10.1016/j.idcr.2021.e01179","A curious case of Lyme carditis in an urban hospital.","Lyme carditis (LC), a manifestation of early disseminated Lyme disease, most commonly presents with cardiac conduction abnormalities. It is a transient condition with good prognosis but in extremely rare cases may be life-threatening. We describe a 42-year-old man who presented with progressively worsening generalized weakness, presyncope and dyspnea on exertion for 2 weeks after sustaining a tick bite. He subsequently developed a 'bull's eye rash' on his flank 2 days before his presentation. He","2021","07","02","IDCases","IDCases","AV, atrioventricular; Cardiology; ECG, electrocardiogram; High-grade AV block; IV, intravenous; Infectious diseases; LC, Lyme carditis; LD, Lyme disease; Lyme carditis; MS, millisecond; Transvenous pacemaker","Sivapalan","Vel","Division of Infectious Diseases, NYC Health &amp",NA
"313","34194998","10.1016/j.idcr.2021.e01179","A curious case of Lyme carditis in an urban hospital.","Lyme carditis (LC), a manifestation of early disseminated Lyme disease, most commonly presents with cardiac conduction abnormalities. It is a transient condition with good prognosis but in extremely rare cases may be life-threatening. We describe a 42-year-old man who presented with progressively worsening generalized weakness, presyncope and dyspnea on exertion for 2 weeks after sustaining a tick bite. He subsequently developed a 'bull's eye rash' on his flank 2 days before his presentation. He","2021","07","02","IDCases","IDCases","AV, atrioventricular; Cardiology; ECG, electrocardiogram; High-grade AV block; IV, intravenous; Infectious diseases; LC, Lyme carditis; LD, Lyme disease; Lyme carditis; MS, millisecond; Transvenous pacemaker","Kurian","Damian","Division of Cardiology, NYC Health &amp",NA
"314","34194966","10.1016/j.pmedr.2021.101466","Herd immunity at what price? Using auctions to estimate what university students must be paid to get the flu vaccine.","There is significant resistance to vaccinations. Fewer than half of adults get a flu shot in the United States in a typical year, and a large minority of Americans say they will not get vaccinated against COVID-19. This resistance to vaccines creates challenges for both public health and the economy. The academic literature needs to consider potential policy solutions that might increase vaccination rates. In this study, we use experimental auctions to estimate how much university students need ","2021","07","02","Prev Med Rep","Preventive medicine reports",NA,"Clark","Nick","Susquehanna University, United States",NA
"315","34194966","10.1016/j.pmedr.2021.101466","Herd immunity at what price? Using auctions to estimate what university students must be paid to get the flu vaccine.","There is significant resistance to vaccinations. Fewer than half of adults get a flu shot in the United States in a typical year, and a large minority of Americans say they will not get vaccinated against COVID-19. This resistance to vaccines creates challenges for both public health and the economy. The academic literature needs to consider potential policy solutions that might increase vaccination rates. In this study, we use experimental auctions to estimate how much university students need ","2021","07","02","Prev Med Rep","Preventive medicine reports",NA,"Corrigan","Jay R","Kenyon College, United States",NA
"316","34194966","10.1016/j.pmedr.2021.101466","Herd immunity at what price? Using auctions to estimate what university students must be paid to get the flu vaccine.","There is significant resistance to vaccinations. Fewer than half of adults get a flu shot in the United States in a typical year, and a large minority of Americans say they will not get vaccinated against COVID-19. This resistance to vaccines creates challenges for both public health and the economy. The academic literature needs to consider potential policy solutions that might increase vaccination rates. In this study, we use experimental auctions to estimate how much university students need ","2021","07","02","Prev Med Rep","Preventive medicine reports",NA,"Rousu","Matthew C","Susquehanna University, United States",NA
"317","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Dickel","Steffen","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"318","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Grimm","Clemens","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"319","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Popp","Maria","Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital of Würzburg, Würzburg, Germany",NA
"320","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Struwe","Claudia","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"321","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Sachkova","Alexandra","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"322","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Golinski","Martin","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"323","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Seeber","Christian","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Leipzig, Leipzig, Germany",NA
"324","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Fichtner","Falk","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Leipzig, Leipzig, Germany",NA
"325","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Heise","Daniel","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"326","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Kranke","Peter","Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital of Würzburg, Würzburg, Germany",NA
"327","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Meissner","Winfried","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Jena, Jena, Germany",NA
"328","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Laudi","Sven","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Leipzig, Leipzig, Germany",NA
"329","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Voigt-Radloff","Sebastian","Institute for Evidence in Medicine, Medical Center &amp",NA
"330","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Meerpohl","Joerg J","Institute for Evidence in Medicine, Medical Center &amp",NA
"331","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Jabs","Jonas","University Hospital Bonn, Institute for Hygiene and Public Health, Bonn, Germany",NA
"332","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Mutters","Nico T","University Hospital Bonn, Institute for Hygiene and Public Health, Bonn, Germany",NA
"333","34194922","10.3205/dgkh000392","Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey.","Aim: Recommendations on hygiene measures, personal protective equipment (PPE), isolation, and antibiotic prophylaxis were developed during the coronavirus 2019 disease (COVID-19) pandemic and have been revised several times to date. Some of the underlying literature indicates a large evidence gap. We suspect that this leads to a large variance of measures on German intensive care units (ICU). Methods: A mixed methods online survey among intensive-care specialists in Germany caring for COVID-19 p","2021","07","02","GMS Hyg Infect Control","GMS hygiene and infection control","COVID-19; PPE; cohort isolation; prophylactic antibiotics; variants of concern","Moerer","Onnen","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany",NA
"334","34194882","10.7759/cureus.15280","Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.","Infection by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is known to have the highest mortality rate among the elderly and those with pre-existing medical conditions. Viral load has been directly correlated with increased risk of mortality in hospitalized patients. Once infected, symptoms first arise approximately six to seven days later followed by immunoglobulin M (IgM) antibodies appearing 8-12 days after onset of clinical symptoms. Recent studies have noted that the monoclon","2021","07","02","Cureus","Cureus","casirivimab; coronavirus; covid-19; imdevimab; monoclonal antibodies; pneumonia","Phan","Alexander T","Internal Medicine, Arrowhead Regional Medical Center, Colton, USA",NA
"335","34194882","10.7759/cureus.15280","Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.","Infection by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is known to have the highest mortality rate among the elderly and those with pre-existing medical conditions. Viral load has been directly correlated with increased risk of mortality in hospitalized patients. Once infected, symptoms first arise approximately six to seven days later followed by immunoglobulin M (IgM) antibodies appearing 8-12 days after onset of clinical symptoms. Recent studies have noted that the monoclon","2021","07","02","Cureus","Cureus","casirivimab; coronavirus; covid-19; imdevimab; monoclonal antibodies; pneumonia","Gukasyan","Janet","Internal Medicine, Arrowhead Regional Medical Center, Colton, USA",NA
"336","34194882","10.7759/cureus.15280","Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.","Infection by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is known to have the highest mortality rate among the elderly and those with pre-existing medical conditions. Viral load has been directly correlated with increased risk of mortality in hospitalized patients. Once infected, symptoms first arise approximately six to seven days later followed by immunoglobulin M (IgM) antibodies appearing 8-12 days after onset of clinical symptoms. Recent studies have noted that the monoclon","2021","07","02","Cureus","Cureus","casirivimab; coronavirus; covid-19; imdevimab; monoclonal antibodies; pneumonia","Arabian","Sarkis","Critical Care, Arrowhead Regional Medical Center, Colton, USA",NA
"337","34194882","10.7759/cureus.15280","Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.","Infection by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is known to have the highest mortality rate among the elderly and those with pre-existing medical conditions. Viral load has been directly correlated with increased risk of mortality in hospitalized patients. Once infected, symptoms first arise approximately six to seven days later followed by immunoglobulin M (IgM) antibodies appearing 8-12 days after onset of clinical symptoms. Recent studies have noted that the monoclon","2021","07","02","Cureus","Cureus","casirivimab; coronavirus; covid-19; imdevimab; monoclonal antibodies; pneumonia","Wang","Sharon","Infectious Disease, Arrowhead Regional Medical Center, Colton, USA",NA
"338","34194882","10.7759/cureus.15280","Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.","Infection by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is known to have the highest mortality rate among the elderly and those with pre-existing medical conditions. Viral load has been directly correlated with increased risk of mortality in hospitalized patients. Once infected, symptoms first arise approximately six to seven days later followed by immunoglobulin M (IgM) antibodies appearing 8-12 days after onset of clinical symptoms. Recent studies have noted that the monoclon","2021","07","02","Cureus","Cureus","casirivimab; coronavirus; covid-19; imdevimab; monoclonal antibodies; pneumonia","Neeki","Michael M","Emergency Medicine, Arrowhead Regional Medical Center, Colton, USA",NA
"339","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Jacob","Jaison","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"340","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Stephen","Shine","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"341","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Issac","Alwin","Psychiatry, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"342","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Krishnan","Nadiya","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"343","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Vadakkethil Radhakrishnan","Rakesh","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"344","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","R","Vijay V","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"345","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Dhandapani","Manju","Neurological Surgery, National Institute of Nursing Education, Post Graduate Institute of Medical Education &amp",NA
"346","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Jose","Sam","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"347","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Sm","Azhar","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"348","34194875","10.7759/cureus.15271","Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.","Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preferenc","2021","07","02","Cureus","Cureus","acceptance; covid vaccine; hesitancy; unwillingness; willingness","Nair","Anoop S","College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, IND",NA
"349","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Agus","Marcello","S.S.D. Chirurgia d'Urgenza, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"350","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Ferrara","Maria Elena","U.O. Medicina di Accettazione e d'Urgenza, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"351","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Bianco","Paola","U.O. Anatomia Patologica, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"352","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Manieli","Cristina","U.O. Anatomia Patologica, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"353","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Mura","Paolo","S.S.D. Chirurgia d'Urgenza, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"354","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Sechi","Raffaele","S.O.C. Chirurgia Generale, P.O. Santissima Trinità, ASL Cagliari, Italy",NA
"355","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Runfola","Matteo","S.S.D. Chirurgia d'Urgenza, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"356","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Polo","Fabrizio","U.O. Medicina di Accettazione e d'Urgenza, P.O. San Michele, ARNAS ""G Brotzu, ""Cagliari, Italy",NA
"357","34194865","10.1155/2021/5553619","Atraumatic Splenic Rupture in a SARS-CoV-2 Patient: Case Report and Review of Literature.","Splenic rupture in the absence of trauma or previously diagnosed disease is rare. Due to the delay of diagnosis and treatment, this is a potentially life-threatening condition. We report a case of atraumatic splenic rupture in a SARS-CoV-2 patient. This report is of particular interest as it first identifies SARS-CoV-2 infection as a possible cause of spontaneous rupture of the spleen. A 46-year-old Caucasian woman presented at the emergency department pale and sweaty, complaining of syncopal ep","2021","07","02","Case Rep Surg","Case reports in surgery",NA,"Cillara","Nicola","S.O.C. Chirurgia Generale, P.O. Santissima Trinità, ASL Cagliari, Italy",NA
"358","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Shala","Nexhmedin","Clinic of Neurology, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"359","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Jashari","Fisnik","Clinic of Neurology, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"360","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Boshnjaku","Dren","Clinic of Neurology, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"361","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Shala","Argjend","Clinic of Neurology, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"362","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Ibrahimi","Pranvera","Clinic of Cardiology, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"363","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Kukaj","Vera","Clinic of Neurology, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"364","34194854","10.1155/2021/5576440","A 14-Year-Old Male Patient with Kawasaki Disease Presented with Stroke after COVID-19.","According to several studies, children represent only about 2% of the patients affected by the current SARS-CoV-2, and most often, they are asymptomatic. However, there is a concern about a vascular inflammatory disease which is similar to Kawasaki disease observed in children and adolescents weeks after infection. We report a case of Kawasaki disease presented with ischemic stroke in a 14-year-old male patient following SARS-Cov-2 infection.","2021","07","02","Case Rep Infect Dis","Case reports in infectious diseases",NA,"Dreshaj","Shemsedin","Clinic of Infectious Disease, University Clinical Center of Kosovo, Pristina 10000, Kosovo",NA
"365","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Steinlechner","Barbara","Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"366","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Kargl","Gabriele","Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"367","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Schlömmer","Christine","Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"368","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Holaubek","Caroline","Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"369","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Scheriau","Georg","Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"370","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Eichinger","Sabine","Division of Hematology and Hemostaseology, Department of Medicine I, Medical University Vienna, Vienna, Austria",NA
"371","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Gratz","Johannes","Division of General Anesthesia and Intensive Care Medicine, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"372","34194852","10.1155/2021/6624682","Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?","Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normal","2021","07","02","Case Reports Immunol","Case reports in immunology",NA,"Rössler","Bernhard","Division of General Anesthesia and Intensive Care Medicine, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria",NA
"373","34194809","10.1002/ccr3.4342","Tension pneumothorax complicating COVID-19 pneumonia.","To emphasize the importance of lung imaging in a patient with acute decompensation in the setting of COVID-19 and to know that pneumothorax is currently a well-recognized complication related to COVID-19 pneumonia.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; pneumothorax","Mohamed","Amr","Department of Internal Medicine Rochester General Hospital Rochester NY USA",NA
"374","34194805","10.1002/ccr3.4323","SARS-CoV-2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report.","During the COVID-19 pandemic, physicians must maintain a high index of suspicion for COVID-19 in cases of urticarial vasculitis or other forms of urticaria. This is particularly important for acute presentations in otherwise asymptomatic individuals and pregnant women, where a prompt approach to the patient can prevent undesirable complications.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; pregnancy; urticaria; urticarial vasculitis; vasculitis","Shahidi Dadras","Mohammad","Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran",NA
"375","34194805","10.1002/ccr3.4323","SARS-CoV-2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report.","During the COVID-19 pandemic, physicians must maintain a high index of suspicion for COVID-19 in cases of urticarial vasculitis or other forms of urticaria. This is particularly important for acute presentations in otherwise asymptomatic individuals and pregnant women, where a prompt approach to the patient can prevent undesirable complications.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; pregnancy; urticaria; urticarial vasculitis; vasculitis","Rakhshan","Azadeh","Clinical Research Development Unit Shohada-e Tajrish Hospital Shahid Beheshti University of Medical Sciences Tehran Iran",NA
"376","34194805","10.1002/ccr3.4323","SARS-CoV-2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report.","During the COVID-19 pandemic, physicians must maintain a high index of suspicion for COVID-19 in cases of urticarial vasculitis or other forms of urticaria. This is particularly important for acute presentations in otherwise asymptomatic individuals and pregnant women, where a prompt approach to the patient can prevent undesirable complications.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; pregnancy; urticaria; urticarial vasculitis; vasculitis","Diab","Reem","Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran",NA
"377","34194805","10.1002/ccr3.4323","SARS-CoV-2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report.","During the COVID-19 pandemic, physicians must maintain a high index of suspicion for COVID-19 in cases of urticarial vasculitis or other forms of urticaria. This is particularly important for acute presentations in otherwise asymptomatic individuals and pregnant women, where a prompt approach to the patient can prevent undesirable complications.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; pregnancy; urticaria; urticarial vasculitis; vasculitis","Abdollahimajd","Fahimeh","Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran",NA
"378","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Mazzaccaro","Daniela","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"379","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Giannetta","Matteo","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"380","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Malacrida","Giovanni","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"381","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Zilio","Dino","Operative Unit of Plastic Surgery IRCCS Policlinico San Donato Milan Italy",NA
"382","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Modafferi","Alfredo","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"383","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Righini","Paolo","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"384","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Marrocco-Trischitta","Massimiliano M","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"385","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Vaienti","Luca","Operative Unit of Plastic Surgery IRCCS Policlinico San Donato Milan Italy",NA
"386","34194791","10.1002/ccr3.4285","Sudden rupture of small aneurysm of the radial artery in a patient with COVID-19 pneumonia.","In patients with COVID-19, even small radial aneurysm may suddenly rupture.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; aneurysm; arterial rupture; radial artery; radial catheter","Nano","Giovanni","Operative Unit of Vascular Surgery IRCCS Policlinico San Donato Milan Italy",NA
"387","34194783","10.1002/ccr3.4257","COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.","Reinfection with COVID-19 is possible after exposure to a high dose of the virus. Due to immunity acquired during the previous infection, light symptoms are expected. The finding indicates importance of continuous protection in healthcare workers.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; case report; pandemic; reinfection","Ahmadian","Shahram","Faculty of Medicine Imam Reza Hospital Tabriz University of Medical Sciences Tabriz Iran",NA
"388","34194783","10.1002/ccr3.4257","COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.","Reinfection with COVID-19 is possible after exposure to a high dose of the virus. Due to immunity acquired during the previous infection, light symptoms are expected. The finding indicates importance of continuous protection in healthcare workers.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; case report; pandemic; reinfection","Fathizadeh","Hadis","Department of laboratory sciences Sirjan School of Medical Sciences Sirjan Iran",NA
"389","34194783","10.1002/ccr3.4257","COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.","Reinfection with COVID-19 is possible after exposure to a high dose of the virus. Due to immunity acquired during the previous infection, light symptoms are expected. The finding indicates importance of continuous protection in healthcare workers.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; case report; pandemic; reinfection","Shabestari Khiabani","Saeid","Faculty of Medicine Imam Reza Hospital Tabriz University of Medical Sciences Tabriz Iran",NA
"390","34194783","10.1002/ccr3.4257","COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.","Reinfection with COVID-19 is possible after exposure to a high dose of the virus. Due to immunity acquired during the previous infection, light symptoms are expected. The finding indicates importance of continuous protection in healthcare workers.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; case report; pandemic; reinfection","Asgharzadeh","Mohammad","Biotechnology Research Center Tabriz University of Medical Sciences Tabriz Iran",NA
"391","34194783","10.1002/ccr3.4257","COVID-19 reinfection in a healthcare worker after exposure with high dose of virus: A case report.","Reinfection with COVID-19 is possible after exposure to a high dose of the virus. Due to immunity acquired during the previous infection, light symptoms are expected. The finding indicates importance of continuous protection in healthcare workers.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; SARS-CoV-2; case report; pandemic; reinfection","Kafil","Hossein Samadi","Drug Applied Research Center Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran",NA
"392","34194776","10.1002/ccr3.4205","COVID-19 cardiac arrest due to Prinzmetal's angina in a previously normal heart.","In COVID-19 patients who develop sudden ST elevations it is necessary to consider cardiac causes other than myocardial infarction, such as coronary vasospasm.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; PEA; Prinzmetal's angina; ST-segment elevation; acute coronary syndrome; atypical presentation; coronary vasospasm","Wang","Melinda","Department of Internal Medicine St. Joseph's Hospital and Medical Center Valleywise Health Medical Center Creighton University School of Medicine Phoenix Campus Phoenix AZ USA",NA
"393","34194776","10.1002/ccr3.4205","COVID-19 cardiac arrest due to Prinzmetal's angina in a previously normal heart.","In COVID-19 patients who develop sudden ST elevations it is necessary to consider cardiac causes other than myocardial infarction, such as coronary vasospasm.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; PEA; Prinzmetal's angina; ST-segment elevation; acute coronary syndrome; atypical presentation; coronary vasospasm","Talon","Andrew","Department of Internal Medicine St. Joseph's Hospital and Medical Center Valleywise Health Medical Center Creighton University School of Medicine Phoenix Campus Phoenix AZ USA",NA
"394","34194776","10.1002/ccr3.4205","COVID-19 cardiac arrest due to Prinzmetal's angina in a previously normal heart.","In COVID-19 patients who develop sudden ST elevations it is necessary to consider cardiac causes other than myocardial infarction, such as coronary vasospasm.","2021","07","02","Clin Case Rep","Clinical case reports","COVID-19; PEA; Prinzmetal's angina; ST-segment elevation; acute coronary syndrome; atypical presentation; coronary vasospasm","Saririan","Mehrdad","Department of Cardiology, Interventional Cardiology District Medical Group Creighton University School of Medicine University of Arizona Phoenix AZ USA",NA
"395","34194681","10.1155/2021/5513679","Artificial Neural Network-Based Deep Learning Model for COVID-19 Patient Detection Using X-Ray Chest Images.","The world is experiencing an unprecedented crisis due to the coronavirus disease (COVID-19) outbreak that has affected nearly 216 countries and territories across the globe. Since the pandemic outbreak, there is a growing interest in computational model-based diagnostic technologies to support the screening and diagnosis of COVID-19 cases using medical imaging such as chest X-ray (CXR) scans. It is discovered in initial studies that patients infected with COVID-19 show abnormalities in their CXR","2021","07","09","J Healthc Eng","Journal of healthcare engineering","COVID-19; Deep Learning; Humans; Lung; Radiographic Image Interpretation, Computer-Assisted; Radiography, Thoracic; SARS-CoV-2; Sensitivity and Specificity","Shorfuzzaman","Mohammad","Department of Computer Science, College of Computers and Information Technology, Taif University, Taif 21974, Saudi Arabia",NA
"396","34194681","10.1155/2021/5513679","Artificial Neural Network-Based Deep Learning Model for COVID-19 Patient Detection Using X-Ray Chest Images.","The world is experiencing an unprecedented crisis due to the coronavirus disease (COVID-19) outbreak that has affected nearly 216 countries and territories across the globe. Since the pandemic outbreak, there is a growing interest in computational model-based diagnostic technologies to support the screening and diagnosis of COVID-19 cases using medical imaging such as chest X-ray (CXR) scans. It is discovered in initial studies that patients infected with COVID-19 show abnormalities in their CXR","2021","07","09","J Healthc Eng","Journal of healthcare engineering","COVID-19; Deep Learning; Humans; Lung; Radiographic Image Interpretation, Computer-Assisted; Radiography, Thoracic; SARS-CoV-2; Sensitivity and Specificity","Masud","Mehedi","Department of Computer Science, College of Computers and Information Technology, Taif University, Taif 21974, Saudi Arabia",NA
"397","34194681","10.1155/2021/5513679","Artificial Neural Network-Based Deep Learning Model for COVID-19 Patient Detection Using X-Ray Chest Images.","The world is experiencing an unprecedented crisis due to the coronavirus disease (COVID-19) outbreak that has affected nearly 216 countries and territories across the globe. Since the pandemic outbreak, there is a growing interest in computational model-based diagnostic technologies to support the screening and diagnosis of COVID-19 cases using medical imaging such as chest X-ray (CXR) scans. It is discovered in initial studies that patients infected with COVID-19 show abnormalities in their CXR","2021","07","09","J Healthc Eng","Journal of healthcare engineering","COVID-19; Deep Learning; Humans; Lung; Radiographic Image Interpretation, Computer-Assisted; Radiography, Thoracic; SARS-CoV-2; Sensitivity and Specificity","Alhumyani","Hesham","Department of Computer Engineering, College of Computers and Information Technology, Taif University, Taif 21974, Saudi Arabia",NA
"398","34194681","10.1155/2021/5513679","Artificial Neural Network-Based Deep Learning Model for COVID-19 Patient Detection Using X-Ray Chest Images.","The world is experiencing an unprecedented crisis due to the coronavirus disease (COVID-19) outbreak that has affected nearly 216 countries and territories across the globe. Since the pandemic outbreak, there is a growing interest in computational model-based diagnostic technologies to support the screening and diagnosis of COVID-19 cases using medical imaging such as chest X-ray (CXR) scans. It is discovered in initial studies that patients infected with COVID-19 show abnormalities in their CXR","2021","07","09","J Healthc Eng","Journal of healthcare engineering","COVID-19; Deep Learning; Humans; Lung; Radiographic Image Interpretation, Computer-Assisted; Radiography, Thoracic; SARS-CoV-2; Sensitivity and Specificity","Anand","Divya","Department of Computer Science and Engineering, Lovely Professional University, Phagwara, Punjab 144411, India",NA
"399","34194681","10.1155/2021/5513679","Artificial Neural Network-Based Deep Learning Model for COVID-19 Patient Detection Using X-Ray Chest Images.","The world is experiencing an unprecedented crisis due to the coronavirus disease (COVID-19) outbreak that has affected nearly 216 countries and territories across the globe. Since the pandemic outbreak, there is a growing interest in computational model-based diagnostic technologies to support the screening and diagnosis of COVID-19 cases using medical imaging such as chest X-ray (CXR) scans. It is discovered in initial studies that patients infected with COVID-19 show abnormalities in their CXR","2021","07","09","J Healthc Eng","Journal of healthcare engineering","COVID-19; Deep Learning; Humans; Lung; Radiographic Image Interpretation, Computer-Assisted; Radiography, Thoracic; SARS-CoV-2; Sensitivity and Specificity","Singh","Aman","Department of Computer Science and Engineering, Lovely Professional University, Phagwara, Punjab 144411, India",NA
"400","34194615","10.4240/wjgs.v13.i6.574","Acute pancreatitis and COVID-19: A literature review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing pandemic of coronavirus disease 2019 (COVID-19), and has caused more than 80 million infections and 1.7 million deaths worldwide. Although it is primarily a respiratory virus, SARS-CoV-2 also has extra-pulmonary effects. Pancreatic injury and cases of acute pancreatitis (AP) have been recognized and attributed to SARS-CoV-2, but the mechanisms of pancreatic injury are still a subject of debate. There is a","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","COVID-19; Pancreas; Pancreatitis; SARS-CoV-2","Correia de Sá","Tiago","Department of General Surgery, Centro Hospitalar do Tâmega e Sousa, Penafiel 4564-007, Portugal. tiago.rc.sa@gmail","tiago.rc.sa@gmail.com"
"401","34194615","10.4240/wjgs.v13.i6.574","Acute pancreatitis and COVID-19: A literature review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing pandemic of coronavirus disease 2019 (COVID-19), and has caused more than 80 million infections and 1.7 million deaths worldwide. Although it is primarily a respiratory virus, SARS-CoV-2 also has extra-pulmonary effects. Pancreatic injury and cases of acute pancreatitis (AP) have been recognized and attributed to SARS-CoV-2, but the mechanisms of pancreatic injury are still a subject of debate. There is a","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","COVID-19; Pancreas; Pancreatitis; SARS-CoV-2","Soares","Carlos","Department of General Surgery, Centro Hospitalar do Tâmega e Sousa, Penafiel 4564-007, Portugal",NA
"402","34194615","10.4240/wjgs.v13.i6.574","Acute pancreatitis and COVID-19: A literature review.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing pandemic of coronavirus disease 2019 (COVID-19), and has caused more than 80 million infections and 1.7 million deaths worldwide. Although it is primarily a respiratory virus, SARS-CoV-2 also has extra-pulmonary effects. Pancreatic injury and cases of acute pancreatitis (AP) have been recognized and attributed to SARS-CoV-2, but the mechanisms of pancreatic injury are still a subject of debate. There is a","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","COVID-19; Pancreas; Pancreatitis; SARS-CoV-2","Rocha","Mónica","Department of General Surgery, Centro Hospitalar do Tâmega e Sousa, Penafiel 4564-007, Portugal",NA
"403","34194613","10.4240/wjgs.v13.i6.548","Association between acute pancreatitis and COVID-19 infection: What do we know?","The disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called coronavirus disease 2019 (COVID-19), first originated in Wuhan, China, displaying atypical pneumonia-like respiratory symptoms in affected patients. SARS-CoV-2 primarily attacks the respiratory system, and the most common symptoms include cough, shortness of breath, and fever. However, its impact on the digestive system has been shown, and various clinical gastrointestinal manifestations of this disea","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","Acute pancreatitis; Angiotensin-converting enzyme 2; COVID-19; SARS-CoV-2","Jablonska","Beata","Department of Digestive Tract Surgery, Medical University of Silesia, Katowice 40-752, Poland. bjablonska@poczta.onet","bjablonska@poczta.onet.pl"
"404","34194613","10.4240/wjgs.v13.i6.548","Association between acute pancreatitis and COVID-19 infection: What do we know?","The disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called coronavirus disease 2019 (COVID-19), first originated in Wuhan, China, displaying atypical pneumonia-like respiratory symptoms in affected patients. SARS-CoV-2 primarily attacks the respiratory system, and the most common symptoms include cough, shortness of breath, and fever. However, its impact on the digestive system has been shown, and various clinical gastrointestinal manifestations of this disea","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","Acute pancreatitis; Angiotensin-converting enzyme 2; COVID-19; SARS-CoV-2","Olakowski","Marek","Department of Digestive Tract Surgery, Medical University of Silesia, Katowice 40-752, Poland",NA
"405","34194613","10.4240/wjgs.v13.i6.548","Association between acute pancreatitis and COVID-19 infection: What do we know?","The disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called coronavirus disease 2019 (COVID-19), first originated in Wuhan, China, displaying atypical pneumonia-like respiratory symptoms in affected patients. SARS-CoV-2 primarily attacks the respiratory system, and the most common symptoms include cough, shortness of breath, and fever. However, its impact on the digestive system has been shown, and various clinical gastrointestinal manifestations of this disea","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","Acute pancreatitis; Angiotensin-converting enzyme 2; COVID-19; SARS-CoV-2","Mrowiec","Slawomir","Department of Digestive Tract Surgery, Medical University of Silesia, Katowice 40-752, Poland",NA
"406","34194611","10.4240/wjgs.v13.i6.529","Special surgical approaches during peri-COVID-19 pandemic: Robotic and transanal minimally invasive surgery.","During the peri-coronavirus disease 2019 pandemic, the need of special care has raised, not only for our patients but also for health care workers. These needs are different regarding the procedure and the approach performed. This is a dynamic review in the use of robotics and transanal approaches for colorectal diseases. We searched PubMed and KSREvidence.com for studies related to coronavirus disease and robotic surgery/transanal mesorectal excision/transanal surgery (primary and systematic re","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","Pandemic; Robotic surgery; Transanal mesorectal excision","Sánchez-Guillén","Luis","Department of Cirugía General, Hospital Universitario de Elche, Elche 03201, Spain",NA
"407","34194611","10.4240/wjgs.v13.i6.529","Special surgical approaches during peri-COVID-19 pandemic: Robotic and transanal minimally invasive surgery.","During the peri-coronavirus disease 2019 pandemic, the need of special care has raised, not only for our patients but also for health care workers. These needs are different regarding the procedure and the approach performed. This is a dynamic review in the use of robotics and transanal approaches for colorectal diseases. We searched PubMed and KSREvidence.com for studies related to coronavirus disease and robotic surgery/transanal mesorectal excision/transanal surgery (primary and systematic re","2021","07","02","World J Gastrointest Surg","World journal of gastrointestinal surgery","Pandemic; Robotic surgery; Transanal mesorectal excision","Jimenez-Rodriguez","Rosa M","Department of Surgery, Hospital Universitario Virgen del Rocio, Unidad de Coloproctologia, Sevilla 41013, Spain. ros_j_r@hotmail",NA
"408","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Serena Low","Woan Ching","Department of Electrical Engineering, Faculty of Engineering, University of Malaya, 40603 Kuala Lumpur, Malaysia",NA
"409","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Chuah","Joon Huang","Department of Electrical Engineering, Faculty of Engineering, University of Malaya, 40603 Kuala Lumpur, Malaysia",NA
"410","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Tee","Clarence Augustine T H","Department of Electrical Engineering, Faculty of Engineering, University of Malaya, 40603 Kuala Lumpur, Malaysia",NA
"411","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Anis","Shazia","Department of Biomedical Engineering, Faculty of Engineering, University of Malaya, 40603 Kuala Lumpur, Malaysia",NA
"412","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Shoaib","Muhammad Ali","Department of Electrical Engineering, Faculty of Engineering, University of Malaya, 40603 Kuala Lumpur, Malaysia",NA
"413","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Faisal","Amir","Department of Biomedical Engineering, Faculty of Production and Industrial Technology, Institut Teknologi Sumatera, Lampung 35365, Indonesia",NA
"414","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Khalil","Azira","Faculty of Science and Technology, Universiti Sains Islam Malaysia, 71800 Nilai, Negeri Sembilan, Malaysia",NA
"415","34194535","10.1155/2021/5528144","An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.","Pneumonia is an infamous life-threatening lung bacterial or viral infection. The latest viral infection endangering the lives of many people worldwide is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. This paper is aimed at detecting and differentiating viral pneumonia and COVID-19 disease using digital X-ray images. The current practices include tedious conventional processes that solely rely on the radiologist or medical consultant's technical expertis","2021","07","09","Comput Math Methods Med","Computational and mathematical methods in medicine","Algorithms; COVID-19; COVID-19 Testing; Computational Biology; Deep Learning; Diagnosis, Differential; Humans; Mathematical Concepts; Neural Networks, Computer; Pneumonia, Viral; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed","Lai","Khin Wee","Department of Biomedical Engineering, Faculty of Engineering, University of Malaya, 40603 Kuala Lumpur, Malaysia",NA
"416","34194534","10.2217/fvl-2020-0384","V483A: an emerging mutation hotspot of SARS-CoV-2.","One of the many mutations that have occurred in the viral genome is the V483A mutation, which is a part of the receptor-binding motif present in the S1 domain of the spike protein. V483A mutant virus is popular in North America with 36 cases so far and frequently occurring in recent days. This review compares the wild-type and the V483A mutants to analyze certain factors like the interaction between the virus and host-cell interface, binding affinity, stability, partition energy, hydrophobicity,","2021","07","02","Future Virol","Future virology","V483A; high transmission; infectivity; spike protein; substitution mutation; virushost cell interaction","Ashwaq","Omar","Department of Chemical &amp",NA
"417","34194534","10.2217/fvl-2020-0384","V483A: an emerging mutation hotspot of SARS-CoV-2.","One of the many mutations that have occurred in the viral genome is the V483A mutation, which is a part of the receptor-binding motif present in the S1 domain of the spike protein. V483A mutant virus is popular in North America with 36 cases so far and frequently occurring in recent days. This review compares the wild-type and the V483A mutants to analyze certain factors like the interaction between the virus and host-cell interface, binding affinity, stability, partition energy, hydrophobicity,","2021","07","02","Future Virol","Future virology","V483A; high transmission; infectivity; spike protein; substitution mutation; virushost cell interaction","Manickavasagam","Pratibha","Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India",NA
"418","34194534","10.2217/fvl-2020-0384","V483A: an emerging mutation hotspot of SARS-CoV-2.","One of the many mutations that have occurred in the viral genome is the V483A mutation, which is a part of the receptor-binding motif present in the S1 domain of the spike protein. V483A mutant virus is popular in North America with 36 cases so far and frequently occurring in recent days. This review compares the wild-type and the V483A mutants to analyze certain factors like the interaction between the virus and host-cell interface, binding affinity, stability, partition energy, hydrophobicity,","2021","07","02","Future Virol","Future virology","V483A; high transmission; infectivity; spike protein; substitution mutation; virushost cell interaction","Haque","Sk Manirul","Department of Chemical &amp",NA
"419","34194512","10.1155/2021/5582589","Mortality and Excess Mortality: Improving FluMOMO.","FluMOMO is a universal formula to forecast mortality in 27 European countries and was developed on EuroMOMO context, http://www.euromomo.eu. The model has a trigonometric baseline and considers any upwards deviation from that to come from flu or extreme temperatures. To measure it, the model considers two variables: influenza activity and extreme temperatures. With the former, the model gives the number of deaths because of flu and with the latter the number of deaths because of extreme temperat","2021","07","13","J Environ Public Health","Journal of environmental and public health","COVID-19; Europe; Female; Humans; Influenza, Human; Male; Models, Statistical; Mortality; Population; Portugal; SARS-CoV-2; Seasons; Vaccination","Portugal","Luís","Partner and Managing Director ACTUARIAL Group, PhD Mathematical Sciences, University of Liverpool, Fellow Actuary, IAP (Portugal), England, UK",NA
"420","34194491","10.1155/2021/8798575","Role of Chest Computed Tomography versus Real Time Reverse Transcription Polymerase Chain Reaction for Diagnosis of COVID-19: A Systematic Review and Meta-Analysis.","The current global pandemic of COVID-19 is considered a public health emergency. The diagnosis of COVID-19 depends on detection of the viral nucleic acid by real time reverse transcription polymerase chain reaction (RT-PCR). However, false-negative RT-PCR tests are reported and could hinder the control of the pandemic. Chest computed tomography could achieve a more reliable diagnosis and represent a complementary diagnostic tool. To perform a meta-analysis and systematic review to find out the r","2021","07","02","Interdiscip Perspect Infect Dis","Interdisciplinary perspectives on infectious diseases",NA,"Ali","Dina M","Tropical Medicine Department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt",NA
"421","34194491","10.1155/2021/8798575","Role of Chest Computed Tomography versus Real Time Reverse Transcription Polymerase Chain Reaction for Diagnosis of COVID-19: A Systematic Review and Meta-Analysis.","The current global pandemic of COVID-19 is considered a public health emergency. The diagnosis of COVID-19 depends on detection of the viral nucleic acid by real time reverse transcription polymerase chain reaction (RT-PCR). However, false-negative RT-PCR tests are reported and could hinder the control of the pandemic. Chest computed tomography could achieve a more reliable diagnosis and represent a complementary diagnostic tool. To perform a meta-analysis and systematic review to find out the r","2021","07","02","Interdiscip Perspect Infect Dis","Interdisciplinary perspectives on infectious diseases",NA,"Zake","Lamiaa G","Chest Department, Faculty of Human Medicine, Zagazig University, Zagazig, Egypt",NA
"422","34194491","10.1155/2021/8798575","Role of Chest Computed Tomography versus Real Time Reverse Transcription Polymerase Chain Reaction for Diagnosis of COVID-19: A Systematic Review and Meta-Analysis.","The current global pandemic of COVID-19 is considered a public health emergency. The diagnosis of COVID-19 depends on detection of the viral nucleic acid by real time reverse transcription polymerase chain reaction (RT-PCR). However, false-negative RT-PCR tests are reported and could hinder the control of the pandemic. Chest computed tomography could achieve a more reliable diagnosis and represent a complementary diagnostic tool. To perform a meta-analysis and systematic review to find out the r","2021","07","02","Interdiscip Perspect Infect Dis","Interdisciplinary perspectives on infectious diseases",NA,"El Kady","Nevine K","Forensic and Clinical Toxicology Department, Faculty of Human Medicine, Cairo University, Cairo, Egypt",NA
"423","34194484","10.1155/2021/8828404","Transfer Learning to Detect COVID-19 Automatically from X-Ray Images Using Convolutional Neural Networks.","The novel coronavirus disease 2019 (COVID-19) is a contagious disease that has caused thousands of deaths and infected millions worldwide. Thus, various technologies that allow for the fast detection of COVID-19 infections with high accuracy can offer healthcare professionals much-needed help. This study is aimed at evaluating the effectiveness of the state-of-the-art pretrained Convolutional Neural Networks (CNNs) on the automatic diagnosis of COVID-19 from chest X-rays (CXRs). The dataset used","2021","07","02","Int J Biomed Imaging","International journal of biomedical imaging",NA,"Taresh","Mundher Mohammed","College of Information Science and Engineering, Hunan University, Changsha 400013, China",NA
"424","34194484","10.1155/2021/8828404","Transfer Learning to Detect COVID-19 Automatically from X-Ray Images Using Convolutional Neural Networks.","The novel coronavirus disease 2019 (COVID-19) is a contagious disease that has caused thousands of deaths and infected millions worldwide. Thus, various technologies that allow for the fast detection of COVID-19 infections with high accuracy can offer healthcare professionals much-needed help. This study is aimed at evaluating the effectiveness of the state-of-the-art pretrained Convolutional Neural Networks (CNNs) on the automatic diagnosis of COVID-19 from chest X-rays (CXRs). The dataset used","2021","07","02","Int J Biomed Imaging","International journal of biomedical imaging",NA,"Zhu","Ningbo","College of Information Science and Engineering, Hunan University, Changsha 400013, China",NA
"425","34194484","10.1155/2021/8828404","Transfer Learning to Detect COVID-19 Automatically from X-Ray Images Using Convolutional Neural Networks.","The novel coronavirus disease 2019 (COVID-19) is a contagious disease that has caused thousands of deaths and infected millions worldwide. Thus, various technologies that allow for the fast detection of COVID-19 infections with high accuracy can offer healthcare professionals much-needed help. This study is aimed at evaluating the effectiveness of the state-of-the-art pretrained Convolutional Neural Networks (CNNs) on the automatic diagnosis of COVID-19 from chest X-rays (CXRs). The dataset used","2021","07","02","Int J Biomed Imaging","International journal of biomedical imaging",NA,"Ali","Talal Ahmed Ali","College of Information Science and Engineering, Hunan University, Changsha 400013, China",NA
"426","34194484","10.1155/2021/8828404","Transfer Learning to Detect COVID-19 Automatically from X-Ray Images Using Convolutional Neural Networks.","The novel coronavirus disease 2019 (COVID-19) is a contagious disease that has caused thousands of deaths and infected millions worldwide. Thus, various technologies that allow for the fast detection of COVID-19 infections with high accuracy can offer healthcare professionals much-needed help. This study is aimed at evaluating the effectiveness of the state-of-the-art pretrained Convolutional Neural Networks (CNNs) on the automatic diagnosis of COVID-19 from chest X-rays (CXRs). The dataset used","2021","07","02","Int J Biomed Imaging","International journal of biomedical imaging",NA,"Hameed","Asaad Shakir","Department of Mathematics, General Directorate of Thi-Qar Education, Ministry of Education, Thi-Qar, Iraq",NA
"427","34194484","10.1155/2021/8828404","Transfer Learning to Detect COVID-19 Automatically from X-Ray Images Using Convolutional Neural Networks.","The novel coronavirus disease 2019 (COVID-19) is a contagious disease that has caused thousands of deaths and infected millions worldwide. Thus, various technologies that allow for the fast detection of COVID-19 infections with high accuracy can offer healthcare professionals much-needed help. This study is aimed at evaluating the effectiveness of the state-of-the-art pretrained Convolutional Neural Networks (CNNs) on the automatic diagnosis of COVID-19 from chest X-rays (CXRs). The dataset used","2021","07","02","Int J Biomed Imaging","International journal of biomedical imaging",NA,"Mutar","Modhi Lafta","Faculty of Information and Communication Technology, Universiti Teknikal Malaysia Melaka, Hang Tuah Jaya, Durian Tunggal, Melaka, Malaysia",NA
"428","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Lafon","Eliott","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"429","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Diem","Gabriel","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"430","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Witting","Christina","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"431","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Zaderer","Viktoria","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"432","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Bellmann-Weiler","Rosa Maria","University Hospital of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria",NA
"433","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Reindl","Markus","Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria",NA
"434","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Bauer","Angelika","Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria",NA
"435","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Griesmacher","Andrea","Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital Innsbruck, Innsbruck, Austria",NA
"436","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Fux","Vilmos","Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital Innsbruck, Innsbruck, Austria",NA
"437","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Hoermann","Gregor","Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital Innsbruck, Innsbruck, Austria",NA
"438","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Miller","Carl","Department of Internal Medicine, Hospital Kufstein, Kufstein, Austria",NA
"439","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Zabernigg","August","Department of Internal Medicine, Hospital Kufstein, Kufstein, Austria",NA
"440","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Wöll","Ewald","Department of Internal Medicine, Hospital Zams, Zams, Austria",NA
"441","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Wilflingseder","Doris","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"442","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Lass-Flörl","Cornelia","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"443","34194438","10.3389/fimmu.2021.684014","Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.","T cells play a fundamental role in the early control and clearance of many viral infections of the respiratory system. In SARS-CoV-2-infected individuals, lymphopenia with drastically reduced CD4<sup>+</sup> and CD8<sup>+</sup> T cells correlates with Coronavirus disease 2019 (COVID-19)-associated disease severity and mortality. In this study, we characterized cellular and humoral immune responses induced in patients with mild, severe and critical COVID-19. Peripheral blood mononuclear cells of ","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; ELISpot assay; SARS-CoV-2; T cell immunity; anaphylatoxin; neutralizing Abs; Adult; Aged; Aged, 80 and over; Anaphylatoxins; Antibodies, Viral; CD8-Positive T-Lymphocytes; COVID-19; Disease Progression; Enzyme-Linked Immunospot Assay; Female; Flow Cytometry; Humans; Immunity, Humoral; Interferon-gamma; Male; Middle Aged; Patient Acuity; SARS-CoV-2","Posch","Wilfried","Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria",NA
"444","34194434","10.3389/fimmu.2021.680891","Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.","The network of tunneling nanotubes (TNTs) represents the filamentous (F)-actin rich tubular structure which is connected to the cytoplasm of the adjacent and or distant cells to mediate efficient cell-to-cell communication. They are long cytoplasmic bridges with an extraordinary ability to perform diverse array of function ranging from maintaining cellular physiology and cell survival to promoting immune surveillance. Ironically, TNTs are now widely documented to promote the spread of various pa","2021","07","12","Front Immunol","Frontiers in immunology","heparan sulfate; tunneling nanotubes (TNT); virus cell interactions; virus cell to cell spread; virus surfing; Animals; COVID-19; Cell Communication; Cytoplasm; Humans; Nanotubes; Neurodegenerative Diseases; Virus Diseases","Tiwari","Vaibhav","Department of Microbiology &amp",NA
"445","34194434","10.3389/fimmu.2021.680891","Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.","The network of tunneling nanotubes (TNTs) represents the filamentous (F)-actin rich tubular structure which is connected to the cytoplasm of the adjacent and or distant cells to mediate efficient cell-to-cell communication. They are long cytoplasmic bridges with an extraordinary ability to perform diverse array of function ranging from maintaining cellular physiology and cell survival to promoting immune surveillance. Ironically, TNTs are now widely documented to promote the spread of various pa","2021","07","12","Front Immunol","Frontiers in immunology","heparan sulfate; tunneling nanotubes (TNT); virus cell interactions; virus cell to cell spread; virus surfing; Animals; COVID-19; Cell Communication; Cytoplasm; Humans; Nanotubes; Neurodegenerative Diseases; Virus Diseases","Koganti","Raghuram","Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, United States",NA
"446","34194434","10.3389/fimmu.2021.680891","Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.","The network of tunneling nanotubes (TNTs) represents the filamentous (F)-actin rich tubular structure which is connected to the cytoplasm of the adjacent and or distant cells to mediate efficient cell-to-cell communication. They are long cytoplasmic bridges with an extraordinary ability to perform diverse array of function ranging from maintaining cellular physiology and cell survival to promoting immune surveillance. Ironically, TNTs are now widely documented to promote the spread of various pa","2021","07","12","Front Immunol","Frontiers in immunology","heparan sulfate; tunneling nanotubes (TNT); virus cell interactions; virus cell to cell spread; virus surfing; Animals; COVID-19; Cell Communication; Cytoplasm; Humans; Nanotubes; Neurodegenerative Diseases; Virus Diseases","Russell","Greer","Department of Biomedical Sciences, College of Graduate Studies, Midwestern University, Downers Grove, IL, United States",NA
"447","34194434","10.3389/fimmu.2021.680891","Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.","The network of tunneling nanotubes (TNTs) represents the filamentous (F)-actin rich tubular structure which is connected to the cytoplasm of the adjacent and or distant cells to mediate efficient cell-to-cell communication. They are long cytoplasmic bridges with an extraordinary ability to perform diverse array of function ranging from maintaining cellular physiology and cell survival to promoting immune surveillance. Ironically, TNTs are now widely documented to promote the spread of various pa","2021","07","12","Front Immunol","Frontiers in immunology","heparan sulfate; tunneling nanotubes (TNT); virus cell interactions; virus cell to cell spread; virus surfing; Animals; COVID-19; Cell Communication; Cytoplasm; Humans; Nanotubes; Neurodegenerative Diseases; Virus Diseases","Sharma","Ananya","Vanderbilt University School of Medicine, Nashville, TN, United States",NA
"448","34194434","10.3389/fimmu.2021.680891","Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.","The network of tunneling nanotubes (TNTs) represents the filamentous (F)-actin rich tubular structure which is connected to the cytoplasm of the adjacent and or distant cells to mediate efficient cell-to-cell communication. They are long cytoplasmic bridges with an extraordinary ability to perform diverse array of function ranging from maintaining cellular physiology and cell survival to promoting immune surveillance. Ironically, TNTs are now widely documented to promote the spread of various pa","2021","07","12","Front Immunol","Frontiers in immunology","heparan sulfate; tunneling nanotubes (TNT); virus cell interactions; virus cell to cell spread; virus surfing; Animals; COVID-19; Cell Communication; Cytoplasm; Humans; Nanotubes; Neurodegenerative Diseases; Virus Diseases","Shukla","Deepak","Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, United States",NA
"449","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Pandolfi","Laura","Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"450","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Bozzini","Sara","Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"451","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Frangipane","Vanessa","Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"452","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Percivalle","Elena","Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy",NA
"453","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","De Luigi","Ada","Laboratory of Biochemistry and Protein Chemistry, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche ""Mario Negri"" IRCCS, Milano, Italy",NA
"454","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Violatto","Martina Bruna","Laboratory of Biochemistry and Protein Chemistry, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche ""Mario Negri"" IRCCS, Milano, Italy",NA
"455","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Lopez","Gianluca","Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milano, Milano, Italy",NA
"456","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Gabanti","Elisa","Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy",NA
"457","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Carsana","Luca","Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milano, Milano, Italy",NA
"458","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","D'Amato","Maura","Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"459","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Morosini","Monica","Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"460","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","De Amici","Mara","Laboratory of Immuno Allergology Clinical Chemistry and Pediatrics Clinic, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy",NA
"461","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Nebuloni","Manuela","Pathology Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milano, Milano, Italy",NA
"462","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Fossali","Tommaso","Division of Anaesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy",NA
"463","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Colombo","Riccardo","Division of Anaesthesiology and Intensive Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy",NA
"464","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Saracino","Laura","Unit of Pneumology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"465","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Codullo","Veronica","Unit of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"466","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Gnecchi","Massimiliano","Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy",NA
"467","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Bigini","Paolo","Laboratory of Biochemistry and Protein Chemistry, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche ""Mario Negri"" IRCCS, Milano, Italy",NA
"468","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Baldanti","Fausto","Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy",NA
"469","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Lilleri","Daniele","Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy",NA
"470","34194429","10.3389/fimmu.2021.663303","Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis.","The release of neutrophil extracellular traps (NETs), a process termed NETosis, avoids pathogen spread but may cause tissue injury. NETs have been found in severe COVID-19 patients, but their role in disease development is still unknown. The aim of this study is to assess the capacity of NETs to drive epithelial-mesenchymal transition (EMT) of lung epithelial cells and to analyze the involvement of NETs in COVID-19. Bronchoalveolar lavage fluid of severe COVID-19 patients showed high concentrati","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; NETosis; SARS-CoV2; epithelial-mesenchymal transition; lung fibrosis; Adult; Biopsy; Bronchoalveolar Lavage Fluid; COVID-19; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Traps; Humans; Lung; Neutrophils; Pulmonary Fibrosis","Meloni","Federica","Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy",NA
"471","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Osman","Ikram Omar","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"472","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Melenotte","Cléa","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"473","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Brouqui","Philippe","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"474","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Million","Matthieu","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"475","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Lagier","Jean-Christophe","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"476","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Parola","Philippe","Aix-Marseille Univ, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France",NA
"477","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Stein","Andréas","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"478","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","La Scola","Bernard","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"479","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Meddeb","Line","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"480","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Mege","Jean-Louis","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"481","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Raoult","Didier","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"482","34194422","10.3389/fimmu.2021.625732","Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.","The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the angiotensin I converting enzyme 2 (ACE2) monocarboxypeptidase. ACE2, present on the surface of many cell types, is known to be a regulator of blood pressure homeostasis through its ability to catalyze the proteolysis of Angiotensin II (Ang II) into Angiotensin-(1-7) [Ang-(1-7)]. We therefore hypothesized that SARS-CoV-2 could tri","2021","07","12","Front Immunol","Frontiers in immunology","ACE2 (Angiotensin Converting Enzyme-2); COVID-19; Hypertension; Renin  Angiotensin  Aldosterone System; SARS  CoV  2; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding","Devaux","Christian A","Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France",NA
"483","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Jagtap","Dhanashree","Department of Structural Biology Division, ICMR-NIRRH, Mumbai, India",NA
"484","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Bhor","Vikrant M","Department of Molecular Immunology &amp",NA
"485","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Bhowmick","Shilpa","Department of Biochemistry &amp",NA
"486","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Kasarpalkar","Nandini","Department of Molecular Immunology &amp",NA
"487","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Sagvekar","Pooja","Department of Biochemistry &amp",NA
"488","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Kulkarni","Bhalchandra","Department of Structural Biology Division, ICMR-NIRRH, Mumbai, India",NA
"489","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Pathak","Manish","Molecular Lab, Kasturba Hospital for Infectious Diseases, Mumbai, India",NA
"490","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Chatterjee","Nirjhar","Department of Microbiology, BYL Nair Hospital, Mumbai, India",NA
"491","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Dolas","Pranam","Kasturba Hospital for Infectious Diseases, Mumbai, India",NA
"492","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Palav","Harsha","Department of Biochemistry &amp",NA
"493","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Kaginkar","Snehal","Department of Biochemistry &amp",NA
"494","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Bhagat","Sharad","Department of Biochemistry &amp",NA
"495","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Munshi","Itti","Department of Primate Biology, ICMR-NIRRH, Mumbai, India",NA
"496","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Parikh","Swapneil","Molecular Lab, Kasturba Hospital for Infectious Diseases, Mumbai, India",NA
"497","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Agrawal","Sachee","Department of Microbiology, BYL Nair Hospital, Mumbai, India",NA
"498","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Pawar","Chandrakant","Kasturba Hospital for Infectious Diseases, Mumbai, India",NA
"499","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Kaneria","Mala","Department of Microbiology, BYL Nair Hospital, Mumbai, India",NA
"500","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Mahale","Smita D","Department of Structural Biology Division, ICMR-NIRRH, Mumbai, India",NA
"501","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Shastri","Jayanthi","Molecular Lab, Kasturba Hospital for Infectious Diseases, Mumbai, India",NA
"502","34194420","10.3389/fimmu.2021.619906","sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.","The role of sMAdCAM, an important gut immune migratory marker, remains unexplored in COVID-19 pathogenesis considering recent studies positing the gut as a sanctuary site for SARS-CoV-2 persistence. Thus, assimilating profiles of systemic inflammatory mediators with sMAdCAM levels may provide insights into the progression of COVID-19 disease. Also, the role of these markers in governing virus specific immunity following infection remains largely unexplored. A cohort (n = 84) of SARS-C0V-2 infect","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; IL-6; SPR; antibodies; inflammation; sMAdCAM; sMIL index; Adolescent; Adult; Aged; Biomarkers; COVID-19; Cell Adhesion Molecules; Cohort Studies; Cytokines; Disease Progression; Female; Humans; Interleukin-6; Intestines; Male; Middle Aged; Mucoproteins; Surface Plasmon Resonance; Young Adult","Patel","Vainav","Department of Biochemistry &amp",NA
"503","34194418","10.3389/fimmu.2021.558270","Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.","The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants a","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; demography; disease outbreaks; surveys and questionnaires; vaccines; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Rural Population; Surveys and Questionnaires; United States; Urban Population; Vaccination Refusal; Vaccines; Young Adult","Shih","Shu-Fang","Department of Health Administration, College of Health Professions, Virginia Commonwealth University, Richmond, VA, United States",NA
"504","34194418","10.3389/fimmu.2021.558270","Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.","The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants a","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; demography; disease outbreaks; surveys and questionnaires; vaccines; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Rural Population; Surveys and Questionnaires; United States; Urban Population; Vaccination Refusal; Vaccines; Young Adult","Wagner","Abram L","Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States",NA
"505","34194418","10.3389/fimmu.2021.558270","Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.","The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants a","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; demography; disease outbreaks; surveys and questionnaires; vaccines; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Rural Population; Surveys and Questionnaires; United States; Urban Population; Vaccination Refusal; Vaccines; Young Adult","Masters","Nina B","Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United States",NA
"506","34194418","10.3389/fimmu.2021.558270","Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.","The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants a","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; demography; disease outbreaks; surveys and questionnaires; vaccines; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Rural Population; Surveys and Questionnaires; United States; Urban Population; Vaccination Refusal; Vaccines; Young Adult","Prosser","Lisa A","Department of Health Administration, College of Health Professions, Virginia Commonwealth University, Richmond, VA, United States",NA
"507","34194418","10.3389/fimmu.2021.558270","Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.","The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants a","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; demography; disease outbreaks; surveys and questionnaires; vaccines; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Rural Population; Surveys and Questionnaires; United States; Urban Population; Vaccination Refusal; Vaccines; Young Adult","Lu","Yihan","Department of Epidemiology, Key Laboratory of Public Health Safety (Ministry of Education), Fudan University School of Public Health, Shanghai, China",NA
"508","34194418","10.3389/fimmu.2021.558270","Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States.","The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different concepts. This study characterized rejection of a hypothetical COVID-19 vaccine, and compared patterns of association between general vaccine hesitancy and COVID-19 vaccine rejection. The survey was conducted online March 20-22, 2020. Participants a","2021","07","12","Front Immunol","Frontiers in immunology","COVID-19; demography; disease outbreaks; surveys and questionnaires; vaccines; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19 Vaccines; Female; Humans; Male; Middle Aged; Rural Population; Surveys and Questionnaires; United States; Urban Population; Vaccination Refusal; Vaccines; Young Adult","Zikmund-Fisher","Brian J","Department of Health Behavior &amp",NA
"509","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Sheikh","Saima","Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom",NA
"510","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Tofique","Sehrish","Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan",NA
"511","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Zehra","Nosheen","Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom",NA
"512","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Amjad","Rabia","Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan",NA
"513","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Rasheed","Maham","Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan",NA
"514","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Usman","Maria","Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan",NA
"515","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Lal","Shanker","Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan",NA
"516","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Hooper","Emma","Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom",NA
"517","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Miah","Jahanara","Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom",NA
"518","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Husain","Nusrat","Division of Global Mental Health, University of Manchester, Manchester, United Kingdom",NA
"519","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Jafri","Hussain","Department of Health, Alzheimer Pakistan, Lahore, Pakistan",NA
"520","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Chaudhry","Nasim","Department of Psychiatry, Pakistan Institute of Living and Learning, Karachi, Pakistan",NA
"521","34194381","10.3389/fneur.2021.654143","SENSE-Cog Asia: A Feasibility Study of a Hearing Intervention to Improve Outcomes in People With Dementia.","Background: There are few evidence-based non-pharmacological interventions adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC). Thus, there is value in culturally adapting existing interventions from other settings. One such intervention for PwD involves hearing rehabilitation, which may improve dementia-related outcomes. Objective: To culturally adapt and evaluate the feasibility and acceptability of a multi-faceted hearing support intervention to e","2021","07","02","Front Neurol","Frontiers in neurology","LMICs; acceptability; dementia; feasibility; hearing impairment; tolerability","Leroi","Iracema","Department of Psychiatry, Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland",NA
"522","34194374","10.3389/fpsyg.2021.684540","Internet-Based Cognitive Behavioral Therapy for Psychological Distress Associated With the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.","Background: The COVID-19 pandemic has been associated with various negative psychological consequences. This is a challenge for the society as regular psychological services cannot be offered to the same extent as before the pandemic. In addition to the requirement of social distancing, there is a need to adjust psychological treatment components like exposure to avoid increasing the spread of the infection. Internet-delivered cognitive behavior therapy (ICBT) has an established evidence ","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; anxiety; controlled trial; depression; internet-based cognitive behavior therapy","Aminoff","Victoria","Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden",NA
"523","34194374","10.3389/fpsyg.2021.684540","Internet-Based Cognitive Behavioral Therapy for Psychological Distress Associated With the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.","Background: The COVID-19 pandemic has been associated with various negative psychological consequences. This is a challenge for the society as regular psychological services cannot be offered to the same extent as before the pandemic. In addition to the requirement of social distancing, there is a need to adjust psychological treatment components like exposure to avoid increasing the spread of the infection. Internet-delivered cognitive behavior therapy (ICBT) has an established evidence ","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; anxiety; controlled trial; depression; internet-based cognitive behavior therapy","Sellén","Malin","Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden",NA
"524","34194374","10.3389/fpsyg.2021.684540","Internet-Based Cognitive Behavioral Therapy for Psychological Distress Associated With the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.","Background: The COVID-19 pandemic has been associated with various negative psychological consequences. This is a challenge for the society as regular psychological services cannot be offered to the same extent as before the pandemic. In addition to the requirement of social distancing, there is a need to adjust psychological treatment components like exposure to avoid increasing the spread of the infection. Internet-delivered cognitive behavior therapy (ICBT) has an established evidence ","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; anxiety; controlled trial; depression; internet-based cognitive behavior therapy","Sörliden","Elise","Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden",NA
"525","34194374","10.3389/fpsyg.2021.684540","Internet-Based Cognitive Behavioral Therapy for Psychological Distress Associated With the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.","Background: The COVID-19 pandemic has been associated with various negative psychological consequences. This is a challenge for the society as regular psychological services cannot be offered to the same extent as before the pandemic. In addition to the requirement of social distancing, there is a need to adjust psychological treatment components like exposure to avoid increasing the spread of the infection. Internet-delivered cognitive behavior therapy (ICBT) has an established evidence ","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; anxiety; controlled trial; depression; internet-based cognitive behavior therapy","Ludvigsson","Mikael","Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden",NA
"526","34194374","10.3389/fpsyg.2021.684540","Internet-Based Cognitive Behavioral Therapy for Psychological Distress Associated With the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.","Background: The COVID-19 pandemic has been associated with various negative psychological consequences. This is a challenge for the society as regular psychological services cannot be offered to the same extent as before the pandemic. In addition to the requirement of social distancing, there is a need to adjust psychological treatment components like exposure to avoid increasing the spread of the infection. Internet-delivered cognitive behavior therapy (ICBT) has an established evidence ","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; anxiety; controlled trial; depression; internet-based cognitive behavior therapy","Berg","Matilda","Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden",NA
"527","34194374","10.3389/fpsyg.2021.684540","Internet-Based Cognitive Behavioral Therapy for Psychological Distress Associated With the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.","Background: The COVID-19 pandemic has been associated with various negative psychological consequences. This is a challenge for the society as regular psychological services cannot be offered to the same extent as before the pandemic. In addition to the requirement of social distancing, there is a need to adjust psychological treatment components like exposure to avoid increasing the spread of the infection. Internet-delivered cognitive behavior therapy (ICBT) has an established evidence ","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; anxiety; controlled trial; depression; internet-based cognitive behavior therapy","Andersson","Gerhard","Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden",NA
"528","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Soriano","Emily C","Department of Psychological and Brain Sciences, University of Delaware, Newark, DE, United States",NA
"529","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Perndorfer","Christine","Department of Psychological and Brain Sciences, University of Delaware, Newark, DE, United States",NA
"530","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Otto","Amy K","Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, United States",NA
"531","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Fenech","Alyssa L","Department of Psychological and Brain Sciences, University of Delaware, Newark, DE, United States",NA
"532","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Siegel","Scott D","Christiana Care Health System, Helen F. Graham Cancer Center and Research Institute, Newark, DE, United States",NA
"533","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Dickson-Witmer","Diana","Christiana Care Health System, Helen F. Graham Cancer Center and Research Institute, Newark, DE, United States",NA
"534","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Clements","Lydia","Christiana Care Health System, Helen F. Graham Cancer Center and Research Institute, Newark, DE, United States",NA
"535","34194367","10.3389/fpsyg.2021.662339","Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","Background: The COVID-19 pandemic caused significant disruptions in cancer care, and preliminary research suggests that these disruptions are associated with increased levels of psychosocial distress among cancer survivors. The purpose of this study was to offer a descriptive report of the psychosocial functioning, perceived risk and fear of cancer progression, and COVID-19 pandemic impact and experiences in a unique, high-risk patient cohort: breast cancer survivors whose cancer treatmen","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; breast cancer; cancer survivorship; fear of cancer progression; fear of cancer recurrence","Laurenceau","Jean-Philippe","Department of Psychological and Brain Sciences, University of Delaware, Newark, DE, United States",NA
"536","34194364","10.3389/fpsyg.2021.660628","Effects of Pandemic on Feelings of Depression in Italy: The Role of Age, Gender, and Individual Experiences During the First Lockdown.","The restrictions to physical contacts that have been imposed in different countries to deal with the coronavirus disease 2019 (COVID-19) pandemic may have contributed to an increase in feelings of depression on top of other negative consequences of the pandemic. This study examines the consequences of the COVID-19 pandemic on feelings of depression using original data collected in Italy between April 14 and 24, 2020. Quota sampling (N = 3,026) was performed to target the population of 18+","2021","07","02","Front Psychol","Frontiers in psychology","Italy; age; coronavirus disease 2019; depressive feelings; gender; life-course","Arpino","Bruno","Department of Statistics, Computer Science, Applications, University of Florence, Firenze, Italy",NA
"537","34194364","10.3389/fpsyg.2021.660628","Effects of Pandemic on Feelings of Depression in Italy: The Role of Age, Gender, and Individual Experiences During the First Lockdown.","The restrictions to physical contacts that have been imposed in different countries to deal with the coronavirus disease 2019 (COVID-19) pandemic may have contributed to an increase in feelings of depression on top of other negative consequences of the pandemic. This study examines the consequences of the COVID-19 pandemic on feelings of depression using original data collected in Italy between April 14 and 24, 2020. Quota sampling (N = 3,026) was performed to target the population of 18+","2021","07","02","Front Psychol","Frontiers in psychology","Italy; age; coronavirus disease 2019; depressive feelings; gender; life-course","Pasqualini","Marta","Observatoire Sociologique du Changement (OSC), Sciences Po, Paris, France",NA
"538","34194360","10.3389/fpsyg.2021.648208","Making Older Adults' Cognitive Health Visible After Covid-19 Outbreak.",NA,"2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; cognitive health; gender; lockdown; metacognition; older adults","Della Gatta","Francesco","Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, València, Spain",NA
"539","34194360","10.3389/fpsyg.2021.648208","Making Older Adults' Cognitive Health Visible After Covid-19 Outbreak.",NA,"2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; cognitive health; gender; lockdown; metacognition; older adults","Terribili","Chiara","Department of Neuroscience, Mental Health and Sense Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy",NA
"540","34194360","10.3389/fpsyg.2021.648208","Making Older Adults' Cognitive Health Visible After Covid-19 Outbreak.",NA,"2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; cognitive health; gender; lockdown; metacognition; older adults","Fabrizi","Elisa","Department of Neuroscience, Mental Health and Sense Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy",NA
"541","34194360","10.3389/fpsyg.2021.648208","Making Older Adults' Cognitive Health Visible After Covid-19 Outbreak.",NA,"2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; cognitive health; gender; lockdown; metacognition; older adults","Moret-Tatay","Carmen","Department of Neuroscience, Mental Health and Sense Organs (NESMOS), Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy",NA
"542","34194358","10.3389/fpsyg.2021.640567","Understanding Perceived Age-Based Judgement as a Precursor to Age-Based Stereotype Threat in Everyday Settings.","Test conditions eliciting negative stereotypes of aging among older adults can prompt age-based stereotype threat (ABST), which results in worse performance on cognitive and memory tests. Much of this research explores ABST as a phenomenon that impacts the performance of older adults. Little is known about the experience of ABST beyond performance settings and how it manifests in everyday contexts across different age groups. Gaps also remain in understanding the wider impacts of ABST, such as e","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; age stereotyping; middle age; older adult; stereotype threat; threat-based concerns; young","Lamont","Ruth A","College of Medicine and Health, University of Exeter, Exeter, United Kingdom",NA
"543","34194358","10.3389/fpsyg.2021.640567","Understanding Perceived Age-Based Judgement as a Precursor to Age-Based Stereotype Threat in Everyday Settings.","Test conditions eliciting negative stereotypes of aging among older adults can prompt age-based stereotype threat (ABST), which results in worse performance on cognitive and memory tests. Much of this research explores ABST as a phenomenon that impacts the performance of older adults. Little is known about the experience of ABST beyond performance settings and how it manifests in everyday contexts across different age groups. Gaps also remain in understanding the wider impacts of ABST, such as e","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; age stereotyping; middle age; older adult; stereotype threat; threat-based concerns; young","Swift","Hannah J","School of Psychology, University of Kent, Canterbury, United Kingdom",NA
"544","34194358","10.3389/fpsyg.2021.640567","Understanding Perceived Age-Based Judgement as a Precursor to Age-Based Stereotype Threat in Everyday Settings.","Test conditions eliciting negative stereotypes of aging among older adults can prompt age-based stereotype threat (ABST), which results in worse performance on cognitive and memory tests. Much of this research explores ABST as a phenomenon that impacts the performance of older adults. Little is known about the experience of ABST beyond performance settings and how it manifests in everyday contexts across different age groups. Gaps also remain in understanding the wider impacts of ABST, such as e","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; age stereotyping; middle age; older adult; stereotype threat; threat-based concerns; young","Drury","Lisbeth","Department of Organizational Psychology, Birkbeck, University of London, London, United Kingdom",NA
"545","34194354","10.3389/fpsyg.2021.607948","Personality and Motives for Social Media Use When Physically Distanced: A Uses and Gratifications Approach.","This paper explores individuals' motives for using social media when living under 'social distancing' conditions imposed during the COVID-19 pandemic, where they were instructed to physically distance from other people. Adopting a 'uses and gratifications' approach, and using a previously established five-factor scale, we examine the relationship between individuals' motives for using social media and their personality traits. Hundred and eighty-nine social media users living in the United Kingd","2021","07","02","Front Psychol","Frontiers in psychology","Big Five; motives; personality; social media; uses and gratifications","Bowden-Green","Thomas","Information, Decisions and Operations Division, School of Management, University of Bath, Bath, United Kingdom",NA
"546","34194354","10.3389/fpsyg.2021.607948","Personality and Motives for Social Media Use When Physically Distanced: A Uses and Gratifications Approach.","This paper explores individuals' motives for using social media when living under 'social distancing' conditions imposed during the COVID-19 pandemic, where they were instructed to physically distance from other people. Adopting a 'uses and gratifications' approach, and using a previously established five-factor scale, we examine the relationship between individuals' motives for using social media and their personality traits. Hundred and eighty-nine social media users living in the United Kingd","2021","07","02","Front Psychol","Frontiers in psychology","Big Five; motives; personality; social media; uses and gratifications","Hinds","Joanne","Information, Decisions and Operations Division, School of Management, University of Bath, Bath, United Kingdom",NA
"547","34194354","10.3389/fpsyg.2021.607948","Personality and Motives for Social Media Use When Physically Distanced: A Uses and Gratifications Approach.","This paper explores individuals' motives for using social media when living under 'social distancing' conditions imposed during the COVID-19 pandemic, where they were instructed to physically distance from other people. Adopting a 'uses and gratifications' approach, and using a previously established five-factor scale, we examine the relationship between individuals' motives for using social media and their personality traits. Hundred and eighty-nine social media users living in the United Kingd","2021","07","02","Front Psychol","Frontiers in psychology","Big Five; motives; personality; social media; uses and gratifications","Joinson","Adam","Information, Decisions and Operations Division, School of Management, University of Bath, Bath, United Kingdom",NA
"548","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Wu","Xingzhe","School of Psychology, Central China Normal University, Wuhan, China",NA
"549","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Wang","Zhi","School of Psychology, Central China Normal University, Wuhan, China",NA
"550","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Zhang","Hongpo","School of Psychology, Central China Normal University, Wuhan, China",NA
"551","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Yuan","Peiming","School of Psychology, Central China Normal University, Wuhan, China",NA
"552","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Yu","Quanlei","School of Psychology, Central China Normal University, Wuhan, China",NA
"553","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Zhou","Zhijin","School of Psychology, Central China Normal University, Wuhan, China",NA
"554","34194353","10.3389/fpsyg.2021.600268","Effects of Internet Language Related to COVID-19 on Mental Health in College Students: The Mediating Effect of Cognitive Flexibility.","During the COVID-19 pandemic, Internet language (INL) has influenced daily life extensively. However, the process by which INL influences people's psychology and behavior is unclear. This study explored the effects of INL on mental health (anxiety and depression). A pilot study was conducted to develop a qualified scale for INL related to COVID-19 (CINL) in college students using an online questionnaire. The CINL scale was found to have two dimensions: frequency and comprehension, as well as goo","2021","07","02","Front Psychol","Frontiers in psychology","COVID-19; Internet language; anxiety; cognitive flexibility; depression","Zhao","Qingbai","School of Psychology, Central China Normal University, Wuhan, China",NA
"555","34194349","10.3389/fpsyt.2021.685964","Problematic Use of Alcohol and Online Gaming as Coping Strategies During the COVID-19 Pandemic: A Mini Review.","The COVID-19 (coronavirus disease 2019) pandemic has dramatically changed our daily lives and activities, including those originally intended to serve for leisure and pleasure. Drinking and online gaming became coping behaviors used to rescue ourselves from the stress and restricted lifestyle during the COVID-19 pandemic. However, frequent drinking and gaming can result in the pathological consequences of addiction. Those affected use the stimuli not to obtain pleasure, but rather to avoid the d","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; addiction; alcohol; coping; online gaming; pandemic","Xu","Shijie","Medical Research Center, Hainan Cancer Hospital, Haikou, China",NA
"556","34194349","10.3389/fpsyt.2021.685964","Problematic Use of Alcohol and Online Gaming as Coping Strategies During the COVID-19 Pandemic: A Mini Review.","The COVID-19 (coronavirus disease 2019) pandemic has dramatically changed our daily lives and activities, including those originally intended to serve for leisure and pleasure. Drinking and online gaming became coping behaviors used to rescue ourselves from the stress and restricted lifestyle during the COVID-19 pandemic. However, frequent drinking and gaming can result in the pathological consequences of addiction. Those affected use the stimuli not to obtain pleasure, but rather to avoid the d","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; addiction; alcohol; coping; online gaming; pandemic","Park","Minkyung","Department of Psychiatry, SMG-SNU Boramae Medical Center, Seoul, South Korea",NA
"557","34194349","10.3389/fpsyt.2021.685964","Problematic Use of Alcohol and Online Gaming as Coping Strategies During the COVID-19 Pandemic: A Mini Review.","The COVID-19 (coronavirus disease 2019) pandemic has dramatically changed our daily lives and activities, including those originally intended to serve for leisure and pleasure. Drinking and online gaming became coping behaviors used to rescue ourselves from the stress and restricted lifestyle during the COVID-19 pandemic. However, frequent drinking and gaming can result in the pathological consequences of addiction. Those affected use the stimuli not to obtain pleasure, but rather to avoid the d","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; addiction; alcohol; coping; online gaming; pandemic","Kang","Ung Gu","Institute of Human Behavioral Medicine, Medical Research Center, Seoul National University, Seoul, South Korea",NA
"558","34194349","10.3389/fpsyt.2021.685964","Problematic Use of Alcohol and Online Gaming as Coping Strategies During the COVID-19 Pandemic: A Mini Review.","The COVID-19 (coronavirus disease 2019) pandemic has dramatically changed our daily lives and activities, including those originally intended to serve for leisure and pleasure. Drinking and online gaming became coping behaviors used to rescue ourselves from the stress and restricted lifestyle during the COVID-19 pandemic. However, frequent drinking and gaming can result in the pathological consequences of addiction. Those affected use the stimuli not to obtain pleasure, but rather to avoid the d","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; addiction; alcohol; coping; online gaming; pandemic","Choi","Jung-Seok","Department of Psychiatry, SMG-SNU Boramae Medical Center, Seoul, South Korea",NA
"559","34194349","10.3389/fpsyt.2021.685964","Problematic Use of Alcohol and Online Gaming as Coping Strategies During the COVID-19 Pandemic: A Mini Review.","The COVID-19 (coronavirus disease 2019) pandemic has dramatically changed our daily lives and activities, including those originally intended to serve for leisure and pleasure. Drinking and online gaming became coping behaviors used to rescue ourselves from the stress and restricted lifestyle during the COVID-19 pandemic. However, frequent drinking and gaming can result in the pathological consequences of addiction. Those affected use the stimuli not to obtain pleasure, but rather to avoid the d","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; addiction; alcohol; coping; online gaming; pandemic","Koo","Ja Wook","Emotion, Cognition and Behavior Research Group, Korea Brain Research Institute, Daegu, South Korea",NA
"560","34194342","10.3389/fpsyt.2021.634454","Compulsive Hoarding Symptoms and the Role of Mindfulness Skills During Social Distancing for the COVID-19 Pandemic: An Exploratory Survey.","People reporting compulsive hoarding symptoms (CHS) have lower mindfulness skills than those without such symptoms. Mindfulness skills can have the role of a protective buffer against stressful periods. The quarantine imposed to contain the COVID-19 spread had a negative impact on daily habits and healthy behaviors (including social interactions). An increased attachment to objects might be one of the under-recognized psychological consequences of these difficult times, yet no study focused on C","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19 pandemic; behavioral addiction; compulsive hoarding; coronavirus; mindfulness; obsessive - compulsive disorder; social distancing","Marazziti","Donatella","Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy",NA
"561","34194342","10.3389/fpsyt.2021.634454","Compulsive Hoarding Symptoms and the Role of Mindfulness Skills During Social Distancing for the COVID-19 Pandemic: An Exploratory Survey.","People reporting compulsive hoarding symptoms (CHS) have lower mindfulness skills than those without such symptoms. Mindfulness skills can have the role of a protective buffer against stressful periods. The quarantine imposed to contain the COVID-19 spread had a negative impact on daily habits and healthy behaviors (including social interactions). An increased attachment to objects might be one of the under-recognized psychological consequences of these difficult times, yet no study focused on C","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19 pandemic; behavioral addiction; compulsive hoarding; coronavirus; mindfulness; obsessive - compulsive disorder; social distancing","Pozza","Andrea","Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy",NA
"562","34194342","10.3389/fpsyt.2021.634454","Compulsive Hoarding Symptoms and the Role of Mindfulness Skills During Social Distancing for the COVID-19 Pandemic: An Exploratory Survey.","People reporting compulsive hoarding symptoms (CHS) have lower mindfulness skills than those without such symptoms. Mindfulness skills can have the role of a protective buffer against stressful periods. The quarantine imposed to contain the COVID-19 spread had a negative impact on daily habits and healthy behaviors (including social interactions). An increased attachment to objects might be one of the under-recognized psychological consequences of these difficult times, yet no study focused on C","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19 pandemic; behavioral addiction; compulsive hoarding; coronavirus; mindfulness; obsessive - compulsive disorder; social distancing","Mucci","Federico","Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy",NA
"563","34194342","10.3389/fpsyt.2021.634454","Compulsive Hoarding Symptoms and the Role of Mindfulness Skills During Social Distancing for the COVID-19 Pandemic: An Exploratory Survey.","People reporting compulsive hoarding symptoms (CHS) have lower mindfulness skills than those without such symptoms. Mindfulness skills can have the role of a protective buffer against stressful periods. The quarantine imposed to contain the COVID-19 spread had a negative impact on daily habits and healthy behaviors (including social interactions). An increased attachment to objects might be one of the under-recognized psychological consequences of these difficult times, yet no study focused on C","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19 pandemic; behavioral addiction; compulsive hoarding; coronavirus; mindfulness; obsessive - compulsive disorder; social distancing","Dettore","Davide","Department of Health Sciences, University of Florence, Florence, Italy",NA
"564","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Liu","Shuang","Department of Emergency Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China",NA
"565","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Han","Wei","Institute of Basic Medical Sciences, School of Basic Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China",NA
"566","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Shen","Chenyu","Department of Psychiatric, Yuquan Hospital Tsinghua University, Beijing, China",NA
"567","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhu","Changju","Department of Emergency Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China",NA
"568","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Wang","Qiaofang","Department of Emergency Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China",NA
"569","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Liang","Xianquan","Department of Emergency Medicine, The Second People's Hospital of Guiyang, Guiyang, China",NA
"570","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","He","Xiangxi","Department of Emergency Medicine, The Second People's Hospital of Guiyang, Guiyang, China",NA
"571","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Xie","Qin","Department of Intensive Care, Zhongnan Hospital of Wuhan University, Wuhan, China",NA
"572","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Wei","Jie","Department of Emergency Medicine, Renmin Hospital of Wuhan University, Wuhan, China",NA
"573","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Wu","Miao","Department of Emergency Medicine, Renmin Hospital of Wuhan University, Wuhan, China",NA
"574","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhao","Xiaodong","Department of Emergency Medicine, Fourth Medical Center of PLA General Hospital, Beijing, China",NA
"575","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Liu","Hongsheng","Department of Emergency Medicine, Fourth Medical Center of PLA General Hospital, Beijing, China",NA
"576","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Liu","Danping","Department of Emergency Medicine, Shaanxi Provincial People's Hospital, Xi'an, China",NA
"577","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Guo","Xiaowang","Department of Emergency Medicine, Shaanxi Provincial People's Hospital, Xi'an, China",NA
"578","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Nie","Shinan","Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China",NA
"579","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Cao","Liping","Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China",NA
"580","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Lu","Linxin","Department of Emergency Medicine, Shanxi Bethune Hospital, Taiyuan, China",NA
"581","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Fang","Yaqin","Department of Emergency Medicine, Shanxi Bethune Hospital, Taiyuan, China",NA
"582","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Lu","Zhongqiu","Department of Emergency Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China",NA
"583","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Wu","Yixu","Department of Emergency Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China",NA
"584","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhao","Min","Department of Emergency Medicine, China Medical University of Shengjing Hospital, Shenyang, China",NA
"585","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Han","Jun","Department of Emergency Medicine, China Medical University of Shengjing Hospital, Shenyang, China",NA
"586","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhang","Xinchao","Department of Emergency Medicine, Beijing Hospital, Beijing, China",NA
"587","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Chang","Jie","Department of Emergency Medicine, Beijing Hospital, Beijing, China",NA
"588","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Xu","Shuogui","Department of Emergency Medicine, Changhai Hospital, Shanghai, China",NA
"589","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Ma","Wenjie","Department of Emergency Medicine, Changhai Hospital, Shanghai, China",NA
"590","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Si","Junli","Department of Emergency Medicine, Qingdao Municipal Hospital, Qingdao, China",NA
"591","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Qi","Suxia","Department of Emergency Medicine, Qingdao Municipal Hospital, Qingdao, China",NA
"592","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Peng","Peng","Department of Emergency Medicine, The First Affiliate Hospital of Xinjiang Medical University, Wulumuqi, China",NA
"593","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Chai","Yage","Department of Emergency Medicine, The First Affiliate Hospital of Xinjiang Medical University, Wulumuqi, China",NA
"594","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Cao","Yu","Department of Emergency Medicine, West China Hospital of Sichuan University, Chengdu, China",NA
"595","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Jiang","Yaowen","Department of Emergency Medicine, West China Hospital of Sichuan University, Chengdu, China",NA
"596","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Yin","Wen","Department of Emergency Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China",NA
"597","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Wang","Yanjun","Department of Emergency Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China",NA
"598","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhan","Hong","Department of Emergency Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China",NA
"599","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Huang","Yingxiong","Department of Emergency Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China",NA
"600","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Deng","Ying","Department of Emergency Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, China",NA
"601","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Song","Juanjuan","Department of Emergency Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, China",NA
"602","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Yang","Lishan","Department of Emergency Medicine, General Hospital of Ningxia Medical University, Nanjing, China",NA
"603","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Wu","Jiali","Department of Emergency Medicine, General Hospital of Ningxia Medical University, Nanjing, China",NA
"604","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Ding","Banghan","Department of Emergency Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China",NA
"605","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zheng","Danwen","Department of Emergency Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China",NA
"606","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Qian","Chuanyun","Department of Emergency Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China",NA
"607","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Huang","Rui","Department of Emergency Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China",NA
"608","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Lin","Jiyan","Department of Emergency Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, China",NA
"609","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Xu","Zhihong","Department of Emergency Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, China",NA
"610","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhang","Guoxiu","Department of Emergency Medicine, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China",NA
"611","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Hu","Yingying","Department of Emergency Medicine, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China",NA
"612","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Dou","Qingli","Department of Emergency Medicine, People's Hospital of Shenzhen, Shenzhen, China",NA
"613","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhang","Xiaoming","Department of Emergency Medicine, People's Hospital of Shenzhen, Shenzhen, China",NA
"614","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Tian","Yingping","Department of Emergency Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China",NA
"615","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Yao","Dongqi","Department of Emergency Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China",NA
"616","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Walline","Joseph Harold","Accident and Emergency Medicine Academic Unit, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong",NA
"617","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Zhu","Huadong","Department of Emergency Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China",NA
"618","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Xu","Jun","Department of Emergency Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China",NA
"619","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Li","Yi","Department of Emergency Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China",NA
"620","34194341","10.3389/fpsyt.2021.566990","Depressive State in the Emergency Department During COVID-19: A National Cross-Sectional Survey in China.","Chinese emergency department (ED) staff encountered significant mental stress while fighting the coronavirus disease 2019 (COVID-19) pandemic. We sought to investigate the prevalence and associated factors for depressive symptoms among ED staff (including physicians, nurses, allied health, and auxiliary ED staff). A cross-sectional national survey of ED staff who were on duty and participated in combating the COVID-19 pandemic was conducted March 1-15, 2020. A total of 6,588 emergency medical pe","2021","07","02","Front Psychiatry","Frontiers in psychiatry","COVID-19; China; PHQ-9; depression; emergency medicine","Yu","Xuezhong","Department of Emergency Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China",NA
"621","34194331","10.3389/fphar.2021.685308","A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.","Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their ability to inhibit the binding of recombinant, trimeric SARS-CoV-2 spike protein to recombinant human ACE2. We identified 56 compounds that inhibited binding in a concentration-dependent manner, meas","2021","07","07","Front Pharmacol","Frontiers in pharmacology","COVID-19; IP-FCM; drug screen; inhibition assay; repurposed","Tsegay","Kaleb B","Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States",NA
"622","34194331","10.3389/fphar.2021.685308","A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.","Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their ability to inhibit the binding of recombinant, trimeric SARS-CoV-2 spike protein to recombinant human ACE2. We identified 56 compounds that inhibited binding in a concentration-dependent manner, meas","2021","07","07","Front Pharmacol","Frontiers in pharmacology","COVID-19; IP-FCM; drug screen; inhibition assay; repurposed","Adeyemi","Christiana M","St. Louis University School of Medicine, Department of Pharmacology and Physiology, St. Louis, MO, United States",NA
"623","34194331","10.3389/fphar.2021.685308","A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.","Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their ability to inhibit the binding of recombinant, trimeric SARS-CoV-2 spike protein to recombinant human ACE2. We identified 56 compounds that inhibited binding in a concentration-dependent manner, meas","2021","07","07","Front Pharmacol","Frontiers in pharmacology","COVID-19; IP-FCM; drug screen; inhibition assay; repurposed","Gniffke","Edward P","Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States",NA
"624","34194331","10.3389/fphar.2021.685308","A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.","Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their ability to inhibit the binding of recombinant, trimeric SARS-CoV-2 spike protein to recombinant human ACE2. We identified 56 compounds that inhibited binding in a concentration-dependent manner, meas","2021","07","07","Front Pharmacol","Frontiers in pharmacology","COVID-19; IP-FCM; drug screen; inhibition assay; repurposed","Sather","D Noah","Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States",NA
"625","34194331","10.3389/fphar.2021.685308","A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.","Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their ability to inhibit the binding of recombinant, trimeric SARS-CoV-2 spike protein to recombinant human ACE2. We identified 56 compounds that inhibited binding in a concentration-dependent manner, meas","2021","07","07","Front Pharmacol","Frontiers in pharmacology","COVID-19; IP-FCM; drug screen; inhibition assay; repurposed","Walker","John K","St. Louis University School of Medicine, Department of Pharmacology and Physiology, St. Louis, MO, United States",NA
"626","34194331","10.3389/fphar.2021.685308","A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.","Repurposed drugs that block the interaction between the SARS-CoV-2 spike protein and its receptor ACE2 could offer a rapid route to novel COVID-19 treatments or prophylactics. Here, we screened 2,701 compounds from a commercial library of drugs approved by international regulatory agencies for their ability to inhibit the binding of recombinant, trimeric SARS-CoV-2 spike protein to recombinant human ACE2. We identified 56 compounds that inhibited binding in a concentration-dependent manner, meas","2021","07","07","Front Pharmacol","Frontiers in pharmacology","COVID-19; IP-FCM; drug screen; inhibition assay; repurposed","Smith","Stephen E P","Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States",NA
"627","34194280","10.4103/jfcm.jfcm_19_21","Patient satisfaction with virtual clinics during the coronavirus disease-19 pandemic in primary healthcare, Riyadh, Saudi Arabia.",NA,"2021","07","02","J Family Community Med","Journal of family &amp; community medicine",NA,"Rajpal","Shweta","Department of Community Medicine, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India",NA
"628","34194277","10.4103/jfcm.jfcm_69_21","Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.","The efficacy of corticosteroid use in patients with acute respiratory illness due to coronavirus disease-2019 (COVID-19) is unclear. In this study, we describe the clinical course of COVID-19 patients who received early course of corticosteroid treatment in patients with severe respiratory distress secondary to COVID-19. The clinical course of 30 COVID-19 patients admitted to King Fahad Military Medical Complex in Dhahran from the period of late March 2020 till June 2020 was assessed and describ","2021","07","02","J Family Community Med","Journal of family &amp; community medicine","COVID-19; Saudi Arabia; dexamethasone; glucocorticoids; methylprednisolone","Al-Bahrani","Salma Y","Department of Infectious Disease, King Fahad Military Medical Complex, Dhahran, Saudi Arabia",NA
"629","34194277","10.4103/jfcm.jfcm_69_21","Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.","The efficacy of corticosteroid use in patients with acute respiratory illness due to coronavirus disease-2019 (COVID-19) is unclear. In this study, we describe the clinical course of COVID-19 patients who received early course of corticosteroid treatment in patients with severe respiratory distress secondary to COVID-19. The clinical course of 30 COVID-19 patients admitted to King Fahad Military Medical Complex in Dhahran from the period of late March 2020 till June 2020 was assessed and describ","2021","07","02","J Family Community Med","Journal of family &amp; community medicine","COVID-19; Saudi Arabia; dexamethasone; glucocorticoids; methylprednisolone","Al-Shammari","Amal S","Department of Infection Control, King Fahad Military Medical Complex, Dhahran, Saudi Arabia",NA
"630","34194277","10.4103/jfcm.jfcm_69_21","Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.","The efficacy of corticosteroid use in patients with acute respiratory illness due to coronavirus disease-2019 (COVID-19) is unclear. In this study, we describe the clinical course of COVID-19 patients who received early course of corticosteroid treatment in patients with severe respiratory distress secondary to COVID-19. The clinical course of 30 COVID-19 patients admitted to King Fahad Military Medical Complex in Dhahran from the period of late March 2020 till June 2020 was assessed and describ","2021","07","02","J Family Community Med","Journal of family &amp; community medicine","COVID-19; Saudi Arabia; dexamethasone; glucocorticoids; methylprednisolone","Al-Otaibi","Maha J","Department of Internal Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia",NA
"631","34194277","10.4103/jfcm.jfcm_69_21","Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.","The efficacy of corticosteroid use in patients with acute respiratory illness due to coronavirus disease-2019 (COVID-19) is unclear. In this study, we describe the clinical course of COVID-19 patients who received early course of corticosteroid treatment in patients with severe respiratory distress secondary to COVID-19. The clinical course of 30 COVID-19 patients admitted to King Fahad Military Medical Complex in Dhahran from the period of late March 2020 till June 2020 was assessed and describ","2021","07","02","J Family Community Med","Journal of family &amp; community medicine","COVID-19; Saudi Arabia; dexamethasone; glucocorticoids; methylprednisolone","Ahmed","Zubair R","Department of Internal Medicine, King Fahad Military Medical Complex, Dhahran, Saudi Arabia",NA
"632","34194260","10.1016/j.jsps.2021.04.014","Expanding pharmacist's educational role using virtual and social media portals before and during COVID19 outbreak.","There are many ways to raise public health awareness and recently, Social media networks (SMN) have played a big role in it. The study aims to assess SMN use for acquiring health care information and publics' perception of virtual encounters with pharmacists for health- related purposes; particularly in times of a pandemic crisis. A bi-phasic cross-sectional survey was distributed on 2017 and again during COVID-19 pandemic. both phases (phase 1) and (phase 2) respectively, were compared and anal","2021","07","02","Saudi Pharm J","Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","CMR; COVID-19; Complete medication review; Corona virus; Digitalization; MTM; Medication therapy management; Pharmacist; Public health; SMN; Social media network; Virtual","Badr","Aisha F","King Abdulaziz University Faculty of Pharmacy, Pharmacy Practice Department, Jeddah, Saudi Arabia",NA
"633","34194260","10.1016/j.jsps.2021.04.014","Expanding pharmacist's educational role using virtual and social media portals before and during COVID19 outbreak.","There are many ways to raise public health awareness and recently, Social media networks (SMN) have played a big role in it. The study aims to assess SMN use for acquiring health care information and publics' perception of virtual encounters with pharmacists for health- related purposes; particularly in times of a pandemic crisis. A bi-phasic cross-sectional survey was distributed on 2017 and again during COVID-19 pandemic. both phases (phase 1) and (phase 2) respectively, were compared and anal","2021","07","02","Saudi Pharm J","Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","CMR; COVID-19; Complete medication review; Corona virus; Digitalization; MTM; Medication therapy management; Pharmacist; Public health; SMN; Social media network; Virtual","Ismail","Ghady A","King Abdulaziz University Faculty of Pharmacy, Pharmacy Practice Department, Jeddah, Saudi Arabia",NA
"634","34194260","10.1016/j.jsps.2021.04.014","Expanding pharmacist's educational role using virtual and social media portals before and during COVID19 outbreak.","There are many ways to raise public health awareness and recently, Social media networks (SMN) have played a big role in it. The study aims to assess SMN use for acquiring health care information and publics' perception of virtual encounters with pharmacists for health- related purposes; particularly in times of a pandemic crisis. A bi-phasic cross-sectional survey was distributed on 2017 and again during COVID-19 pandemic. both phases (phase 1) and (phase 2) respectively, were compared and anal","2021","07","02","Saudi Pharm J","Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","CMR; COVID-19; Complete medication review; Corona virus; Digitalization; MTM; Medication therapy management; Pharmacist; Public health; SMN; Social media network; Virtual","Alghuraybi","Rawan H","King Abdulaziz University Faculty of Pharmacy, Pharmacy Practice Department, Jeddah, Saudi Arabia",NA
"635","34194260","10.1016/j.jsps.2021.04.014","Expanding pharmacist's educational role using virtual and social media portals before and during COVID19 outbreak.","There are many ways to raise public health awareness and recently, Social media networks (SMN) have played a big role in it. The study aims to assess SMN use for acquiring health care information and publics' perception of virtual encounters with pharmacists for health- related purposes; particularly in times of a pandemic crisis. A bi-phasic cross-sectional survey was distributed on 2017 and again during COVID-19 pandemic. both phases (phase 1) and (phase 2) respectively, were compared and anal","2021","07","02","Saudi Pharm J","Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","CMR; COVID-19; Complete medication review; Corona virus; Digitalization; MTM; Medication therapy management; Pharmacist; Public health; SMN; Social media network; Virtual","Lahza","Raghad Z","King Abdulaziz University Faculty of Pharmacy, Pharmacy Practice Department, Jeddah, Saudi Arabia",NA
"636","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","Hajek","André","Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany",NA
"637","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","Bertram","Franziska","Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"638","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","van Rüth","Victoria","Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"639","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","Kretzler","Benedikt","Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany",NA
"640","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","Püschel","Klaus","Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"641","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","Heinrich","Fabian","Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"642","34194250","10.2147/RMHP.S317039","Prevalence and Factors Associated with Fear of COVID-19 Among Homeless Individuals During the COVID-19 Pandemic: Evidence from the Hamburg Survey of Homeless Individuals.","To clarify the prevalence and determinants of fear of COVID-19 among homeless individuals during the COVID-19 pandemic. Data were taken from the Hamburg survey of homeless individuals (n=150) covering homeless adults in Hamburg, Germany. Multiple linear regressions were used. Beyond sociodemographic and lifestyle-related independent variables, COVID-19-related factors were also used as independent variables. In sum, 56.2% of homeless individuals reported no fear of COVID-19, 23.8% reported a lit","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19 worry; SARS-CoV-2; alcohol; anxiety of COVID-19; coronavirus; fear of COVID-19; homeless","König","Hans-Helmut","Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany",NA
"643","34194248","10.2147/RMHP.S314750","Whether County Lockdown Could Deter the Contagion of COVID-19 in the USA.","Whether to lock down a country or not during COVID-19 pandemic becomes a vital issue, since it affects people's daily life. The objective of this research is to design a measurement that could be utilised to predict the efficacy of a lockdown decision. One would expect that the effectiveness of lockdown lies in the assumption that the virus spreads from one area to another area in a rippling way. If the virus spreads in a radiating way, then lockdown should be an effective countermeasure to cont","2021","07","02","Risk Manag Healthc Policy","Risk management and healthcare policy","COVID-19; graph; lockdown; minimal distance; neighbouring; transport","Chen","Ray-Ming","School of Mathematics and Statistics, Baise University, Baise CIty, Guangxi Province, People's Republic of China",NA
"644","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Di Pierro","Francesco","Scientific &amp",NA
"645","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Iqtadar","Somia","Department of Medicine, King Edward Medical University, Lahore, Pakistan",NA
"646","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Khan","Amjad","Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK",NA
"647","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Ullah Mumtaz","Sami","Department of Medicine, King Edward Medical University, Lahore, Pakistan",NA
"648","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Masud Chaudhry","Mohsin","Department of Medicine, King Edward Medical University, Lahore, Pakistan",NA
"649","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Bertuccioli","Alexander","Department of Biomolecular Sciences (DISB), University of Urbino, Urbino, Italy",NA
"650","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Derosa","Giuseppe","Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy",NA
"651","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Maffioli","Pamela","Laboratory of Molecular Medicine, University of Pavia, Pavia, Italy",NA
"652","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Togni","Stefano","Indena Research Department, Milan, Italy",NA
"653","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Riva","Antonella","Indena Research Department, Milan, Italy",NA
"654","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Allegrini","Pietro","Indena Research Department, Milan, Italy",NA
"655","34194240","10.2147/IJGM.S318949","Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral role of quercetin, and on its described anti-blood clotting, anti-inflammatory and antioxidant properties, we hypothesize that subjects with mild COVID-19 treated with Quercetin Phytosome<sup>®</sup> (QP), a novel bioavailable form of quercetin, may have a shorter time to virus clearance, a milder symptomatology, and higher probabilities","2021","07","02","Int J Gen Med","International journal of general medicine","CRP; D-dimer; LDH; RT-PCR; SARS-CoV-2; coronavirus; ferritin; phytosome®","Khan","Saeed","Department of Molecular Pathology, Dow University of Health Sciences, Karachi, Pakistan",NA
"656","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Xu","Yuan","Chongqing Medical University, Chongqing, 400014, People's Republic of China",NA
"657","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Yang","Huan","Department of Clinical Laboratory, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, 400014, People's Republic of China",NA
"658","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Wang","Jing","Department of Clinical Laboratory, Chongqing Public Health Medical Center, Chongqing, 400036, People's Republic of China",NA
"659","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Li","Xiaoying","Department of Clinical Laboratory, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, 400014, People's Republic of China",NA
"660","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Xue","Chengjun","Department of Clinical Laboratory, Chongqing Public Health Medical Center, Chongqing, 400036, People's Republic of China",NA
"661","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Niu","Changchun","Department of Clinical Laboratory, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, 400014, People's Republic of China",NA
"662","34194238","10.2147/IJGM.S312521","Serum Albumin Levels are a Predictor of COVID-19 Patient Prognosis: Evidence from a Single Cohort in Chongqing, China.","COVID-19 infections are still at pandemic levels globally and there are currently no specific drugs to treat these infections. Previous studies have demonstrated that serum albumin levels were abnormally low in COVID-19 patients and might be used as a prognosis biomarker. Supplemental albumin has been used as an experimental therapeutic method. However, dynamic evaluation of albumin in patients with COVID-19 was limited and whether serum albumin could predict the prognosis of these patients is u","2021","07","02","Int J Gen Med","International journal of general medicine","COVID-19; SARS-CoV-2; albumin; liver function; prognosis","Liao","Pu","Chongqing Medical University, Chongqing, 400014, People's Republic of China",NA
"663","34194232","10.2147/IDR.S320771","COVID-19 Vaccination Acceptance and Its Associated Factors in Sodo Town, Wolaita Zone, Southern Ethiopia: Cross-Sectional Study.","Coronavirus disease (COVID-19) pandemic has still affected many countries around the world. The COVID-19 vaccine has been presented as the perfect solution for solving the current pandemic. Understanding the willingness of the community to receive the COVID-19 vaccine will help in the development and implementation of effective COVID-19 vaccination promotion programs. The aim of this study was to assess the COVID-19 vaccination acceptance and its associated factors in Sodo town, Wolaita zone, So","2021","07","02","Infect Drug Resist","Infection and drug resistance","COVID-19; Ethiopia; Sodo town; acceptance; vaccine","Mesele","Molalegn","School of Midwifery, College of Health Science and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia",NA
"664","34194222","10.2147/OPTH.S318897","Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.","To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. Only patients with primary open angle glaucoma (POAG), who had a cup-disc ratio (CDR) of 0.9 or a near total cupping on maximum tolerated medical therapy for at least 4 weeks and yet could not meet the target IOP were included. Target IOP was defined as =12 mm Hg. A total of 30 patients were enrolled. All pat","2021","07","02","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19 lockdown; ROCK1 inhibitor; advanced glaucoma; maximally-tolerated-medical-therapy; ripausdil","Naik","Mayuresh","Department of Ophthalmology, H.I.M.S.R &amp",NA
"665","34194222","10.2147/OPTH.S318897","Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.","To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. Only patients with primary open angle glaucoma (POAG), who had a cup-disc ratio (CDR) of 0.9 or a near total cupping on maximum tolerated medical therapy for at least 4 weeks and yet could not meet the target IOP were included. Target IOP was defined as =12 mm Hg. A total of 30 patients were enrolled. All pat","2021","07","02","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19 lockdown; ROCK1 inhibitor; advanced glaucoma; maximally-tolerated-medical-therapy; ripausdil","Kapur","Monika","Department of Ophthalmology, School of Medical Sciences &amp",NA
"666","34194222","10.2147/OPTH.S318897","Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.","To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. Only patients with primary open angle glaucoma (POAG), who had a cup-disc ratio (CDR) of 0.9 or a near total cupping on maximum tolerated medical therapy for at least 4 weeks and yet could not meet the target IOP were included. Target IOP was defined as =12 mm Hg. A total of 30 patients were enrolled. All pat","2021","07","02","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19 lockdown; ROCK1 inhibitor; advanced glaucoma; maximally-tolerated-medical-therapy; ripausdil","Gupta","VishnuSwarup","Department of Ophthalmology, H.I.M.S.R &amp",NA
"667","34194222","10.2147/OPTH.S318897","Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.","To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. Only patients with primary open angle glaucoma (POAG), who had a cup-disc ratio (CDR) of 0.9 or a near total cupping on maximum tolerated medical therapy for at least 4 weeks and yet could not meet the target IOP were included. Target IOP was defined as =12 mm Hg. A total of 30 patients were enrolled. All pat","2021","07","02","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19 lockdown; ROCK1 inhibitor; advanced glaucoma; maximally-tolerated-medical-therapy; ripausdil","Sethi","HarinderSingh","Department of Ophthalmology, V.M.M.C &amp",NA
"668","34194222","10.2147/OPTH.S318897","Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.","To elucidate the use of Ripasudil in patients of advanced glaucoma on maximally tolerated medical therapy who could not be offered the option of surgery due to the global pandemic lockdown. Only patients with primary open angle glaucoma (POAG), who had a cup-disc ratio (CDR) of 0.9 or a near total cupping on maximum tolerated medical therapy for at least 4 weeks and yet could not meet the target IOP were included. Target IOP was defined as =12 mm Hg. A total of 30 patients were enrolled. All pat","2021","07","02","Clin Ophthalmol","Clinical ophthalmology (Auckland, N.Z.)","COVID-19 lockdown; ROCK1 inhibitor; advanced glaucoma; maximally-tolerated-medical-therapy; ripausdil","Srivastava","Kartikeya","Department of Ophthalmology, V.M.M.C &amp",NA
"669","34194219","","Equitable COVID-19 Vaccine Access.",NA,"2021","07","21","Health Hum Rights","Health and human rights","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Human Rights; Humans; SARS-CoV-2","Torreele","Els","Visiting Fellow at the Institute of Innovation and Public Purpose, University College London, UK",NA
"670","34194219","","Equitable COVID-19 Vaccine Access.",NA,"2021","07","21","Health Hum Rights","Health and human rights","COVID-19; COVID-19 Vaccines; Health Services Accessibility; Human Rights; Humans; SARS-CoV-2","Amon","Joseph J","Senior Editor of the Health and Human Rights Journal and Director of Global Health at the Drexel Dornsife School of Public Health, Philadelphia, USA",NA
"671","34194216","","Fault Lines of Refugee Exclusion: Statelessness, Gender, and COVID-19 in South Asia.","Despite widespread recognition of the right to a nationality, statelessness and its attendant vulnerabilities continue to characterize the lives of millions in South Asia. During the onset of the COVID-19 pandemic, when states turned inward to protect their own citizens, refugees and de facto stateless persons found themselves excluded from humanitarian services and health care and were denied the ability to claim rights. Stateless women faced the additional burden of gender-based violence, a ho","2021","07","02","Health Hum Rights","Health and human rights",NA,"Chakraborty","Roshni","Undergraduate student in the Committee on Degrees in Social Studies and the Department of Global Health and Health Policy at Harvard College, Cambridge, USA",NA
"672","34194216","","Fault Lines of Refugee Exclusion: Statelessness, Gender, and COVID-19 in South Asia.","Despite widespread recognition of the right to a nationality, statelessness and its attendant vulnerabilities continue to characterize the lives of millions in South Asia. During the onset of the COVID-19 pandemic, when states turned inward to protect their own citizens, refugees and de facto stateless persons found themselves excluded from humanitarian services and health care and were denied the ability to claim rights. Stateless women faced the additional burden of gender-based violence, a ho","2021","07","02","Health Hum Rights","Health and human rights",NA,"Bhabha","Jacqueline","Professor of the Practice of Health and Human Rights at the Harvard T.H. Chan School of Public Health, Director of Research at the François-Xavier Bagnoud Center for Health and Human Rights at Harvard University, and Jeremiah Smith Jr. Lecturer at Harvard Law School, Cambridge, USA",NA
"673","34194212","","Safe Abortion in Women's Hands: Autonomy and a Human Rights Approach to COVID-19 and Beyond.",NA,"2021","07","21","Health Hum Rights","Health and human rights","Abortion, Induced; COVID-19; Female; Human Rights; Humans; Pandemics; Personal Autonomy; Pregnancy; Reproductive Rights; SARS-CoV-2; Women's Rights","López Cabello","Andrés","Lawyer at the Center for Legal and Social Studies, Buenos Aires, Argentina",NA
"674","34194212","","Safe Abortion in Women's Hands: Autonomy and a Human Rights Approach to COVID-19 and Beyond.",NA,"2021","07","21","Health Hum Rights","Health and human rights","Abortion, Induced; COVID-19; Female; Human Rights; Humans; Pandemics; Personal Autonomy; Pregnancy; Reproductive Rights; SARS-CoV-2; Women's Rights","Gaitán","Ana Cecilia","Assistant Researcher at the National University of San Martín, Buenos Aires, Argentina",NA
"675","34194210","","Is Mandatory Vaccination for COVID-19 Constitutional under Brazilian Law?","Mandatory vaccination for COVID-19 has been the object of heated debate in Brazil. This article discusses the legality and constitutionality of such a policy. First, it analyzes the laws, regulations, and Supreme Court decisions that provide for the possibility of mandatory COVID-19 vaccination. Subsequently, it analyzes the constitutionality of a mandatory vaccination policy through the proportionality method to address the conflict between, on one side, the right to individual autonomy, which ","2021","07","02","Health Hum Rights","Health and human rights",NA,"Wang","Daniel Wei Liang","Associate Professor at Fundação Getúlio Vargas Law School, São Paulo, Brazil",NA
"676","34194210","","Is Mandatory Vaccination for COVID-19 Constitutional under Brazilian Law?","Mandatory vaccination for COVID-19 has been the object of heated debate in Brazil. This article discusses the legality and constitutionality of such a policy. First, it analyzes the laws, regulations, and Supreme Court decisions that provide for the possibility of mandatory COVID-19 vaccination. Subsequently, it analyzes the constitutionality of a mandatory vaccination policy through the proportionality method to address the conflict between, on one side, the right to individual autonomy, which ","2021","07","02","Health Hum Rights","Health and human rights",NA,"Moribe","Gabriela","Master in law and development candidate at Fundação Getúlio Vargas Law School, São Paulo, Brazil",NA
"677","34194210","","Is Mandatory Vaccination for COVID-19 Constitutional under Brazilian Law?","Mandatory vaccination for COVID-19 has been the object of heated debate in Brazil. This article discusses the legality and constitutionality of such a policy. First, it analyzes the laws, regulations, and Supreme Court decisions that provide for the possibility of mandatory COVID-19 vaccination. Subsequently, it analyzes the constitutionality of a mandatory vaccination policy through the proportionality method to address the conflict between, on one side, the right to individual autonomy, which ","2021","07","02","Health Hum Rights","Health and human rights",NA,"Arruda","Ana Luiza Gajardoni De M","Master in law and development candidate at Fundação Getúlio Vargas Law School, São Paulo, Brazil",NA
"678","34194209","","Supreme Court v. Necropolitics: The Chaotic Judicialization of COVID-19 in Brazil.","Worldwide, governments have reacted to the COVID-19 pandemic with emergency orders and policies restricting rights to movement, assembly, and education that have impacted daily lives and livelihoods in profound ways. But some leaders, such as President Jair Bolsonaro in Brazil, have resisted taking such steps, denying the seriousness of the pandemic and sabotaging local control measures, thereby compromising population health. Facing one of the world's highest rates of COVID-19 infections and de","2021","07","02","Health Hum Rights","Health and human rights",NA,"Biehl","João","Susan Dod Brown Professor of Anthropology and Director of the Brazil LAB at Princeton University, Princeton, USA",NA
"679","34194209","","Supreme Court v. Necropolitics: The Chaotic Judicialization of COVID-19 in Brazil.","Worldwide, governments have reacted to the COVID-19 pandemic with emergency orders and policies restricting rights to movement, assembly, and education that have impacted daily lives and livelihoods in profound ways. But some leaders, such as President Jair Bolsonaro in Brazil, have resisted taking such steps, denying the seriousness of the pandemic and sabotaging local control measures, thereby compromising population health. Facing one of the world's highest rates of COVID-19 infections and de","2021","07","02","Health Hum Rights","Health and human rights",NA,"Prates","Lucas E A","Attorney licensed by the Brazilian Bar Association and a PhD student in the Department of Anthropology at Princeton University, Princeton, USA",NA
"680","34194209","","Supreme Court v. Necropolitics: The Chaotic Judicialization of COVID-19 in Brazil.","Worldwide, governments have reacted to the COVID-19 pandemic with emergency orders and policies restricting rights to movement, assembly, and education that have impacted daily lives and livelihoods in profound ways. But some leaders, such as President Jair Bolsonaro in Brazil, have resisted taking such steps, denying the seriousness of the pandemic and sabotaging local control measures, thereby compromising population health. Facing one of the world's highest rates of COVID-19 infections and de","2021","07","02","Health Hum Rights","Health and human rights",NA,"Amon","Joseph J","Director of Global Health and Clinical Professor at the Office of Global Health, Dornsife School of Public Health, Drexel University, Philadelphia, USA",NA
"681","34194208","","Should COVID-19 Vaccines Authorized for Emergency Use Be Considered ""Essential"" Medicines?","A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine's safety and efficacy should be required before it is considered ""essential""? If a COVID-19 vaccine were to be designated an essential medicine by the World Health Organization, this would invoke special ""core"" human rights duties for governments to provide the vaccine as a matter of priority irrespective of resource constraints. S","2021","07","02","Health Hum Rights","Health and human rights",NA,"Smith","Maxwell J","Assistant Professor and Co-Director of the Health Ethics, Law, and Policy Lab in the Faculty of Health Sciences at Western University, London, Canada",NA
"682","34194208","","Should COVID-19 Vaccines Authorized for Emergency Use Be Considered ""Essential"" Medicines?","A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine's safety and efficacy should be required before it is considered ""essential""? If a COVID-19 vaccine were to be designated an essential medicine by the World Health Organization, this would invoke special ""core"" human rights duties for governments to provide the vaccine as a matter of priority irrespective of resource constraints. S","2021","07","02","Health Hum Rights","Health and human rights",NA,"Forman","Lisa","Associate Professor and Canada Research Chair in Human Rights and Global Health Equity in the Dalla Lana School of Public Health at the University of Toronto, Canada",NA
"683","34194208","","Should COVID-19 Vaccines Authorized for Emergency Use Be Considered ""Essential"" Medicines?","A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine's safety and efficacy should be required before it is considered ""essential""? If a COVID-19 vaccine were to be designated an essential medicine by the World Health Organization, this would invoke special ""core"" human rights duties for governments to provide the vaccine as a matter of priority irrespective of resource constraints. S","2021","07","02","Health Hum Rights","Health and human rights",NA,"Parker","Michael","Professor of Bioethics and Director of the Wellcome Centre for Ethics and Humanities and the Ethox Centre at the University of Oxford, United Kingdom",NA
"684","34194208","","Should COVID-19 Vaccines Authorized for Emergency Use Be Considered ""Essential"" Medicines?","A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine's safety and efficacy should be required before it is considered ""essential""? If a COVID-19 vaccine were to be designated an essential medicine by the World Health Organization, this would invoke special ""core"" human rights duties for governments to provide the vaccine as a matter of priority irrespective of resource constraints. S","2021","07","02","Health Hum Rights","Health and human rights",NA,"Perehudoff","Katrina","Post-Doctoral Research Fellow in European and Global Health at the Law Centre for Health and Life at the University of Amsterdam, Netherlands, and a Post-Doctoral Assistant at the International Centre for Reproductive Health at Ghent University, Belgium",NA
"685","34194208","","Should COVID-19 Vaccines Authorized for Emergency Use Be Considered ""Essential"" Medicines?","A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine's safety and efficacy should be required before it is considered ""essential""? If a COVID-19 vaccine were to be designated an essential medicine by the World Health Organization, this would invoke special ""core"" human rights duties for governments to provide the vaccine as a matter of priority irrespective of resource constraints. S","2021","07","02","Health Hum Rights","Health and human rights",NA,"Rawson","Belinda","Associate Tutor and Academic Researcher in the School of Law at the University of Warwick, Coventry, United Kingdom",NA
"686","34194208","","Should COVID-19 Vaccines Authorized for Emergency Use Be Considered ""Essential"" Medicines?","A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine's safety and efficacy should be required before it is considered ""essential""? If a COVID-19 vaccine were to be designated an essential medicine by the World Health Organization, this would invoke special ""core"" human rights duties for governments to provide the vaccine as a matter of priority irrespective of resource constraints. S","2021","07","02","Health Hum Rights","Health and human rights",NA,"Sekalala","Sharifah","Associate Professor in the School of Law at the University of Warwick, Coventry, United Kingdom",NA
"687","34194206","","We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis.","The inequity in access to COVID-19 vaccines that we are witnessing today is yet another symptom of a pharmaceutical economy that is not fit for purpose. That it was possible to develop multiple COVID-19 vaccines in less than a year, while at the same time fostering extreme inequities, calls for transformative change in the health innovation and access ecosystem. Brought into the spotlight through the AIDS drugs access crisis, challenges in accessing lifesaving medicines and vaccines-because they","2021","07","02","Health Hum Rights","Health and human rights",NA,"Krikorian","Gaëlle","Member of Remix the Commons, Paris, France",NA
"688","34194206","","We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis.","The inequity in access to COVID-19 vaccines that we are witnessing today is yet another symptom of a pharmaceutical economy that is not fit for purpose. That it was possible to develop multiple COVID-19 vaccines in less than a year, while at the same time fostering extreme inequities, calls for transformative change in the health innovation and access ecosystem. Brought into the spotlight through the AIDS drugs access crisis, challenges in accessing lifesaving medicines and vaccines-because they","2021","07","02","Health Hum Rights","Health and human rights",NA,"Torreele","Els","Visiting Fellow at the Institute for Innovation and Public Purpose, University College London, UK",NA
"689","34194200","","The Right to Mental Health in Yemen: A Distressed and Ignored Foundation for Peace.","Mental health issues are all too common consequences of conflict and atrocity crimes, often causing upwards of one-quarter of the postconflict, post-atrocity population to suffer from physical and mental sequelae that linger long after weapons have been silenced. After more than six years of ongoing conflict, Yemen's already weak health care system is on the brink of collapse, and population resilience has been severely stressed by indiscriminate attacks, airstrikes, torture, food insecurity, un","2021","07","02","Health Hum Rights","Health and human rights",NA,"Alhariri","Waleed","Policy and Partnerships Director at the Sana'a Center for Strategic Studies",NA
"690","34194200","","The Right to Mental Health in Yemen: A Distressed and Ignored Foundation for Peace.","Mental health issues are all too common consequences of conflict and atrocity crimes, often causing upwards of one-quarter of the postconflict, post-atrocity population to suffer from physical and mental sequelae that linger long after weapons have been silenced. After more than six years of ongoing conflict, Yemen's already weak health care system is on the brink of collapse, and population resilience has been severely stressed by indiscriminate attacks, airstrikes, torture, food insecurity, un","2021","07","02","Health Hum Rights","Health and human rights",NA,"Mcnally","Amanda","Research Fellow at the Sana'a Center for Strategic Studies",NA
"691","34194200","","The Right to Mental Health in Yemen: A Distressed and Ignored Foundation for Peace.","Mental health issues are all too common consequences of conflict and atrocity crimes, often causing upwards of one-quarter of the postconflict, post-atrocity population to suffer from physical and mental sequelae that linger long after weapons have been silenced. After more than six years of ongoing conflict, Yemen's already weak health care system is on the brink of collapse, and population resilience has been severely stressed by indiscriminate attacks, airstrikes, torture, food insecurity, un","2021","07","02","Health Hum Rights","Health and human rights",NA,"Knuckey","Sarah","Clinical Professor of Law and Director of the Human Rights Clinic and Institute at Columbia Law School",NA
"692","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Kiro","Vandana Vijayeta","Department of Microbiology (Laboratory Medicine), AIIMS, New Delhi, India",NA
"693","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Gupta","Ankesh","Department of Infectious Diseases, AIIMS, New Delhi, India",NA
"694","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Singh","Parul","Department of Microbiology (Laboratory Medicine), AIIMS, New Delhi, India",NA
"695","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Sharad","Neha","Department of Microbiology (Laboratory Medicine), AIIMS, New Delhi, India",NA
"696","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Khurana","Surbhi","Department of Laboratory Medicine, AIIMS, New Delhi, India",NA
"697","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Prakash","S","Department of Hospital Administration, AIIMS, New Delhi, India",NA
"698","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Dar","Lalit","Department of Microbiology, AIIMS, New Delhi,, India",NA
"699","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Malhotra","Rajesh","Department of Orthopedics, AIIMS, New Delhi,, India",NA
"700","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Wig","Naveet","Department of Medicine, AIIMS, New Delhi,, India",NA
"701","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Kumar","Arvind","Department of Medicine, AIIMS, New Delhi,, India",NA
"702","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Trikha","Anjan","Department of Anaesthesia and Critical Care, AIIMS, New Delhi,, India",NA
"703","34194176","10.4103/jgid.jgid_316_20","Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2.","Tests detecting SARS-CoV-2-specific antigen have recently been developed, and many of them are now commercially available. However, the real-world performance of these assays is uncertain; therefore, their validation is important. In this study, we have evaluated the performance of STANDARD F COVID-19 antigen fluorescence immunoassay (FIA) kit. Nasopharyngeal samples collected from patients were subjected to the test as per manufacturer's instructions. The performance of the kit was compared wit","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","Analyzer; COVID-19; SARS-CoV-2; fluorescence immunoassay; rapid antigen test","Mathur","Purva","Department of Laboratory Medicine (Microbiology Division), JPNATC, AIIMS, New Delhi,, India",NA
"704","34194172","10.4103/jgid.jgid_358_20","Incidence of Secondary Bacterial Infections Following Utilization of Tocilizumab for the Treatment of COVID-19 - A Matched Retrospective Cohort Study.","Immunosuppressive agents are theorized to target the cytokine storm syndrome in COVID-19. However, the downstream effects regarding susceptibilities to secondary infection risk remains unknown. This study seeks to determine risk differences for secondary infections among COVID-19 patients who did and did not receive tocilizumab. We conducted a matched retrospective cohort study from two large, acute care hospitals in Western Connecticut from March 1, to May 31, 2020. We collected variables using","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","COVID-19; Coronavirus; IL-6; SARS-CoV-2; secondary infection; tocilizumab","Moore","Joanna L","Department of Medicine, Nuvance Health, University of Vermont School of Medicine, Norwalk, Connecticut, USA",NA
"705","34194172","10.4103/jgid.jgid_358_20","Incidence of Secondary Bacterial Infections Following Utilization of Tocilizumab for the Treatment of COVID-19 - A Matched Retrospective Cohort Study.","Immunosuppressive agents are theorized to target the cytokine storm syndrome in COVID-19. However, the downstream effects regarding susceptibilities to secondary infection risk remains unknown. This study seeks to determine risk differences for secondary infections among COVID-19 patients who did and did not receive tocilizumab. We conducted a matched retrospective cohort study from two large, acute care hospitals in Western Connecticut from March 1, to May 31, 2020. We collected variables using","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","COVID-19; Coronavirus; IL-6; SARS-CoV-2; secondary infection; tocilizumab","Stroever","Stephanie J","Department of Innovation and Research, Nuvance Health, Danbury, Connecticut, USA",NA
"706","34194172","10.4103/jgid.jgid_358_20","Incidence of Secondary Bacterial Infections Following Utilization of Tocilizumab for the Treatment of COVID-19 - A Matched Retrospective Cohort Study.","Immunosuppressive agents are theorized to target the cytokine storm syndrome in COVID-19. However, the downstream effects regarding susceptibilities to secondary infection risk remains unknown. This study seeks to determine risk differences for secondary infections among COVID-19 patients who did and did not receive tocilizumab. We conducted a matched retrospective cohort study from two large, acute care hospitals in Western Connecticut from March 1, to May 31, 2020. We collected variables using","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","COVID-19; Coronavirus; IL-6; SARS-CoV-2; secondary infection; tocilizumab","Rondain","Patricia E","Department of Medicine, Nuvance Health, University of Vermont School of Medicine, Norwalk, Connecticut, USA",NA
"707","34194172","10.4103/jgid.jgid_358_20","Incidence of Secondary Bacterial Infections Following Utilization of Tocilizumab for the Treatment of COVID-19 - A Matched Retrospective Cohort Study.","Immunosuppressive agents are theorized to target the cytokine storm syndrome in COVID-19. However, the downstream effects regarding susceptibilities to secondary infection risk remains unknown. This study seeks to determine risk differences for secondary infections among COVID-19 patients who did and did not receive tocilizumab. We conducted a matched retrospective cohort study from two large, acute care hospitals in Western Connecticut from March 1, to May 31, 2020. We collected variables using","2021","07","02","J Glob Infect Dis","Journal of global infectious diseases","COVID-19; Coronavirus; IL-6; SARS-CoV-2; secondary infection; tocilizumab","Scatena","Robyn N","Department of Pulmonary and Critical Care, Yale School of Medicine, University of Vermont School of Medicine, Nuvance Health, Norwalk, Connecticut, USA",NA
"708","34194171","10.4103/jgid.jgid_114_21","State of the Globe: The Frenzy of Self-Medication, Cocktail Regimens and Everchanging Guidelines on SARS-CoV-2.",NA,"2021","07","02","J Glob Infect Dis","Journal of global infectious diseases",NA,"Chauhan","Vivek","Department of Medicine, IGMC, Shimla, Himachal Pradesh, India",NA
"709","34194171","10.4103/jgid.jgid_114_21","State of the Globe: The Frenzy of Self-Medication, Cocktail Regimens and Everchanging Guidelines on SARS-CoV-2.",NA,"2021","07","02","J Glob Infect Dis","Journal of global infectious diseases",NA,"Thakur","Suman","Department of, Microbiology, IGMC, Shimla, Himachal Pradesh, India",NA
"710","34194131","10.4103/UA.UA_133_20","""Tele-urology"": Is the COVID-19 pandemic a wake-up call?","The purpose of this research is to measure the current use of telemedicine technologies among urologists, their readiness to adopt the same, and to assess the barriers preventing such usage. Two hundred and twenty eight board-certified urologists completed our self-designed survey. An analysis was done to assess the increase in the use of telemedicine and the urologists' telemedicine experience responses. Data analysis was done using SPSS software. There has been a tremendous increase in the use","2021","07","02","Urol Ann","Urology annals","Pandemic; Saudi Arabia; telemedicine; urology","Almannie","Raed","Department of Surgery, Division of Urology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"711","34194131","10.4103/UA.UA_133_20","""Tele-urology"": Is the COVID-19 pandemic a wake-up call?","The purpose of this research is to measure the current use of telemedicine technologies among urologists, their readiness to adopt the same, and to assess the barriers preventing such usage. Two hundred and twenty eight board-certified urologists completed our self-designed survey. An analysis was done to assess the increase in the use of telemedicine and the urologists' telemedicine experience responses. Data analysis was done using SPSS software. There has been a tremendous increase in the use","2021","07","02","Urol Ann","Urology annals","Pandemic; Saudi Arabia; telemedicine; urology","Almuhaideb","Mana","Department of Surgery, Division of Urology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"712","34194131","10.4103/UA.UA_133_20","""Tele-urology"": Is the COVID-19 pandemic a wake-up call?","The purpose of this research is to measure the current use of telemedicine technologies among urologists, their readiness to adopt the same, and to assess the barriers preventing such usage. Two hundred and twenty eight board-certified urologists completed our self-designed survey. An analysis was done to assess the increase in the use of telemedicine and the urologists' telemedicine experience responses. Data analysis was done using SPSS software. There has been a tremendous increase in the use","2021","07","02","Urol Ann","Urology annals","Pandemic; Saudi Arabia; telemedicine; urology","Alzahrani","Meshari","Department of Surgery, Division of Urology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"713","34194131","10.4103/UA.UA_133_20","""Tele-urology"": Is the COVID-19 pandemic a wake-up call?","The purpose of this research is to measure the current use of telemedicine technologies among urologists, their readiness to adopt the same, and to assess the barriers preventing such usage. Two hundred and twenty eight board-certified urologists completed our self-designed survey. An analysis was done to assess the increase in the use of telemedicine and the urologists' telemedicine experience responses. Data analysis was done using SPSS software. There has been a tremendous increase in the use","2021","07","02","Urol Ann","Urology annals","Pandemic; Saudi Arabia; telemedicine; urology","Binsaleh","Saleh","Department of Surgery, Division of Urology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"714","34194131","10.4103/UA.UA_133_20","""Tele-urology"": Is the COVID-19 pandemic a wake-up call?","The purpose of this research is to measure the current use of telemedicine technologies among urologists, their readiness to adopt the same, and to assess the barriers preventing such usage. Two hundred and twenty eight board-certified urologists completed our self-designed survey. An analysis was done to assess the increase in the use of telemedicine and the urologists' telemedicine experience responses. Data analysis was done using SPSS software. There has been a tremendous increase in the use","2021","07","02","Urol Ann","Urology annals","Pandemic; Saudi Arabia; telemedicine; urology","Alyami","Fahad","Department of Surgery, Division of Urology, College of Medicine, King Saud University, Riyadh, Saudi Arabia",NA
"715","34194069","10.4103/psychiatry.IndianJPsychiatry_509_20","Experience of conducting MD examinations in the mid of COVID-19 crisis.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Das","Anindya","Department of Psychiatry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"716","34194069","10.4103/psychiatry.IndianJPsychiatry_509_20","Experience of conducting MD examinations in the mid of COVID-19 crisis.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Krishnan","Vijay","Department of Psychiatry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"717","34194069","10.4103/psychiatry.IndianJPsychiatry_509_20","Experience of conducting MD examinations in the mid of COVID-19 crisis.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Gupta","Ravi","Department of Psychiatry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India",NA
"718","34194069","10.4103/psychiatry.IndianJPsychiatry_509_20","Experience of conducting MD examinations in the mid of COVID-19 crisis.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Grover","Sandeep","Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India",NA
"719","34194069","10.4103/psychiatry.IndianJPsychiatry_509_20","Experience of conducting MD examinations in the mid of COVID-19 crisis.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Sagar","Rajesh","Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India. E-mail: andydas@rediffmail","andydas@rediffmail.com"
"720","34194066","10.4103/psychiatry.IndianJPsychiatry_646_20","""Screen-time"" for children and adolescents in COVID-19 times: Need to have the contextually informed perspective.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Singh","Swarndeep","Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India",NA
"721","34194066","10.4103/psychiatry.IndianJPsychiatry_646_20","""Screen-time"" for children and adolescents in COVID-19 times: Need to have the contextually informed perspective.",NA,"2021","07","02","Indian J Psychiatry","Indian journal of psychiatry",NA,"Balhara","Yatan Pal Singh","Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India",NA
"722","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Grover","Sandeep","Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"723","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Vaishnav","Mrugesh","Samvedana Group of Hospitals and Research Centre, Ahmedabad, Gujarat, India",NA
"724","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Tripathi","Adarsh","Department of Psychiatry, King Georges Medical University, Lucknow, Uttar Pradesh, India",NA
"725","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Rao","T S S","Department of Psychiatry, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"726","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Avasthi","Ajit","Department of Psychiatry, Fortis Hospital Mohali and CMC, Chandigarh, India",NA
"727","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Dalal","P K","Department of Psychiatry, King Georges Medical University, Lucknow, Uttar Pradesh, India",NA
"728","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Mehra","Aseem","Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"729","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Sahoo","Swapnajeet","Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India",NA
"730","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Manohar","Shivanand","Department of Psychiatry, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"731","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Chandran","Suhas","Department of Psychiatry, St Johns Medical College Hospital, Bengaluru, Karnataka, India",NA
"732","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Kumar","Ajay","Department of Psychiatry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India",NA
"733","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Sharma","Pratheek","Department of Psychiatry, St Johns Medical College Hospital, Bengaluru, Karnataka, India",NA
"734","34194056","10.4103/psychiatry.IndianJPsychiatry_860_20","Sexual functioning during the lockdown period in India: An online survey.","This study aimed to evaluate the impact of lockdown on sexual functioning in India. In addition, impact of lockdown on relationship with the partner and mental health was evaluated. An online survey was conducted using changes in sexual functioning questionnaire, Patient Health Questionnaire-4, and a self-designed questionnaire. The mean age of the participants was 41.5 (standard deviation: 11.2; range: 22-77; median: 39.5) years, with the majority being males 385 (85.6%). The participants repor","2021","07","02","Indian J Psychiatry","Indian journal of psychiatry","COVID-19; lockdown; sexual dysfunction","Rao","Suman S","Department of Psychiatry, JSS Medical College and Hospital, JSS Academy of Higher Education and Research, Mysore, Karnataka, India",NA
"735","34194035","10.1038/s41564-021-00931-x","How SARS-CoV-2 makes the cut.",NA,"2021","07","08","Nat Microbiol","Nature microbiology","Animals; COVID-19; Ferrets; Furin; Humans; Immune Evasion; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Hoffmann","Markus","Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany",NA
"736","34194035","10.1038/s41564-021-00931-x","How SARS-CoV-2 makes the cut.",NA,"2021","07","08","Nat Microbiol","Nature microbiology","Animals; COVID-19; Ferrets; Furin; Humans; Immune Evasion; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization","Pöhlmann","Stefan","Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany. spoehlmann@dpz","spoehlmann@dpz.eu"
"737","34194016","10.1038/d41586-021-01749-7","Beyond coronavirus: the virus discoveries transforming biology.",NA,"2021","07","08","Nature","Nature","Ecology; Evolution; Virology; Animals; Carbon; Classification; Databases, Genetic; Datasets as Topic; Ecosystem; Genome, Viral; Giant Viruses; Host Microbial Interactions; Humans; Metagenome; Permafrost; SARS-CoV-2; Species Specificity; Terminology as Topic; Virology; Viruses; Waste Water","Dance","Amber",NA,NA
"738","34193999","10.1038/d41586-021-01721-5","Engineered single-domain antibodies tackle COVID variants.",NA,"2021","07","09","Nature","Nature","Immunology; Medical research; SARS-CoV-2; Antibodies, Neutralizing; COVID-19; Humans; SARS-CoV-2; Single-Domain Antibodies; Spike Glycoprotein, Coronavirus","Voss","James E",NA,NA
"739","34193982","10.1038/s41433-021-01655-2","The effect of home education on myopia progression in children during the COVID-19 pandemic.","To evaluate the effect of the COVID-19 pandemic restrictions on myopia progression (MP) in school age children. A total of 115 children aged 8-17 years with a diagnosis of myopia who had been followed-up for at least three years, were included in this study with a retrospective and single-centre design. The subjects' age, the history of myopia in the family, the time spent in front of a screen, the digital devices used during home education (computer, tablet, smartphone, television), the time sp","2021","07","03","Eye (Lond)","Eye (London, England)",NA,"Aslan","Fatih","Faculty of Medicine, Department of Ophthalmology, Alanya Alaaddin Keykubat University, Antalya, Turkey. fatih.aslan@alanya.edu","fatih.aslan@alanya.edu.tr"
"740","34193982","10.1038/s41433-021-01655-2","The effect of home education on myopia progression in children during the COVID-19 pandemic.","To evaluate the effect of the COVID-19 pandemic restrictions on myopia progression (MP) in school age children. A total of 115 children aged 8-17 years with a diagnosis of myopia who had been followed-up for at least three years, were included in this study with a retrospective and single-centre design. The subjects' age, the history of myopia in the family, the time spent in front of a screen, the digital devices used during home education (computer, tablet, smartphone, television), the time sp","2021","07","03","Eye (Lond)","Eye (London, England)",NA,"Sahinoglu-Keskek","Nedime","Faculty of Medicine, Department of Ophthalmology, Alanya Alaaddin Keykubat University, Antalya, Turkey. nedime_sahin@yahoo","sahin@yahoo.com"
"741","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Lupo-Stanghellini","Maria Teresa","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"742","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Xue","Elisabetta","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"743","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Mastaglio","Sara","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"744","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Oltolini","Chiara","Clinic of Infectious Diseases, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"745","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Angelillo","Piera","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"746","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Messina","Carlo","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"747","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Piemontese","Simona","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"748","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Girlanda","Stefania","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"749","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Farina","Francesca","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"750","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Lazzari","Lorenzo","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"751","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Cicalese","Maria Pia","Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"752","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Erbella","Federico","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"753","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Greco","Raffaella","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"754","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Locatelli","Massimo","Laboratory Medicine Service, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"755","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Milani","Raffaella","Immunohematology and Transfusion Medicine Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"756","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Peccatori","Jacopo","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"757","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Corti","Consuelo","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"758","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Marktel","Sarah","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"759","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Assanelli","Andrea","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy",NA
"760","34193980","10.1038/s41409-021-01278-x","COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.",NA,"2021","07","03","Bone Marrow Transplant","Bone marrow transplantation",NA,"Ciceri","Fabio","Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy. fabio.ciceri@hsr","fabio.ciceri@hsr.it"
"761","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Mika","Justyna","Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland",NA
"762","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Tobiasz","Joanna","Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland",NA
"763","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Zyla","Joanna","Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland",NA
"764","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Papiez","Anna","Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland",NA
"765","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Bach","Malgorzata","Department of Applied Informatics, Silesian University of Technology, Gliwice, Poland",NA
"766","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Werner","Aleksandra","Department of Applied Informatics, Silesian University of Technology, Gliwice, Poland",NA
"767","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Kozielski","Michal","Department of Computer Networks and Systems, Silesian University of Technology, Gliwice, Poland",NA
"768","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Kania","Mateusz","Department of Graphics, Computer Vision and Digital Systems, Silesian University of Technology, Gliwice, Poland",NA
"769","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Gruca","Aleksandra","Department of Computer Networks and Systems, Silesian University of Technology, Gliwice, Poland",NA
"770","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Piotrowski","Damian","Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland",NA
"771","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Sobala-Szczygiel","Barbara","Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland",NA
"772","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Wlostowska","Bozena","Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland",NA
"773","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Foszner","Pawel","Department of Graphics, Computer Vision and Digital Systems, Silesian University of Technology, Gliwice, Poland",NA
"774","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Sikora","Marek","Department of Computer Networks and Systems, Silesian University of Technology, Gliwice, Poland",NA
"775","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Polanska","Joanna","Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland. joanna.polanska@polsl","joanna.polanska@polsl.pl"
"776","34193945","10.1038/s41598-021-93046-6","Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.","In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p &lt; 0.0001), body temperature above 38<U+2103> (OR = 1.67, p &lt; 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache","2021","07","19","Sci Rep","Scientific reports","Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Ageusia; COVID-19; Child; Child, Preschool; Cough; Diagnosis, Differential; Dyspnea; Female; Fever; Headache; Humans; Infant; Male; Middle Aged; Odds Ratio; Olfaction Disorders; Pilot Projects; Poland; Respiratory Tract Infections; SARS-CoV-2; Surveys and Questionnaires; Symptom Assessment; Young Adult","Jaroszewicz","Jerzy","Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland",NA
"777","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Summer","Sabrina","Center for Anatomy and Cell Biology, Medical University of Vienna, 1090, Vienna, Austria",NA
"778","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Schmidt","Ralf","Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",NA
"779","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Herdina","Anna Nele","Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",NA
"780","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Krickl","Isabella","Department of Gynecological Endocrinology and Reproduction Medicine, Ambulance of In-Vitro Fertilization, Medical University of Vienna, 1090, Vienna, Austria",NA
"781","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Madner","Julia","Department of Gynecological Endocrinology and Reproduction Medicine, Ambulance of In-Vitro Fertilization, Medical University of Vienna, 1090, Vienna, Austria",NA
"782","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Greiner","Georg","Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",NA
"783","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Mayer","Florian J","Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",NA
"784","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Perkmann-Nagele","Nicole","Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria",NA
"785","34193912","10.1038/s41598-021-93028-8","Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.","With global demand for SARS-CoV-2 testing ever rising, shortages in commercially available viral transport media pose a serious problem for laboratories and health care providers. For reliable diagnosis of SARS-CoV-2 and other respiratory viruses, executed by Real-time PCR, the quality of respiratory specimens, predominantly determined by transport and storage conditions, is crucial. Therefore, our aim was to explore the reliability of minimal transport media, comprising saline or the CDC recomm","2021","07","19","Sci Rep","Scientific reports","COVID-19; COVID-19 Nucleic Acid Testing; Cold Temperature; Culture Media; Humans; Laboratory Chemicals; Preservation, Biological; Reproducibility of Results; SARS-CoV-2; Specimen Handling; Time Factors; Virology","Strassl","Robert","Department of Laboratory Medicine, Division of Clinical Virology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. robert.strassl@meduniwien.ac","robert.strassl@meduniwien.ac.at"
"786","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Lee","Sul A","Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, 50-1 Yonsei-ro, Sinchon-dong, Seodaemun-gu, Seoul, South Korea",NA
"787","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Park","Robin","Department of Medicine, MetroWest Medical Center/Tufts University School of Medicine, Framingham, MA, USA",NA
"788","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Yang","Ji Hyun","Department of Medicine, MetroWest Medical Center/Tufts University School of Medicine, Framingham, MA, USA",NA
"789","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Min","In Kyung","Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea",NA
"790","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Park","Jung Tak","Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, 50-1 Yonsei-ro, Sinchon-dong, Seodaemun-gu, Seoul, South Korea",NA
"791","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Han","Seung Hyeok","Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, 50-1 Yonsei-ro, Sinchon-dong, Seodaemun-gu, Seoul, South Korea",NA
"792","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Kang","Shin-Wook","Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, 50-1 Yonsei-ro, Sinchon-dong, Seodaemun-gu, Seoul, South Korea",NA
"793","34193877","10.1038/s41598-021-92323-8","Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.","Acute kidney injury (AKI) is a severe complication of coronavirus disease (COVID-19) that negatively affects its outcome. Concern had been raised about the potential effect of renin-angiotensin-aldosterone system (RAAS) blockades on renal outcomes in COVID-19 patients. However, the association between RAAS blockade use and incident AKI in COVID-19 patients has not been fully understood. We investigated the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patien","2021","07","19","Sci Rep","Scientific reports","Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; COVID-19; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Risk Factors","Yoo","Tae-Hyun","Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, 50-1 Yonsei-ro, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. yoosy0316@yuhs","yoosy0316@yuhs.ac"
"794","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Jung","Jae Hyung","Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea",NA
"795","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Rha","Min-Seok","Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea",NA
"796","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Sa","Moa","Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea",NA
"797","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Choi","Hee Kyoung","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, Republic of Korea",NA
"798","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Jeon","Ji Hoon","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, Republic of Korea",NA
"799","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Seok","Hyeri","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, Republic of Korea",NA
"800","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Park","Dae Won","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, Republic of Korea",NA
"801","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Park","Su-Hyung","Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea",NA
"802","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Jeong","Hye Won","Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea. hwjeong@chungbuk.ac","hwjeong@chungbuk.ac.kr"
"803","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Choi","Won Suk","Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Ansan Hospital, Ansan, Republic of Korea. cmcws@korea.ac","cmcws@korea.ac.kr"
"804","34193870","10.1038/s41467-021-24377-1","SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.","Memory T cells contribute to rapid viral clearance during re-infection, but the longevity and differentiation of SARS-CoV-2-specific memory T cells remain unclear. Here we conduct ex vivo assays to evaluate SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses in COVID-19 convalescent patients up to 317 days post-symptom onset (DPSO), and find that memory T cell responses are maintained during the study period regardless of the severity of COVID-19. In particular, we observe s","2021","07","14","Nat Commun","Nature communications","Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Enzyme-Linked Immunosorbent Assay; Humans; Immunologic Memory; Interferon-gamma; SARS-CoV-2; Vaccination","Shin","Eui-Cheol","Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea. ecshin@kaist.ac","ecshin@kaist.ac.kr"
"805","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Hoffmann","Donata","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"806","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Corleis","Björn","Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"807","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Rauch","Susanne","CureVac AG, Tübingen, Germany",NA
"808","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Roth","Nicole","CureVac AG, Tübingen, Germany",NA
"809","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Mühe","Janine","CureVac AG, Tübingen, Germany",NA
"810","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Halwe","Nico Joel","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"811","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Ulrich","Lorenz","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"812","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Fricke","Charlie","Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"813","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Schön","Jacob","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"814","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Kraft","Anna","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"815","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Breithaupt","Angele","Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"816","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Wernike","Kerstin","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"817","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Michelitsch","Anna","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"818","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Sick","Franziska","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"819","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Wylezich","Claudia","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"820","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Hoffmann","Bernd","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"821","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Thran","Moritz","CureVac AG, Tübingen, Germany",NA
"822","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Thess","Andreas","CureVac AG, Tübingen, Germany",NA
"823","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Mueller","Stefan O","CureVac AG, Tübingen, Germany",NA
"824","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Mettenleiter","Thomas C","Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany",NA
"825","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Petsch","Benjamin","CureVac AG, Tübingen, Germany",NA
"826","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Dorhoi","Anca","Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. anca.dorhoi@fli","anca.dorhoi@fli.de"
"827","34193869","10.1038/s41467-021-24339-7","CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2.","The ongoing SARS-CoV-2 pandemic necessitates the fast development of vaccines. Recently, viral mutants termed variants of concern (VOC) which may escape host immunity have emerged. The efficacy of spike encoding mRNA vaccines (CVnCoV and CV2CoV) against the ancestral strain and the VOC B.1.351 was tested in a K18-hACE2 transgenic mouse model. Naive mice and mice immunized with a formalin-inactivated SARS-CoV-2 preparation were used as controls. mRNA-immunized mice develop elevated SARS-CoV-2 RBD","2021","07","14","Nat Commun","Nature communications","Angiotensin-Converting Enzyme 2; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Cell Line; Chlorocebus aethiops; Genome, Viral; Humans; Mice; Mice, Transgenic; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells","Beer","Martin","Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. martin.beer@fli","martin.beer@fli.de"
"828","34193864","10.1038/s41536-021-00147-x","Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected nearly 118 million people and caused ~2.6 million deaths worldwide by early 2021, during the coronavirus disease 2019 (COVID-19) pandemic. Although the majority of infected patients show mild-to-moderate symptoms, a small fraction of patients develops severe symptoms. Uncontrolled cytokine production and the lack of substantive adaptive immune response result in hypoxia, acute respiratory distress syndrome (ARDS), or multi","2021","07","22","NPJ Regen Med","NPJ Regenerative medicine",NA,"Sharma","Dhavan","Department of Biomedical Engineering, Texas A&amp",NA
"829","34193864","10.1038/s41536-021-00147-x","Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected nearly 118 million people and caused ~2.6 million deaths worldwide by early 2021, during the coronavirus disease 2019 (COVID-19) pandemic. Although the majority of infected patients show mild-to-moderate symptoms, a small fraction of patients develops severe symptoms. Uncontrolled cytokine production and the lack of substantive adaptive immune response result in hypoxia, acute respiratory distress syndrome (ARDS), or multi","2021","07","22","NPJ Regen Med","NPJ Regenerative medicine",NA,"Zhao","Feng","Department of Biomedical Engineering, Texas A&amp","fengzhao@tamu.edu"
"830","34193809","10.12659/MSM.930168","Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.","Coronavirus Disease-2019 (COVID-19) is a rapidly spreading pandemic that began at the end of 2019. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reproductive health has always been one of the most important healthcare problems, and the impacts of COVID-19 on the reproductive systems have become an emerging topic. The effects of infection with SARS-CoV-2 on males are more harmful than on females. The outcomes of pregnancy also can show the condition of male a","2021","07","05","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Angiotensin-Converting Enzyme 2; Antibodies, Viral; COVID-19; Female; Fertility; Genitalia; Gonadal Steroid Hormones; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Reproductive Health; Risk Factors; SARS-CoV-2; Sex Factors; Virus Internalization","Liu","Chunlian","Center for Reproductive Medicine, General Hospital, Ningxia Medical University, Yinchuan, Ningxia, China (mainland)",NA
"831","34193809","10.12659/MSM.930168","Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.","Coronavirus Disease-2019 (COVID-19) is a rapidly spreading pandemic that began at the end of 2019. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reproductive health has always been one of the most important healthcare problems, and the impacts of COVID-19 on the reproductive systems have become an emerging topic. The effects of infection with SARS-CoV-2 on males are more harmful than on females. The outcomes of pregnancy also can show the condition of male a","2021","07","05","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Angiotensin-Converting Enzyme 2; Antibodies, Viral; COVID-19; Female; Fertility; Genitalia; Gonadal Steroid Hormones; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Reproductive Health; Risk Factors; SARS-CoV-2; Sex Factors; Virus Internalization","Mu","Chunlan","Key Laboratory of Fertility Preservation and Maintenance, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia, China (mainland)",NA
"832","34193809","10.12659/MSM.930168","Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.","Coronavirus Disease-2019 (COVID-19) is a rapidly spreading pandemic that began at the end of 2019. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reproductive health has always been one of the most important healthcare problems, and the impacts of COVID-19 on the reproductive systems have become an emerging topic. The effects of infection with SARS-CoV-2 on males are more harmful than on females. The outcomes of pregnancy also can show the condition of male a","2021","07","05","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Angiotensin-Converting Enzyme 2; Antibodies, Viral; COVID-19; Female; Fertility; Genitalia; Gonadal Steroid Hormones; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Reproductive Health; Risk Factors; SARS-CoV-2; Sex Factors; Virus Internalization","Zhang","Qian","Center for Reproductive Medicine, General Hospital, Ningxia Medical University, Yinchuan, Ningxia, China (mainland)",NA
"833","34193809","10.12659/MSM.930168","Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.","Coronavirus Disease-2019 (COVID-19) is a rapidly spreading pandemic that began at the end of 2019. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reproductive health has always been one of the most important healthcare problems, and the impacts of COVID-19 on the reproductive systems have become an emerging topic. The effects of infection with SARS-CoV-2 on males are more harmful than on females. The outcomes of pregnancy also can show the condition of male a","2021","07","05","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Angiotensin-Converting Enzyme 2; Antibodies, Viral; COVID-19; Female; Fertility; Genitalia; Gonadal Steroid Hormones; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Reproductive Health; Risk Factors; SARS-CoV-2; Sex Factors; Virus Internalization","Yang","Xiwen","Key Laboratory of Fertility Preservation and Maintenance, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia, China (mainland)",NA
"834","34193809","10.12659/MSM.930168","Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.","Coronavirus Disease-2019 (COVID-19) is a rapidly spreading pandemic that began at the end of 2019. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reproductive health has always been one of the most important healthcare problems, and the impacts of COVID-19 on the reproductive systems have become an emerging topic. The effects of infection with SARS-CoV-2 on males are more harmful than on females. The outcomes of pregnancy also can show the condition of male a","2021","07","05","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Angiotensin-Converting Enzyme 2; Antibodies, Viral; COVID-19; Female; Fertility; Genitalia; Gonadal Steroid Hormones; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Reproductive Health; Risk Factors; SARS-CoV-2; Sex Factors; Virus Internalization","Yan","Hui","Center for Reproductive Medicine, General Hospital, Ningxia Medical University, Yinchuan, Ningxia, China (mainland)",NA
"835","34193809","10.12659/MSM.930168","Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.","Coronavirus Disease-2019 (COVID-19) is a rapidly spreading pandemic that began at the end of 2019. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reproductive health has always been one of the most important healthcare problems, and the impacts of COVID-19 on the reproductive systems have become an emerging topic. The effects of infection with SARS-CoV-2 on males are more harmful than on females. The outcomes of pregnancy also can show the condition of male a","2021","07","05","Med Sci Monit","Medical science monitor : international medical journal of experimental and clinical research","Angiotensin-Converting Enzyme 2; Antibodies, Viral; COVID-19; Female; Fertility; Genitalia; Gonadal Steroid Hormones; Humans; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Reproductive Health; Risk Factors; SARS-CoV-2; Sex Factors; Virus Internalization","Jiao","Haiyan","Key Laboratory of Fertility Preservation and Maintenance, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia, China (mainland)",NA
"836","34193750","10.5582/bst.2021.01263","Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.","Traditional Chinese medicine (TCM) is a valuable form of medicine with a long history in China. It has played a significant role in the control and prevention of infectious diseases including SARS and H7N9 flu. After the outbreak of COVID-19, China's National Health Commission included TCM in the Diagnosis and Treatment Protocol for COVID-19. During the COVID-19 pandemic, three traditional Chinese medicines (Jinhua Qinggan granules, Lianhua Qingwen medicine, and a Xuebijing Injection) and three ","2021","07","01","Biosci Trends","Bioscience trends","COVID-19; Chinese protocol; Traditional Chinese Medicine; clinical trials; underlying mechanisms","Qi","Fanghua","Department of Traditional Chinese Medicine, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China",NA
"837","34193750","10.5582/bst.2021.01263","Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.","Traditional Chinese medicine (TCM) is a valuable form of medicine with a long history in China. It has played a significant role in the control and prevention of infectious diseases including SARS and H7N9 flu. After the outbreak of COVID-19, China's National Health Commission included TCM in the Diagnosis and Treatment Protocol for COVID-19. During the COVID-19 pandemic, three traditional Chinese medicines (Jinhua Qinggan granules, Lianhua Qingwen medicine, and a Xuebijing Injection) and three ","2021","07","01","Biosci Trends","Bioscience trends","COVID-19; Chinese protocol; Traditional Chinese Medicine; clinical trials; underlying mechanisms","Tang","Wei","International Health Care Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"838","34193749","10.5582/bst.2021.01261","Rapid evolution of the COVID-19 pandemic calls for a unified public health response.","The globe has witnessed the rapid evolution of SARS-CoV-2 mutations and emerging variants of concern (VOCs) and variants of interest (VOIs) that have broadly impacted the transmissibility, antigenicity, morbidity, and mortality of the virus. Although around 2.5 billion vaccine doses have been administered worldwide, vaccine coverage remains far behind the minimum threshold needed to achieve herd immunity overall and it varies substantially by country. Many countries, and especially low- and midd","2021","07","01","Biosci Trends","Bioscience trends","NPIs; SARS-CoV-2; evolution; unified public health response; vaccine","He","Na","Department of Epidemiology, School of Public Health and Ministry of Education Key Laboratory of Public Health Safety, Fudan University",NA
"839","34193697","10.1254/fpj.21020","[Current challenges and future perspectives of pharmacological testing using new approach methodologies].","The mission of regulatory science is to promote human longevity by providing safer and more effective drugs and ensuring human health. At present, various in vitro and in vivo evaluation methods are used for drug development, and no major problems have been observed. However, there is still room for improvement in terms of risk prediction in humans. Thus, new approaches and methodologies (NAMs) have recently been developed to predict adverse events in humans more accurately. Based on the animal ","2021","07","02","Nihon Yakurigaku Zasshi","Nihon yakurigaku zasshi. Folia pharmacologica Japonica","Animal Testing Alternatives; Animals; COVID-19; Drug Development; Humans; Pandemics; SARS-CoV-2","Tsuji","Kayoko","Division of Pharmacology, National Institute of Health Sciences (NIHS)",NA
"840","34193697","10.1254/fpj.21020","[Current challenges and future perspectives of pharmacological testing using new approach methodologies].","The mission of regulatory science is to promote human longevity by providing safer and more effective drugs and ensuring human health. At present, various in vitro and in vivo evaluation methods are used for drug development, and no major problems have been observed. However, there is still room for improvement in terms of risk prediction in humans. Thus, new approaches and methodologies (NAMs) have recently been developed to predict adverse events in humans more accurately. Based on the animal ","2021","07","02","Nihon Yakurigaku Zasshi","Nihon yakurigaku zasshi. Folia pharmacologica Japonica","Animal Testing Alternatives; Animals; COVID-19; Drug Development; Humans; Pandemics; SARS-CoV-2","Satsuka","Ayano","Division of Pharmacology, National Institute of Health Sciences (NIHS)",NA
"841","34193697","10.1254/fpj.21020","[Current challenges and future perspectives of pharmacological testing using new approach methodologies].","The mission of regulatory science is to promote human longevity by providing safer and more effective drugs and ensuring human health. At present, various in vitro and in vivo evaluation methods are used for drug development, and no major problems have been observed. However, there is still room for improvement in terms of risk prediction in humans. Thus, new approaches and methodologies (NAMs) have recently been developed to predict adverse events in humans more accurately. Based on the animal ","2021","07","02","Nihon Yakurigaku Zasshi","Nihon yakurigaku zasshi. Folia pharmacologica Japonica","Animal Testing Alternatives; Animals; COVID-19; Drug Development; Humans; Pandemics; SARS-CoV-2","Kanda","Yasunari","Division of Pharmacology, National Institute of Health Sciences (NIHS)",NA
"842","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Yahara","Megumi","Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences",NA
"843","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Niki","Kazuyuki","Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences",NA
"844","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Ueno","Keita","Osaka Prefecture University Graduate School of Comprehensive Rehabilitation",NA
"845","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Okamoto","Mio","Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences",NA
"846","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Okuda","Takeshi","Social Welfare Corporation Misasagikai",NA
"847","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Tanaka","Hiroyuki","Osaka Prefecture University Graduate School of Comprehensive Rehabilitation",NA
"848","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Naito","Yasuo","Osaka Prefecture University Graduate School of Comprehensive Rehabilitation",NA
"849","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Ishii","Ryouhei","Osaka Prefecture University Graduate School of Comprehensive Rehabilitation",NA
"850","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Ueda","Mikiko","Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences",NA
"851","34193684","10.1248/bpb.b21-00052","Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.","To prevent cognitive decline, non-pharmacological therapies such as reminiscence for mild cognitive impairment (MCI) are required, however, the use of nursing homes was limited due to coronavirus disease 2019 (COVID-19). Therefore, the demand for remote-care is increasing. We hypothesized that immersive virtual reality (iVR) could be used more effectively than conventional reminiscence for anxiety. We first examined the effectiveness and safety of reminiscence using iVR (iVR reminiscence session","2021","07","05","Biol Pharm Bull","Biological &amp; pharmaceutical bulletin","coronavirus disease 2019; dementia; digital; mild cognitive impairment; reminiscence; virtual reality; Aged, 80 and over; Anxiety; Cognitive Dysfunction; Female; Humans; Imagery, Psychotherapy; Male; Mobile Applications; Nursing Homes; Patient Satisfaction; Telemedicine; Treatment Outcome; Virtual Reality","Ito","Toshinori","Osaka Center for Cancer and Cardiovascular Disease Prevention",NA
"852","34193667","10.7883/yoken.JJID.2021.213","Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan.","Various variants of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is re","2021","07","01","Jpn J Infect Dis","Japanese journal of infectious diseases","Coronavirus Diseases 2019 (COVID-19); real-time RT-PCR; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); variant of concern (VOC)","Shirato","Kazuya","Department of Virology III, National Institute of Infectious Disease, Japan",NA
"853","34193667","10.7883/yoken.JJID.2021.213","Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan.","Various variants of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is re","2021","07","01","Jpn J Infect Dis","Japanese journal of infectious diseases","Coronavirus Diseases 2019 (COVID-19); real-time RT-PCR; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); variant of concern (VOC)","Matsuyama","Shutoku","Department of Virology III, National Institute of Infectious Disease, Japan",NA
"854","34193667","10.7883/yoken.JJID.2021.213","Less frequent sequence mismatches in variants of concern (VOCs) of SARS-CoV-2 in the real-time RT-PCR assays developed by the National Institute of Infectious Diseases, Japan.","Various variants of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) began emerging worldwide from the end of 2020 to the beginning of 2021. The variants GRY/VOC202012/01 (B1.1.7), GH/N501Y.V2 (B1.351), and GR/N501Y.V3 (P1) are characterized by N to Y amino acid substitution at position 501 in the S protein. The variant containing L to R substitution at position 452 in the S protein G/L452R.V3 (B1.617) was endemic to India. The heightened concern regarding these variants is re","2021","07","01","Jpn J Infect Dis","Japanese journal of infectious diseases","Coronavirus Diseases 2019 (COVID-19); real-time RT-PCR; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); variant of concern (VOC)","Takeda","Makoto","Department of Virology III, National Institute of Infectious Disease, Japan",NA
"855","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Zafar","Noman",NA,NA
"856","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Kashora","Florence",NA,NA
"857","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Qurashi","Kamran",NA,NA
"858","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Al-Musawi","Jasim",NA,NA
"859","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Watfah","Josef",NA,NA
"860","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Liasis","Lampros",NA,NA
"861","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Sen","Manoj",NA,NA
"862","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Gould","Stuart",NA,NA
"863","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"J Vaizey","Carolynne",NA,NA
"864","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Warusavitarne","Janindra",NA,NA
"865","34193649","","Mitigating surgical emergency practice during COVID-19 pandemic?","To define the change in Emergency Surgical Unit (ESU) workload during the COVID-19 pandemic. Patient data for a three-week period was prospectively collected for ESU patients during lockdown period and compared to the ESU workload for the same time period prior to lockdown. Surgical emergencies admissions reduced by 2.5 times during our study period (p value = 0.001). In this changed paradigm, the overall number of surgical emergencies were reduced. A high mortality (n = 4, 5.7%) was noted durin","2021","07","01","Ann Ital Chir","Annali italiani di chirurgia",NA,"Leo","Cosimo Alex",NA,NA
"866","34193630","10.1123/apaq.2020-0109","WhatsApp-Based Physical Activity Intervention for Children With Autism Spectrum Disorder During the Novel Coronavirus (COVID-19) Pandemic: A Feasibility Trial.","The aim of this study was to evaluate the feasibility and potential efficacy of a WhatsApp-based physical activity for children with autism spectrum disorder (ASD). Fourteen parents and their children with ASD participated in the study. The intervention included parents conducting physical activities with their children with ASD for 4 weeks. Physical activity contents were provided to parents via the WhatsApp group. The data were collected through the Leisure Time Exercise Questionnaire and a fe","2021","07","01","Adapt Phys Activ Q","Adapted physical activity quarterly : APAQ","disability; exercise; social media","Esentürk","Oguz K","Erzincan Binali Yildirim University",NA
"867","34193630","10.1123/apaq.2020-0109","WhatsApp-Based Physical Activity Intervention for Children With Autism Spectrum Disorder During the Novel Coronavirus (COVID-19) Pandemic: A Feasibility Trial.","The aim of this study was to evaluate the feasibility and potential efficacy of a WhatsApp-based physical activity for children with autism spectrum disorder (ASD). Fourteen parents and their children with ASD participated in the study. The intervention included parents conducting physical activities with their children with ASD for 4 weeks. Physical activity contents were provided to parents via the WhatsApp group. The data were collected through the Leisure Time Exercise Questionnaire and a fe","2021","07","01","Adapt Phys Activ Q","Adapted physical activity quarterly : APAQ","disability; exercise; social media","Yarimkaya","Erkan","Turkish Ministry of National Education",NA
"868","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Paret","Michal","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York",NA
"869","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Lalani","Karim","Department of Pediatrics, New York University Grossman School of Medicine, New York",NA
"870","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Hedari","Carine","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York",NA
"871","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Jaffer","Annum","Department of Pediatrics, New York University Grossman School of Medicine, New York",NA
"872","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Narayanan","Nisha","Division of Pediatric Emergency Medicine, New York University Grossman School of Medicine, New York",NA
"873","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Noor","Asif","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Long Island School of Medicine, New York",NA
"874","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Lighter","Jennifer","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York",NA
"875","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Madan","Rebecca Pellett","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York",NA
"876","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Shust","Gail F","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York",NA
"877","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Ratner","Adam J","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York",NA
"878","34193619","10.1542/peds.2020-044685","SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.",NA,"2021","07","01","Pediatrics","Pediatrics",NA,"Raabe","Vanessa N","Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York","Vanessa.Raabe@nyulangone.org"
"879","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Matchett","William E","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"880","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Joag","Vineet","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"881","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Stolley","J Michael","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"882","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Shepherd","Frances K","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"883","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Quarnstrom","Clare F","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"884","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Mickelson","Clayton K","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"885","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Wijeyesinghe","Sathi","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"886","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Soerens","Andrew G","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"887","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Becker","Samuel","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"888","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Thiede","Joshua M","Center for Immunology, University of Minnesota, Minneapolis, MN",NA
"889","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Weyu","Eyob","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"890","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"O'Flanagan","Stephen D","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"891","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Walter","Jennifer A","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"892","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Vu","Michelle N","Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX",NA
"893","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Menachery","Vineet D","Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX",NA
"894","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Bold","Tyler D","Center for Immunology, University of Minnesota, Minneapolis, MN",NA
"895","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Vezys","Vaiva","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN",NA
"896","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Jenkins","Marc K","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN","jenki002@umn.edu"
"897","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Langlois","Ryan A","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN","jenki002@umn.edu"
"898","34193597","10.4049/jimmunol.2100421","Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and ","2021","07","07","J Immunol","Journal of immunology (Baltimore, Md. : 1950)",NA,"Masopust","David","Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN","jenki002@umn.edu"
"899","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Meireles","Paula","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal paula.meireles@ispup.up","paula.meireles@ispup.up.pt"
"900","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Amaro","Joana","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"901","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Pinto da Costa","Joana","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"902","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Lopes","Mariana Mendes","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"903","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Varandas","Tatiana","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"904","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Norton","Pedro","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"905","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Guimarães","João Tiago","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"906","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Severo","Milton","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"907","34193594","10.1136/oemed-2021-107519","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","To assess the prevalence of SARS-CoV-2-specific IgM and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020. A rapid point-of-care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers (SD Biosensor STANDARD Q COVID-19 IgM/IgG Duo and STANDARD Q COVID-19 IgM/IgG Combo). Testing was performed and a questionnaire was completed by 4592 workers on a voluntary basis from 21 May to 31 July 2020. We computed the ","2021","07","01","Occup Environ Med","Occupational and environmental medicine","COVID-19; Epidemiology; Occupational Health; Public Health Surveillance","Barros","Henrique","EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal",NA
"908","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","Murtha","Tara","Women's Law Project, Philadelphia, Pennsylvania, USA",NA
"909","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","Clark","Kim C","Legal Voice, Seattle, Washington, USA",NA
"910","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","Hall","Christy L","Gender Justice, St. Paul, Minnesota, USA",NA
"911","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","Basgall","Wendy Lee","Southwest Women's Law Center, Albuquerque, New Mexico, USA",NA
"912","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","Poyer","Amy C","California Women's Law Center, El Segundo, California, USA",NA
"913","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","McKenna","M Jenifer","The Alliance: State Advocates for Women's Rights &amp",NA
"914","34193588","10.1136/bmjsrh-2021-201208","Essential services? Operating status of crisis pregnancy centres in the United States during the COVID-19 pandemic.",NA,"2021","07","01","BMJ Sex Reprod Health","BMJ sexual &amp; reproductive health","COVID-19; Reproductive Health Services; family planning services","Dodge","Laura E","Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA ledodge@bidmc.harvard","ledodge@bidmc.harvard.edu"
"915","34193571","10.1136/jech-2020-216068","Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.","Previous studies have demonstrated that socioeconomic factors are associated with COVID-19 incidence. In this study, we analysed a broad range of socioeconomic indicators in relation to hospitalised cases in the Paris area. We extracted 303 socioeconomic indicators from French census data for 855 residential units in Paris and assessed their association with COVID-19 hospitalisation risk. The indicators most associated with hospitalisation risk were the third decile of population income (OR=9.10","2021","07","01","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; cohort studies; communicable diseases; deprivation; healthcare disparities","Jannot","Anne-Sophie","Hôpital Européen Georges Pompidou, Service d'informatique médicale, biostatistiques et santé publique, AP-HP, Paris, France annesophie.jannot@aphp","annesophie.jannot@aphp.fr"
"916","34193571","10.1136/jech-2020-216068","Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.","Previous studies have demonstrated that socioeconomic factors are associated with COVID-19 incidence. In this study, we analysed a broad range of socioeconomic indicators in relation to hospitalised cases in the Paris area. We extracted 303 socioeconomic indicators from French census data for 855 residential units in Paris and assessed their association with COVID-19 hospitalisation risk. The indicators most associated with hospitalisation risk were the third decile of population income (OR=9.10","2021","07","01","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; cohort studies; communicable diseases; deprivation; healthcare disparities","Countouris","Hector","Hôpital Européen Georges Pompidou, Service d'informatique médicale, biostatistiques et santé publique, AP-HP, Paris, France",NA
"917","34193571","10.1136/jech-2020-216068","Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.","Previous studies have demonstrated that socioeconomic factors are associated with COVID-19 incidence. In this study, we analysed a broad range of socioeconomic indicators in relation to hospitalised cases in the Paris area. We extracted 303 socioeconomic indicators from French census data for 855 residential units in Paris and assessed their association with COVID-19 hospitalisation risk. The indicators most associated with hospitalisation risk were the third decile of population income (OR=9.10","2021","07","01","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; cohort studies; communicable diseases; deprivation; healthcare disparities","Van Straaten","Alexis","Hôpital Européen Georges Pompidou, Service d'informatique médicale, biostatistiques et santé publique, AP-HP, Paris, France",NA
"918","34193571","10.1136/jech-2020-216068","Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.","Previous studies have demonstrated that socioeconomic factors are associated with COVID-19 incidence. In this study, we analysed a broad range of socioeconomic indicators in relation to hospitalised cases in the Paris area. We extracted 303 socioeconomic indicators from French census data for 855 residential units in Paris and assessed their association with COVID-19 hospitalisation risk. The indicators most associated with hospitalisation risk were the third decile of population income (OR=9.10","2021","07","01","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; cohort studies; communicable diseases; deprivation; healthcare disparities","Burgun","Anita","Hôpital Européen Georges Pompidou, Service d'informatique médicale, biostatistiques et santé publique, AP-HP, Paris, France",NA
"919","34193571","10.1136/jech-2020-216068","Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.","Previous studies have demonstrated that socioeconomic factors are associated with COVID-19 incidence. In this study, we analysed a broad range of socioeconomic indicators in relation to hospitalised cases in the Paris area. We extracted 303 socioeconomic indicators from French census data for 855 residential units in Paris and assessed their association with COVID-19 hospitalisation risk. The indicators most associated with hospitalisation risk were the third decile of population income (OR=9.10","2021","07","01","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; cohort studies; communicable diseases; deprivation; healthcare disparities","Katsahian","Sandrine","Hôpital Européen Georges Pompidou, Service d'informatique médicale, biostatistiques et santé publique, AP-HP, Paris, France",NA
"920","34193571","10.1136/jech-2020-216068","Low-income neighbourhood was a key determinant of severe COVID-19 incidence during the first wave of the epidemic in Paris.","Previous studies have demonstrated that socioeconomic factors are associated with COVID-19 incidence. In this study, we analysed a broad range of socioeconomic indicators in relation to hospitalised cases in the Paris area. We extracted 303 socioeconomic indicators from French census data for 855 residential units in Paris and assessed their association with COVID-19 hospitalisation risk. The indicators most associated with hospitalisation risk were the third decile of population income (OR=9.10","2021","07","01","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; cohort studies; communicable diseases; deprivation; healthcare disparities","Rance","Bastien","Hôpital Européen Georges Pompidou, Service d'informatique médicale, biostatistiques et santé publique, AP-HP, Paris, France",NA
"921","34193569","10.1136/jech-2020-216030","Characteristics of those most vulnerable to employment changes during the COVID-19 pandemic: a nationally representative cross-sectional study in Wales.","The public health response to the SARS-CoV-2 (COVID-19) pandemic has had a detrimental impact on employment and there are concerns the impact may be greatest among the most vulnerable. We examined the characteristics of those who experienced changes in employment status during the early months of the pandemic. Data were collected from a cross-sectional, nationally representative household survey of the working age population (18-64 years) in Wales in May/June 2020 (n=1379). We looked at changes ","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; employment; health inequalities; social inequalities; unemployment","Gray","Benjamin J","Research and Evaluation Division, Public Health Wales, Cardiff, UK benjamin.gray@wales.nhs","benjamin.gray@wales.nhs.uk"
"922","34193569","10.1136/jech-2020-216030","Characteristics of those most vulnerable to employment changes during the COVID-19 pandemic: a nationally representative cross-sectional study in Wales.","The public health response to the SARS-CoV-2 (COVID-19) pandemic has had a detrimental impact on employment and there are concerns the impact may be greatest among the most vulnerable. We examined the characteristics of those who experienced changes in employment status during the early months of the pandemic. Data were collected from a cross-sectional, nationally representative household survey of the working age population (18-64 years) in Wales in May/June 2020 (n=1379). We looked at changes ","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; employment; health inequalities; social inequalities; unemployment","Kyle","Richard G","Research and Evaluation Division, Public Health Wales, Cardiff, UK",NA
"923","34193569","10.1136/jech-2020-216030","Characteristics of those most vulnerable to employment changes during the COVID-19 pandemic: a nationally representative cross-sectional study in Wales.","The public health response to the SARS-CoV-2 (COVID-19) pandemic has had a detrimental impact on employment and there are concerns the impact may be greatest among the most vulnerable. We examined the characteristics of those who experienced changes in employment status during the early months of the pandemic. Data were collected from a cross-sectional, nationally representative household survey of the working age population (18-64 years) in Wales in May/June 2020 (n=1379). We looked at changes ","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; employment; health inequalities; social inequalities; unemployment","Song","Jiao","Research and Evaluation Division, Public Health Wales, Cardiff, UK",NA
"924","34193569","10.1136/jech-2020-216030","Characteristics of those most vulnerable to employment changes during the COVID-19 pandemic: a nationally representative cross-sectional study in Wales.","The public health response to the SARS-CoV-2 (COVID-19) pandemic has had a detrimental impact on employment and there are concerns the impact may be greatest among the most vulnerable. We examined the characteristics of those who experienced changes in employment status during the early months of the pandemic. Data were collected from a cross-sectional, nationally representative household survey of the working age population (18-64 years) in Wales in May/June 2020 (n=1379). We looked at changes ","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","COVID-19; employment; health inequalities; social inequalities; unemployment","Davies","Alisha R","Research and Evaluation Division, Public Health Wales, Cardiff, UK",NA
"925","34193568","10.1136/jech-2020-214579","COVID-19 distribution in Bogotá, Colombia: effect of poverty during the first 2 months of pandemic.","The current SARS-CoV-2 pandemic has especially affected individuals living in conglomerate settings having poverty as common characteristic. However, evidence of the association between COVID-19 severity and social determinants is still scarce, particularly, for Latin American countries. The objective was to assess the effect of socioeconomic deprivation in the clinical severity of COVID-19 infection among different localities of Bogotá, Colombia. Secondary analyses using data of SARS-CoV-2 infe","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","economics; epidemics; multilevel modelling; social epidemiology","Moreno-Montoya","Jose","Clinical Studies and Clinical Epidemiology Division, Hospital Universitario de la Fundación Santa Fe de Bogotá, Bogota, Colombia josemorenomontoya@gmail","josemorenomontoya@gmail.com"
"926","34193568","10.1136/jech-2020-214579","COVID-19 distribution in Bogotá, Colombia: effect of poverty during the first 2 months of pandemic.","The current SARS-CoV-2 pandemic has especially affected individuals living in conglomerate settings having poverty as common characteristic. However, evidence of the association between COVID-19 severity and social determinants is still scarce, particularly, for Latin American countries. The objective was to assess the effect of socioeconomic deprivation in the clinical severity of COVID-19 infection among different localities of Bogotá, Colombia. Secondary analyses using data of SARS-CoV-2 infe","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","economics; epidemics; multilevel modelling; social epidemiology","Ballesteros","Silvia Marcela","Clinical Studies and Clinical Epidemiology Division, Hospital Universitario de la Fundación Santa Fe de Bogotá, Bogota, Colombia",NA
"927","34193568","10.1136/jech-2020-214579","COVID-19 distribution in Bogotá, Colombia: effect of poverty during the first 2 months of pandemic.","The current SARS-CoV-2 pandemic has especially affected individuals living in conglomerate settings having poverty as common characteristic. However, evidence of the association between COVID-19 severity and social determinants is still scarce, particularly, for Latin American countries. The objective was to assess the effect of socioeconomic deprivation in the clinical severity of COVID-19 infection among different localities of Bogotá, Colombia. Secondary analyses using data of SARS-CoV-2 infe","2021","07","10","J Epidemiol Community Health","Journal of epidemiology and community health","economics; epidemics; multilevel modelling; social epidemiology","Idrovo","Alvaro Javier","Salud Publica, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia",NA
"928","34193549","10.1136/postgradmedj-2021-140409","Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.","Statin potentially improved outcome in patients with COVID-19. Patients who receive statin generally have a higher proportion of comorbidities than those who did not, which may introduce bias. In this meta-analysis, we aimed to investigate the association between statin use and mortality in patients with COVID-19 by pooling the adjusted effect estimates from propensity-score matching (PSM) matched studies or randomised controlled trials to reduce bias. A systematic literature search using the Pu","2021","07","10","Postgrad Med J","Postgraduate medical journal","COVID-19; cardiology; clinical pharmacology","Zein","Ahmad Fariz Malvi Zamzam","Department of Internal Medicine, Faculty of Medicine, Universitas Swadaya Gunung Jati, Cirebon, Jawa Barat, Indonesia fariz_zein_dr@yahoo",NA
"929","34193549","10.1136/postgradmedj-2021-140409","Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.","Statin potentially improved outcome in patients with COVID-19. Patients who receive statin generally have a higher proportion of comorbidities than those who did not, which may introduce bias. In this meta-analysis, we aimed to investigate the association between statin use and mortality in patients with COVID-19 by pooling the adjusted effect estimates from propensity-score matching (PSM) matched studies or randomised controlled trials to reduce bias. A systematic literature search using the Pu","2021","07","10","Postgrad Med J","Postgraduate medical journal","COVID-19; cardiology; clinical pharmacology","Sulistiyana","Catur Setiya","Department of Medical Education, Faculty of Medicine, Universitas Swadaya Gunung Jati, Cirebon, Jawa Barat, Indonesia",NA
"930","34193549","10.1136/postgradmedj-2021-140409","Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.","Statin potentially improved outcome in patients with COVID-19. Patients who receive statin generally have a higher proportion of comorbidities than those who did not, which may introduce bias. In this meta-analysis, we aimed to investigate the association between statin use and mortality in patients with COVID-19 by pooling the adjusted effect estimates from propensity-score matching (PSM) matched studies or randomised controlled trials to reduce bias. A systematic literature search using the Pu","2021","07","10","Postgrad Med J","Postgraduate medical journal","COVID-19; cardiology; clinical pharmacology","Khasanah","Uswatun","Department of Biostatistics and Epidemiology, Faculty of Medicine, Universitas Swadaya Gunung Jati, Cirebon, Jawa Barat, Indonesia",NA
"931","34193549","10.1136/postgradmedj-2021-140409","Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.","Statin potentially improved outcome in patients with COVID-19. Patients who receive statin generally have a higher proportion of comorbidities than those who did not, which may introduce bias. In this meta-analysis, we aimed to investigate the association between statin use and mortality in patients with COVID-19 by pooling the adjusted effect estimates from propensity-score matching (PSM) matched studies or randomised controlled trials to reduce bias. A systematic literature search using the Pu","2021","07","10","Postgrad Med J","Postgraduate medical journal","COVID-19; cardiology; clinical pharmacology","Wibowo","Arief","Department of Cardiology and Vascular Medicine, Universitas Padjadjaran, Bandung, Jawa Barat, Indonesia",NA
"932","34193549","10.1136/postgradmedj-2021-140409","Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.","Statin potentially improved outcome in patients with COVID-19. Patients who receive statin generally have a higher proportion of comorbidities than those who did not, which may introduce bias. In this meta-analysis, we aimed to investigate the association between statin use and mortality in patients with COVID-19 by pooling the adjusted effect estimates from propensity-score matching (PSM) matched studies or randomised controlled trials to reduce bias. A systematic literature search using the Pu","2021","07","10","Postgrad Med J","Postgraduate medical journal","COVID-19; cardiology; clinical pharmacology","Lim","Michael Anthonius","Universitas Pelita Harapan Fakultas Kedokteran, Tangerang, Banten, Indonesia",NA
"933","34193549","10.1136/postgradmedj-2021-140409","Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.","Statin potentially improved outcome in patients with COVID-19. Patients who receive statin generally have a higher proportion of comorbidities than those who did not, which may introduce bias. In this meta-analysis, we aimed to investigate the association between statin use and mortality in patients with COVID-19 by pooling the adjusted effect estimates from propensity-score matching (PSM) matched studies or randomised controlled trials to reduce bias. A systematic literature search using the Pu","2021","07","10","Postgrad Med J","Postgraduate medical journal","COVID-19; cardiology; clinical pharmacology","Pranata","Raymond","Medicine, Universitas Pelita Harapan Fakultas Kedokteran, Tangerang, Indonesia",NA
"934","34193548","10.1136/postgradmedj-2021-140500","Bilateral paracentral acute middle maculopathy in a SARS-CoV-2-positive patient.",NA,"2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; medical ophthalmology; medical retina","Naughton","Aoife","Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK aoife.naughton@ouh.nhs","aoife.naughton@ouh.nhs.uk"
"935","34193548","10.1136/postgradmedj-2021-140500","Bilateral paracentral acute middle maculopathy in a SARS-CoV-2-positive patient.",NA,"2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; medical ophthalmology; medical retina","Ong","Ariel Yuhan","Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"936","34193548","10.1136/postgradmedj-2021-140500","Bilateral paracentral acute middle maculopathy in a SARS-CoV-2-positive patient.",NA,"2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; medical ophthalmology; medical retina","Gkika","Theodora","Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"937","34193548","10.1136/postgradmedj-2021-140500","Bilateral paracentral acute middle maculopathy in a SARS-CoV-2-positive patient.",NA,"2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; medical ophthalmology; medical retina","Downes","Susan","Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK",NA
"939","34193542","10.1136/postgradmedj-2021-140330","Changing face of medical education during a pandemic: tragedy or opportunity?","The COVID-19 pandemic has changed forever the way we do certain things. Although the race for a cure and vaccine has taken centre stage, traditional face-to-face medical education has slowly metamorphosised in the background to a virtual world with innumerable webinars, virtual tutorials and lectures in the World Wide Web. Despite this seemingly 'perfect' solution, there remains a hidden cost. Educators are forced to learn new skills to engage students as well as manipulate the electronic platfo","2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; information management; medical education &amp; training","Leong","Jean Mei Ching","Haematology, Borders General Hospital, Melrose, UK",NA
"940","34193542","10.1136/postgradmedj-2021-140330","Changing face of medical education during a pandemic: tragedy or opportunity?","The COVID-19 pandemic has changed forever the way we do certain things. Although the race for a cure and vaccine has taken centre stage, traditional face-to-face medical education has slowly metamorphosised in the background to a virtual world with innumerable webinars, virtual tutorials and lectures in the World Wide Web. Despite this seemingly 'perfect' solution, there remains a hidden cost. Educators are forced to learn new skills to engage students as well as manipulate the electronic platfo","2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; information management; medical education &amp; training","Lam","Wee Leon","Plastic Surgery, Royal Hospital for Sick Children, Edinburgh, UK lamweeleon@gmail","lamweeleon@gmail.com"
"941","34193542","10.1136/postgradmedj-2021-140330","Changing face of medical education during a pandemic: tragedy or opportunity?","The COVID-19 pandemic has changed forever the way we do certain things. Although the race for a cure and vaccine has taken centre stage, traditional face-to-face medical education has slowly metamorphosised in the background to a virtual world with innumerable webinars, virtual tutorials and lectures in the World Wide Web. Despite this seemingly 'perfect' solution, there remains a hidden cost. Educators are forced to learn new skills to engage students as well as manipulate the electronic platfo","2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; information management; medical education &amp; training","Tan","Shi Zhuan","Opthalmology, St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UK",NA
"942","34193542","10.1136/postgradmedj-2021-140330","Changing face of medical education during a pandemic: tragedy or opportunity?","The COVID-19 pandemic has changed forever the way we do certain things. Although the race for a cure and vaccine has taken centre stage, traditional face-to-face medical education has slowly metamorphosised in the background to a virtual world with innumerable webinars, virtual tutorials and lectures in the World Wide Web. Despite this seemingly 'perfect' solution, there remains a hidden cost. Educators are forced to learn new skills to engage students as well as manipulate the electronic platfo","2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; information management; medical education &amp; training","Ng","Chye Yew","Orthopaedics, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK",NA
"943","34193539","10.1136/postgradmedj-2021-140426","Why face-to-face medical education will prevail despite the world's swift acclimatisation to virtual learning.",NA,"2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; medical education &amp; training","Enoch","Tanya Rebekah","School of Medicine, Cardiff University, Cardiff, UK",NA
"944","34193539","10.1136/postgradmedj-2021-140426","Why face-to-face medical education will prevail despite the world's swift acclimatisation to virtual learning.",NA,"2021","07","01","Postgrad Med J","Postgraduate medical journal","COVID-19; medical education &amp; training","Williams","Rebecca Charlene","Department of Educational Assessment, University of Oxford, Oxford, UK rebecca.williams2@education.ox.ac","rebecca.williams2@education.ox.ac.uk"
"945","34193531","10.1136/sextrans-2021-055110","Video-based HIV testing services among cisgender men who have sex with men as a component of an HIV behavioural surveillance study during the COVID-19 pandemic in New York City: implementation, feasibility and lessons learned.",NA,"2021","07","11","Sex Transm Infect","Sexually transmitted infections","COVID-19; HIV; population surveillance; public health","Rivera","Alexis","Bureau of HIV, New York City Department of Health and Mental Hygiene, New York, New York, USA arivera6@health.nyc","arivera6@health.nyc.gov"
"946","34193531","10.1136/sextrans-2021-055110","Video-based HIV testing services among cisgender men who have sex with men as a component of an HIV behavioural surveillance study during the COVID-19 pandemic in New York City: implementation, feasibility and lessons learned.",NA,"2021","07","11","Sex Transm Infect","Sexually transmitted infections","COVID-19; HIV; population surveillance; public health","Martinez","Pablo","Bureau of HIV, New York City Department of Health and Mental Hygiene, New York, New York, USA",NA
"947","34193531","10.1136/sextrans-2021-055110","Video-based HIV testing services among cisgender men who have sex with men as a component of an HIV behavioural surveillance study during the COVID-19 pandemic in New York City: implementation, feasibility and lessons learned.",NA,"2021","07","11","Sex Transm Infect","Sexually transmitted infections","COVID-19; HIV; population surveillance; public health","Braunstein","Sarah","Bureau of HIV, New York City Department of Health and Mental Hygiene, New York, New York, USA",NA
"948","34193527","10.1136/bmj.n1625","Could expanding the covid-19 case definition improve the UK's pandemic response?",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Diseases; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Health Policy; Humans; Pandemics; United Kingdom","Crozier","Alex","Division of Biosciences, University College London, London, UK alexander.crozier.20@ucl.ac","alexander.crozier.20@ucl.ac.uk"
"949","34193527","10.1136/bmj.n1625","Could expanding the covid-19 case definition improve the UK's pandemic response?",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Diseases; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Health Policy; Humans; Pandemics; United Kingdom","Dunning","Jake","Royal Free London NHS Foundation Trust, London, UK",NA
"950","34193527","10.1136/bmj.n1625","Could expanding the covid-19 case definition improve the UK's pandemic response?",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Diseases; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Health Policy; Humans; Pandemics; United Kingdom","Rajan","Selina","Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK",NA
"951","34193527","10.1136/bmj.n1625","Could expanding the covid-19 case definition improve the UK's pandemic response?",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Diseases; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Health Policy; Humans; Pandemics; United Kingdom","Semple","Malcolm G","NIHR Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK",NA
"952","34193527","10.1136/bmj.n1625","Could expanding the covid-19 case definition improve the UK's pandemic response?",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Asymptomatic Diseases; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Health Policy; Humans; Pandemics; United Kingdom","Buchan","Iain E","NIHR Health Protection Research Unit in Emerging and Zoonotic Infections and Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK",NA
"953","34193525","10.1136/bmj.n1616","Covid-19: ""Life on hold"" for NHS patients needing musculoskeletal care.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)",NA,"Oxtoby","Kathy","London, UK",NA
"954","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Wang","Ying","Codagenix Inc., Farmingdale, NY 11735",NA
"955","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Yang","Chen","Codagenix Inc., Farmingdale, NY 11735",NA
"956","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Song","Yutong","Codagenix Inc., Farmingdale, NY 11735",NA
"957","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Coleman","J Robert","Codagenix Inc., Farmingdale, NY 11735",NA
"958","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Stawowczyk","Marcin","Codagenix Inc., Farmingdale, NY 11735",NA
"959","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Tafrova","Juliana","Codagenix Inc., Farmingdale, NY 11735",NA
"960","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Tasker","Sybil","Codagenix Inc., Farmingdale, NY 11735",NA
"961","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Boltz","David","Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616",NA
"962","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Baker","Robert","Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616",NA
"963","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Garcia","Liliana","Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616",NA
"964","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Seale","Olivia","Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616",NA
"965","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Kushnir","Anna","Codagenix Inc., Farmingdale, NY 11735",NA
"966","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Wimmer","Eckard","Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794 eckard.wimmer@stonybrook.edu mueller@codagenix","eckard.wimmer@stonybrook.edu"
"967","34193524","10.1073/pnas.2102775118","Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.","Successfully combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd immunity. Here, we describe COVI-VAC, the only live attenuated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine currently in clinical development. COVI-VAC was developed by recoding a segment of the viral spike protein with synonymous suboptimal codon pairs (codon-pair deoptimization), thereby introducing 283 silent (point) mutations. In addition, the furin cleavage","2021","07","08","Proc Natl Acad Sci U S A","Proceedings of the National Academy of Sciences of the United States of America","COVID-19; codon deoptimization; live attenuated; vaccine; Animals; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Chlorocebus aethiops; Female; Humans; Male; Mesocricetus; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines, Attenuated; Vero Cells","Mueller","Steffen","Codagenix Inc., Farmingdale, NY 11735","eckard.wimmer@stonybrook.edu"
"968","34193507","10.1136/bmjopen-2021-053506","Exploring the impact of the COVID-19 pandemic on doctors' core workplace needs: a qualitative study of internal medicine trainees in Scotland.","This study aimed to explore how the COVID-19 pandemic has impacted the workplace core needs of internal medicine (IM) trainees in Scotland. This qualitative study used an observational approach of interprofessional workshops combined with subsequent individual interviews with IM trainees. Workshops and interviews were audiorecorded, transcribed verbatim and analysed utilising NVivo software. Template analysis was used with the Autonomy/control, Belonging and Competence (ABC) of doctors' core nee","2021","07","05","BMJ Open","BMJ open","COVID-19; internal medicine; medical education &amp; training; qualitative research; COVID-19; Clinical Competence; Education, Medical, Graduate; Humans; Internal Medicine; Pandemics; SARS-CoV-2; Scotland; Workplace","Kerins","Joanne","Scottish Centre for Simulation and Clinical Human Factors, Larbert, UK joanne.kerins@ggc.scot.nhs","joanne.kerins@ggc.scot.nhs.uk"
"969","34193507","10.1136/bmjopen-2021-053506","Exploring the impact of the COVID-19 pandemic on doctors' core workplace needs: a qualitative study of internal medicine trainees in Scotland.","This study aimed to explore how the COVID-19 pandemic has impacted the workplace core needs of internal medicine (IM) trainees in Scotland. This qualitative study used an observational approach of interprofessional workshops combined with subsequent individual interviews with IM trainees. Workshops and interviews were audiorecorded, transcribed verbatim and analysed utilising NVivo software. Template analysis was used with the Autonomy/control, Belonging and Competence (ABC) of doctors' core nee","2021","07","05","BMJ Open","BMJ open","COVID-19; internal medicine; medical education &amp; training; qualitative research; COVID-19; Clinical Competence; Education, Medical, Graduate; Humans; Internal Medicine; Pandemics; SARS-CoV-2; Scotland; Workplace","Hamilton","Ailsa Lauren","The University of Edinburgh, Edinburgh, UK",NA
"970","34193507","10.1136/bmjopen-2021-053506","Exploring the impact of the COVID-19 pandemic on doctors' core workplace needs: a qualitative study of internal medicine trainees in Scotland.","This study aimed to explore how the COVID-19 pandemic has impacted the workplace core needs of internal medicine (IM) trainees in Scotland. This qualitative study used an observational approach of interprofessional workshops combined with subsequent individual interviews with IM trainees. Workshops and interviews were audiorecorded, transcribed verbatim and analysed utilising NVivo software. Template analysis was used with the Autonomy/control, Belonging and Competence (ABC) of doctors' core nee","2021","07","05","BMJ Open","BMJ open","COVID-19; internal medicine; medical education &amp; training; qualitative research; COVID-19; Clinical Competence; Education, Medical, Graduate; Humans; Internal Medicine; Pandemics; SARS-CoV-2; Scotland; Workplace","Pringle","Jemma","NHS Education for Scotland, Edinburgh, UK",NA
"971","34193507","10.1136/bmjopen-2021-053506","Exploring the impact of the COVID-19 pandemic on doctors' core workplace needs: a qualitative study of internal medicine trainees in Scotland.","This study aimed to explore how the COVID-19 pandemic has impacted the workplace core needs of internal medicine (IM) trainees in Scotland. This qualitative study used an observational approach of interprofessional workshops combined with subsequent individual interviews with IM trainees. Workshops and interviews were audiorecorded, transcribed verbatim and analysed utilising NVivo software. Template analysis was used with the Autonomy/control, Belonging and Competence (ABC) of doctors' core nee","2021","07","05","BMJ Open","BMJ open","COVID-19; internal medicine; medical education &amp; training; qualitative research; COVID-19; Clinical Competence; Education, Medical, Graduate; Humans; Internal Medicine; Pandemics; SARS-CoV-2; Scotland; Workplace","Farquhar","Fiona","Acute medicine, NHS Lanarkshire, Bothwell, UK",NA
"972","34193507","10.1136/bmjopen-2021-053506","Exploring the impact of the COVID-19 pandemic on doctors' core workplace needs: a qualitative study of internal medicine trainees in Scotland.","This study aimed to explore how the COVID-19 pandemic has impacted the workplace core needs of internal medicine (IM) trainees in Scotland. This qualitative study used an observational approach of interprofessional workshops combined with subsequent individual interviews with IM trainees. Workshops and interviews were audiorecorded, transcribed verbatim and analysed utilising NVivo software. Template analysis was used with the Autonomy/control, Belonging and Competence (ABC) of doctors' core nee","2021","07","05","BMJ Open","BMJ open","COVID-19; internal medicine; medical education &amp; training; qualitative research; COVID-19; Clinical Competence; Education, Medical, Graduate; Humans; Internal Medicine; Pandemics; SARS-CoV-2; Scotland; Workplace","Tallentire","Victoria Ruth","Scottish Centre for Simulation and Clinical Human Factors, Larbert, UK",NA
"973","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Busatto","Geraldo Filho","Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil geraldo.busatto@gmail","geraldo.busatto@gmail.com"
"974","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","de Araújo","Adriana Ladeira","Diretoria Executiva dos LIMs, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"975","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Duarte","Alberto José da Silva","Departamento de Dermatologia, Laboratório de Dermatologia e Imunodeficiências, Faculdade de Medicina e Instituto de Medicina Tropical de São Paulo, Sao Paulo, Brazil",NA
"976","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Levin","Anna Sara","Departamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"977","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Guedes","Bruno Fukelmann","Instituto Central, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, Sao Paulo, Brazil",NA
"978","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Kallas","Esper Georges","Departamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"979","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Pinna","Fabio Rezende","Instituto Central, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo HCFMUSP, Sao Paulo, Brazil",NA
"980","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","de Souza","Heraldo Possolo","Departamento de Clínica Médica, Laboratório de Emergências Clínicas, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"981","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","da Silva","Katia Regina","Instituto do Coração (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"982","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Sawamura","Marcio Valente Yamada","Instituto de Radiologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"983","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Seelaender","Marilia","Departamento de Cirurgia, Laboratório de Pesquisa em Cirurgia Experimental, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"984","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Imamura","Marta","Instituto de Medicina Física e de Reabilitação, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"985","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Garcia","Michelle Louvaes","Departamento de Cardio-Pneumologia, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"986","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Forlenza","Orestes Vicente","Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"987","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Nitrini","Ricardo","Departamento de Neurologia, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"988","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Damiano","Rodolfo Furlan","Departamento e Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"989","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Rocha","Vanderson Geraldo","Departamento de Clínica Médica, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"990","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Batisttella","Linamara Rizzo","Instituto de Medicina Física e de Reabilitação, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"991","34193506","10.1136/bmjopen-2021-051706","Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.","COVID-19 may lead to persistent and potentially incapacitating clinical manifestations (post-acute sequelae of SARS-CoV-2 infection (PASC)). Using easy-to-apply questionnaires and scales (often by telephone interviewing), several studies evaluated samples of COVID-19 inpatients from 4 weeks to several months after discharge. However, studies conducting systematic multidisciplinary assessments of PASC manifestations are scarce, with thorough in-person objective evaluations restricted to modestly ","2021","07","05","BMJ Open","BMJ open","COVID-19; epidemiology; rehabilitation medicine; Brazil; COVID-19; Hospitalization; Humans; Observational Studies as Topic; SARS-CoV-2","Carvalho","Carlos Roberto Ribeiro de","Departamento de Cardio-Pneumologia, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil",NA
"992","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Lamb","Danielle","Department of Applied Health Research, University College London, London, UK d.lamb@ucl.ac","d.lamb@ucl.ac.uk"
"993","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Greenberg","Neil","Institute of Psychiatry, Psychology &amp",NA
"994","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Hotopf","Matthew","Institute of Psychiatry, Psychology &amp",NA
"995","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Raine","Rosalind","Department of Applied Health Research, University College London, London, UK",NA
"996","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Razavi","Reza","Institute of Psychiatry, Psychology &amp",NA
"997","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Bhundia","Rupa","Institute of Psychiatry, Psychology &amp",NA
"998","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Scott","Hannah","Institute of Psychiatry, Psychology &amp",NA
"999","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Carr","Ewan","Institute of Psychiatry, Psychology &amp",NA
"1000","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Gafoor","Rafael","Department of Applied Health Research, University College London, London, UK",NA
"1001","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Bakolis","Ioannis","Institute of Psychiatry, Psychology &amp",NA
"1002","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Hegarty","Siobhan","Institute of Psychiatry, Psychology &amp",NA
"1003","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Souliou","Emilia","Institute of Psychiatry, Psychology &amp",NA
"1004","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Rafferty","Anne Marie","Institute of Psychiatry, Psychology &amp",NA
"1005","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Rhead","Rebecca","Institute of Psychiatry, Psychology &amp",NA
"1006","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Weston","Danny","Institute of Psychiatry, Psychology &amp",NA
"1007","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Gnangapragasam","Sam","Institute of Psychiatry, Psychology &amp",NA
"1008","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Marlow","Sally","Institute of Psychiatry, Psychology &amp",NA
"1009","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Wessely","Simon","Institute of Psychiatry, Psychology &amp",NA
"1010","34193505","10.1136/bmjopen-2021-051687","NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers.","The COVID-19 pandemic has had profound effects on the working lives of healthcare workers (HCWs), but the extent to which their well-being and mental health have been affected remains unclear. This longitudinal cohort study aims to recruit a cohort of National Health Service (NHS) HCWs, conducting surveys at regular intervals to provide evidence about the prevalence of symptoms of mental disorders, and investigate associated factors such as occupational contexts and support interventions availab","2021","07","05","BMJ Open","BMJ open","COVID-19; mental health; occupational &amp; industrial medicine; COVID-19; Cohort Studies; England; Health Personnel; Humans; Longitudinal Studies; Pandemics; SARS-CoV-2; State Medicine","Stevelink","Sharon","Institute of Psychiatry, Psychology &amp",NA
"1011","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Mollerup","Annette","Research Unit for Dietary Studies, The Parker Institute, Frederiksberg, Copenhagen University Hospital, Frederiksberg, Denmark annette.mollerup@regionh","annette.mollerup@regionh.dk"
"1012","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Larsen","Sofus Christian","Research Unit for Dietary Studies, The Parker Institute, Frederiksberg, Copenhagen University Hospital, Frederiksberg, Denmark",NA
"1013","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Bennetzen","Anita Selmer","Research Unit for Dietary Studies, The Parker Institute, Frederiksberg, Copenhagen University Hospital, Frederiksberg, Denmark",NA
"1014","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Henriksen","Marius","The Parker Institute, Frederiksberg, Copenhagen University Hospital, Frederiksberg, Denmark",NA
"1015","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Simonsen","Mette Kildevaeld","Department of Neurology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark",NA
"1016","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Weis","Nina","Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark",NA
"1017","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Kofod","Linette Marie","Department of Physio- and Occupational Therapy and PMR-C, Copenhagen University Hospital - Hvidovre, Copenhagen, Denmark",NA
"1018","34193503","10.1136/bmjopen-2021-050582","PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.","Infection with SARS-CoV-2 may progress to severe pulmonary disease, COVID-19. Currently, patients admitted to hospital because of COVID-19 have better prognosis than during the first period of the pandemic due to improved treatment. However, the overall societal susceptibility of being infected makes it pivotal to prevent severe courses of disease to avoid high mortality rates and collapse of the healthcare systems. Positive expiratory pressure (PEP) self-care is used in chronic pulmonary diseas","2021","07","05","BMJ Open","BMJ open","COVID-19; clinical trials; infectious diseases; preventive medicine; public health; respiratory medicine (see thoracic medicine); Activities of Daily Living; COVID-19; Hospitalization; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Self Care; Treatment Outcome","Heitmann","Berit Lilienthal","Research Unit for Dietary Studies, The Parker Institute, Frederiksberg, Copenhagen University Hospital, Frederiksberg, Denmark",NA
"1019","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Attwell","Katie","School of Social Sciences, The University of Western Australia, Perth, Western Australia, Australia katie.attwell@uwa.edu","katie.attwell@uwa.edu.au"
"1020","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Carlson","Samantha","School of Social Sciences, The University of Western Australia, Perth, Western Australia, Australia",NA
"1021","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Tchilingirian","Jordan","School of Social Sciences, The University of Western Australia, Perth, Western Australia, Australia",NA
"1022","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Harper","Tauel","Faculty of Arts, Business, Law and Education, The University of Western Australia, Perth, Western Australia, Australia",NA
"1023","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","McKenzie","Lara","School of Social Sciences, The University of Western Australia, Perth, Western Australia, Australia",NA
"1024","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Roberts","Leah","School of Social Sciences, The University of Western Australia, Perth, Western Australia, Australia",NA
"1025","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Rizzi","Marco","School of Law, The University of Western Australia, Perth, Western Australia, Australia",NA
"1026","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Westphal","Darren","Communicable Disease Control Directorate, Department of Health Government of Western Australia, Perth, Western Australia, Australia",NA
"1027","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Effler","Paul","Communicable Disease Control Directorate, Department of Health Government of Western Australia, Perth, Western Australia, Australia",NA
"1028","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Hughes","Catherine","Immunisation Foundation of Australia, Perth, Western Australia, Australia",NA
"1029","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Swift","Valerie","Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia",NA
"1030","34193501","10.1136/bmjopen-2021-049356","Coronavax: preparing community and government for COVID-19 vaccination: a research protocol for a mixed methods social research project.","Ahead of the implementation of a COVID-19 vaccination programme, the interdisciplinary Coronavax research team developed a multicomponent mixed methods project to support successful roll-out of the COVID-19 vaccine in Western Australia. This project seeks to analyse community attitudes about COVID-19 vaccination, vaccine access and information needs. We also study how government incorporates research findings into the vaccination programme. The Coronavax protocol employs an analytical social med","2021","07","05","BMJ Open","BMJ open","COVID-19; health policy; infection control; public health; Adolescent; Australia; COVID-19; COVID-19 Vaccines; Child; Child, Preschool; Government; Humans; Infant; SARS-CoV-2; Vaccination; Western Australia; Young Adult","Blyth","Christopher C","Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Nedlands, Western Australia, Australia",NA
"1031","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Pouwels","Beau D C","Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands beaupouwels@gmail","beaupouwels@gmail.com"
"1032","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Simons","Sami O","Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University Medical Centre+, Maastricht, The Netherlands",NA
"1033","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Theunissen","Maurice","Centre of Expertise for Palliative Care, Maastricht University Medical Centre+, Maastricht, The Netherlands",NA
"1034","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Peters","Madelon L","Department of Clinical Psychological Science, Maastricht University, Maastricht, The Netherlands",NA
"1035","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Schoenmaekers","Janna J","Respiratory Medicine and Centre of Expertise for Palliative Care, Maastricht University Medical Centre+, Maastricht, The Netherlands",NA
"1036","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","Bekkers","Sebastiaan C","Cardiology, Maastricht University Medical Centre+, Maastricht, The Netherlands",NA
"1037","34193494","10.1136/bmjopen-2020-046883","Healthcare use during COVID-19 and the effect on psychological distress in patients with chronic cardiopulmonary disorders in the Netherlands: a cross-sectional study.","The COVID-19 pandemic caused a massive shift in the focus of healthcare. Such changes could have affected health status and mental health in vulnerable patient groups. We aimed to investigate whether patients with chronic pulmonary and cardiac diseases had experienced high levels of psychological distress during the COVID-19 pandemic in the Netherlands. A cross-sectional study. COVID-19 pandemic-related changes in healthcare use, health status and psychological distress were investigated among p","2021","07","05","BMJ Open","BMJ open","COVID-19; anxiety disorders; mental health; palliative care; quality in health care; Anxiety; COVID-19; Cross-Sectional Studies; Delivery of Health Care; Depression; Humans; Netherlands; Pandemics; Psychological Distress; SARS-CoV-2; Stress, Psychological; Surveys and Questionnaires","van den Beuken-van Everdingen","Marieke H J","Centre of Expertise for Palliative Care, Maastricht University Medical Centre+, Maastricht, The Netherlands",NA
"1038","34193476","10.1136/bmjgh-2021-006564","COVID-19 and a coup: blockage of internet and social media access further exacerbate gender-based violence risks for women in Myanmar.",NA,"2021","07","05","BMJ Glob Health","BMJ global health","COVID-19; public health; COVID-19; Female; Gender-Based Violence; Humans; Internet; Myanmar; SARS-CoV-2; Social Media","Sharma","Vandana","Department of Global Health and Population, T H Chan School of Public Health, Harvard University, Boston, Massachusetts, USA vsharma@hsph.harvard","vsharma@hsph.harvard.edu"
"1039","34193476","10.1136/bmjgh-2021-006564","COVID-19 and a coup: blockage of internet and social media access further exacerbate gender-based violence risks for women in Myanmar.",NA,"2021","07","05","BMJ Glob Health","BMJ global health","COVID-19; public health; COVID-19; Female; Gender-Based Violence; Humans; Internet; Myanmar; SARS-CoV-2; Social Media","Oo","Phyu Phyu","Griffith University, Nathan, Brisbane, Australia",NA
"1040","34193476","10.1136/bmjgh-2021-006564","COVID-19 and a coup: blockage of internet and social media access further exacerbate gender-based violence risks for women in Myanmar.",NA,"2021","07","05","BMJ Glob Health","BMJ global health","COVID-19; public health; COVID-19; Female; Gender-Based Violence; Humans; Internet; Myanmar; SARS-CoV-2; Social Media","Hollaender","Julia","International Medical Corps, Tripoli, Libya",NA
"1041","34193476","10.1136/bmjgh-2021-006564","COVID-19 and a coup: blockage of internet and social media access further exacerbate gender-based violence risks for women in Myanmar.",NA,"2021","07","05","BMJ Glob Health","BMJ global health","COVID-19; public health; COVID-19; Female; Gender-Based Violence; Humans; Internet; Myanmar; SARS-CoV-2; Social Media","Scott","Jennifer","Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA",NA
"1042","34193473","10.1136/bmj.n1665","Covid-19: GP staff have faced threats and abuse during vaccination programme, poll finds.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)",NA,"Rimmer","Abi","The BMJ",NA
"1043","34193470","10.1136/bmj.n1677","Covid-19: Government must tackle stark regional health inequalities exposed by pandemic, says Marmot.",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)",NA,"Mahase","Elisabeth","The BMJ",NA
"1044","34193457","10.1136/bmj.n1605","How long does covid-19 immunity last?",NA,"2021","07","01","BMJ","BMJ (Clinical research ed.)",NA,"Baraniuk","Chris","Belfast",NA
"1045","34193437","10.1136/bmj.n1667","Governments and public trust: a public covid inquiry that reported quickly could shape response to the third wave.",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Access to Information; COVID-19; Federal Government; Health Policy; Humans; Information Dissemination; Pandemics; Public Health; Time Factors; Trust; United Kingdom","Puntis","John","Leeds, UK",NA
"1046","34193437","10.1136/bmj.n1667","Governments and public trust: a public covid inquiry that reported quickly could shape response to the third wave.",NA,"2021","07","12","BMJ","BMJ (Clinical research ed.)","Access to Information; COVID-19; Federal Government; Health Policy; Humans; Information Dissemination; Pandemics; Public Health; Time Factors; Trust; United Kingdom","O'Sullivan","Tony","London, UK",NA
"1047","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Ruran","Hana B","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA",NA
"1048","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Adamkiewicz","Gary","Department of Environmental Health, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA",NA
"1049","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Cunningham","Amparito","Boston Children's Hospital Division of Immunology, Boston, Massachusetts, USA",NA
"1050","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Petty","Carter R","Boston Children's Hospital, Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Boston, Massachusetts, USA",NA
"1051","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Greco","Kimberly F","Boston Children's Hospital, Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Boston, Massachusetts, USA",NA
"1052","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Gunnlaugsson","Sigfus","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA",NA
"1053","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Stamatiadis","Natalie","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA",NA
"1054","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Sierra","Gabriella","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA",NA
"1055","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Vallarino","Jose","Department of Environmental Health, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA",NA
"1056","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Alvarez","Marty","Department of Environmental Health, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA",NA
"1057","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Hayden","Lystra P","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA",NA
"1058","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Sheils","Catherine A","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA",NA
"1059","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Weller","Edie","Boston Children's Hospital, Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Boston, Massachusetts, USA",NA
"1060","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Phipatanakul","Wanda","Boston Children's Hospital Division of Immunology, Boston, Massachusetts, USA",NA
"1061","34193433","10.1136/bmjresp-2021-000915","Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic.","Almost half of all school-age children with bronchopulmonary dysplasia (BPD) have asthma-like symptoms and more suffer from lung function deficits. While air pollution and indoor respiratory irritants are known to affect high-risk populations of children, few studies have objectively evaluated environmental contributions to long-term respiratory morbidity in this population. This study aimed to examine the role of indoor environmental exposures on respiratory morbidity in children with BPD. The ","2021","07","15","BMJ Open Respir Res","BMJ open respiratory research","Paediatric Lung Disaese; Air Pollution; Air Pollution, Indoor; Allergens; Asthma; Bronchopulmonary Dysplasia; COVID-19; Child; Cohort Studies; Environmental Exposure; Female; Humans; Humidity; Male; Nitric Oxide; Nitrogen Dioxide; Particulate Matter; Prospective Studies; Respiratory Function Tests; SARS-CoV-2; Temperature","Gaffin","Jonathan M","Boston Children's Hospital Division of Pulmonary and Respiratory Diseases, Boston, Massachusetts, USA jonathan.gaffin@childrens.harvard","jonathan.gaffin@childrens.harvard.edu"
"1062","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Han","Namshik","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. n.han@milner.cam.ac.uk t.kouzarides@gurdon.cam.ac","n.han@milner.cam.ac.uk"
"1063","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Hwang","Woochang","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1064","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Tzelepis","Konstantinos","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1065","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Schmerer","Patrick","Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, Gießen 35392, Germany",NA
"1066","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Yankova","Eliza","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1067","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","MacMahon","Méabh","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1068","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Lei","Winnie","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1069","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","M Katritsis","Nicholas","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1070","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Liu","Anika","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1071","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Felgenhauer","Ulrike","Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, Gießen 35392, Germany",NA
"1072","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Schuldt","Alison","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1073","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Harris","Rebecca","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1074","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Chapman","Kathryn","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK",NA
"1075","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","McCaughan","Frank","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"1076","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Weber","Friedemann","Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, Gießen 35392, Germany",NA
"1077","34193418","10.1126/sciadv.abh3032","Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.","The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitates the rapid development of new therapies against coronavirus disease 2019 (COVID-19) infection. Here, we present the identification of 200 approved drugs, appropriate for repurposing against COVID-19. We constructed a SARS-CoV-2-induced protein network, based on disease signatures defined by COVID-19 multiomics datasets, and cross-examined these pathways against approved drugs. This analysis identified","2021","07","14","Sci Adv","Science advances","Antiviral Agents; COVID-19; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication","Kouzarides","Tony","Milner Therapeutics Institute, University of Cambridge, Cambridge, UK. n.han@milner.cam.ac.uk t.kouzarides@gurdon.cam.ac","n.han@milner.cam.ac.uk"
"1078","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Petrov","Megan E","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA. Electronic address: Megan.Petrov@asu","Megan.Petrov@asu.edu"
"1079","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Pituch","Keenan A","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA",NA
"1080","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Kasraeian","Kimiya","College of Health Solutions, Arizona State University, Phoenix, Arizona, USA",NA
"1081","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Jiao","Nana","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA",NA
"1082","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Mattingly","Jennifer","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA",NA
"1083","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Hasanaj","Kristina","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA",NA
"1084","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Youngstedt","Shawn D","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA",NA
"1085","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Buman","Matthew P","College of Health Solutions, Arizona State University, Phoenix, Arizona, USA",NA
"1086","34193394","10.1016/j.sleh.2021.05.007","Impact of the COVID-19 pandemic on change in sleep patterns in an exploratory, cross-sectional online sample of 79 countries.","To describe changes in sleep patterns during the coronavirus disease 2019 (COVID-19) pandemic, develop profiles according to these patterns, and assess sociodemographic, economic, COVID-19 related, and sleep and mental health factors associated with these profiles. A 25-minute online survey was distributed worldwide through social media from 5/21/2020 to 7/1/2020. Participants reported sociodemographic/economic information, the impact of the pandemic on major life domains, insomnia and depressiv","2021","07","01","Sleep Health","Sleep health","Coronavirus; Depression; Gender differences; Insomnia severity; Latent profile analysis; Quarantine","Epstein","Dana R","Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona, USA",NA
"1087","34193391","10.1016/j.bjps.2021.05.025","WALANT Protocol: Stop before you block.","The use of Wide Awake Local Anaesthetic No Tourniquet (WALANT) amongst Plastic and Orthopaedic Hand Surgeons has been accelerated by the impact of the COVID-19 pandemic and associated risks of general anaesthesia. Benefits of WALANT include a bloodless field, improved recovery, on-table testing, as well as cost and time savings. Whilst more clinical trials are underway to fully elucidate safety-profile and outcomes, there is a lack of consensus and clarity over contraindications to WALANT. A sur","2021","07","03","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Adrenaline; Hand surgery; Safety; Trauma; WALANT","Zargaran","David","Royal Free Hospital, Pond St, London NW3 2QG",NA
"1088","34193391","10.1016/j.bjps.2021.05.025","WALANT Protocol: Stop before you block.","The use of Wide Awake Local Anaesthetic No Tourniquet (WALANT) amongst Plastic and Orthopaedic Hand Surgeons has been accelerated by the impact of the COVID-19 pandemic and associated risks of general anaesthesia. Benefits of WALANT include a bloodless field, improved recovery, on-table testing, as well as cost and time savings. Whilst more clinical trials are underway to fully elucidate safety-profile and outcomes, there is a lack of consensus and clarity over contraindications to WALANT. A sur","2021","07","03","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Adrenaline; Hand surgery; Safety; Trauma; WALANT","Zargaran","Alexander","St Thomas' Hospital, Westminster Bridge Rd, London SE1 7EH. Electronic address: alexanderzargaran@gmail","alexanderzargaran@gmail.com"
"1089","34193391","10.1016/j.bjps.2021.05.025","WALANT Protocol: Stop before you block.","The use of Wide Awake Local Anaesthetic No Tourniquet (WALANT) amongst Plastic and Orthopaedic Hand Surgeons has been accelerated by the impact of the COVID-19 pandemic and associated risks of general anaesthesia. Benefits of WALANT include a bloodless field, improved recovery, on-table testing, as well as cost and time savings. Whilst more clinical trials are underway to fully elucidate safety-profile and outcomes, there is a lack of consensus and clarity over contraindications to WALANT. A sur","2021","07","03","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Adrenaline; Hand surgery; Safety; Trauma; WALANT","Nikkhah","Dariush","Royal Free Hospital, Pond St, London NW3 2QG",NA
"1090","34193391","10.1016/j.bjps.2021.05.025","WALANT Protocol: Stop before you block.","The use of Wide Awake Local Anaesthetic No Tourniquet (WALANT) amongst Plastic and Orthopaedic Hand Surgeons has been accelerated by the impact of the COVID-19 pandemic and associated risks of general anaesthesia. Benefits of WALANT include a bloodless field, improved recovery, on-table testing, as well as cost and time savings. Whilst more clinical trials are underway to fully elucidate safety-profile and outcomes, there is a lack of consensus and clarity over contraindications to WALANT. A sur","2021","07","03","J Plast Reconstr Aesthet Surg","Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS","Adrenaline; Hand surgery; Safety; Trauma; WALANT","Mosahebi","Afshin","Royal Free Hospital, Pond St, London NW3 2QG",NA
"1091","34193390","10.1016/j.bj.2021.04.006","Role of SARS-CoV-2 and ACE2 variations in COVID-19.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is one of the worst medical emergencies that has hit the world in almost a century. The virus has now spread to a large number of countries/territories and has caused over three million deaths. Evidently, the virus has been mutating and adapting during this period. Significant effort has been spent on identifying these variations and their impact on transmission, virulence and pathoge","2021","07","03","Biomed J","Biomedical journal","ACE2; COVID-19; SARS-CoV-2; Spike protein; Variations","Antony","Priya","Department of Biology, College of Science, United Arab Emirates University, PO Box 15551, Al Ain, Abu Dhabi, United Arab Emirates",NA
"1092","34193390","10.1016/j.bj.2021.04.006","Role of SARS-CoV-2 and ACE2 variations in COVID-19.","Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is one of the worst medical emergencies that has hit the world in almost a century. The virus has now spread to a large number of countries/territories and has caused over three million deaths. Evidently, the virus has been mutating and adapting during this period. Significant effort has been spent on identifying these variations and their impact on transmission, virulence and pathoge","2021","07","03","Biomed J","Biomedical journal","ACE2; COVID-19; SARS-CoV-2; Spike protein; Variations","Vijayan","Ranjit","Department of Biology, College of Science, United Arab Emirates University, PO Box 15551, Al Ain, Abu Dhabi, United Arab Emirates. Electronic address: ranjit.v@uaeu.ac","ranjit.v@uaeu.ac.ae"
"1093","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Pandit","Anuja","National Cancer Institute, Badsa, Jhajjar, Haryana 124105, India",NA
"1094","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Bhalani","Nirav","Rhythm Heart Institute, Near Siddharth Bungalows, Sama Savli Road, Vadodara 390022, Gujarat, India",NA
"1095","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Bhushan","B L Shashi","Victoria Hospital, Bangalore Medical College &amp",NA
"1096","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Koradia","Parshottam","BAPS Pramukh Swami Hospital, Shri Pramukh Swami Maharaj Marg, Adajan Char Road, Adajan, Surat 395009, Gujarat, India",NA
"1097","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Gargiya","Shweta","Tapan Research Centre, Basement Tapan Hospital Nr. Platinum Hall, Anandnagar Cross Road Satellite, Ahmedabad 380015, Gujarat, India",NA
"1098","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Bhomia","Vinay","Sanjivani Super Speciality Hospital, 1, Uday Park Society, Nr. Sunrise Park, Vastrapur, Ahmedabad 380015, Gujarat, India",NA
"1099","34193375","10.1016/j.ijid.2021.06.030","Corrigendum to ""Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study"" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521].",NA,"2021","07","03","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases",NA,"Kansagra","Kevinkumar","Zydus Research Centre, Clinical R &amp","kevinkumarkansagra@zyduscadila.com"
"1100","34193373","10.1016/j.ejim.2021.06.015","Mask-off policy in the shadow of emerging variants of SARS-COV-2.",NA,"2021","07","03","Eur J Intern Med","European journal of internal medicine","COVID-19; Emerging variants; Masks; SARS-CoV-2","Shahraki","Abdolrazagh Hashemi","Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA",NA
"1101","34193373","10.1016/j.ejim.2021.06.015","Mask-off policy in the shadow of emerging variants of SARS-COV-2.",NA,"2021","07","03","Eur J Intern Med","European journal of internal medicine","COVID-19; Emerging variants; Masks; SARS-CoV-2","Vahed","Majid","Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA",NA
"1102","34193373","10.1016/j.ejim.2021.06.015","Mask-off policy in the shadow of emerging variants of SARS-COV-2.",NA,"2021","07","03","Eur J Intern Med","European journal of internal medicine","COVID-19; Emerging variants; Masks; SARS-CoV-2","Mirsaeidi","Mehdi","Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA","msm249@med.miami.edu"
"1103","34193364","10.1016/j.jfma.2021.06.009","Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.","The association between dysregulated innate immune responses seen in Kawasaki disease (KD) with predisposition to Kawasaki-like multisystem inflammatory syndrome in children (MIS-C) remains unclear. We aimed to compare the innate immunity transcriptome signature between COVID-19 and KD, and to analyze the interactions of these molecules with genes known to predispose to KD. Transcriptome datasets of COVID-19 and KD cohorts (E-MTAB-9357, GSE-63881, GSE-68004) were downloaded from ArrayExpress for","2021","07","03","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Innate immunity; Kawasaki disease; Multisystem inflammatory syndrome","Yang","Chin-An","College of Medicine, China Medical University, Taichung, 40402, Taiwan",NA
"1104","34193364","10.1016/j.jfma.2021.06.009","Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.","The association between dysregulated innate immune responses seen in Kawasaki disease (KD) with predisposition to Kawasaki-like multisystem inflammatory syndrome in children (MIS-C) remains unclear. We aimed to compare the innate immunity transcriptome signature between COVID-19 and KD, and to analyze the interactions of these molecules with genes known to predispose to KD. Transcriptome datasets of COVID-19 and KD cohorts (E-MTAB-9357, GSE-63881, GSE-68004) were downloaded from ArrayExpress for","2021","07","03","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Innate immunity; Kawasaki disease; Multisystem inflammatory syndrome","Huang","Ya-Ling","Divisions of Laboratory Medicine and Pediatrics, China Medical University Hsinchu Hospital, Zhubei City, Hsinchu County, 302, Taiwan",NA
"1105","34193364","10.1016/j.jfma.2021.06.009","Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.","The association between dysregulated innate immune responses seen in Kawasaki disease (KD) with predisposition to Kawasaki-like multisystem inflammatory syndrome in children (MIS-C) remains unclear. We aimed to compare the innate immunity transcriptome signature between COVID-19 and KD, and to analyze the interactions of these molecules with genes known to predispose to KD. Transcriptome datasets of COVID-19 and KD cohorts (E-MTAB-9357, GSE-63881, GSE-68004) were downloaded from ArrayExpress for","2021","07","03","J Formos Med Assoc","Journal of the Formosan Medical Association = Taiwan yi zhi","COVID-19; Innate immunity; Kawasaki disease; Multisystem inflammatory syndrome","Chiang","Bor-Luen","Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan","gicmbor@ntu.edu.tw"
"1106","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Liu","Weimin",NA,NA
"1107","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Russell","Ronnie M",NA,NA
"1108","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Bibollet-Ruche","Frederic",NA,NA
"1109","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Skelly","Ashwin N",NA,NA
"1110","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Sherrill-Mix","Scott",NA,NA
"1111","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Freeman","Drew A",NA,NA
"1112","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Stoltz","Regina",NA,NA
"1113","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Lindemuth","Emily",NA,NA
"1114","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Lee","Fang-Hua",NA,NA
"1115","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Sterrett","Sarah",NA,NA
"1116","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Bar","Katharine J",NA,NA
"1117","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Erdmann","Nathaniel",NA,NA
"1118","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Gouma","Sigrid",NA,NA
"1119","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Hensley","Scott E",NA,NA
"1120","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Ketas","Thomas",NA,NA
"1121","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Cupo","Albert",NA,NA
"1122","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Cruz Portillo","Victor M",NA,NA
"1123","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Moore","John P",NA,NA
"1124","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Bieniasz","Paul D",NA,NA
"1125","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Hatziioannou","Theodora",NA,NA
"1126","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Massey","Greer",NA,NA
"1127","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Minyard","Mary-Beth",NA,NA
"1128","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Saag","Michael S",NA,NA
"1129","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Davis","Randall S",NA,NA
"1130","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Shaw","George M",NA,NA
"1131","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Britt","William J",NA,NA
"1132","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Leal","Sixto M",NA,NA
"1133","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Goepfert","Paul",NA,NA
"1134","34193339","10.3201/eid2709.211042","Predictors of Nonseroconversion after SARS-CoV-2 Infection.","Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Hahn","Beatrice H",NA,NA
"1135","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Otieno","Nancy A",NA,NA
"1136","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Azziz-Baumgartner","Eduardo",NA,NA
"1137","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Nyawanda","Bryan O",NA,NA
"1138","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Oreri","Eunice",NA,NA
"1139","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Ellington","Sascha",NA,NA
"1140","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Onyango","Clayton",NA,NA
"1141","34193338","10.3201/eid2709.210849","SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.","We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020-2021. Incidence of severe acute respiratory syndrome coronavirus 2 was highest among pregnant women, followed by postpartum women and infants. No influenza virus infections were identified.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; COVID-like illness; Kenya; SARS-CoV-2; coronavirus disease; infants; influenza; postpartum; pregnancy; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Emukule","Gideon O",NA,NA
"1142","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Burke","Rachel M",NA,NA
"1143","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Calderwood","Laura",NA,NA
"1144","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Killerby","Marie E",NA,NA
"1145","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Ashworth","Candace E",NA,NA
"1146","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Berns","Abby L",NA,NA
"1147","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Brennan","Skyler",NA,NA
"1148","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Bressler","Jonathan M",NA,NA
"1149","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Morano","Laurel Harduar",NA,NA
"1150","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Lewis","Nathaniel M",NA,NA
"1151","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Markus","Tiffanie M",NA,NA
"1152","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Newton","Suzanne",NA,NA
"1153","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Read","Jennifer S",NA,NA
"1154","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Rissman","Tamara",NA,NA
"1155","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Taylor","Joanne",NA,NA
"1156","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Tate","Jacqueline E",NA,NA
"1157","34193337","10.3201/eid2709.204577","Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.","We characterized common exposures reported by a convenience sample of 202 US patients with coronavirus disease during January-April 2020 and identified factors associated with presumed household transmission. The most commonly reported settings of known exposure were households and healthcare facilities; among case-patients who had known contact with a confirmed case-patient compared with those who did not, healthcare occupations were more common. Among case-patients without known contact, use o","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; SARS-CoV-2; United States; coronavirus disease; household transmission; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Midgley","Claire M",NA,NA
"1158","34193336","10.3201/eid2709.211177","SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021.",NA,"2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; SARS-CoV-2; air change rates; coronavirus disease; disease control strategies; disease transmission; gymnasiums; severe acute respiratory syndrome coronavirus 2","Marr","Linsey C",NA,NA
"1159","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Subbarao","Sathyavani",NA,NA
"1160","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Campbell","Helen",NA,NA
"1161","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Ribeiro","Sonia",NA,NA
"1162","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Clark","Stephen A",NA,NA
"1163","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Lucidarme","Jay",NA,NA
"1164","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Ramsay","Mary",NA,NA
"1165","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Borrow","Ray",NA,NA
"1166","34193335","10.3201/eid2709.204866","Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.","Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses","Ladhani","Shamez",NA,NA
"1167","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Buchwald","Andrea G",NA,NA
"1168","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Bayham","Jude",NA,NA
"1169","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Adams","Jimi",NA,NA
"1170","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Bortz","David",NA,NA
"1171","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Colborn","Katie",NA,NA
"1172","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Zarella","Olivia",NA,NA
"1173","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Buran","Meghan",NA,NA
"1174","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Samet","Jonathan",NA,NA
"1175","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Ghosh","Debashis",NA,NA
"1176","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Herlihy","Rachel",NA,NA
"1177","34193334","10.3201/eid2709.204167","Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid local public health response, but studies examining the impact of social distancing policies on SARS-CoV-2 transmission have struggled to capture regional-level dynamics. We developed a susceptible-exposed-infected-recovered transmission model, parameterized to Colorado, USA-specific data, to estimate the impact of coronavirus disease-related policy measures on mobility and SARS-CoV-2 transmission in rea","2021","07","01","Emerg Infect Dis","Emerging infectious diseases","COVID-19; Colorado; SARS-CoV-2; United States; coronavirus disease; coronaviruses; infectious disease transmission; mathematical models; mobility; real time; respiratory infections; severe acute respiratory syndrome coronavirus 2; social distancing; viruses; zoonoses","Carlton","Elizabeth J",NA,NA
"1178","34193312","10.1186/s41256-021-00204-4","Does city lockdown prevent the spread of COVID-19? New evidence from the synthetic control method.","At 10 a.m. on January 23, 2020 Wuhan, China imposed a 76-day travel lockdown on its 11 million residents in order to stop the spread of COVID-19. This lockdown represented the largest quarantine in the history of public health and provides us with an opportunity to critically examine the relationship between a city lockdown on human mobility and controlling the spread of a viral epidemic, in this case COVID-19. This study aims to assess the causal impact of the Wuhan lockdown on population movem","2021","07","07","Glob Health Res Policy","Global health research and policy","COVID-19; Growth rate of newly confirmed cases; Population migration; Synthetic control method; COVID-19; China; Cities; Communicable Disease Control; Humans; Quarantine; Travel","Yang","Xiaoxuan","Harris School of Public Policy, University of Chicago, IL, 60637, Chicago, USA. xyang5@uchicago","xyang5@uchicago.edu"
"1179","34193306","10.1186/s13690-021-00641-0","Healthcare workers' behaviors on infection prevention and control and their determinants during the COVID-19 pandemic: a cross-sectional study based on the theoretical domains framework in Wuhan, China.","Infection prevention and control (IPC) measures are crucial to combat the COVID-19 pandemic. This study aimed to explore the levels and determinants of HCWs' IPC behaviors based on the theoretical domains framework (TDF), which has been shown to be effective in guiding behavior change. A cross-sectional survey was conducted in Wuhan, China in January 2020. Self-reported hand hygiene and droplet isolation behaviors (including the use of masks, gloves, goggles and gowns) were set as dependent vari","2021","07","04","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; Hand hygiene; Healthcare workers; Infection prevention and control; Personal protective equipment; Theoretical domains framework","Yang","Qiuxia","School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, No. 13, Hangkong Road, Wuhan, 430030, Hubei Province, China",NA
"1180","34193306","10.1186/s13690-021-00641-0","Healthcare workers' behaviors on infection prevention and control and their determinants during the COVID-19 pandemic: a cross-sectional study based on the theoretical domains framework in Wuhan, China.","Infection prevention and control (IPC) measures are crucial to combat the COVID-19 pandemic. This study aimed to explore the levels and determinants of HCWs' IPC behaviors based on the theoretical domains framework (TDF), which has been shown to be effective in guiding behavior change. A cross-sectional survey was conducted in Wuhan, China in January 2020. Self-reported hand hygiene and droplet isolation behaviors (including the use of masks, gloves, goggles and gowns) were set as dependent vari","2021","07","04","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; Hand hygiene; Healthcare workers; Infection prevention and control; Personal protective equipment; Theoretical domains framework","Wang","Xuemei","School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, No. 13, Hangkong Road, Wuhan, 430030, Hubei Province, China",NA
"1181","34193306","10.1186/s13690-021-00641-0","Healthcare workers' behaviors on infection prevention and control and their determinants during the COVID-19 pandemic: a cross-sectional study based on the theoretical domains framework in Wuhan, China.","Infection prevention and control (IPC) measures are crucial to combat the COVID-19 pandemic. This study aimed to explore the levels and determinants of HCWs' IPC behaviors based on the theoretical domains framework (TDF), which has been shown to be effective in guiding behavior change. A cross-sectional survey was conducted in Wuhan, China in January 2020. Self-reported hand hygiene and droplet isolation behaviors (including the use of masks, gloves, goggles and gowns) were set as dependent vari","2021","07","04","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; Hand hygiene; Healthcare workers; Infection prevention and control; Personal protective equipment; Theoretical domains framework","Zhou","Qian","School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, No. 13, Hangkong Road, Wuhan, 430030, Hubei Province, China",NA
"1182","34193306","10.1186/s13690-021-00641-0","Healthcare workers' behaviors on infection prevention and control and their determinants during the COVID-19 pandemic: a cross-sectional study based on the theoretical domains framework in Wuhan, China.","Infection prevention and control (IPC) measures are crucial to combat the COVID-19 pandemic. This study aimed to explore the levels and determinants of HCWs' IPC behaviors based on the theoretical domains framework (TDF), which has been shown to be effective in guiding behavior change. A cross-sectional survey was conducted in Wuhan, China in January 2020. Self-reported hand hygiene and droplet isolation behaviors (including the use of masks, gloves, goggles and gowns) were set as dependent vari","2021","07","04","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; Hand hygiene; Healthcare workers; Infection prevention and control; Personal protective equipment; Theoretical domains framework","Tan","Li","Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, 430030, Hubei Province, China",NA
"1183","34193306","10.1186/s13690-021-00641-0","Healthcare workers' behaviors on infection prevention and control and their determinants during the COVID-19 pandemic: a cross-sectional study based on the theoretical domains framework in Wuhan, China.","Infection prevention and control (IPC) measures are crucial to combat the COVID-19 pandemic. This study aimed to explore the levels and determinants of HCWs' IPC behaviors based on the theoretical domains framework (TDF), which has been shown to be effective in guiding behavior change. A cross-sectional survey was conducted in Wuhan, China in January 2020. Self-reported hand hygiene and droplet isolation behaviors (including the use of masks, gloves, goggles and gowns) were set as dependent vari","2021","07","04","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; Hand hygiene; Healthcare workers; Infection prevention and control; Personal protective equipment; Theoretical domains framework","Zhang","Xinping","School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, No. 13, Hangkong Road, Wuhan, 430030, Hubei Province, China. xpzhang602@hust.edu","xpzhang602@hust.edu.cn"
"1184","34193306","10.1186/s13690-021-00641-0","Healthcare workers' behaviors on infection prevention and control and their determinants during the COVID-19 pandemic: a cross-sectional study based on the theoretical domains framework in Wuhan, China.","Infection prevention and control (IPC) measures are crucial to combat the COVID-19 pandemic. This study aimed to explore the levels and determinants of HCWs' IPC behaviors based on the theoretical domains framework (TDF), which has been shown to be effective in guiding behavior change. A cross-sectional survey was conducted in Wuhan, China in January 2020. Self-reported hand hygiene and droplet isolation behaviors (including the use of masks, gloves, goggles and gowns) were set as dependent vari","2021","07","04","Arch Public Health","Archives of public health = Archives belges de sante publique","COVID-19; Hand hygiene; Healthcare workers; Infection prevention and control; Personal protective equipment; Theoretical domains framework","Lai","Xiaoquan","Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, 430030, Hubei Province, China. 3057606997@qq",NA
"1185","34193303","10.1186/s42358-021-00200-9","The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study.","During the COVID-19 pandemic, individuals faced psychological stress caused by fear and anxiety due to the high transmission and mortality rate of the disease, the social isolation, economic problems, and difficulties in reaching health services. Fibromyalgia (FM) is a chronic centralized pain sensitivity disorder. Psychological, physical and/or autoimmune stressors were found to increase FM symptoms. This pilot study aimed to evaluate the COVID-19 fear and anxiety level, and to examine their ef","2021","07","08","Adv Rheumatol","Advances in rheumatology (London, England)","COVID-19; Coronavirus anxiety scale; Fear of COVID-19 scale; Fibromyalgia; Symptom severity; Adult; Affect; Aged; Anxiety; COVID-19; Cross-Sectional Studies; Fear; Female; Fibromyalgia; Health Surveys; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sleep; Socioeconomic Factors","Cankurtaran","Damla","Department of Physical Medicine and Rehabilitation, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Altindag, 06080, Ankara, Turkey. damlacengizftr@gmail","damlacengizftr@gmail.com"
"1186","34193303","10.1186/s42358-021-00200-9","The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study.","During the COVID-19 pandemic, individuals faced psychological stress caused by fear and anxiety due to the high transmission and mortality rate of the disease, the social isolation, economic problems, and difficulties in reaching health services. Fibromyalgia (FM) is a chronic centralized pain sensitivity disorder. Psychological, physical and/or autoimmune stressors were found to increase FM symptoms. This pilot study aimed to evaluate the COVID-19 fear and anxiety level, and to examine their ef","2021","07","08","Adv Rheumatol","Advances in rheumatology (London, England)","COVID-19; Coronavirus anxiety scale; Fear of COVID-19 scale; Fibromyalgia; Symptom severity; Adult; Affect; Aged; Anxiety; COVID-19; Cross-Sectional Studies; Fear; Female; Fibromyalgia; Health Surveys; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sleep; Socioeconomic Factors","Tezel","Nihal","Department of Physical Medicine and Rehabilitation, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Altindag, 06080, Ankara, Turkey",NA
"1187","34193303","10.1186/s42358-021-00200-9","The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study.","During the COVID-19 pandemic, individuals faced psychological stress caused by fear and anxiety due to the high transmission and mortality rate of the disease, the social isolation, economic problems, and difficulties in reaching health services. Fibromyalgia (FM) is a chronic centralized pain sensitivity disorder. Psychological, physical and/or autoimmune stressors were found to increase FM symptoms. This pilot study aimed to evaluate the COVID-19 fear and anxiety level, and to examine their ef","2021","07","08","Adv Rheumatol","Advances in rheumatology (London, England)","COVID-19; Coronavirus anxiety scale; Fear of COVID-19 scale; Fibromyalgia; Symptom severity; Adult; Affect; Aged; Anxiety; COVID-19; Cross-Sectional Studies; Fear; Female; Fibromyalgia; Health Surveys; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sleep; Socioeconomic Factors","Ercan","Buse","Department of Physical Medicine and Rehabilitation, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Altindag, 06080, Ankara, Turkey",NA
"1188","34193303","10.1186/s42358-021-00200-9","The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study.","During the COVID-19 pandemic, individuals faced psychological stress caused by fear and anxiety due to the high transmission and mortality rate of the disease, the social isolation, economic problems, and difficulties in reaching health services. Fibromyalgia (FM) is a chronic centralized pain sensitivity disorder. Psychological, physical and/or autoimmune stressors were found to increase FM symptoms. This pilot study aimed to evaluate the COVID-19 fear and anxiety level, and to examine their ef","2021","07","08","Adv Rheumatol","Advances in rheumatology (London, England)","COVID-19; Coronavirus anxiety scale; Fear of COVID-19 scale; Fibromyalgia; Symptom severity; Adult; Affect; Aged; Anxiety; COVID-19; Cross-Sectional Studies; Fear; Female; Fibromyalgia; Health Surveys; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sleep; Socioeconomic Factors","Yildiz","Sadik Yigit","Department of Physical Medicine and Rehabilitation, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Altindag, 06080, Ankara, Turkey",NA
"1189","34193303","10.1186/s42358-021-00200-9","The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study.","During the COVID-19 pandemic, individuals faced psychological stress caused by fear and anxiety due to the high transmission and mortality rate of the disease, the social isolation, economic problems, and difficulties in reaching health services. Fibromyalgia (FM) is a chronic centralized pain sensitivity disorder. Psychological, physical and/or autoimmune stressors were found to increase FM symptoms. This pilot study aimed to evaluate the COVID-19 fear and anxiety level, and to examine their ef","2021","07","08","Adv Rheumatol","Advances in rheumatology (London, England)","COVID-19; Coronavirus anxiety scale; Fear of COVID-19 scale; Fibromyalgia; Symptom severity; Adult; Affect; Aged; Anxiety; COVID-19; Cross-Sectional Studies; Fear; Female; Fibromyalgia; Health Surveys; Humans; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Sleep; Socioeconomic Factors","Akyuz","Ece Unlu","Department of Physical Medicine and Rehabilitation, University of Health Sciences Diskapi Yildirim Beyazit Training and Research Hospital, Altindag, 06080, Ankara, Turkey",NA
"1190","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Stewart","Catherine","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1191","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Konstantellou","Anna","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1192","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Kassamali","Fatema","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1193","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","McLaughlin","Natalie","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1194","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Cutinha","Darren","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1195","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Bryant-Waugh","Rachel","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1196","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Simic","Mima","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1197","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Eisler","Ivan","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK",NA
"1198","34193291","10.1186/s40337-021-00429-1","Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic.","Prior to the COVID-19 pandemic, research in virtual care for young people with eating disorders was preliminary and implementation rare. This study explored the experience of young people, parents and clinicians when therapy was transitioned to virtual provision as a result of the UK lockdown in March 2020. A mixed-method approach was used in this study. Online questionnaires that included a mixture of rating (Likert scale) and free-text response questions were completed by 53 young people with ","2021","07","04","J Eat Disord","Journal of eating disorders","Adolescent; Anorexia nervosa; Bulimia nervosa; Child; Online therapy; Telehealth","Baudinet","Julian","Maudsley Centre for Child and Adolescent Eating Disorders, Maudsley Hospital, De Crespigny Park, Denmark Hill, London, SE8 5AZ, UK. Julian.Baudinet@slam.nhs","Julian.Baudinet@slam.nhs.uk"
"1199","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Fernández Villalobos","Nathalie Verónica","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany",NA
"1200","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Ott","Jördis Jennifer","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany",NA
"1201","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Klett-Tammen","Carolina Judith","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany",NA
"1202","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Bockey","Annabelle","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany",NA
"1203","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Vanella","Patrizio","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany",NA
"1204","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Krause","Gérard","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany",NA
"1205","34193261","10.1186/s13643-021-01732-3","Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.","Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditi","2021","07","05","Syst Rev","Systematic reviews","COVID-19-associated hospitalisation; COVID-19-associated mortality; Comorbidity; Effect modification; Interaction; Meta-analyses; COVID-19; Comorbidity; Hospitalization; Humans; Intensive Care Units; SARS-CoV-2","Lange","Berit","Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstraße 7, 38124, Braunschweig, Germany. Berit.Lange@helmholtz-hzi",NA
"1206","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Rydwik","E","Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden. elisabeth.rydwik@ki",NA
"1207","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Anmyr","L","Women's Health and Allied Health Professionals Theme, Department of Social Work in Health, Karolinska University Hospital, Solna, Sweden",NA
"1208","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Regardt","M","Women's Health and Allied Health Professionals Theme, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Solna, Sweden",NA
"1209","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","McAllister","A","Women's Health and Allied Health Professionals Theme, Medical Unit Speech and Language Pathology, Karolinska University Hospital, Stockholm, Sweden",NA
"1210","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Zarenoe","R","Women's Health and Allied Health Professionals Theme, Department of Social Work in Health, Karolinska University Hospital, Solna, Sweden",NA
"1211","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Åkerman","E","Perioperative Medicine and Intensive Care Function, Department of Intensive Care, Karolinska University Hospital, Stockholm, Sweden",NA
"1212","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Orrevall","Y","Women's Health and Allied Health Professionals Theme, Medical Unit Clinical Nutrition, Karolinska University Hospital, Stockholm, Sweden",NA
"1213","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Bragesjö","M","Department of Clinical Neuroscience, Division of Psychology Karolinska Institutet, Stockholm, Sweden",NA
"1214","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Dahl","O","Perioperative Medicine and Intensive Care Function, Department of Intensive Care, Karolinska University Hospital, Stockholm, Sweden",NA
"1215","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Kemani","M K","Women's Health and Allied Health Professionals Theme, Medical Unit Medical Psychology Karolinska University Hospital, Solna, Sweden",NA
"1216","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Nordstrand","L","Department of Neurobiology, Care Sciences and Society, Division of Occupational Therapy, Karolinska Institutet, Huddinge, Sweden",NA
"1217","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Ekman","U","Women's Health and Allied Health Professionals Theme, Medical Unit Medical Psychology Karolinska University Hospital, Solna, Sweden",NA
"1218","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Holmström","L","Department of Clinical Neuroscience, Division of Psychology Karolinska Institutet, Stockholm, Sweden",NA
"1219","34193260","10.1186/s13102-021-00299-9","ReCOV: recovery and rehabilitation during and after COVID-19 - a study protocol of a longitudinal observational study on patients, next of kin and health care staff.","The knowledge of the long-term consequences of covid-19 is limited. In patients, symptoms such as fatigue, decreased physical, psychological, and cognitive function, and nutritional problems have been reported. How the disease has affected next of kin, as well as staff involved in the care of patients with covid-19, is also largely unknown. The overall aim of this study is therefore three-fold: (1) to describe and evaluate predictors of patient recovery, the type of rehabilitation received and p","2021","07","04","BMC Sports Sci Med Rehabil","BMC sports science, medicine &amp; rehabilitation","Infection; Physical function; Well-being","Nygren-Bonnier","M","Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden",NA
"1220","34193242","10.1186/s13054-021-03653-y","The impact of frailty on survival in elderly intensive care patients with COVID-19: do not dismiss intensive care unit overcrowding.",NA,"2021","07","05","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Care; Frailty; Humans; Intensive Care Units; SARS-CoV-2","Jouffroy","Romain","Intensive Care Unit, Ambroise Paré Hospital, Assistance Publique - Hôpitaux de Paris and Paris Saclay University, Boulogne Billancourt, France",NA
"1221","34193242","10.1186/s13054-021-03653-y","The impact of frailty on survival in elderly intensive care patients with COVID-19: do not dismiss intensive care unit overcrowding.",NA,"2021","07","05","Crit Care","Critical care (London, England)","Aged; COVID-19; Critical Care; Frailty; Humans; Intensive Care Units; SARS-CoV-2","Vivien","Benoît","SAMU de Paris, Service d'Anesthésie Réanimation, Hôpital Universitaire Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris University, Paris, France. benoit.vivien@aphp","benoit.vivien@aphp.fr"
"1222","34193240","10.1186/s13047-021-00486-4","COVID-19 lockdown disrupts support networks integral to maintaining foot health: a mixed-methods study.","In response to the COVID-19 pandemic, populations were advised to remain at home to control viral spread. Government-mandated restrictions on free movement affected individuals' engagement with physical activity, with reported increases leading to biopsychosocial health benefits and conversely increased sedentary behaviour leading to poorer health. Good foot health is key to enabling physical activity and maximal participation in activities of occupation and daily living. A population-based cros","2021","07","15","J Foot Ankle Res","Journal of foot and ankle research","COVID-19; Exercise; Foot heath; Infection; Mixed methods; Pain; Physical activity; Self-care; Self-management; Support; Survey; Unmet need; Activities of Daily Living; Adult; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Evaluation Studies as Topic; Exercise; Female; Foot; Government Regulation; Humans; Male; Middle Aged; Musculoskeletal Pain; Patient Participation; SARS-CoV-2; Sedentary Behavior; Self Care; Self-Help Groups; Social Isolation; Surveys and Questionnaires","Cherry","Lindsey","School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Building 67, University Road, Southampton, SO17 1BJ, UK. l.cherry@soton.ac","l.cherry@soton.ac.uk"
"1223","34193240","10.1186/s13047-021-00486-4","COVID-19 lockdown disrupts support networks integral to maintaining foot health: a mixed-methods study.","In response to the COVID-19 pandemic, populations were advised to remain at home to control viral spread. Government-mandated restrictions on free movement affected individuals' engagement with physical activity, with reported increases leading to biopsychosocial health benefits and conversely increased sedentary behaviour leading to poorer health. Good foot health is key to enabling physical activity and maximal participation in activities of occupation and daily living. A population-based cros","2021","07","15","J Foot Ankle Res","Journal of foot and ankle research","COVID-19; Exercise; Foot heath; Infection; Mixed methods; Pain; Physical activity; Self-care; Self-management; Support; Survey; Unmet need; Activities of Daily Living; Adult; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Evaluation Studies as Topic; Exercise; Female; Foot; Government Regulation; Humans; Male; Middle Aged; Musculoskeletal Pain; Patient Participation; SARS-CoV-2; Sedentary Behavior; Self Care; Self-Help Groups; Social Isolation; Surveys and Questionnaires","Gates","Lucy","School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Building 67, University Road, Southampton, SO17 1BJ, UK",NA
"1224","34193240","10.1186/s13047-021-00486-4","COVID-19 lockdown disrupts support networks integral to maintaining foot health: a mixed-methods study.","In response to the COVID-19 pandemic, populations were advised to remain at home to control viral spread. Government-mandated restrictions on free movement affected individuals' engagement with physical activity, with reported increases leading to biopsychosocial health benefits and conversely increased sedentary behaviour leading to poorer health. Good foot health is key to enabling physical activity and maximal participation in activities of occupation and daily living. A population-based cros","2021","07","15","J Foot Ankle Res","Journal of foot and ankle research","COVID-19; Exercise; Foot heath; Infection; Mixed methods; Pain; Physical activity; Self-care; Self-management; Support; Survey; Unmet need; Activities of Daily Living; Adult; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Evaluation Studies as Topic; Exercise; Female; Foot; Government Regulation; Humans; Male; Middle Aged; Musculoskeletal Pain; Patient Participation; SARS-CoV-2; Sedentary Behavior; Self Care; Self-Help Groups; Social Isolation; Surveys and Questionnaires","Culliford","David","School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Building 67, University Road, Southampton, SO17 1BJ, UK",NA
"1225","34193240","10.1186/s13047-021-00486-4","COVID-19 lockdown disrupts support networks integral to maintaining foot health: a mixed-methods study.","In response to the COVID-19 pandemic, populations were advised to remain at home to control viral spread. Government-mandated restrictions on free movement affected individuals' engagement with physical activity, with reported increases leading to biopsychosocial health benefits and conversely increased sedentary behaviour leading to poorer health. Good foot health is key to enabling physical activity and maximal participation in activities of occupation and daily living. A population-based cros","2021","07","15","J Foot Ankle Res","Journal of foot and ankle research","COVID-19; Exercise; Foot heath; Infection; Mixed methods; Pain; Physical activity; Self-care; Self-management; Support; Survey; Unmet need; Activities of Daily Living; Adult; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Evaluation Studies as Topic; Exercise; Female; Foot; Government Regulation; Humans; Male; Middle Aged; Musculoskeletal Pain; Patient Participation; SARS-CoV-2; Sedentary Behavior; Self Care; Self-Help Groups; Social Isolation; Surveys and Questionnaires","Walker-Bone","Karen","MRC Versus Arthritis Centre for Musculoskeletal Health and Work, Southampton General Hospital, Southampton, SO16 6YD, UK",NA
"1226","34193240","10.1186/s13047-021-00486-4","COVID-19 lockdown disrupts support networks integral to maintaining foot health: a mixed-methods study.","In response to the COVID-19 pandemic, populations were advised to remain at home to control viral spread. Government-mandated restrictions on free movement affected individuals' engagement with physical activity, with reported increases leading to biopsychosocial health benefits and conversely increased sedentary behaviour leading to poorer health. Good foot health is key to enabling physical activity and maximal participation in activities of occupation and daily living. A population-based cros","2021","07","15","J Foot Ankle Res","Journal of foot and ankle research","COVID-19; Exercise; Foot heath; Infection; Mixed methods; Pain; Physical activity; Self-care; Self-management; Support; Survey; Unmet need; Activities of Daily Living; Adult; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Evaluation Studies as Topic; Exercise; Female; Foot; Government Regulation; Humans; Male; Middle Aged; Musculoskeletal Pain; Patient Participation; SARS-CoV-2; Sedentary Behavior; Self Care; Self-Help Groups; Social Isolation; Surveys and Questionnaires","Portillo","Mari Carmen","School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Building 67, University Road, Southampton, SO17 1BJ, UK",NA
"1227","34193239","10.1186/s13018-021-02563-7","COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.","Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody","2021","07","08","J Orthop Surg Res","Journal of orthopaedic surgery and research","Antibodies; COVID-19; LTT; Lymphocytes; Total joint arthroplasty; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Biomarkers; COVID-19; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Pandemics; Preoperative Period; Retrospective Studies; SARS-CoV-2","Caicedo","Marco S","Orthopedic Analysis, LLC, Chicago, IL, 60612, USA",NA
"1228","34193239","10.1186/s13018-021-02563-7","COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.","Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody","2021","07","08","J Orthop Surg Res","Journal of orthopaedic surgery and research","Antibodies; COVID-19; LTT; Lymphocytes; Total joint arthroplasty; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Biomarkers; COVID-19; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Pandemics; Preoperative Period; Retrospective Studies; SARS-CoV-2","Flores","Vianey","Orthopedic Analysis, LLC, Chicago, IL, 60612, USA",NA
"1229","34193239","10.1186/s13018-021-02563-7","COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.","Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody","2021","07","08","J Orthop Surg Res","Journal of orthopaedic surgery and research","Antibodies; COVID-19; LTT; Lymphocytes; Total joint arthroplasty; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Biomarkers; COVID-19; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Pandemics; Preoperative Period; Retrospective Studies; SARS-CoV-2","Padilla","Alicia","Orthopedic Analysis, LLC, Chicago, IL, 60612, USA",NA
"1230","34193239","10.1186/s13018-021-02563-7","COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.","Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody","2021","07","08","J Orthop Surg Res","Journal of orthopaedic surgery and research","Antibodies; COVID-19; LTT; Lymphocytes; Total joint arthroplasty; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Biomarkers; COVID-19; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Pandemics; Preoperative Period; Retrospective Studies; SARS-CoV-2","Lauryn","Samelko","Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 60612, USA",NA
"1231","34193239","10.1186/s13018-021-02563-7","COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.","Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody","2021","07","08","J Orthop Surg Res","Journal of orthopaedic surgery and research","Antibodies; COVID-19; LTT; Lymphocytes; Total joint arthroplasty; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Biomarkers; COVID-19; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Pandemics; Preoperative Period; Retrospective Studies; SARS-CoV-2","Jacobs","Joshua J","Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 60612, USA",NA
"1232","34193239","10.1186/s13018-021-02563-7","COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.","Recent studies indicate that, in addition to antibody production, lymphocyte responses to SARS-CoV-2 may play an important role in protective immunity to COVID-19 and a percentage of the general population may exhibit lymphocyte memory due to unknown/asymptomatic exposure to SARS-CoV-2 or cross-reactivity to other more common coronaviruses pre-vaccination. Total joint replacement (TJR) candidates returning to elective surgeries (median age 68 years) may exhibit similar lymphocyte and/or antibody","2021","07","08","J Orthop Surg Res","Journal of orthopaedic surgery and research","Antibodies; COVID-19; LTT; Lymphocytes; Total joint arthroplasty; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement; Biomarkers; COVID-19; Female; Humans; Inflammation; Lymphocytes; Male; Middle Aged; Pandemics; Preoperative Period; Retrospective Studies; SARS-CoV-2","Hallab","Nadim J","Orthopedic Analysis, LLC, Chicago, IL, 60612, USA. info@orthopedicanalysis","info@orthopedicanalysis.com"
"1233","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Sulaiman","Khalid","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia. alsulaimankh@hotmail","alsulaimankh@hotmail.com"
"1234","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Aljuhani","Ohoud","Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia",NA
"1235","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Dossari","Maram","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1236","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Alshahrani","Asma","Department of Pharmacy Practice, Faculty of Pharmacy, King Khalid University, Abha, Saudi Arabia",NA
"1237","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Alharbi","Aisha","Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia",NA
"1238","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Algarni","Rahmah","Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia",NA
"1239","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Jeraisy","Majed","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1240","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Harbi","Shmeylan","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1241","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Katheri","Abdulmalik","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1242","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Eidan","Fahad","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1243","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Bekairy","Abdulkareem M","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1244","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Qahtani","Nouf","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1245","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Muqrin","Mashael","Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia",NA
"1246","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Vishwakarma","Ramesh","Biostatistics and Bioinformatics Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia",NA
"1247","34193235","10.1186/s13054-021-03648-9","Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.","Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multiple studies; however, it's role in COVID-19 patients is still unclear. The aim of this study was to evaluate the use of thiamine as an adjunctive therapy on mortality in COVID-19 critically ill patients. This is a two-ce","2021","07","09","Crit Care","Critical care (London, England)","30-day mortality; COVID-19; Critically ill; Intensive care units (ICUs); SARS-CoV-2; Thiamine; Vitamin B1; Vitamins; Adult; COVID-19; Critical Illness; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Pneumonia, Viral; Propensity Score; Retrospective Studies; Risk Factors; SARS-CoV-2; Thiamine; Thrombosis","Al Ghamdi","Ghassan","College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia",NA
"1248","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Milani","Gregorio P","Pediatric Emergency Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1249","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Casazza","Giovanni","Dipartimento di Scienze Biomediche e Cliniche ""L. Sacco"", Università degli Studi di Milano, Milan, Italy",NA
"1250","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Corsello","Antonio","Department of Clinical Science and Community Health, University of Milan, Milan, Italy",NA
"1251","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Marchisio","Paola","Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy",NA
"1252","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Rocchi","Alessia","Pediatric Emergency Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"1253","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Colombo","Giulia","Department of Clinical Science and Community Health, University of Milan, Milan, Italy",NA
"1254","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Agostoni","Carlo","Department of Clinical Science and Community Health, University of Milan, Milan, Italy. carlo.agostoni@unimi","carlo.agostoni@unimi.it"
"1255","34193222","10.1186/s13052-021-01095-4","Early evidence of SARS-CoV-2 in Milan, Jan-Feb 2020.","A few studies have suggested that the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) was present in Northern Italy several weeks before its official detection on February 21, 2020. On the other hand, no clinical data have been provided so far to support such hypothesis. We investigated clinical-epidemiological evidence of SARS-CoV-2 infection among children and adults referring to emergency department (ED) in the main hospital of the center of Milan (Italy) before February 21, 2020","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","Adults; Children; Europe; Onset; Origin; Outbreak; SARS-CoV-2 infection; Adolescent; Adult; Aged; COVID-19; Child; Child, Preschool; Cities; Emergency Service, Hospital; Humans; Infant; Italy; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2","Costantino","Giorgio","Department of Clinical Science and Community Health, University of Milan, Milan, Italy",NA
"1256","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","de Roquetaillade","Charles","Department of Anesthesiology and Critical Care, Hôpital Lariboisière, FHU PROMICE, DMU Parabol, APHP. Nord, Paris, France",NA
"1257","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Bredin","Swann","Intensive Care Unit, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris Centre, Paris, France",NA
"1258","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Lascarrou","Jean-Baptiste","Intensive Care Unit, Hôpital Hôtel-Dieu, Nantes, France",NA
"1259","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Soumagne","Thibaud","Intensive Care Unit, Hôpital Jean Minjoz Hospital, Besançon, France",NA
"1260","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Cojocaru","Mariana","Surgical Intensive Care Unit, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris Centre, Paris, France",NA
"1261","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Chousterman","Benjamin Glenn","Department of Anesthesiology and Critical Care, Hôpital Lariboisière, FHU PROMICE, DMU Parabol, APHP. Nord, Paris, France",NA
"1262","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Leclerc","Maxime","Intensive Care Unit, Centre Hospitalier Mémorial France Etats-Unis, Saint-Lô, France",NA
"1263","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Gouhier","Albin","Intensive Care Unit, Centre Hospitalier Intercommunal Alençon Mamers, Alençon, France",NA
"1264","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Piton","Gaël","Intensive Care Unit, Hôpital Jean Minjoz Hospital, Besançon, France",NA
"1265","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Pène","Frédéric","Intensive Care Unit, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris Centre, Paris, France",NA
"1266","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Stoclin","Annabelle","Intensive Care Unit, Gustave Roussy, Université Paris-Saclay, Villejuif, France",NA
"1267","34193220","10.1186/s13054-021-03639-w","Timing and causes of death in severe COVID-19 patients.","Previous studies reporting the causes of death in patients with severe COVID-19 have provided conflicting results. The objective of this study was to describe the causes and timing of death in patients with severe COVID-19 admitted to the intensive care unit (ICU). We performed a retrospective study in eight ICUs across seven French hospitals. All consecutive adult patients (aged = 18 years) admitted to the ICU with PCR-confirmed SARS-CoV-2 infection and acute respiratory failure were included i","2021","07","09","Crit Care","Critical care (London, England)","COVID-19; Causes of death; Intensive care unit; Mortality; SARS-CoV-2; Adult; COVID-19; Cause of Death; Female; Hospital Mortality; Humans; Hypoxia; Intensive Care Units; Ischemia; Male; Multiple Organ Failure; Pneumonia, Ventilator-Associated; Pneumonia, Viral; Pulmonary Fibrosis; Retrospective Studies; SARS-CoV-2","Llitjos","Jean-François","Intensive Care Unit, Gustave Roussy, Université Paris-Saclay, Villejuif, France. jeanfrancois.llitjos@gustaveroussy","jeanfrancois.llitjos@gustaveroussy.fr"
"1268","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Li","Jun","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1269","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Yuan","Xiaowei","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1270","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Cao","Yinqiang","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1271","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Liu","Tao","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1272","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Gou","Pan","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1273","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Li","Xiang","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1274","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Li","Ming","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China",NA
"1275","34193213","10.1186/s13052-021-01092-7","The effects of home confinement on pediatric fractures during the COVID 19 outbreak.","To control the transmission of coronavirus disease 2019 (COVID-19), the Chinese government encouraged people to stay at home. This study aimed to evaluate the effects of home confinement on the occurrence of fractures among children. We retrospectively reviewed children admitted to Children's Hospital of Chongqing Medical University, for traumatic injury from January 24 to March 10, 2020, and the same time period in 2017, 2018 and 2019. At the same time, children with fracture were screened out ","2021","07","08","Ital J Pediatr","Italian journal of pediatrics","COVID-19; Epidemiology; Home confinement; Pediatric fractures; Adolescent; COVID-19; Child; Child, Preschool; China; Female; Fractures, Bone; Humans; Infant; Male; Pandemics; Physical Distancing; Retrospective Studies; SARS-CoV-2","Liu","Xing","Department I of Orthopedic of Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China. liuxingda@126","liuxingda@126.com"
"1276","34193209","10.1186/s12967-021-02958-4","Regarding: ""The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial"".",NA,"2021","07","05","J Transl Med","Journal of translational medicine","COVID-19; Critical Illness; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Humans; SARS-CoV-2","Nakata","Takeshi","Department of Endocrinology Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi Yufu, Oita, 879-5593, Japan. nakata@oita-u.ac",NA
"1277","34193209","10.1186/s12967-021-02958-4","Regarding: ""The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial"".",NA,"2021","07","05","J Transl Med","Journal of translational medicine","COVID-19; Critical Illness; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Humans; SARS-CoV-2","Ariie","Takashi","Department of Physical Therapy, School of Health Sciences at Fukuoka, International University of Health and Welfare, 137-1 Enokizu, Okawa-shi, Fukuoka, 831-8501, Japan",NA
"1278","34193209","10.1186/s12967-021-02958-4","Regarding: ""The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial"".",NA,"2021","07","05","J Transl Med","Journal of translational medicine","COVID-19; Critical Illness; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Humans; SARS-CoV-2","Taito","Shunsuke","Systematic Review Workshop Peer Support Group (SRWS-PSG), Osaka, Japan",NA
"1279","34193201","10.1186/s12969-021-00586-2","Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.","H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlation. The pathognomonic sign of HS is cutaneous hyperpigmentation located mainly in the inner thighs and often accompanied by other systemic manifestations. Improvement after tocilizumab treatment has been reported in a few patients with HS. We report the first patient with HS who presented c","2021","07","12","Pediatr Rheumatol Online J","Pediatric rheumatology online journal","CT-scan; Cardiogenic shock; Case report; Digital ischemia; H syndrome; Interleukin-6; Multiorgan infiltration; Paediatric intensive care unit; Tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Cardiomyopathy, Dilated; Child; Glucocorticoids; Hereditary Autoinflammatory Diseases; Humans; Ischemia; Kidney Diseases; Liver Diseases; Lung Diseases; Lymphadenopathy; Male; Methylprednisolone; Multiple Organ Failure; Nucleoside Transport Proteins; Pulse Therapy, Drug; Respiration, Artificial; SARS-CoV-2; Shock, Cardiogenic; Splenic Diseases; Toes; Tomography, X-Ray Computed; Treatment Outcome","Ventura-Espejo","Laura","Paediatric Department, Hospital Universitario Son Espases, Carretera de Valldemosa, 79, 07120, Palma, Spain",NA
"1280","34193201","10.1186/s12969-021-00586-2","Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.","H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlation. The pathognomonic sign of HS is cutaneous hyperpigmentation located mainly in the inner thighs and often accompanied by other systemic manifestations. Improvement after tocilizumab treatment has been reported in a few patients with HS. We report the first patient with HS who presented c","2021","07","12","Pediatr Rheumatol Online J","Pediatric rheumatology online journal","CT-scan; Cardiogenic shock; Case report; Digital ischemia; H syndrome; Interleukin-6; Multiorgan infiltration; Paediatric intensive care unit; Tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Cardiomyopathy, Dilated; Child; Glucocorticoids; Hereditary Autoinflammatory Diseases; Humans; Ischemia; Kidney Diseases; Liver Diseases; Lung Diseases; Lymphadenopathy; Male; Methylprednisolone; Multiple Organ Failure; Nucleoside Transport Proteins; Pulse Therapy, Drug; Respiration, Artificial; SARS-CoV-2; Shock, Cardiogenic; Splenic Diseases; Toes; Tomography, X-Ray Computed; Treatment Outcome","Gracia-Darder","Inés","Dermatology Department, Hospital Universitario Son Espases, Palma, Spain",NA
"1281","34193201","10.1186/s12969-021-00586-2","Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.","H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlation. The pathognomonic sign of HS is cutaneous hyperpigmentation located mainly in the inner thighs and often accompanied by other systemic manifestations. Improvement after tocilizumab treatment has been reported in a few patients with HS. We report the first patient with HS who presented c","2021","07","12","Pediatr Rheumatol Online J","Pediatric rheumatology online journal","CT-scan; Cardiogenic shock; Case report; Digital ischemia; H syndrome; Interleukin-6; Multiorgan infiltration; Paediatric intensive care unit; Tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Cardiomyopathy, Dilated; Child; Glucocorticoids; Hereditary Autoinflammatory Diseases; Humans; Ischemia; Kidney Diseases; Liver Diseases; Lung Diseases; Lymphadenopathy; Male; Methylprednisolone; Multiple Organ Failure; Nucleoside Transport Proteins; Pulse Therapy, Drug; Respiration, Artificial; SARS-CoV-2; Shock, Cardiogenic; Splenic Diseases; Toes; Tomography, X-Ray Computed; Treatment Outcome","Escribá-Bori","Silvia","Paediatric Department, Hospital Universitario Son Espases, Carretera de Valldemosa, 79, 07120, Palma, Spain",NA
"1282","34193201","10.1186/s12969-021-00586-2","Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.","H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlation. The pathognomonic sign of HS is cutaneous hyperpigmentation located mainly in the inner thighs and often accompanied by other systemic manifestations. Improvement after tocilizumab treatment has been reported in a few patients with HS. We report the first patient with HS who presented c","2021","07","12","Pediatr Rheumatol Online J","Pediatric rheumatology online journal","CT-scan; Cardiogenic shock; Case report; Digital ischemia; H syndrome; Interleukin-6; Multiorgan infiltration; Paediatric intensive care unit; Tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Cardiomyopathy, Dilated; Child; Glucocorticoids; Hereditary Autoinflammatory Diseases; Humans; Ischemia; Kidney Diseases; Liver Diseases; Lung Diseases; Lymphadenopathy; Male; Methylprednisolone; Multiple Organ Failure; Nucleoside Transport Proteins; Pulse Therapy, Drug; Respiration, Artificial; SARS-CoV-2; Shock, Cardiogenic; Splenic Diseases; Toes; Tomography, X-Ray Computed; Treatment Outcome","Amador-González","Eva Regina","Paediatric Radiology Department, Hospital Universitario Son Espases, Palma, Spain",NA
"1283","34193201","10.1186/s12969-021-00586-2","Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.","H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlation. The pathognomonic sign of HS is cutaneous hyperpigmentation located mainly in the inner thighs and often accompanied by other systemic manifestations. Improvement after tocilizumab treatment has been reported in a few patients with HS. We report the first patient with HS who presented c","2021","07","12","Pediatr Rheumatol Online J","Pediatric rheumatology online journal","CT-scan; Cardiogenic shock; Case report; Digital ischemia; H syndrome; Interleukin-6; Multiorgan infiltration; Paediatric intensive care unit; Tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Cardiomyopathy, Dilated; Child; Glucocorticoids; Hereditary Autoinflammatory Diseases; Humans; Ischemia; Kidney Diseases; Liver Diseases; Lung Diseases; Lymphadenopathy; Male; Methylprednisolone; Multiple Organ Failure; Nucleoside Transport Proteins; Pulse Therapy, Drug; Respiration, Artificial; SARS-CoV-2; Shock, Cardiogenic; Splenic Diseases; Toes; Tomography, X-Ray Computed; Treatment Outcome","Martín-Santiago","Ana","Dermatology Department, Hospital Universitario Son Espases, Palma, Spain",NA
"1284","34193201","10.1186/s12969-021-00586-2","Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.","H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlation. The pathognomonic sign of HS is cutaneous hyperpigmentation located mainly in the inner thighs and often accompanied by other systemic manifestations. Improvement after tocilizumab treatment has been reported in a few patients with HS. We report the first patient with HS who presented c","2021","07","12","Pediatr Rheumatol Online J","Pediatric rheumatology online journal","CT-scan; Cardiogenic shock; Case report; Digital ischemia; H syndrome; Interleukin-6; Multiorgan infiltration; Paediatric intensive care unit; Tocilizumab; Antibodies, Monoclonal, Humanized; COVID-19; Cardiomyopathy, Dilated; Child; Glucocorticoids; Hereditary Autoinflammatory Diseases; Humans; Ischemia; Kidney Diseases; Liver Diseases; Lung Diseases; Lymphadenopathy; Male; Methylprednisolone; Multiple Organ Failure; Nucleoside Transport Proteins; Pulse Therapy, Drug; Respiration, Artificial; SARS-CoV-2; Shock, Cardiogenic; Splenic Diseases; Toes; Tomography, X-Ray Computed; Treatment Outcome","Ramakers","Jan","Paediatric Department, Hospital Universitario Son Espases, Carretera de Valldemosa, 79, 07120, Palma, Spain. jan.ramakers@ssib","jan.ramakers@ssib.es"
"1285","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Webster","Gregory","Division of Cardiology, Department of Pediatrics, Ann &amp","rgwebster@luriechildrens.org"
"1286","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Patel","Ami B","Division of Infectious Diseases, Ann &amp",NA
"1287","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Carr","Michael R","Division of Cardiology, Department of Pediatrics, Ann &amp",NA
"1288","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Rigsby","Cynthia K","Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"1289","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Rychlik","Karen","Biostatistics Research Core, Stanley Manne Children's Research Institute, Chicago, IL, USA",NA
"1290","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Rowley","Anne H","Division of Infectious Diseases, Ann &amp",NA
"1291","34193197","10.1186/s12968-021-00786-5","Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study.","Cardiac evaluations, including cardiovascular magnetic resonance (CMR) imaging and biomarker results, are needed in children during mid-term recovery after infection with SARS-CoV-2. The incidence of CMR abnormalities 1-3 months after recovery is over 50% in older adults and has ranged between 1 and 15% in college athletes. Abnormal cardiac biomarkers are common in adults, even during recovery. We performed CMR imaging in a prospectively-recruited pediatric cohort recovered from COVID-19 and mul","2021","07","08","J Cardiovasc Magn Reson","Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance","COVID-19; Cardiac magnetic resonance imaging; MIS-C; Pediatric; SARS-CoV-2; Adolescent; Biomarkers; COVID-19; Child; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; SARS-CoV-2; Systemic Inflammatory Response Syndrome","Robinson","Joshua D","Division of Cardiology, Department of Pediatrics, Ann &amp",NA
"1292","34193163","10.1186/s12939-021-01481-8","Affordability of current, and healthy, more equitable, sustainable diets by area of socioeconomic disadvantage and remoteness in Queensland: insights into food choice.","Poor diet is the leading preventable risk factor contributing to the burden of disease globally and in Australia, and is inequitably distributed. As the price of healthy foods is a perceived barrier to improved diets, evidence on the cost and affordability of current (unhealthy) and recommended (healthy, more equitable and sustainable) diets is required to support policy action. This study applied the Healthy Diets ASAP (Australian Standardised Affordability and Pricing) methods protocol to meas","2021","07","06","Int J Equity Health","International journal for equity in health","Diet affordability; Diet prices; Equitable diet; Food prices; Healthy diet; INFORMAS; Remote; Socioeconomic disadvantage; Sustainable diet; Adolescent; Adult; Child; Costs and Cost Analysis; Diet; Diet, Healthy; Female; Food Preferences; Health Equity; Humans; Male; Middle Aged; Poverty Areas; Queensland; Rural Population","Lee","Amanda","School of Public Health, Faculty of Medicine, University of Queensland, 266 Herston Rd, Herston, QLD, 4006, Australia. amanda.lee@uq.edu","amanda.lee@uq.edu.au"
"1293","34193163","10.1186/s12939-021-01481-8","Affordability of current, and healthy, more equitable, sustainable diets by area of socioeconomic disadvantage and remoteness in Queensland: insights into food choice.","Poor diet is the leading preventable risk factor contributing to the burden of disease globally and in Australia, and is inequitably distributed. As the price of healthy foods is a perceived barrier to improved diets, evidence on the cost and affordability of current (unhealthy) and recommended (healthy, more equitable and sustainable) diets is required to support policy action. This study applied the Healthy Diets ASAP (Australian Standardised Affordability and Pricing) methods protocol to meas","2021","07","06","Int J Equity Health","International journal for equity in health","Diet affordability; Diet prices; Equitable diet; Food prices; Healthy diet; INFORMAS; Remote; Socioeconomic disadvantage; Sustainable diet; Adolescent; Adult; Child; Costs and Cost Analysis; Diet; Diet, Healthy; Female; Food Preferences; Health Equity; Humans; Male; Middle Aged; Poverty Areas; Queensland; Rural Population","Patay","Dori","School of Public Health, Faculty of Medicine, University of Queensland, 266 Herston Rd, Herston, QLD, 4006, Australia",NA
"1294","34193163","10.1186/s12939-021-01481-8","Affordability of current, and healthy, more equitable, sustainable diets by area of socioeconomic disadvantage and remoteness in Queensland: insights into food choice.","Poor diet is the leading preventable risk factor contributing to the burden of disease globally and in Australia, and is inequitably distributed. As the price of healthy foods is a perceived barrier to improved diets, evidence on the cost and affordability of current (unhealthy) and recommended (healthy, more equitable and sustainable) diets is required to support policy action. This study applied the Healthy Diets ASAP (Australian Standardised Affordability and Pricing) methods protocol to meas","2021","07","06","Int J Equity Health","International journal for equity in health","Diet affordability; Diet prices; Equitable diet; Food prices; Healthy diet; INFORMAS; Remote; Socioeconomic disadvantage; Sustainable diet; Adolescent; Adult; Child; Costs and Cost Analysis; Diet; Diet, Healthy; Female; Food Preferences; Health Equity; Humans; Male; Middle Aged; Poverty Areas; Queensland; Rural Population","Herron","Lisa-Maree","School of Public Health, Faculty of Medicine, University of Queensland, 266 Herston Rd, Herston, QLD, 4006, Australia",NA
"1295","34193163","10.1186/s12939-021-01481-8","Affordability of current, and healthy, more equitable, sustainable diets by area of socioeconomic disadvantage and remoteness in Queensland: insights into food choice.","Poor diet is the leading preventable risk factor contributing to the burden of disease globally and in Australia, and is inequitably distributed. As the price of healthy foods is a perceived barrier to improved diets, evidence on the cost and affordability of current (unhealthy) and recommended (healthy, more equitable and sustainable) diets is required to support policy action. This study applied the Healthy Diets ASAP (Australian Standardised Affordability and Pricing) methods protocol to meas","2021","07","06","Int J Equity Health","International journal for equity in health","Diet affordability; Diet prices; Equitable diet; Food prices; Healthy diet; INFORMAS; Remote; Socioeconomic disadvantage; Sustainable diet; Adolescent; Adult; Child; Costs and Cost Analysis; Diet; Diet, Healthy; Female; Food Preferences; Health Equity; Humans; Male; Middle Aged; Poverty Areas; Queensland; Rural Population","Parnell Harrison","Ella","School of Public Health, Faculty of Medicine, University of Queensland, 266 Herston Rd, Herston, QLD, 4006, Australia",NA
"1296","34193163","10.1186/s12939-021-01481-8","Affordability of current, and healthy, more equitable, sustainable diets by area of socioeconomic disadvantage and remoteness in Queensland: insights into food choice.","Poor diet is the leading preventable risk factor contributing to the burden of disease globally and in Australia, and is inequitably distributed. As the price of healthy foods is a perceived barrier to improved diets, evidence on the cost and affordability of current (unhealthy) and recommended (healthy, more equitable and sustainable) diets is required to support policy action. This study applied the Healthy Diets ASAP (Australian Standardised Affordability and Pricing) methods protocol to meas","2021","07","06","Int J Equity Health","International journal for equity in health","Diet affordability; Diet prices; Equitable diet; Food prices; Healthy diet; INFORMAS; Remote; Socioeconomic disadvantage; Sustainable diet; Adolescent; Adult; Child; Costs and Cost Analysis; Diet; Diet, Healthy; Female; Food Preferences; Health Equity; Humans; Male; Middle Aged; Poverty Areas; Queensland; Rural Population","Lewis","Meron","School of Public Health, Faculty of Medicine, University of Queensland, 266 Herston Rd, Herston, QLD, 4006, Australia",NA
"1297","34193134","10.1186/s12913-021-06674-z","Professionals' views on working in the field of domestic violence and abuse during the first wave of COVID-19: a qualitative study in the Netherlands.","The COVID-19 pandemic and lockdown evoked great worries among professionals in the field of domestic violence and abuse (DVA) as they expected a rise of the phenomenon. While many countries reported increased DVA, the Netherlands did not. To understand this discrepancy and the overall impact of the lockdown on DVA support services, we interviewed DVA professionals about their experiences with DVA during the rise of COVID-19, the impact of the lockdown on clients and working conditions, and views","2021","07","02","BMC Health Serv Res","BMC health services research","COVID-19; Child abuse; Coronavirus; Domestic violence and abuse; Intimate partner violence and abuse; Occupational health; Online; Pandemic; Working conditions; eHealth; COVID-19; Communicable Disease Control; Domestic Violence; Humans; Netherlands; Pandemics; SARS-CoV-2","van Gelder","Nicole E","Gender Unit, Department of Primary and Transmural Care, Radboud University Medical Center, Postbus 9101, Nijmegen, Netherlands. nicole.vangelder@radboudumc","nicole.vangelder@radboudumc.nl"
"1298","34193134","10.1186/s12913-021-06674-z","Professionals' views on working in the field of domestic violence and abuse during the first wave of COVID-19: a qualitative study in the Netherlands.","The COVID-19 pandemic and lockdown evoked great worries among professionals in the field of domestic violence and abuse (DVA) as they expected a rise of the phenomenon. While many countries reported increased DVA, the Netherlands did not. To understand this discrepancy and the overall impact of the lockdown on DVA support services, we interviewed DVA professionals about their experiences with DVA during the rise of COVID-19, the impact of the lockdown on clients and working conditions, and views","2021","07","02","BMC Health Serv Res","BMC health services research","COVID-19; Child abuse; Coronavirus; Domestic violence and abuse; Intimate partner violence and abuse; Occupational health; Online; Pandemic; Working conditions; eHealth; COVID-19; Communicable Disease Control; Domestic Violence; Humans; Netherlands; Pandemics; SARS-CoV-2","van Haalen","Ditte L","Gender Unit, Department of Primary and Transmural Care, Radboud University Medical Center, Postbus 9101, Nijmegen, Netherlands",NA
"1299","34193134","10.1186/s12913-021-06674-z","Professionals' views on working in the field of domestic violence and abuse during the first wave of COVID-19: a qualitative study in the Netherlands.","The COVID-19 pandemic and lockdown evoked great worries among professionals in the field of domestic violence and abuse (DVA) as they expected a rise of the phenomenon. While many countries reported increased DVA, the Netherlands did not. To understand this discrepancy and the overall impact of the lockdown on DVA support services, we interviewed DVA professionals about their experiences with DVA during the rise of COVID-19, the impact of the lockdown on clients and working conditions, and views","2021","07","02","BMC Health Serv Res","BMC health services research","COVID-19; Child abuse; Coronavirus; Domestic violence and abuse; Intimate partner violence and abuse; Occupational health; Online; Pandemic; Working conditions; eHealth; COVID-19; Communicable Disease Control; Domestic Violence; Humans; Netherlands; Pandemics; SARS-CoV-2","Ekker","Kyra","Gender Unit, Department of Primary and Transmural Care, Radboud University Medical Center, Postbus 9101, Nijmegen, Netherlands",NA
"1300","34193134","10.1186/s12913-021-06674-z","Professionals' views on working in the field of domestic violence and abuse during the first wave of COVID-19: a qualitative study in the Netherlands.","The COVID-19 pandemic and lockdown evoked great worries among professionals in the field of domestic violence and abuse (DVA) as they expected a rise of the phenomenon. While many countries reported increased DVA, the Netherlands did not. To understand this discrepancy and the overall impact of the lockdown on DVA support services, we interviewed DVA professionals about their experiences with DVA during the rise of COVID-19, the impact of the lockdown on clients and working conditions, and views","2021","07","02","BMC Health Serv Res","BMC health services research","COVID-19; Child abuse; Coronavirus; Domestic violence and abuse; Intimate partner violence and abuse; Occupational health; Online; Pandemic; Working conditions; eHealth; COVID-19; Communicable Disease Control; Domestic Violence; Humans; Netherlands; Pandemics; SARS-CoV-2","Ligthart","Suzanne A","Gender Unit, Department of Primary and Transmural Care, Radboud University Medical Center, Postbus 9101, Nijmegen, Netherlands",NA
"1301","34193134","10.1186/s12913-021-06674-z","Professionals' views on working in the field of domestic violence and abuse during the first wave of COVID-19: a qualitative study in the Netherlands.","The COVID-19 pandemic and lockdown evoked great worries among professionals in the field of domestic violence and abuse (DVA) as they expected a rise of the phenomenon. While many countries reported increased DVA, the Netherlands did not. To understand this discrepancy and the overall impact of the lockdown on DVA support services, we interviewed DVA professionals about their experiences with DVA during the rise of COVID-19, the impact of the lockdown on clients and working conditions, and views","2021","07","02","BMC Health Serv Res","BMC health services research","COVID-19; Child abuse; Coronavirus; Domestic violence and abuse; Intimate partner violence and abuse; Occupational health; Online; Pandemic; Working conditions; eHealth; COVID-19; Communicable Disease Control; Domestic Violence; Humans; Netherlands; Pandemics; SARS-CoV-2","Oertelt-Prigione","Sabine","Gender Unit, Department of Primary and Transmural Care, Radboud University Medical Center, Postbus 9101, Nijmegen, Netherlands",NA
"1302","34193102","10.1186/s12889-021-11315-5","A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.","We aimed to document the impact of the coronavirus disease 2019 (COVID-19) pandemic on regions within a European country. Parents arriving at two pediatric emergency departments (EDs) in North of Switzerland and two in South of Switzerland completed an online survey during the first peak of the pandemic (April-June 2020). They were asked to rate their concern about their children or themselves having COVID-19. A total of 662 respondents completed the survey. Parents in the South were significant","2021","07","05","BMC Public Health","BMC public health","COVID-19; Emergency department; Parental concern; SARS-CoV-2; Switzerland; COVID-19; Child; Europe; Humans; Pandemics; Parents; SARS-CoV-2; Switzerland","Seiler","Michelle","Pediatric Emergency Department, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland. michelle.seiler@kispi.uzh","michelle.seiler@kispi.uzh.ch"
"1303","34193102","10.1186/s12889-021-11315-5","A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.","We aimed to document the impact of the coronavirus disease 2019 (COVID-19) pandemic on regions within a European country. Parents arriving at two pediatric emergency departments (EDs) in North of Switzerland and two in South of Switzerland completed an online survey during the first peak of the pandemic (April-June 2020). They were asked to rate their concern about their children or themselves having COVID-19. A total of 662 respondents completed the survey. Parents in the South were significant","2021","07","05","BMC Public Health","BMC public health","COVID-19; Emergency department; Parental concern; SARS-CoV-2; Switzerland; COVID-19; Child; Europe; Humans; Pandemics; Parents; SARS-CoV-2; Switzerland","Staubli","Georg","Pediatric Emergency Department, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland",NA
"1304","34193102","10.1186/s12889-021-11315-5","A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.","We aimed to document the impact of the coronavirus disease 2019 (COVID-19) pandemic on regions within a European country. Parents arriving at two pediatric emergency departments (EDs) in North of Switzerland and two in South of Switzerland completed an online survey during the first peak of the pandemic (April-June 2020). They were asked to rate their concern about their children or themselves having COVID-19. A total of 662 respondents completed the survey. Parents in the South were significant","2021","07","05","BMC Public Health","BMC public health","COVID-19; Emergency department; Parental concern; SARS-CoV-2; Switzerland; COVID-19; Child; Europe; Humans; Pandemics; Parents; SARS-CoV-2; Switzerland","Hoeffe","Julia","Pediatric Emergency Department, Inselspital University Hospital of Bern, Bern, Switzerland",NA
"1305","34193102","10.1186/s12889-021-11315-5","A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.","We aimed to document the impact of the coronavirus disease 2019 (COVID-19) pandemic on regions within a European country. Parents arriving at two pediatric emergency departments (EDs) in North of Switzerland and two in South of Switzerland completed an online survey during the first peak of the pandemic (April-June 2020). They were asked to rate their concern about their children or themselves having COVID-19. A total of 662 respondents completed the survey. Parents in the South were significant","2021","07","05","BMC Public Health","BMC public health","COVID-19; Emergency department; Parental concern; SARS-CoV-2; Switzerland; COVID-19; Child; Europe; Humans; Pandemics; Parents; SARS-CoV-2; Switzerland","Gualco","Gianluca","Pediatric Emergency Department, Pediatric Institute of Italian part of Switzerland, Bellinzona, Switzerland",NA
"1306","34193102","10.1186/s12889-021-11315-5","A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.","We aimed to document the impact of the coronavirus disease 2019 (COVID-19) pandemic on regions within a European country. Parents arriving at two pediatric emergency departments (EDs) in North of Switzerland and two in South of Switzerland completed an online survey during the first peak of the pandemic (April-June 2020). They were asked to rate their concern about their children or themselves having COVID-19. A total of 662 respondents completed the survey. Parents in the South were significant","2021","07","05","BMC Public Health","BMC public health","COVID-19; Emergency department; Parental concern; SARS-CoV-2; Switzerland; COVID-19; Child; Europe; Humans; Pandemics; Parents; SARS-CoV-2; Switzerland","Manzano","Sergio","Pediatric Emergency Department, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland",NA
"1307","34193102","10.1186/s12889-021-11315-5","A tale of two parts of Switzerland: regional differences in the impact of the COVID-19 pandemic on parents.","We aimed to document the impact of the coronavirus disease 2019 (COVID-19) pandemic on regions within a European country. Parents arriving at two pediatric emergency departments (EDs) in North of Switzerland and two in South of Switzerland completed an online survey during the first peak of the pandemic (April-June 2020). They were asked to rate their concern about their children or themselves having COVID-19. A total of 662 respondents completed the survey. Parents in the South were significant","2021","07","05","BMC Public Health","BMC public health","COVID-19; Emergency department; Parental concern; SARS-CoV-2; Switzerland; COVID-19; Child; Europe; Humans; Pandemics; Parents; SARS-CoV-2; Switzerland","Goldman","Ran D","The Pediatric Research in Emergency Therapeutics (PRETx) Program, Division of Emergency Medicine, Department of Pediatrics, University of British Columbia, and BC Children's Hospital Research Institute, Vancouver, BC, Canada",NA
"1308","34193093","10.1186/s12889-021-11312-8","Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.","Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, community non-medical anti-epidemic workers have played an important role in the prevention of COVID-19 in China. The present study aimed to assess sleep quality and its associated factors among community non-medical anti-epidemic workers. A survey was conducted using anonymous online questionnaire to collect information from 16 March 2020 to 24 March 2020. A total of 474 participants were included, with a 94.23% complet","2021","07","05","BMC Public Health","BMC public health","COVID-19; Community non-medical anti-epidemic workers; Sleep quality; Wuhan; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Epidemics; Humans; SARS-CoV-2; Sleep; Surveys and Questionnaires","Si","Guanglin","School of Health Sciences, Wuhan University, Wuhan, 430071, China",NA
"1309","34193093","10.1186/s12889-021-11312-8","Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.","Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, community non-medical anti-epidemic workers have played an important role in the prevention of COVID-19 in China. The present study aimed to assess sleep quality and its associated factors among community non-medical anti-epidemic workers. A survey was conducted using anonymous online questionnaire to collect information from 16 March 2020 to 24 March 2020. A total of 474 participants were included, with a 94.23% complet","2021","07","05","BMC Public Health","BMC public health","COVID-19; Community non-medical anti-epidemic workers; Sleep quality; Wuhan; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Epidemics; Humans; SARS-CoV-2; Sleep; Surveys and Questionnaires","Xu","Yi","School of Health Sciences, Wuhan University, Wuhan, 430071, China",NA
"1310","34193093","10.1186/s12889-021-11312-8","Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.","Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, community non-medical anti-epidemic workers have played an important role in the prevention of COVID-19 in China. The present study aimed to assess sleep quality and its associated factors among community non-medical anti-epidemic workers. A survey was conducted using anonymous online questionnaire to collect information from 16 March 2020 to 24 March 2020. A total of 474 participants were included, with a 94.23% complet","2021","07","05","BMC Public Health","BMC public health","COVID-19; Community non-medical anti-epidemic workers; Sleep quality; Wuhan; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Epidemics; Humans; SARS-CoV-2; Sleep; Surveys and Questionnaires","Li","Mengying","School of Health Sciences, Wuhan University, Wuhan, 430071, China",NA
"1311","34193093","10.1186/s12889-021-11312-8","Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.","Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, community non-medical anti-epidemic workers have played an important role in the prevention of COVID-19 in China. The present study aimed to assess sleep quality and its associated factors among community non-medical anti-epidemic workers. A survey was conducted using anonymous online questionnaire to collect information from 16 March 2020 to 24 March 2020. A total of 474 participants were included, with a 94.23% complet","2021","07","05","BMC Public Health","BMC public health","COVID-19; Community non-medical anti-epidemic workers; Sleep quality; Wuhan; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Epidemics; Humans; SARS-CoV-2; Sleep; Surveys and Questionnaires","Zhang","Yuting","School of Nursing, Shenzhen University, Shenzhen, 518037, China",NA
"1312","34193093","10.1186/s12889-021-11312-8","Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.","Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, community non-medical anti-epidemic workers have played an important role in the prevention of COVID-19 in China. The present study aimed to assess sleep quality and its associated factors among community non-medical anti-epidemic workers. A survey was conducted using anonymous online questionnaire to collect information from 16 March 2020 to 24 March 2020. A total of 474 participants were included, with a 94.23% complet","2021","07","05","BMC Public Health","BMC public health","COVID-19; Community non-medical anti-epidemic workers; Sleep quality; Wuhan; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Epidemics; Humans; SARS-CoV-2; Sleep; Surveys and Questionnaires","Peng","Shuzhen","Huangpi District People's Hospital, Wuhan, 430300, China. 13647226126@163","13647226126@163.com"
"1313","34193093","10.1186/s12889-021-11312-8","Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.","Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December 2019, community non-medical anti-epidemic workers have played an important role in the prevention of COVID-19 in China. The present study aimed to assess sleep quality and its associated factors among community non-medical anti-epidemic workers. A survey was conducted using anonymous online questionnaire to collect information from 16 March 2020 to 24 March 2020. A total of 474 participants were included, with a 94.23% complet","2021","07","05","BMC Public Health","BMC public health","COVID-19; Community non-medical anti-epidemic workers; Sleep quality; Wuhan; Anxiety; COVID-19; China; Cross-Sectional Studies; Depression; Epidemics; Humans; SARS-CoV-2; Sleep; Surveys and Questionnaires","Tan","Xiaodong","School of Health Sciences, Wuhan University, Wuhan, 430071, China. 00300469@whu.edu","00300469@whu.edu.cn"
"1314","34193072","10.1186/s12879-021-06347-6","Comparative evaluation of the Thermo fisher TaqPath COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens.","With over 50 SARS-CoV-2 gene amplification assays that have been EUA cleared with minimal experimental validation performed, it is likely that not all of these assays are comparable in their ability to detect SARS-CoV-2 in clinical specimens. Thermo Fisher Scientific is a relatively new company in the molecular diagnostics field and the purpose of this study was to compare the performance of the Thermo Fisher TaqPath Combo Kit with an established test, the Cepheid Xpert® Xpress SARS-CoV-2 assay","2021","07","14","BMC Infect Dis","BMC infectious diseases","COVID-19; Gene amplification tests; PCR; SARS-CoV-2; Sanger sequencing; TaqPath combo kit; Xpert Xpress SARS-CoV-2 assay; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Molecular Diagnostic Techniques; Nasopharynx; SARS-CoV-2; Sensitivity and Specificity","Granato","Paul A","Microbiology Department, Laboratory Alliance of Central New York, Liverpool, New York, USA. granatop@upstate","granatop@upstate.edu"
"1315","34193072","10.1186/s12879-021-06347-6","Comparative evaluation of the Thermo fisher TaqPath COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens.","With over 50 SARS-CoV-2 gene amplification assays that have been EUA cleared with minimal experimental validation performed, it is likely that not all of these assays are comparable in their ability to detect SARS-CoV-2 in clinical specimens. Thermo Fisher Scientific is a relatively new company in the molecular diagnostics field and the purpose of this study was to compare the performance of the Thermo Fisher TaqPath Combo Kit with an established test, the Cepheid Xpert® Xpress SARS-CoV-2 assay","2021","07","14","BMC Infect Dis","BMC infectious diseases","COVID-19; Gene amplification tests; PCR; SARS-CoV-2; Sanger sequencing; TaqPath combo kit; Xpert Xpress SARS-CoV-2 assay; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Molecular Diagnostic Techniques; Nasopharynx; SARS-CoV-2; Sensitivity and Specificity","Kimball","Simon R","Microbiology Department, Laboratory Alliance of Central New York, Liverpool, New York, USA",NA
"1316","34193072","10.1186/s12879-021-06347-6","Comparative evaluation of the Thermo fisher TaqPath COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens.","With over 50 SARS-CoV-2 gene amplification assays that have been EUA cleared with minimal experimental validation performed, it is likely that not all of these assays are comparable in their ability to detect SARS-CoV-2 in clinical specimens. Thermo Fisher Scientific is a relatively new company in the molecular diagnostics field and the purpose of this study was to compare the performance of the Thermo Fisher TaqPath Combo Kit with an established test, the Cepheid Xpert® Xpress SARS-CoV-2 assay","2021","07","14","BMC Infect Dis","BMC infectious diseases","COVID-19; Gene amplification tests; PCR; SARS-CoV-2; Sanger sequencing; TaqPath combo kit; Xpert Xpress SARS-CoV-2 assay; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Molecular Diagnostic Techniques; Nasopharynx; SARS-CoV-2; Sensitivity and Specificity","Alkins","Brenda R","Microbiology Department, Laboratory Alliance of Central New York, Liverpool, New York, USA",NA
"1317","34193072","10.1186/s12879-021-06347-6","Comparative evaluation of the Thermo fisher TaqPath COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens.","With over 50 SARS-CoV-2 gene amplification assays that have been EUA cleared with minimal experimental validation performed, it is likely that not all of these assays are comparable in their ability to detect SARS-CoV-2 in clinical specimens. Thermo Fisher Scientific is a relatively new company in the molecular diagnostics field and the purpose of this study was to compare the performance of the Thermo Fisher TaqPath Combo Kit with an established test, the Cepheid Xpert® Xpress SARS-CoV-2 assay","2021","07","14","BMC Infect Dis","BMC infectious diseases","COVID-19; Gene amplification tests; PCR; SARS-CoV-2; Sanger sequencing; TaqPath combo kit; Xpert Xpress SARS-CoV-2 assay; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Molecular Diagnostic Techniques; Nasopharynx; SARS-CoV-2; Sensitivity and Specificity","Cross","Deirdre C","Genetic Sciences Division, Thermo Fisher Scientific, Carlsbad, California, USA",NA
"1318","34193072","10.1186/s12879-021-06347-6","Comparative evaluation of the Thermo fisher TaqPath COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens.","With over 50 SARS-CoV-2 gene amplification assays that have been EUA cleared with minimal experimental validation performed, it is likely that not all of these assays are comparable in their ability to detect SARS-CoV-2 in clinical specimens. Thermo Fisher Scientific is a relatively new company in the molecular diagnostics field and the purpose of this study was to compare the performance of the Thermo Fisher TaqPath Combo Kit with an established test, the Cepheid Xpert® Xpress SARS-CoV-2 assay","2021","07","14","BMC Infect Dis","BMC infectious diseases","COVID-19; Gene amplification tests; PCR; SARS-CoV-2; Sanger sequencing; TaqPath combo kit; Xpert Xpress SARS-CoV-2 assay; COVID-19; COVID-19 Nucleic Acid Testing; Humans; Molecular Diagnostic Techniques; Nasopharynx; SARS-CoV-2; Sensitivity and Specificity","Unz","Melissa M","Microbiology Department, Laboratory Alliance of Central New York, Liverpool, New York, USA",NA
"1319","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Siette","Joyce","Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia. joyce.siette@mq.edu","joyce.siette@mq.edu.au"
"1320","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Seaman","Karla","Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1321","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Dodds","Laura","Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1322","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Ludlow","Kristiana","Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1323","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Johnco","Carly","Centre for Ageing, Cognition and Wellbeing, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1324","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Wuthrich","Viviana","Centre for Ageing, Cognition and Wellbeing, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1325","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Earl","Joanne K","Centre for Ageing, Cognition and Wellbeing, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1326","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Dawes","Piers","Centre for Ageing, Cognition and Wellbeing, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1327","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Strutt","Paul","Centre for Ageing, Cognition and Wellbeing, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1328","34193070","10.1186/s12877-021-02352-1","A national survey on COVID-19 second-wave lockdowns on older adults' mental wellbeing, health-seeking behaviours and social outcomes across Australia.","The impact of severe second lockdown measures on older adults' wellbeing is unknown. We aimed to (i) identify the impact of the second lockdown that resulted from the second wave of COVID-19 cases on older Australians' quality of life; (ii) compare the impact of second wave lockdowns in Victoria, Australia's second most populous State, to those in other States and Territories not in lockdown. A national cross-sectional study of community-dwelling older adults completed online questionnaires for ","2021","07","05","BMC Geriatr","BMC geriatrics","2019 novel coronavirus diseases (COVID-19); Lifestyle restrictions; Lockdown; Social networks; Wellbeing; Aged; COVID-19; Communicable Disease Control; Cross-Sectional Studies; Female; Humans; Male; Quality of Life; SARS-CoV-2; Victoria","Westbrook","Johanna I","Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, New South Wales, 2109, Macqaurie Park, Australia",NA
"1329","34193015","10.1080/10826084.2021.1942058","It's Not All Smoke and Mirrors: The Role of Social Norms, Alcohol Use, and Pandemic Partying in e-Cigarette Use During COVID-19.","E-cigarette use among college students is increasing. In the era of COVID-19, such usage is especially dangerous given that the virus can be deadly for those with impaired respiratory systems. A small but growing body of research suggests that social norms may predict e-cigarette use. However, one's perception of e-cigarette use behaviors (descriptive norms) and approval by peers (injunctive norms) have yet to be studied in college students. The overarching purpose of this study is to determine ","2021","07","23","Subst Use Misuse","Substance use &amp; misuse","COVID-19; college students; descriptive norms; e-cigarette use; injunctive norms; party","Doxbeck","Courtney R","Department of Counseling, School, and Educational Psychology, University at Buffalo, Buffalo, NY, USA",NA
"1330","34193015","10.1080/10826084.2021.1942058","It's Not All Smoke and Mirrors: The Role of Social Norms, Alcohol Use, and Pandemic Partying in e-Cigarette Use During COVID-19.","E-cigarette use among college students is increasing. In the era of COVID-19, such usage is especially dangerous given that the virus can be deadly for those with impaired respiratory systems. A small but growing body of research suggests that social norms may predict e-cigarette use. However, one's perception of e-cigarette use behaviors (descriptive norms) and approval by peers (injunctive norms) have yet to be studied in college students. The overarching purpose of this study is to determine ","2021","07","23","Subst Use Misuse","Substance use &amp; misuse","COVID-19; college students; descriptive norms; e-cigarette use; injunctive norms; party","Osberg","Timothy M","Department of Psychology, Niagara University, NY, USA",NA
"1331","34193002","10.1080/13548506.2021.1946571","Combining rationality with morality - integrating theory of planned behavior with norm activation theory to explain compliance with COVID-19 prevention guidelines.","As COVID-19 cases surge around the world, public health authorities are looking for effective strategies to influence individuals to follow COVID-19 prevention guidelines. However, limited empirical research was conducted to identify the factors behind individuals' compliance with COVID-19 prevention guidelines. This research proposed an integrated model based on the theory of planned behavior and norm activation theory to explain compliance towards COVID-19 prevention guidelines. Data from a su","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Theory of planned behavior; compliance with Covid-19 prevention guidelines; norm activation theory","Shanka","Mesay Sata","Rabat Business School, International University of Rabat, Salé, Morocco",NA
"1332","34193002","10.1080/13548506.2021.1946571","Combining rationality with morality - integrating theory of planned behavior with norm activation theory to explain compliance with COVID-19 prevention guidelines.","As COVID-19 cases surge around the world, public health authorities are looking for effective strategies to influence individuals to follow COVID-19 prevention guidelines. However, limited empirical research was conducted to identify the factors behind individuals' compliance with COVID-19 prevention guidelines. This research proposed an integrated model based on the theory of planned behavior and norm activation theory to explain compliance towards COVID-19 prevention guidelines. Data from a su","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Theory of planned behavior; compliance with Covid-19 prevention guidelines; norm activation theory","Gebremariam Kotecho","Messay","School of Social Work, Addis Ababa University, Addis Ababa, Ethiopia",NA
"1333","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Ansani","Alessandro","Cosmic Lab, Department of Philosophy, 19012Roma Tre University, Italy",NA
"1334","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Marini","Marco","Department of Psychology, Sapienza University of Rome, Italy",NA
"1335","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Cecconi","Christian","Cosmic Lab, Department of Philosophy, Communication, and Performing Arts, 19012Roma Tre University, Italy",NA
"1336","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Dragoni","Daniele","Cosmic Lab, Department of Philosophy, Communication, and Performing Arts, 19012Roma Tre University, Italy",NA
"1337","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Rinallo","Elena","Department of Human Studies-Communication, Education, and Psychology, 19011LUMSA University, Italy",NA
"1338","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Poggi","Isabella","Cosmic Lab, Department of Philosophy, Communication, and Performing Arts, 19012Roma Tre University, Italy",NA
"1339","34193001","10.1177/00332941211027829","Analyzing the Perceived Utility of Covid-19 Countermeasures: The Role of Pronominalization, Moral Foundations, Moral Disengagement, Fake News Embracing, and Health Anxiety.","An online survey (N = 210) is presented on how the perceived utility of correct and exaggerated countermeasures against Covid-19 is affected by different pronominalization strategies (impersonal form, you, we). In evaluating the pronominalization effect, we have statistically controlled for the roles of several personal characteristics: Moral Disengagement, Moral Foundations, Health Anxiety, and Embracing of Fake News. Results indicate that, net of personal proclivities, the you form decr","2021","07","01","Psychol Rep","Psychological reports","Personal pronouns; fake news; health prescriptions; moral values; nudge","Mallia","Luca","Department of Movement, Human and Health Sciences, University of Rome Foro Italico, Italy",NA
"1340","34192997","10.1080/13548506.2021.1944653","Mental health and social support among nurses during the COVID-19 pandemic.","This study aimed to investigate the prevalence of mental problems and social support among nurses during the COVID-19 epidemic and to explore the correlation. We carried out a multicentre, large-sample questionnaire survey in Chongqing (China). The WeChat-based survey program Questionnaire Star was used to distribute a questionnaire with self-designed items to obtain general information, the Depression, Anxiety and Stress Scale-21 (DASS-21), and the Social Support Rating Scale (SSRS). A total of","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; Neonates; cross-sectional study; nurses; social support rating scale; the depression anxiety stress scale","Shen","Yu-Jie","Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, Chongqing, P.R. China",NA
"1341","34192997","10.1080/13548506.2021.1944653","Mental health and social support among nurses during the COVID-19 pandemic.","This study aimed to investigate the prevalence of mental problems and social support among nurses during the COVID-19 epidemic and to explore the correlation. We carried out a multicentre, large-sample questionnaire survey in Chongqing (China). The WeChat-based survey program Questionnaire Star was used to distribute a questionnaire with self-designed items to obtain general information, the Depression, Anxiety and Stress Scale-21 (DASS-21), and the Social Support Rating Scale (SSRS). A total of","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; Neonates; cross-sectional study; nurses; social support rating scale; the depression anxiety stress scale","Wei","Lu","Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, Chongqing, P.R. China",NA
"1342","34192997","10.1080/13548506.2021.1944653","Mental health and social support among nurses during the COVID-19 pandemic.","This study aimed to investigate the prevalence of mental problems and social support among nurses during the COVID-19 epidemic and to explore the correlation. We carried out a multicentre, large-sample questionnaire survey in Chongqing (China). The WeChat-based survey program Questionnaire Star was used to distribute a questionnaire with self-designed items to obtain general information, the Depression, Anxiety and Stress Scale-21 (DASS-21), and the Social Support Rating Scale (SSRS). A total of","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; Neonates; cross-sectional study; nurses; social support rating scale; the depression anxiety stress scale","Li","Qian","Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, Chongqing, P.R. China",NA
"1343","34192997","10.1080/13548506.2021.1944653","Mental health and social support among nurses during the COVID-19 pandemic.","This study aimed to investigate the prevalence of mental problems and social support among nurses during the COVID-19 epidemic and to explore the correlation. We carried out a multicentre, large-sample questionnaire survey in Chongqing (China). The WeChat-based survey program Questionnaire Star was used to distribute a questionnaire with self-designed items to obtain general information, the Depression, Anxiety and Stress Scale-21 (DASS-21), and the Social Support Rating Scale (SSRS). A total of","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; Neonates; cross-sectional study; nurses; social support rating scale; the depression anxiety stress scale","Li","Lu-Quan","Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, Chongqing, P.R. China",NA
"1344","34192997","10.1080/13548506.2021.1944653","Mental health and social support among nurses during the COVID-19 pandemic.","This study aimed to investigate the prevalence of mental problems and social support among nurses during the COVID-19 epidemic and to explore the correlation. We carried out a multicentre, large-sample questionnaire survey in Chongqing (China). The WeChat-based survey program Questionnaire Star was used to distribute a questionnaire with self-designed items to obtain general information, the Depression, Anxiety and Stress Scale-21 (DASS-21), and the Social Support Rating Scale (SSRS). A total of","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","COVID-19; Neonates; cross-sectional study; nurses; social support rating scale; the depression anxiety stress scale","Zhang","Xian-Hong","Neonatal Diagnosis and Treatment Center, Children's Hospital of Chongqing Medical University, Chongqing, P.R. China",NA
"1345","34192994","10.1080/13548506.2021.1944656","Quality of life, physical activity and burnout syndrome during online learning period in Brazilian university students during the COVID-19 pandemic: a cluster analysis.","The COVID-19 pandemic caused several changes in the teaching-learning process, as it abruptly replaced the conventional classes into online classes despite social distancing requirements. Such changes may be associated with several mental health problems and negatively affect the quality of life and academic performance of university students. We performed a cluster analysis in a large sample of Brazilian undergraduate students, considering sociodemographic data, physical activity frequency, stu","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Burnout syndrome; COVID-19 outbreak; online learning; quality of life","Azzi","Diana Vilela",NA,NA
"1346","34192994","10.1080/13548506.2021.1944656","Quality of life, physical activity and burnout syndrome during online learning period in Brazilian university students during the COVID-19 pandemic: a cluster analysis.","The COVID-19 pandemic caused several changes in the teaching-learning process, as it abruptly replaced the conventional classes into online classes despite social distancing requirements. Such changes may be associated with several mental health problems and negatively affect the quality of life and academic performance of university students. We performed a cluster analysis in a large sample of Brazilian undergraduate students, considering sociodemographic data, physical activity frequency, stu","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Burnout syndrome; COVID-19 outbreak; online learning; quality of life","Melo","Júlia",NA,NA
"1347","34192994","10.1080/13548506.2021.1944656","Quality of life, physical activity and burnout syndrome during online learning period in Brazilian university students during the COVID-19 pandemic: a cluster analysis.","The COVID-19 pandemic caused several changes in the teaching-learning process, as it abruptly replaced the conventional classes into online classes despite social distancing requirements. Such changes may be associated with several mental health problems and negatively affect the quality of life and academic performance of university students. We performed a cluster analysis in a large sample of Brazilian undergraduate students, considering sociodemographic data, physical activity frequency, stu","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Burnout syndrome; COVID-19 outbreak; online learning; quality of life","Neto","Armindo de Arruda Campos",NA,NA
"1348","34192994","10.1080/13548506.2021.1944656","Quality of life, physical activity and burnout syndrome during online learning period in Brazilian university students during the COVID-19 pandemic: a cluster analysis.","The COVID-19 pandemic caused several changes in the teaching-learning process, as it abruptly replaced the conventional classes into online classes despite social distancing requirements. Such changes may be associated with several mental health problems and negatively affect the quality of life and academic performance of university students. We performed a cluster analysis in a large sample of Brazilian undergraduate students, considering sociodemographic data, physical activity frequency, stu","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Burnout syndrome; COVID-19 outbreak; online learning; quality of life","Castelo","Paula Midori",NA,NA
"1349","34192994","10.1080/13548506.2021.1944656","Quality of life, physical activity and burnout syndrome during online learning period in Brazilian university students during the COVID-19 pandemic: a cluster analysis.","The COVID-19 pandemic caused several changes in the teaching-learning process, as it abruptly replaced the conventional classes into online classes despite social distancing requirements. Such changes may be associated with several mental health problems and negatively affect the quality of life and academic performance of university students. We performed a cluster analysis in a large sample of Brazilian undergraduate students, considering sociodemographic data, physical activity frequency, stu","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Burnout syndrome; COVID-19 outbreak; online learning; quality of life","Andrade","Eric Francelino",NA,NA
"1350","34192994","10.1080/13548506.2021.1944656","Quality of life, physical activity and burnout syndrome during online learning period in Brazilian university students during the COVID-19 pandemic: a cluster analysis.","The COVID-19 pandemic caused several changes in the teaching-learning process, as it abruptly replaced the conventional classes into online classes despite social distancing requirements. Such changes may be associated with several mental health problems and negatively affect the quality of life and academic performance of university students. We performed a cluster analysis in a large sample of Brazilian undergraduate students, considering sociodemographic data, physical activity frequency, stu","2021","07","01","Psychol Health Med","Psychology, health &amp; medicine","Burnout syndrome; COVID-19 outbreak; online learning; quality of life","Pereira","Luciano José",NA,NA
"1351","34192969","10.1177/11206721211029132","Eye care professionals' patient care and personal protective equipment adapts during the second wave of SARS-CoV-2: Survey in Israel.","The coronavirus disease (COVID-19) began spreading in December 2019 and rapidly evolved to a global pandemic. Initially information was nonexistent and eye care professionals (ECPs) were anxious as the close proximity involved in patient care put them at high risk. Recognizing this stress and the probable effect on behavior initiated this survey. The survey presented here was conducted in three stages. The expectation was a change in behavior during the second wave when modes of transmission and","2021","07","01","Eur J Ophthalmol","European journal of ophthalmology","COVID-19; contact lens fitting; eye care practitioners; personal protection equipment; survey","Erdinest","Nir","Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel",NA
"1352","34192969","10.1177/11206721211029132","Eye care professionals' patient care and personal protective equipment adapts during the second wave of SARS-CoV-2: Survey in Israel.","The coronavirus disease (COVID-19) began spreading in December 2019 and rapidly evolved to a global pandemic. Initially information was nonexistent and eye care professionals (ECPs) were anxious as the close proximity involved in patient care put them at high risk. Recognizing this stress and the probable effect on behavior initiated this survey. The survey presented here was conducted in three stages. The expectation was a change in behavior during the second wave when modes of transmission and","2021","07","01","Eur J Ophthalmol","European journal of ophthalmology","COVID-19; contact lens fitting; eye care practitioners; personal protection equipment; survey","London","Naomi","Private Practice, Jerusalem, Israel",NA
"1353","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Devkota","Kanchan","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1354","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Schapira","Matthieu","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1355","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Perveen","Sumera","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1356","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Khalili Yazdi","Aliakbar","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1357","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Li","Fengling","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1358","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Chau","Irene","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1359","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Ghiabi","Pegah","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1360","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Hajian","Taraneh","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1361","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Loppnau","Peter","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1362","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Bolotokova","Albina","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1363","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Satchell","Karla J F","Department of Microbiology-Immunology, Northwestern University, Center for Structural Genomics of Infectious Diseases, Feinberg School of Medicine, Chicago, IL, USA",NA
"1364","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Wang","Ke","Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"1365","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Li","Deyao","Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"1366","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Liu","Jing","Departments of Pharmacological Sciences and Oncological Sciences, Mount Sinai Center for Therapeutics Discovery, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1367","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Smil","David","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1368","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Luo","Minkui","Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA",NA
"1369","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Jin","Jian","Departments of Pharmacological Sciences and Oncological Sciences, Mount Sinai Center for Therapeutics Discovery, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1370","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Fish","Paul V","Alzheimer's Research UK UCL Drug Discovery Institute, University College London, London, UK",NA
"1371","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Brown","Peter J","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1372","34192965","10.1177/24725552211026261","Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.","The COVID-19 pandemic has clearly brought the healthcare systems worldwide to a breaking point, along with devastating socioeconomic consequences. The SARS-CoV-2 virus, which causes the disease, uses RNA capping to evade the human immune system. Nonstructural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the viral RNA at N7-guanosine in the cap formation process. To discover small-molecule inhibitors of nsp14 methyltransferase (MTase) activity, we develope","2021","07","07","SLAS Discov","SLAS discovery : advancing life sciences R &amp; D","COVID-19; SARS-CoV-2; coronavirus; nsp14","Vedadi","Masoud","Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada",NA
"1373","34192958","10.1177/09612033211027940","SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.",NA,"2021","07","01","Lupus","Lupus",NA,"Ceccarelli","Fulvia","Lupus Clinic, Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma, Italy",NA
"1374","34192958","10.1177/09612033211027940","SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.",NA,"2021","07","01","Lupus","Lupus",NA,"Olivieri","Giulio","Lupus Clinic, Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma, Italy",NA
"1375","34192958","10.1177/09612033211027940","SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.",NA,"2021","07","01","Lupus","Lupus",NA,"Natalucci","Francesco","Lupus Clinic, Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma, Italy",NA
"1376","34192958","10.1177/09612033211027940","SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.",NA,"2021","07","01","Lupus","Lupus",NA,"Alessandri","Cristiano","Lupus Clinic, Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma, Italy",NA
"1377","34192958","10.1177/09612033211027940","SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.",NA,"2021","07","01","Lupus","Lupus",NA,"Conti","Fabrizio","Lupus Clinic, Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma, Italy",NA
"1378","34192944","10.1177/00099228211029821","Expectations of Patients Seen in the Emergency Department for SARS-CoV-2 During the Pandemic.",NA,"2021","07","01","Clin Pediatr (Phila)","Clinical pediatrics",NA,"Castany","Estel","Hospital Sant Joan de Déu, Barcelona, Spain",NA
"1379","34192944","10.1177/00099228211029821","Expectations of Patients Seen in the Emergency Department for SARS-CoV-2 During the Pandemic.",NA,"2021","07","01","Clin Pediatr (Phila)","Clinical pediatrics",NA,"Marti","Celia","Hospital Sant Joan de Déu, Barcelona, Spain",NA
"1380","34192944","10.1177/00099228211029821","Expectations of Patients Seen in the Emergency Department for SARS-CoV-2 During the Pandemic.",NA,"2021","07","01","Clin Pediatr (Phila)","Clinical pediatrics",NA,"Parra","Cristina","Hospital Sant Joan de Déu, Barcelona, Spain",NA
"1381","34192944","10.1177/00099228211029821","Expectations of Patients Seen in the Emergency Department for SARS-CoV-2 During the Pandemic.",NA,"2021","07","01","Clin Pediatr (Phila)","Clinical pediatrics",NA,"Goldman","Ran","University of British Columbia, Vancouver, British Columbia, Canada",NA
"1382","34192944","10.1177/00099228211029821","Expectations of Patients Seen in the Emergency Department for SARS-CoV-2 During the Pandemic.",NA,"2021","07","01","Clin Pediatr (Phila)","Clinical pediatrics",NA,"Luaces","Carles","Hospital Sant Joan de Déu, Barcelona, Spain",NA
"1383","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Srivastava","Pratyaksh K","Division of Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA. (P.K.S., G.C",NA
"1384","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Zhang","Shuaiqi","Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. (S.Z., Y.X., B",NA
"1385","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Xian","Ying","Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. (S.Z., Y.X., B",NA
"1386","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Xu","Hanzhang","Department of Family Medicine and Community Health (H",NA
"1387","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Rutan","Christine","American Heart Association, Dallas, TX (C.R., H.M.A., J.G.W., J.H",NA
"1388","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Alger","Heather M","American Heart Association, Dallas, TX (C.R., H.M.A., J.G.W., J.H",NA
"1389","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Walchok","Jason G","American Heart Association, Dallas, TX (C.R., H.M.A., J.G.W., J.H",NA
"1390","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Williams","Joseph H","American Heart Association, Dallas, TX (C.R., H.M.A., J.G.W., J.H",NA
"1391","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","de Lemos","James A","Division of Cardiology, UT Southwestern Medical Center, Dallas, TX (J.A.d",NA
"1392","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Decker-Palmer","Marquita R","Genentech, San Francisco, CA (M.R.D",NA
"1393","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Alhanti","Brooke","Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. (S.Z., Y.X., B",NA
"1394","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Elkind","Mitchell S V","Department of Neurology and Department of Epidemiology, Columbia University, NY (M.S.V",NA
"1395","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Messé","Steve R","Department of Neurology, University of Pennsylvania, Philadelphia (S.R",NA
"1396","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Smith","Eric E","Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Alberta, Canada (E.E",NA
"1397","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Schwamm","Lee H","Department of Neurology, Comprehensive Stroke Center, Massachusetts General Hospital, Boston (L.H",NA
"1398","34192897","10.1161/STROKEAHA.120.034414","Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19: An Analysis From Get With The Guidelines-Stroke.","The coronavirus disease 2019 (COVID-19) pandemic has created challenges in the delivery of acute stroke care. In this study, we analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic stroke (AIS) pre-COVID-19 and during COVID-19. Get With The Guidelines-Stroke is a national registry of adults with stroke in the United States. Using this registry, we identified patients with a diagnosis of AIS before (n=39 113; November 1, 2019-Febr","2021","07","01","Stroke","Stroke","coronavirus; inpatient; ischemic stroke; pandemics; tomography","Fonarow","Gregg C","Division of Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA. (P.K.S., G.C",NA
"1399","34192886","10.1177/10499091211030456","As the Pandemic Recedes, Will Moral Distress Continue to Surge?","Palliative care practitioners have encountered morally distressing situations during the COVID-19 pandemic, and have supported their colleagues experiencing moral distress. Familiarity with the concept of moral distress and with COVID-specific causes of moral distress may help palliative care practitioners recognize moral distress in themselves and in their colleagues. This essay provides a brief review of the concept of moral distress, a list of potential COVID-19 specific causes of moral distr","2021","07","01","Am J Hosp Palliat Care","The American journal of hospice &amp; palliative care","COVID-19; clinician wellness; moral distress; pandemic","Vig","Elizabeth K","Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA",NA
"1401","34192837","10.1515/jom-2020-0277","Effect of a standardized patient encounter on first year medical student confidence and satisfaction with telemedicine.","Although the coronavirus 2019 (COVID-19) pandemic has accelerated the use of telemedicine platforms across the country, medical students may lack confidence in their ability to conduct satisfactory patient encounters and practice clinical medicine through telemedicine. To evaluate the role of a standardized patient encounter on first year medical student confidence and satisfaction in using telemedicine. One hundred and sixty two first year medical students recruited from Edward Via College of O","2021","06","30","J Osteopath Med","Journal of osteopathic medicine","confidence; medical education; satisfaction; standardized patient; telemedicine","Unrue","Emily L","Edward Via College of Osteopathic Medicine, Spartanburg, SC, USA",NA
"1402","34192837","10.1515/jom-2020-0277","Effect of a standardized patient encounter on first year medical student confidence and satisfaction with telemedicine.","Although the coronavirus 2019 (COVID-19) pandemic has accelerated the use of telemedicine platforms across the country, medical students may lack confidence in their ability to conduct satisfactory patient encounters and practice clinical medicine through telemedicine. To evaluate the role of a standardized patient encounter on first year medical student confidence and satisfaction in using telemedicine. One hundred and sixty two first year medical students recruited from Edward Via College of O","2021","06","30","J Osteopath Med","Journal of osteopathic medicine","confidence; medical education; satisfaction; standardized patient; telemedicine","White","Grayson","Edward Via College of Osteopathic Medicine, Spartanburg, SC, USA",NA
"1403","34192837","10.1515/jom-2020-0277","Effect of a standardized patient encounter on first year medical student confidence and satisfaction with telemedicine.","Although the coronavirus 2019 (COVID-19) pandemic has accelerated the use of telemedicine platforms across the country, medical students may lack confidence in their ability to conduct satisfactory patient encounters and practice clinical medicine through telemedicine. To evaluate the role of a standardized patient encounter on first year medical student confidence and satisfaction in using telemedicine. One hundred and sixty two first year medical students recruited from Edward Via College of O","2021","06","30","J Osteopath Med","Journal of osteopathic medicine","confidence; medical education; satisfaction; standardized patient; telemedicine","Cheng","Ning","Edward Via College of Osteopathic Medicine, Spartanburg, SC, USA",NA
"1404","34192837","10.1515/jom-2020-0277","Effect of a standardized patient encounter on first year medical student confidence and satisfaction with telemedicine.","Although the coronavirus 2019 (COVID-19) pandemic has accelerated the use of telemedicine platforms across the country, medical students may lack confidence in their ability to conduct satisfactory patient encounters and practice clinical medicine through telemedicine. To evaluate the role of a standardized patient encounter on first year medical student confidence and satisfaction in using telemedicine. One hundred and sixty two first year medical students recruited from Edward Via College of O","2021","06","30","J Osteopath Med","Journal of osteopathic medicine","confidence; medical education; satisfaction; standardized patient; telemedicine","Lindsey","Tom","Edward Via College of Osteopathic Medicine, Spartanburg, SC, USA",NA
"1405","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Navaeian","Amene","Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1406","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Mahmoudi","Shima","Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1407","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Pourakbari","Babak","Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1408","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Bakhtiari","Maryam","Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1409","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Khodabandeh","Mahmoud","Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1410","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Abdolsalehi","Mohammad Reza","Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1411","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Sharari","Alieh Safari","Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1412","34192829","10.1515/jbcpp-2021-0057","COVID-19 infection in children with underlying malignancies in Iran.","Although coronavirus disease 2019 (COVID-19) prognosis is mostly good in pediatric patients with no underlying diseases, there are a few reports on children with oncological underlying malignancies. This study aimed to describe the clinical and laboratory features of 20 children with COVID-19 who had underlying malignancies in an Iranian referral pediatrics hospital. All children under 15-year-old of age with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive real-time polymer","2021","06","30","J Basic Clin Physiol Pharmacol","Journal of basic and clinical physiology and pharmacology","COVID-19; SARS-CoV-2; children; malignancies","Mamishi","Setareh","Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran",NA
"1413","34192789","10.1055/s-0041-1730936","Management of Neurological Emergencies in Children: An Updated Overview.","Neurological emergencies account for about one-third of the highest severity codes attributed in emergency pediatric departments. About 75% of children with acute neurological symptoms presents with seizures, headache, or other paroxysmal events. Life-threatening conditions involve a minor proportion of patients (e.g., less than 15% of children with headache and less than 5% of children with febrile seizures). This review highlights updated insights about clinical features, diagnostic workup, an","2021","07","16","Neuropediatrics","Neuropediatrics",NA,"Mastrangelo","Mario","Child Neurology and Infantile Psychiatry Unit, Department of Human Neuroscience, Sapienza Università di Roma, Rome, Italy",NA
"1414","34192789","10.1055/s-0041-1730936","Management of Neurological Emergencies in Children: An Updated Overview.","Neurological emergencies account for about one-third of the highest severity codes attributed in emergency pediatric departments. About 75% of children with acute neurological symptoms presents with seizures, headache, or other paroxysmal events. Life-threatening conditions involve a minor proportion of patients (e.g., less than 15% of children with headache and less than 5% of children with febrile seizures). This review highlights updated insights about clinical features, diagnostic workup, an","2021","07","16","Neuropediatrics","Neuropediatrics",NA,"Baglioni","Valentina","Child Neurology and Infantile Psychiatry Unit, Department of Human Neuroscience, Sapienza Università di Roma, Rome, Italy",NA
"1415","34192777","10.1055/a-1369-3488","COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.",NA,"2021","07","07","Hamostaseologie","Hamostaseologie","COVID-19; COVID-19 Vaccines; Humans; Platelet Count; SARS-CoV-2; Thrombocytopenia; Thrombosis","Scharf","Rüdiger E","Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA",NA
"1416","34192777","10.1055/a-1369-3488","COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.",NA,"2021","07","07","Hamostaseologie","Hamostaseologie","COVID-19; COVID-19 Vaccines; Humans; Platelet Count; SARS-CoV-2; Thrombocytopenia; Thrombosis","Alberio","Lorenzo","Division of Hematology and Central Hematology Laboratory, University Hospital of Lausanne, Lausanne, Switzerland",NA
"1417","34192742","10.1093/neuros/nyab232","Letter: Impact of Sub-Internship Cancellations in Neurosurgery During COVID-19.",NA,"2021","06","30","Neurosurgery","Neurosurgery",NA,"Wilson","Chidinma M","Perelman School of Medicine University of Pennsylvania Philadelphia, Pennsylvania, USA",NA
"1418","34192742","10.1093/neuros/nyab232","Letter: Impact of Sub-Internship Cancellations in Neurosurgery During COVID-19.",NA,"2021","06","30","Neurosurgery","Neurosurgery",NA,"Brown","Nolan J","University of California, Irvine School of Medicine Irvine, California, USA",NA
"1419","34192742","10.1093/neuros/nyab232","Letter: Impact of Sub-Internship Cancellations in Neurosurgery During COVID-19.",NA,"2021","06","30","Neurosurgery","Neurosurgery",NA,"Detchou","Donald K E","Perelman School of Medicine University of Pennsylvania Philadelphia, Pennsylvania, USA",NA
"1420","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Collier","Dami A","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1421","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Ferreira","Isabella A T M","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1422","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Kotagiri","Prasanti","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1423","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Datir","Rawlings P","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1424","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Lim","Eleanor Y","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"1425","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Touizer","Emma","Division of Infection and Immunity, University College London, London, UK",NA
"1426","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Meng","Bo","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1427","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Abdullahi","Adam","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1428","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Elmer","Anne","NIHR Bioresource, Cambridge, UK",NA
"1429","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Kingston","Nathalie","NIHR Bioresource, Cambridge, UK",NA
"1430","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Graves","Barbara","NIHR Bioresource, Cambridge, UK",NA
"1431","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Le Gresley","Emma","NIHR Bioresource, Cambridge, UK",NA
"1432","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Caputo","Daniela","NIHR Bioresource, Cambridge, UK",NA
"1433","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Bergamaschi","Laura","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1434","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Smith","Kenneth G C","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1435","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Bradley","John R","Department of Medicine, University of Cambridge, Cambridge, UK",NA
"1436","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Ceron-Gutierrez","Lourdes","Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, Cambridge, UK",NA
"1437","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Cortes-Acevedo","Paulina","Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico",NA
"1438","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Barcenas-Morales","Gabriela","Laboratorio de Inmunología, FES-Cuautitlán, UNAM, Mexico City, Mexico",NA
"1439","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Linterman","Michelle A","Immunology Programme, Babraham Institute, Cambridge, UK",NA
"1440","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"McCoy","Laura E","Division of Infection and Immunity, University College London, London, UK",NA
"1441","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Davis","Chris","MRC Centre for Virus Research, University of Glasgow, Glasgow, UK",NA
"1442","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Thomson","Emma","MRC Centre for Virus Research, University of Glasgow, Glasgow, UK",NA
"1443","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Lyons","Paul A","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK",NA
"1444","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"McKinney","Eoin","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. efm30@medschl.cam.ac","efm30@medschl.cam.ac.uk"
"1445","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Doffinger","Rainer","Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. rd270@medschl.cam.ac","rd270@medschl.cam.ac.uk"
"1446","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Wills","Mark","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. mrw1004@cam.ac","mrw1004@cam.ac.uk"
"1447","34192737","10.1038/s41586-021-03739-1","Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.","Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is little information about vaccine efficacy against variants of concern (VOC) in individuals above eighty years of age<sup>1</sup>. Here we analysed immune responses following vaccination with the BNT162b2 mRNA vaccine<sup>2</sup> in elderly participants and younger healthcare workers. Serum neutralization and levels of binding IgG or IgA after the first vaccine dose were lower in older individuals, with ","2021","07","15","Nature","Nature",NA,"Gupta","Ravindra K","Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac","rkg20@cam.ac.uk"
"1448","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Lemey","Philippe","Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium. philippe.lemey@kuleuven","philippe.lemey@kuleuven.be"
"1449","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Ruktanonchai","Nick","WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, UK",NA
"1450","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Hong","Samuel L","Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"1451","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Colizza","Vittoria","INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Paris, France",NA
"1452","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Poletto","Chiara","INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Paris, France",NA
"1453","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Van den Broeck","Frederik","Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"1454","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Gill","Mandev S","Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"1455","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Ji","Xiang","Department of Mathematics, School of Science &amp",NA
"1456","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Levasseur","Anthony","UMR MEPHI (Microbes, Evolution, Phylogeny and Infections), Aix-Marseille Université (AMU) and Institut Universitaire de France (IUF), Marseille, France",NA
"1457","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Oude Munnink","Bas B","Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Erasmus MC, Rotterdam, The Netherlands",NA
"1458","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Koopmans","Marion","Department of Viroscience, WHO Collaborating Centre for Arbovirus and Viral Hemorrhagic Fever Reference and Research, Erasmus MC, Rotterdam, The Netherlands",NA
"1459","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Sadilek","Adam","Google, Mountain View, CA, USA",NA
"1460","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Lai","Shengjie","WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, UK",NA
"1461","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Tatem","Andrew J","WorldPop, School of Geography and Environmental Science, University of Southampton, Southampton, UK",NA
"1462","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Baele","Guy","Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium",NA
"1463","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Suchard","Marc A","Department of Biomathematics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA",NA
"1464","34192736","10.1038/s41586-021-03754-2","Untangling introductions and persistence in COVID-19 resurgence in Europe.","After the first wave of SARS-CoV-2 infections in spring 2020, Europe experienced a resurgence of the virus starting in late summer 2020 that was deadlier and more difficult to contain<sup>1</sup>. Relaxed intervention measures and summer travel have been implicated as drivers of the second wave<sup>2</sup>. Here we build a phylogeographical model to evaluate how newly introduced lineages, as opposed to the rekindling of persistent lineages, contributed to the resurgence of COVID-19 in Europe. We","2021","07","22","Nature","Nature",NA,"Dellicour","Simon","Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium. simon.dellicour@ulb.ac","simon.dellicour@ulb.ac.be"
"1465","34192717","10.1097/ACM.0000000000004219","Development of a Single-Institution Virtual Internal Medicine Subinternship With Near-Peer Teaching in Response to the COVID-19 Pandemic.","In March 2020, medical students at the University of Washington School of Medicine were removed from clinical settings in response to the COVID-19 pandemic. As subinternships are required for graduation and an important way to prepare for internship, a virtual subinternship was created to include practical elements of in-person learning and to address limited teaching faculty from COVID-19 inpatient surges. A virtual, interactive subinternship was developed with case-based teaching sessions, com","2021","07","01","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Holmberg","Mackenzie H","M.H. Holmberg is resident physician, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. E. dela Cruz is resident physician, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California. A. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. N. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. B. Çoruh is associate professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. S.E. Merel is associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington",NA
"1466","34192717","10.1097/ACM.0000000000004219","Development of a Single-Institution Virtual Internal Medicine Subinternship With Near-Peer Teaching in Response to the COVID-19 Pandemic.","In March 2020, medical students at the University of Washington School of Medicine were removed from clinical settings in response to the COVID-19 pandemic. As subinternships are required for graduation and an important way to prepare for internship, a virtual subinternship was created to include practical elements of in-person learning and to address limited teaching faculty from COVID-19 inpatient surges. A virtual, interactive subinternship was developed with case-based teaching sessions, com","2021","07","01","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Dela Cruz","Erin","M.H. Holmberg is resident physician, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. E. dela Cruz is resident physician, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California. A. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. N. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. B. Çoruh is associate professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. S.E. Merel is associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington",NA
"1467","34192717","10.1097/ACM.0000000000004219","Development of a Single-Institution Virtual Internal Medicine Subinternship With Near-Peer Teaching in Response to the COVID-19 Pandemic.","In March 2020, medical students at the University of Washington School of Medicine were removed from clinical settings in response to the COVID-19 pandemic. As subinternships are required for graduation and an important way to prepare for internship, a virtual subinternship was created to include practical elements of in-person learning and to address limited teaching faculty from COVID-19 inpatient surges. A virtual, interactive subinternship was developed with case-based teaching sessions, com","2021","07","01","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Longino","August","M.H. Holmberg is resident physician, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. E. dela Cruz is resident physician, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California. A. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. N. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. B. Çoruh is associate professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. S.E. Merel is associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington",NA
"1468","34192717","10.1097/ACM.0000000000004219","Development of a Single-Institution Virtual Internal Medicine Subinternship With Near-Peer Teaching in Response to the COVID-19 Pandemic.","In March 2020, medical students at the University of Washington School of Medicine were removed from clinical settings in response to the COVID-19 pandemic. As subinternships are required for graduation and an important way to prepare for internship, a virtual subinternship was created to include practical elements of in-person learning and to address limited teaching faculty from COVID-19 inpatient surges. A virtual, interactive subinternship was developed with case-based teaching sessions, com","2021","07","01","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Longino","Natalie","M.H. Holmberg is resident physician, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. E. dela Cruz is resident physician, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California. A. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. N. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. B. Çoruh is associate professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. S.E. Merel is associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington",NA
"1469","34192717","10.1097/ACM.0000000000004219","Development of a Single-Institution Virtual Internal Medicine Subinternship With Near-Peer Teaching in Response to the COVID-19 Pandemic.","In March 2020, medical students at the University of Washington School of Medicine were removed from clinical settings in response to the COVID-19 pandemic. As subinternships are required for graduation and an important way to prepare for internship, a virtual subinternship was created to include practical elements of in-person learning and to address limited teaching faculty from COVID-19 inpatient surges. A virtual, interactive subinternship was developed with case-based teaching sessions, com","2021","07","01","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Çoruh","Basak","M.H. Holmberg is resident physician, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. E. dela Cruz is resident physician, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California. A. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. N. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. B. Çoruh is associate professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. S.E. Merel is associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington",NA
"1470","34192717","10.1097/ACM.0000000000004219","Development of a Single-Institution Virtual Internal Medicine Subinternship With Near-Peer Teaching in Response to the COVID-19 Pandemic.","In March 2020, medical students at the University of Washington School of Medicine were removed from clinical settings in response to the COVID-19 pandemic. As subinternships are required for graduation and an important way to prepare for internship, a virtual subinternship was created to include practical elements of in-person learning and to address limited teaching faculty from COVID-19 inpatient surges. A virtual, interactive subinternship was developed with case-based teaching sessions, com","2021","07","01","Acad Med","Academic medicine : journal of the Association of American Medical Colleges",NA,"Merel","Susan E","M.H. Holmberg is resident physician, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. E. dela Cruz is resident physician, Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California. A. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. N. Longino is resident physician, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado. B. Çoruh is associate professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington. S.E. Merel is associate professor, Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington",NA
"1471","34192703","10.1159/000516298","COVID-19 Virtual Care for the Geriatric Population: Exploring Two Sides of the Coin.","Virtual care (VC) continues to gain attention as we make changes to the way we deliver care amidst our current COVID-19 pandemic. Exploring various ways of delivering care is of importance as we try our best to ensure we prioritize the health and safety of every one of our patients. One mode of care that is continuing to garner attention is telemedicine - the use of virtual technology to deliver care to our patients. The geriatric population has been of particular focus during this time. As with","2021","06","30","Gerontology","Gerontology","COVID-19; Geriatrics; Healthcare; Virtual care","Senderovich","Helen","Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"1472","34192703","10.1159/000516298","COVID-19 Virtual Care for the Geriatric Population: Exploring Two Sides of the Coin.","Virtual care (VC) continues to gain attention as we make changes to the way we deliver care amidst our current COVID-19 pandemic. Exploring various ways of delivering care is of importance as we try our best to ensure we prioritize the health and safety of every one of our patients. One mode of care that is continuing to garner attention is telemedicine - the use of virtual technology to deliver care to our patients. The geriatric population has been of particular focus during this time. As with","2021","06","30","Gerontology","Gerontology","COVID-19; Geriatrics; Healthcare; Virtual care","Wignarajah","Shaira","Department of Medicine, University of Limerick, Limerick, Ireland",NA
"1473","34192695","10.1159/000516643","CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.","Being frequently exposed to foreign nucleic acids, bacteria and archaea have developed an ingenious adaptive defense system, called CRISPR-Cas. The system is composed of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) array, together with CRISPR (cas)-associated genes. This system consists of a complex machinery that integrates fragments of foreign nucleic acids from viruses and mobile genetic elements (MGEs), into CRISPR arrays. The inserted segments (spacers) are transcr","2021","06","30","Microb Physiol","Microbial physiology","Adaptation; CRISPR; Interference; Spacer acquisition; cas genes","Butiuc-Keul","Anca","Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babes-Bolyai University, Cluj-Napoca, Romania",NA
"1474","34192695","10.1159/000516643","CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.","Being frequently exposed to foreign nucleic acids, bacteria and archaea have developed an ingenious adaptive defense system, called CRISPR-Cas. The system is composed of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) array, together with CRISPR (cas)-associated genes. This system consists of a complex machinery that integrates fragments of foreign nucleic acids from viruses and mobile genetic elements (MGEs), into CRISPR arrays. The inserted segments (spacers) are transcr","2021","06","30","Microb Physiol","Microbial physiology","Adaptation; CRISPR; Interference; Spacer acquisition; cas genes","Farkas","Anca","Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babes-Bolyai University, Cluj-Napoca, Romania",NA
"1475","34192695","10.1159/000516643","CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.","Being frequently exposed to foreign nucleic acids, bacteria and archaea have developed an ingenious adaptive defense system, called CRISPR-Cas. The system is composed of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) array, together with CRISPR (cas)-associated genes. This system consists of a complex machinery that integrates fragments of foreign nucleic acids from viruses and mobile genetic elements (MGEs), into CRISPR arrays. The inserted segments (spacers) are transcr","2021","06","30","Microb Physiol","Microbial physiology","Adaptation; CRISPR; Interference; Spacer acquisition; cas genes","Carpa","Rahela","Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babes-Bolyai University, Cluj-Napoca, Romania",NA
"1476","34192695","10.1159/000516643","CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes.","Being frequently exposed to foreign nucleic acids, bacteria and archaea have developed an ingenious adaptive defense system, called CRISPR-Cas. The system is composed of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) array, together with CRISPR (cas)-associated genes. This system consists of a complex machinery that integrates fragments of foreign nucleic acids from viruses and mobile genetic elements (MGEs), into CRISPR arrays. The inserted segments (spacers) are transcr","2021","06","30","Microb Physiol","Microbial physiology","Adaptation; CRISPR; Interference; Spacer acquisition; cas genes","Iordache","Dumitrana","Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babes-Bolyai University, Cluj-Napoca, Romania",NA
"1477","34192610","10.1016/j.dsx.2021.05.019","Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.","There are increasing case reports of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. We aim to conduct a systematic review of literature to find out the patient's characteristics having mucormycosis and COVID-19. We searched the electronic database of PubMed and Google Scholar from inception until May 13, 2021 using keywords. We retrieved all the g","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Corticosteroids; Diabetes mellitus; Mucormycosis; Systematic review","Singh","Awadhesh Kumar","Department of Diabetes &amp","drawadheshkumarsingh@gmail.com"
"1478","34192610","10.1016/j.dsx.2021.05.019","Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.","There are increasing case reports of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. We aim to conduct a systematic review of literature to find out the patient's characteristics having mucormycosis and COVID-19. We searched the electronic database of PubMed and Google Scholar from inception until May 13, 2021 using keywords. We retrieved all the g","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Corticosteroids; Diabetes mellitus; Mucormycosis; Systematic review","Singh","Ritu","Department of Diabetes &amp",NA
"1479","34192610","10.1016/j.dsx.2021.05.019","Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.","There are increasing case reports of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. We aim to conduct a systematic review of literature to find out the patient's characteristics having mucormycosis and COVID-19. We searched the electronic database of PubMed and Google Scholar from inception until May 13, 2021 using keywords. We retrieved all the g","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Corticosteroids; Diabetes mellitus; Mucormycosis; Systematic review","Joshi","Shashank R","Department of Diabetes &amp",NA
"1480","34192610","10.1016/j.dsx.2021.05.019","Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.","There are increasing case reports of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. We aim to conduct a systematic review of literature to find out the patient's characteristics having mucormycosis and COVID-19. We searched the electronic database of PubMed and Google Scholar from inception until May 13, 2021 using keywords. We retrieved all the g","2021","07","19","Diabetes Metab Syndr","Diabetes &amp; metabolic syndrome","COVID-19; Corticosteroids; Diabetes mellitus; Mucormycosis; Systematic review","Misra","Anoop","Fortis C-DOC Hospital for Diabetes &amp",NA
"1481","34192604","10.1016/j.puhe.2021.05.024","COVID-19 media fatigue: predictors of decreasing interest and avoidance of COVID-19-related news.","COVID-19-related news is important for adherence to public health measures. We examined predictors of interest and avoidance of COVID-19 news in Lithuania. This is an online survey. An online survey was conducted between October and December 2020 targeting the general population in Lithuania. Participants rated their interest and avoidance of news about the COVID-19 pandemic, with possible answers ranging from 'completely agree' to 'completely disagree'. The participants were also evaluated for ","2021","07","21","Public Health","Public health","Anxiety; Avoidance; COVID-19; Depression; Fear; News; Stress","Buneviciene","I","Vytautas Magnus University, Department of Public Communications, Kaunas, Lithuania","i.birbilaite@yahoo.com"
"1482","34192604","10.1016/j.puhe.2021.05.024","COVID-19 media fatigue: predictors of decreasing interest and avoidance of COVID-19-related news.","COVID-19-related news is important for adherence to public health measures. We examined predictors of interest and avoidance of COVID-19 news in Lithuania. This is an online survey. An online survey was conducted between October and December 2020 targeting the general population in Lithuania. Participants rated their interest and avoidance of news about the COVID-19 pandemic, with possible answers ranging from 'completely agree' to 'completely disagree'. The participants were also evaluated for ","2021","07","21","Public Health","Public health","Anxiety; Avoidance; COVID-19; Depression; Fear; News; Stress","Bunevicius","R","ProIT, Vilnius, Lithuania",NA
"1483","34192604","10.1016/j.puhe.2021.05.024","COVID-19 media fatigue: predictors of decreasing interest and avoidance of COVID-19-related news.","COVID-19-related news is important for adherence to public health measures. We examined predictors of interest and avoidance of COVID-19 news in Lithuania. This is an online survey. An online survey was conducted between October and December 2020 targeting the general population in Lithuania. Participants rated their interest and avoidance of news about the COVID-19 pandemic, with possible answers ranging from 'completely agree' to 'completely disagree'. The participants were also evaluated for ","2021","07","21","Public Health","Public health","Anxiety; Avoidance; COVID-19; Depression; Fear; News; Stress","Bagdonas","S","ProIT, Vilnius, Lithuania",NA
"1484","34192604","10.1016/j.puhe.2021.05.024","COVID-19 media fatigue: predictors of decreasing interest and avoidance of COVID-19-related news.","COVID-19-related news is important for adherence to public health measures. We examined predictors of interest and avoidance of COVID-19 news in Lithuania. This is an online survey. An online survey was conducted between October and December 2020 targeting the general population in Lithuania. Participants rated their interest and avoidance of news about the COVID-19 pandemic, with possible answers ranging from 'completely agree' to 'completely disagree'. The participants were also evaluated for ","2021","07","21","Public Health","Public health","Anxiety; Avoidance; COVID-19; Depression; Fear; News; Stress","Bunevicius","A","Cura Te Ipsum, Garliava, Lithuania",NA
"1485","34192577","10.1016/j.ijid.2021.06.051","Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.","In this systematic review and meta-analysis, we aimed to compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. Additionally, we also explored factors that may affect the difference in terms of vWF antigen between the two groups. A comprehensive literature search was performed using the PubMed, Embase, and Scopus databases from inception up until 7 April 2021. The main outcome was poor outcome, which is a composite of mortality and sever","2021","07","02","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Coagulopathy; Coronavirus; Endothelial dysfunction; Mortality; Thrombosis","Wibowo","Arief","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia. Electronic address: ariefwibowo.doc@gmail","ariefwibowo.doc@gmail.com"
"1486","34192577","10.1016/j.ijid.2021.06.051","Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.","In this systematic review and meta-analysis, we aimed to compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. Additionally, we also explored factors that may affect the difference in terms of vWF antigen between the two groups. A comprehensive literature search was performed using the PubMed, Embase, and Scopus databases from inception up until 7 April 2021. The main outcome was poor outcome, which is a composite of mortality and sever","2021","07","02","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Coagulopathy; Coronavirus; Endothelial dysfunction; Mortality; Thrombosis","Pranata","Raymond","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia","ariefwibowo.doc@gmail.com"
"1487","34192577","10.1016/j.ijid.2021.06.051","Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.","In this systematic review and meta-analysis, we aimed to compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. Additionally, we also explored factors that may affect the difference in terms of vWF antigen between the two groups. A comprehensive literature search was performed using the PubMed, Embase, and Scopus databases from inception up until 7 April 2021. The main outcome was poor outcome, which is a composite of mortality and sever","2021","07","02","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Coagulopathy; Coronavirus; Endothelial dysfunction; Mortality; Thrombosis","Lim","Michael Anthonius","Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia",NA
"1488","34192577","10.1016/j.ijid.2021.06.051","Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.","In this systematic review and meta-analysis, we aimed to compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. Additionally, we also explored factors that may affect the difference in terms of vWF antigen between the two groups. A comprehensive literature search was performed using the PubMed, Embase, and Scopus databases from inception up until 7 April 2021. The main outcome was poor outcome, which is a composite of mortality and sever","2021","07","02","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Coagulopathy; Coronavirus; Endothelial dysfunction; Mortality; Thrombosis","Akbar","Mohammad Rizki","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"1489","34192577","10.1016/j.ijid.2021.06.051","Endotheliopathy Marked by High von Willebrand Factor (vWF) Antigen in COVID-19 is Associated with Poor Outcome: A Systematic Review and Meta-analysis.","In this systematic review and meta-analysis, we aimed to compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. Additionally, we also explored factors that may affect the difference in terms of vWF antigen between the two groups. A comprehensive literature search was performed using the PubMed, Embase, and Scopus databases from inception up until 7 April 2021. The main outcome was poor outcome, which is a composite of mortality and sever","2021","07","02","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","Coagulopathy; Coronavirus; Endothelial dysfunction; Mortality; Thrombosis","Martha","Januar Wibawa","Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Bandung, Indonesia",NA
"1490","34192576","10.1016/j.cmi.2021.06.022","Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.",NA,"2021","07","14","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Al Jalali","Valentin","Department of Clinical Pharmacology, Medical University of Vienna, Austria. Electronic address: valentin.aljalali@meduniwien.ac","valentin.aljalali@meduniwien.ac.at"
"1491","34192576","10.1016/j.cmi.2021.06.022","Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.",NA,"2021","07","14","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Scherzer","Sabine","Department of Cardiothoracic Surgery, Medical University of Vienna, Austria",NA
"1492","34192576","10.1016/j.cmi.2021.06.022","Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.",NA,"2021","07","14","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Zeitlinger","Markus","Department of Clinical Pharmacology, Medical University of Vienna, Austria. Electronic address: markus.zeitlinger@meduniwien.ac","markus.zeitlinger@meduniwien.ac.at"
"1493","34192575","10.1016/j.cmi.2021.06.025","COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?",NA,"2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Fekkar","Arnaud","AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France. Electronic address: arnaud.fekkar@aphp","arnaud.fekkar@aphp.fr"
"1494","34192575","10.1016/j.cmi.2021.06.025","COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?",NA,"2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Neofytos","Dionysios","Division of Infectious Diseases, University Hospital of Geneva, Geneva, Switzerland",NA
"1495","34192575","10.1016/j.cmi.2021.06.025","COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?",NA,"2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Nguyen","Minh-Hong","Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA, USA",NA
"1496","34192575","10.1016/j.cmi.2021.06.025","COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?",NA,"2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Clancy","Cornelius J","Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA, USA",NA
"1497","34192575","10.1016/j.cmi.2021.06.025","COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?",NA,"2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Kontoyiannis","Dimitrios P","Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"1498","34192575","10.1016/j.cmi.2021.06.025","COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?",NA,"2021","07","21","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases",NA,"Lamoth","Frederic","Infectious Diseases Service and Institute of Microbiology, University Hospital of Lausanne and Lausanne University, Lausanne, Switzerland",NA
"1499","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Taber","Peter","Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States. Electronic address: peter.taber@hsc.utah","peter.taber@hsc.utah.edu"
"1500","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Staes","Catherine J","Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States",NA
"1501","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Phengphoo","Saifon","Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States",NA
"1502","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Rocha","Elisa","University of Massachusetts Medical School, Worcester, MA, United States",NA
"1503","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Lam","Adria","Albany Medical College, Albany, NY, United States",NA
"1504","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Del Fiol","Guilherme","Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, United States",NA
"1505","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Maviglia","Saverio M","Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States",NA
"1506","34192573","10.1016/j.jbi.2021.103852","Developing a sampling method and preliminary taxonomy for classifying COVID-19 public health guidance for healthcare organizations and the general public.","Development and dissemination of public health (PH) guidance to healthcare organizations and the general public (e.g., businesses, schools, individuals) during emergencies like the COVID-19 pandemic is vital for policy, clinical, and public decision-making. Yet, the rapidly evolving nature of these events poses significant challenges for guidance development and dissemination strategies predicated on well-understood concepts and clearly defined access and distribution pathways. Taxonomies are an","2021","07","24","J Biomed Inform","Journal of biomedical informatics","COVID-19; Content analysis; Indexing; Knowledge management; Public health guidance; Taxonomy","Rocha","Roberto A","Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States",NA
"1507","34192555","10.1016/j.envres.2021.111565","The impact of atmospheric pollution on outdoor cultural heritage: an analytic methodology for the characterization of the carbonaceous fraction in black crusts present on stone surfaces.","COVID-19 has reduced tourism in both museums and historical sites with negative economic effect. The wellbeing and good preservation of monuments is a key factor to encourage again tourism. Historical monuments exposed to outdoor pollution are subjected to well known degradation phenomenon including the formation on their surface of black crusts (BCs) causing blackening and deterioration of the monuments and, as a consequence, a worst fruition by the visitors. The aim of this research is the dev","2021","07","20","Environ Res","Environmental research","Black crusts; Carbon analysis; Cultural heritage; Elemental carbon; Organic carbon; Stones; TGA","Comite","Valeria","Dipartimento di Chimica, University of Milan, Milan, 20133, Italy",NA
"1508","34192555","10.1016/j.envres.2021.111565","The impact of atmospheric pollution on outdoor cultural heritage: an analytic methodology for the characterization of the carbonaceous fraction in black crusts present on stone surfaces.","COVID-19 has reduced tourism in both museums and historical sites with negative economic effect. The wellbeing and good preservation of monuments is a key factor to encourage again tourism. Historical monuments exposed to outdoor pollution are subjected to well known degradation phenomenon including the formation on their surface of black crusts (BCs) causing blackening and deterioration of the monuments and, as a consequence, a worst fruition by the visitors. The aim of this research is the dev","2021","07","20","Environ Res","Environmental research","Black crusts; Carbon analysis; Cultural heritage; Elemental carbon; Organic carbon; Stones; TGA","Miani","Alessandro","Italian Society of Environmental Medicine, (SIMA), Milan, 20123, Italy",NA
"1509","34192555","10.1016/j.envres.2021.111565","The impact of atmospheric pollution on outdoor cultural heritage: an analytic methodology for the characterization of the carbonaceous fraction in black crusts present on stone surfaces.","COVID-19 has reduced tourism in both museums and historical sites with negative economic effect. The wellbeing and good preservation of monuments is a key factor to encourage again tourism. Historical monuments exposed to outdoor pollution are subjected to well known degradation phenomenon including the formation on their surface of black crusts (BCs) causing blackening and deterioration of the monuments and, as a consequence, a worst fruition by the visitors. The aim of this research is the dev","2021","07","20","Environ Res","Environmental research","Black crusts; Carbon analysis; Cultural heritage; Elemental carbon; Organic carbon; Stones; TGA","Ricca","Michela","Dipartimento di Biologia, Ecologia e Scienze Della Terra (DiBEST), Università Della Calabria, Arcavacata di Rende, 87036, CS, Italy",NA
"1510","34192555","10.1016/j.envres.2021.111565","The impact of atmospheric pollution on outdoor cultural heritage: an analytic methodology for the characterization of the carbonaceous fraction in black crusts present on stone surfaces.","COVID-19 has reduced tourism in both museums and historical sites with negative economic effect. The wellbeing and good preservation of monuments is a key factor to encourage again tourism. Historical monuments exposed to outdoor pollution are subjected to well known degradation phenomenon including the formation on their surface of black crusts (BCs) causing blackening and deterioration of the monuments and, as a consequence, a worst fruition by the visitors. The aim of this research is the dev","2021","07","20","Environ Res","Environmental research","Black crusts; Carbon analysis; Cultural heritage; Elemental carbon; Organic carbon; Stones; TGA","La Russa","Mauro","Dipartimento di Biologia, Ecologia e Scienze Della Terra (DiBEST), Università Della Calabria, Arcavacata di Rende, 87036, CS, Italy",NA
"1511","34192555","10.1016/j.envres.2021.111565","The impact of atmospheric pollution on outdoor cultural heritage: an analytic methodology for the characterization of the carbonaceous fraction in black crusts present on stone surfaces.","COVID-19 has reduced tourism in both museums and historical sites with negative economic effect. The wellbeing and good preservation of monuments is a key factor to encourage again tourism. Historical monuments exposed to outdoor pollution are subjected to well known degradation phenomenon including the formation on their surface of black crusts (BCs) causing blackening and deterioration of the monuments and, as a consequence, a worst fruition by the visitors. The aim of this research is the dev","2021","07","20","Environ Res","Environmental research","Black crusts; Carbon analysis; Cultural heritage; Elemental carbon; Organic carbon; Stones; TGA","Pulimeno","Manuela","Staff UNESCO, Chair on Health Education and Sustainable Development, Federico II University of Naples, Naples, 80138, Italy",NA
"1512","34192555","10.1016/j.envres.2021.111565","The impact of atmospheric pollution on outdoor cultural heritage: an analytic methodology for the characterization of the carbonaceous fraction in black crusts present on stone surfaces.","COVID-19 has reduced tourism in both museums and historical sites with negative economic effect. The wellbeing and good preservation of monuments is a key factor to encourage again tourism. Historical monuments exposed to outdoor pollution are subjected to well known degradation phenomenon including the formation on their surface of black crusts (BCs) causing blackening and deterioration of the monuments and, as a consequence, a worst fruition by the visitors. The aim of this research is the dev","2021","07","20","Environ Res","Environmental research","Black crusts; Carbon analysis; Cultural heritage; Elemental carbon; Organic carbon; Stones; TGA","Fermo","Paola","Dipartimento di Chimica, University of Milan, Milan, 20133, Italy","paola.fermo@unimi.it"
"1513","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Amanat","Fatima","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1514","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Thapa","Mahima","Department of Pathology &amp",NA
"1515","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Lei","Tinting","Department of Pathology &amp",NA
"1516","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Ahmed","Shaza M Sayed","Department of Pathology &amp",NA
"1517","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Adelsberg","Daniel C","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1518","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Carreño","Juan Manuel","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1519","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Strohmeier","Shirin","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1520","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Schmitz","Aaron J","Department of Pathology &amp",NA
"1521","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Zafar","Sarah","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1522","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Zhou","Julian Q","AbCellera Biologics Inc., Vancouver, BC V5Y 0A1, Canada",NA
"1523","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Rijnink","Willemijn","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1524","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Alshammary","Hala","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1525","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Borcherding","Nicholas","Department of Pathology &amp",NA
"1526","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Reiche","Ana Gonzalez","Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1527","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Srivastava","Komal","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1528","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Sordillo","Emilia Mia","Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1529","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","van Bakel","Harm","Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA",NA
"1530","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Turner","Jackson S","Department of Pathology &amp",NA
"1531","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Bajic","Goran","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: goran.bajic@mssm","goran.bajic@mssm.edu"
"1532","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Simon","Viviana","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA","viviana.simon@mssm.edu"
"1533","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Ellebedy","Ali H","Department of Pathology &amp","ellebedy@wustl.edu"
"1534","34192529","10.1016/j.cell.2021.06.005","SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.","In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal antibody responses in vaccinees were robust and comparable to or exceeded those seen after natural infection. However, the ratio of binding to neutralizing antibodies after vaccination was greater than that after natural infection and, at the monoclonal level, we found that the majority of vaccine-induced antibodies did not ha","2021","07","23","Cell","Cell","NTD; RBD; SARS-CoV-2; mAbs; mRNA vaccination; plasmablasts; spike","Krammer","Florian","Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: florian.krammer@mssm","florian.krammer@mssm.edu"
"1535","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Case","James Brett","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA",NA
"1536","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Chen","Rita E","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA",NA
"1537","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Cao","Longxing","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1538","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Ying","Baoling","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA",NA
"1539","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Winkler","Emma S","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA",NA
"1540","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Johnson","Max","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1541","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Goreshnik","Inna","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1542","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Pham","Minh N","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1543","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Shrihari","Swathi","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA",NA
"1544","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Kafai","Natasha M","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA",NA
"1545","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Bailey","Adam L","Department of Pathology &amp",NA
"1546","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Xie","Xuping","Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA",NA
"1547","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Shi","Pei-Yong","Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA",NA
"1548","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Ravichandran","Rashmi","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1549","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Carter","Lauren","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1550","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Stewart","Lance","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1551","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Baker","David","Department of Biochemistry, University of Washington, Seattle, WA 98195, USA",NA
"1552","34192518","10.1016/j.chom.2021.06.008","Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.","Despite the introduction of public health measures and spike protein-based vaccines to mitigate the COVID-19 pandemic, SARS-CoV-2 infections and deaths continue to have a global impact. Previously, we used a structural design approach to develop picomolar range miniproteins targeting the SARS-CoV-2 spike receptor-binding domain. Here, we investigated the capacity of modified versions of one lead miniprotein, LCB1, to protect against SARS-CoV-2-mediated lung disease in mice. Systemic administrati","2021","07","19","Cell Host Microbe","Cell host &amp; microbe","COVID-19; SARS-CoV-2; intranasal; mice; miniprotein; pathogenesis; prophylaxis; receptor-binding domain; therapy; variants","Diamond","Michael S","Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA","diamond@wusm.wustl.edu"
"1553","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"McPeake","Joanne","NHS Greater Glasgow and Clyde, 3529, Glasgow Royal Infirmary , Glasgow, United Kingdom of Great Britain and Northern Ireland","joanne.mcpeake@glasgow.ac.uk"
"1554","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Shaw","Martin","NHS Greater Glasgow and Clyde, 3529, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1555","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"MacTavish","Pamela","NHS Greater Glasgow and Clyde, 3529, Glasgow Royal Infirmary, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1556","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Blyth","Kevin","Queen Elizabeth University Hospital, Respiratory Medicine, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1557","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Devine","Helen","NHS Greater Glasgow and Clyde, 3529, Glasgow Royal Infirmary, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1558","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Fleming","Gillian","NHS Fife, 3049, Kirkcaldy, Fife, United Kingdom of Great Britain and Northern Ireland",NA
"1559","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Gemmell","Lisa","NHS Greater Glasgow and Clyde, 3529, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1560","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Griffin","Justine","NHS Greater Glasgow and Clyde, 3529, Glasgow Royal Infirmary , Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1561","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Grose","Pauline","NHS Greater Glasgow and Clyde, 3529, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1562","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Henderson","Mark","NHS Greater Glasgow and Clyde , Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1563","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Henderson","Philip","NHS Greater Glasgow and Clyde, 3529, Glasgow Royal Infirmary , Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1564","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Hogg","Lucy","NHS Fife, 3049, Kirkcaldy, Fife, United Kingdom of Great Britain and Northern Ireland",NA
"1565","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"King","Kirstin","NHS Greater Glasgow and Clyde, 3529, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1566","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"McInnes","Iain","University of Glasgow, 3526, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1567","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"O'Brien","Peter","NHS Ayrshire and Arran, 1442, Ayr, South Ayrshire, United Kingdom of Great Britain and Northern Ireland",NA
"1568","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Puxty","Kathryn","NHS Greater Glasgow and Clyde, 3529, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1569","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Rainey","Callum","NHS Ayrshire and Arran, 1442, Ayr, South Ayrshire, United Kingdom of Great Britain and Northern Ireland",NA
"1570","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Sharma","Varun","NHS Greater Glasgow and Clyde, 3529, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1571","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Sim","Malcolm","University of Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1572","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Strachan","Laura","NHS Greater Glasgow and Clyde, 3529, Glasgow Royal Infirmary , Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1573","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Siebert","Stefan","University of Glasgow College of Medical Veterinary and Life Sciences, 223860, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1574","34192506","10.1513/AnnalsATS.202104-481RL","Long-term Outcomes Following Severe COVID-19 Infection: A Multicenter Cohort Study of Family Member Outcomes.",NA,"2021","06","30","Ann Am Thorac Soc","Annals of the American Thoracic Society",NA,"Quasim","Tara","University of Glasgow, 3526, School of Medicine, Dentistry, and Nursing, Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland",NA
"1575","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Parikh","S","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1576","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Cooper","L","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1577","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Matthews","W","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1578","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Khan","M","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1579","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Syed","S","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1580","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Vasudevan","S P","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1581","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Brosnan","C","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1582","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Barr","L","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1583","34192500","10.1308/rcsann.2021.0094","Safety of emergency, elective and day case operating during the winter period at East Suffolk and North Essex NHS Foundation Trust: lessons from the outcomes of 4,254 surgical patients from the first COVID-19 wave.","There is limited evidence on perioperative outcomes of surgical patients during the COVID-19 pandemic to inform continued operating into the winter period. We retrospectively analysed the rate of 30-day COVID-19 transmission and mortality of all surgical patients in the three hospitals in our trust in the East of England during the first lockdown in March 2020. All patients who underwent a swab were swabbed on or 24 hours prior to admission. There were 4,254 patients and an overall 30-day mortal","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Surgical outcomes; Winter pressures; Ambulatory Surgical Procedures; COVID-19; COVID-19 Testing; Elective Surgical Procedures; Emergency Service, Hospital; Emergency Treatment; England; Female; Hospital Mortality; Humans; Incidence; Infection Control; Length of Stay; Male; Pandemics; Patient Admission; Retrospective Studies; SARS-CoV-2; State Medicine","Loeffler","M","East Suffolk and North Essex NHS Foundation Trust, UK",NA
"1584","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Mamidanna","R","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1585","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Askari","A","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1586","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Patel","K","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1587","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Adil","M T","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1588","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Jain","V","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1589","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Jambulingam","P","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1590","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Whitelaw","D","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1591","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Rashid","F","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1592","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Munasinghe","A","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1593","34192498","10.1308/rcsann.2021.0053","Safety and feasibility of resuming bariatric surgery under the cloud of COVID-19.","Because of the COVID-19 pandemic, numerous bariatric surgical units globally have halted weight loss surgery. Obesity itself has been shown to be a predictor of poor outcome in people infected with the virus. The aim of this study was to report our experience as a high-volume bariatric institution resuming elective weight loss surgery safely amidst emergency admissions of COVID-19-positive patients. A standard operating procedure based on national guidance and altered to accommodate local consid","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Bariatric; Bypass; Metabolic; Obesity; Pandemic; Surgery; Adult; Bariatric Surgery; COVID-19; COVID-19 Testing; Clinical Protocols; Communicable Disease Control; Elective Surgical Procedures; Enhanced Recovery After Surgery; Feasibility Studies; Female; Humans; Length of Stay; Male; Middle Aged; Obesity, Morbid; Pandemics; Patient Readmission; Postoperative Complications; Prospective Studies; Retrospective Studies; Risk Assessment; SARS-CoV-2; Surgery Department, Hospital","Al-Taan","O","Bedfordshire Hospitals NHS Foundation Trust, UK",NA
"1594","34192487","10.1308/rcsann.2021.0042","Adapting an emergency general surgery service in response to the COVID-19 pandemic.","In response to the COVID-19 pandemic, our emergency general surgery (EGS) service underwent significant restructuring, including establishing an enhanced ambulatory service and undertaking nonoperative management of selected pathologies. The aim of this study was to compare the activity of our EGS service before and after these changes. Patients referred by the emergency department were identified prospectively over a 4-week period beginning from the date our EGS service was reconfigured (COVID)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Ambulatory care; COVID-19; Emergency health services; General surgery; Healthcare reform; Adult; Aged; Ambulatory Surgical Procedures; COVID-19; Conservative Treatment; Emergency Service, Hospital; Emergency Treatment; Female; Follow-Up Studies; General Surgery; Hospital Mortality; Humans; Infection Control; Male; Middle Aged; Pandemics; Patient Readmission; Patient Safety; Prospective Studies; Referral and Consultation; Retrospective Studies; SARS-CoV-2; Surgery Department, Hospital","Hickland","P","Craigavon Area Hospital, UK",NA
"1595","34192487","10.1308/rcsann.2021.0042","Adapting an emergency general surgery service in response to the COVID-19 pandemic.","In response to the COVID-19 pandemic, our emergency general surgery (EGS) service underwent significant restructuring, including establishing an enhanced ambulatory service and undertaking nonoperative management of selected pathologies. The aim of this study was to compare the activity of our EGS service before and after these changes. Patients referred by the emergency department were identified prospectively over a 4-week period beginning from the date our EGS service was reconfigured (COVID)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Ambulatory care; COVID-19; Emergency health services; General surgery; Healthcare reform; Adult; Aged; Ambulatory Surgical Procedures; COVID-19; Conservative Treatment; Emergency Service, Hospital; Emergency Treatment; Female; Follow-Up Studies; General Surgery; Hospital Mortality; Humans; Infection Control; Male; Middle Aged; Pandemics; Patient Readmission; Patient Safety; Prospective Studies; Referral and Consultation; Retrospective Studies; SARS-CoV-2; Surgery Department, Hospital","Clements","J M","Craigavon Area Hospital, UK",NA
"1596","34192487","10.1308/rcsann.2021.0042","Adapting an emergency general surgery service in response to the COVID-19 pandemic.","In response to the COVID-19 pandemic, our emergency general surgery (EGS) service underwent significant restructuring, including establishing an enhanced ambulatory service and undertaking nonoperative management of selected pathologies. The aim of this study was to compare the activity of our EGS service before and after these changes. Patients referred by the emergency department were identified prospectively over a 4-week period beginning from the date our EGS service was reconfigured (COVID)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Ambulatory care; COVID-19; Emergency health services; General surgery; Healthcare reform; Adult; Aged; Ambulatory Surgical Procedures; COVID-19; Conservative Treatment; Emergency Service, Hospital; Emergency Treatment; Female; Follow-Up Studies; General Surgery; Hospital Mortality; Humans; Infection Control; Male; Middle Aged; Pandemics; Patient Readmission; Patient Safety; Prospective Studies; Referral and Consultation; Retrospective Studies; SARS-CoV-2; Surgery Department, Hospital","Convie","L J","Craigavon Area Hospital, UK",NA
"1597","34192487","10.1308/rcsann.2021.0042","Adapting an emergency general surgery service in response to the COVID-19 pandemic.","In response to the COVID-19 pandemic, our emergency general surgery (EGS) service underwent significant restructuring, including establishing an enhanced ambulatory service and undertaking nonoperative management of selected pathologies. The aim of this study was to compare the activity of our EGS service before and after these changes. Patients referred by the emergency department were identified prospectively over a 4-week period beginning from the date our EGS service was reconfigured (COVID)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Ambulatory care; COVID-19; Emergency health services; General surgery; Healthcare reform; Adult; Aged; Ambulatory Surgical Procedures; COVID-19; Conservative Treatment; Emergency Service, Hospital; Emergency Treatment; Female; Follow-Up Studies; General Surgery; Hospital Mortality; Humans; Infection Control; Male; Middle Aged; Pandemics; Patient Readmission; Patient Safety; Prospective Studies; Referral and Consultation; Retrospective Studies; SARS-CoV-2; Surgery Department, Hospital","McKay","D","Craigavon Area Hospital, UK",NA
"1598","34192487","10.1308/rcsann.2021.0042","Adapting an emergency general surgery service in response to the COVID-19 pandemic.","In response to the COVID-19 pandemic, our emergency general surgery (EGS) service underwent significant restructuring, including establishing an enhanced ambulatory service and undertaking nonoperative management of selected pathologies. The aim of this study was to compare the activity of our EGS service before and after these changes. Patients referred by the emergency department were identified prospectively over a 4-week period beginning from the date our EGS service was reconfigured (COVID)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Ambulatory care; COVID-19; Emergency health services; General surgery; Healthcare reform; Adult; Aged; Ambulatory Surgical Procedures; COVID-19; Conservative Treatment; Emergency Service, Hospital; Emergency Treatment; Female; Follow-Up Studies; General Surgery; Hospital Mortality; Humans; Infection Control; Male; Middle Aged; Pandemics; Patient Readmission; Patient Safety; Prospective Studies; Referral and Consultation; Retrospective Studies; SARS-CoV-2; Surgery Department, Hospital","McElvanna","K","Craigavon Area Hospital, UK",NA
"1599","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Brown","C","Prince Charles Hospital, UK",NA
"1600","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Waterman","J","Prince Charles Hospital, UK",NA
"1601","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","El Hitti","E","Princess of Wales Hospital, UK",NA
"1602","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Luton","O","Royal Glamorgan Hospital, UK",NA
"1603","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Joseph","A","Prince Charles Hospital, UK",NA
"1604","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Pollitt","M J","Prince Charles Hospital, UK",NA
"1605","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Thippeswamy","K","Prince Charles Hospital, UK",NA
"1606","34192486","10.1308/rcsann.2021.0089","Appendicitis in the COVID-19 era: a modern challenge for experienced hands.","The first wave of COVID-19 was accompanied by global uncertainty. Delayed presentation of patients to hospitals ensued, with surgical pathologies no exception. This study aimed to assess whether delayed presentations resulted in more complex appendicectomies during the first wave of COVID-19. Operation notes for all presentations of appendicitis (n=216) within a single health board (three hospitals) during two three-month periods (control period (pre-COVID) vs COVID pandemic) were analysed, and ","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","Appendicitis; Emergency; Gastrointestinal; General surgery; Adolescent; Adult; Appendectomy; Appendicitis; Appendix; COVID-19; COVID-19 Testing; Humans; Infection Control; Length of Stay; Lymphocyte Count; Male; Middle Aged; Pandemics; Postoperative Complications; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Time-to-Treatment; Tomography, X-Ray Computed; Young Adult","Robinson","Dbt","Prince Charles Hospital, UK",NA
"1607","34192485","10.1308/rcsann.2021.0100","The effect of the COVID-19 pandemic on non-elective otolaryngology admissions and a positive change in clinical practice.","As the COVID-19 pandemic progressed across the UK and Northern Ireland in March 2020, our otolaryngology department began to make preparations and changes in practice to accommodate for potentially large numbers of patients with COVID-19 related respiratory illness in the hospital. We retrospectively reviewed the number of non-elective admissions to our department between the months of January and May in 2019 and 2020. A significant reduction in admissions of up to 94% during the months of the p","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Non-elective admissions; Otolaryngology; Sars-CoV-2; Ambulatory Surgical Procedures; COVID-19; Epistaxis; Humans; Infection Control; Northern Ireland; Otorhinolaryngologic Surgical Procedures; Pandemics; Patient Admission; Peritonsillar Abscess; Retrospective Studies; Surgery Department, Hospital","Wright","B","Craigavon Area Hospital, UK",NA
"1608","34192485","10.1308/rcsann.2021.0100","The effect of the COVID-19 pandemic on non-elective otolaryngology admissions and a positive change in clinical practice.","As the COVID-19 pandemic progressed across the UK and Northern Ireland in March 2020, our otolaryngology department began to make preparations and changes in practice to accommodate for potentially large numbers of patients with COVID-19 related respiratory illness in the hospital. We retrospectively reviewed the number of non-elective admissions to our department between the months of January and May in 2019 and 2020. A significant reduction in admissions of up to 94% during the months of the p","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Non-elective admissions; Otolaryngology; Sars-CoV-2; Ambulatory Surgical Procedures; COVID-19; Epistaxis; Humans; Infection Control; Northern Ireland; Otorhinolaryngologic Surgical Procedures; Pandemics; Patient Admission; Peritonsillar Abscess; Retrospective Studies; Surgery Department, Hospital","McKenna","C","Craigavon Area Hospital, UK",NA
"1609","34192485","10.1308/rcsann.2021.0100","The effect of the COVID-19 pandemic on non-elective otolaryngology admissions and a positive change in clinical practice.","As the COVID-19 pandemic progressed across the UK and Northern Ireland in March 2020, our otolaryngology department began to make preparations and changes in practice to accommodate for potentially large numbers of patients with COVID-19 related respiratory illness in the hospital. We retrospectively reviewed the number of non-elective admissions to our department between the months of January and May in 2019 and 2020. A significant reduction in admissions of up to 94% during the months of the p","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Non-elective admissions; Otolaryngology; Sars-CoV-2; Ambulatory Surgical Procedures; COVID-19; Epistaxis; Humans; Infection Control; Northern Ireland; Otorhinolaryngologic Surgical Procedures; Pandemics; Patient Admission; Peritonsillar Abscess; Retrospective Studies; Surgery Department, Hospital","Reddy","Cee","Craigavon Area Hospital, UK",NA
"1610","34192482","10.1308/rcsann.2020.7070","The Colorectal Telephone Clinic: a new normal post-COVID-19?","In light of the COVID-19 recommendations from the Association of Coloproctology of Great Britain and Ireland, we aimed to study patient and clinician satisfaction with a newly established telephone (TP) colorectal clinic service in lieu of traditional face-to-face (FTF) appointments. Comparative outcomes included patient versus clinician satisfaction; patient versus clinician desire to continue TP clinics postpandemic; and views of Specialty Trainee 3+ (ST3+)/Specialty Associate Specialist (SAS)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Colorectal surgery; Outpatients; SARS-CoV-2; Telephone; Aftercare; COVID-19; Colorectal Neoplasms; Humans; Infection Control; Job Satisfaction; Medical Oncology; Patient Satisfaction; Prospective Studies; Remote Consultation; Surgeons; Surveys and Questionnaires; Telephone; United Kingdom","Sagar","A","Milton Keynes University Hospital, UK",NA
"1611","34192482","10.1308/rcsann.2020.7070","The Colorectal Telephone Clinic: a new normal post-COVID-19?","In light of the COVID-19 recommendations from the Association of Coloproctology of Great Britain and Ireland, we aimed to study patient and clinician satisfaction with a newly established telephone (TP) colorectal clinic service in lieu of traditional face-to-face (FTF) appointments. Comparative outcomes included patient versus clinician satisfaction; patient versus clinician desire to continue TP clinics postpandemic; and views of Specialty Trainee 3+ (ST3+)/Specialty Associate Specialist (SAS)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Colorectal surgery; Outpatients; SARS-CoV-2; Telephone; Aftercare; COVID-19; Colorectal Neoplasms; Humans; Infection Control; Job Satisfaction; Medical Oncology; Patient Satisfaction; Prospective Studies; Remote Consultation; Surgeons; Surveys and Questionnaires; Telephone; United Kingdom","Mai","Dvc","Milton Keynes University Hospital, UK",NA
"1612","34192482","10.1308/rcsann.2020.7070","The Colorectal Telephone Clinic: a new normal post-COVID-19?","In light of the COVID-19 recommendations from the Association of Coloproctology of Great Britain and Ireland, we aimed to study patient and clinician satisfaction with a newly established telephone (TP) colorectal clinic service in lieu of traditional face-to-face (FTF) appointments. Comparative outcomes included patient versus clinician satisfaction; patient versus clinician desire to continue TP clinics postpandemic; and views of Specialty Trainee 3+ (ST3+)/Specialty Associate Specialist (SAS)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Colorectal surgery; Outpatients; SARS-CoV-2; Telephone; Aftercare; COVID-19; Colorectal Neoplasms; Humans; Infection Control; Job Satisfaction; Medical Oncology; Patient Satisfaction; Prospective Studies; Remote Consultation; Surgeons; Surveys and Questionnaires; Telephone; United Kingdom","Rumy","N","Milton Keynes University Hospital, UK",NA
"1613","34192482","10.1308/rcsann.2020.7070","The Colorectal Telephone Clinic: a new normal post-COVID-19?","In light of the COVID-19 recommendations from the Association of Coloproctology of Great Britain and Ireland, we aimed to study patient and clinician satisfaction with a newly established telephone (TP) colorectal clinic service in lieu of traditional face-to-face (FTF) appointments. Comparative outcomes included patient versus clinician satisfaction; patient versus clinician desire to continue TP clinics postpandemic; and views of Specialty Trainee 3+ (ST3+)/Specialty Associate Specialist (SAS)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Colorectal surgery; Outpatients; SARS-CoV-2; Telephone; Aftercare; COVID-19; Colorectal Neoplasms; Humans; Infection Control; Job Satisfaction; Medical Oncology; Patient Satisfaction; Prospective Studies; Remote Consultation; Surgeons; Surveys and Questionnaires; Telephone; United Kingdom","Al-Habsi","R","Milton Keynes University Hospital, UK",NA
"1614","34192482","10.1308/rcsann.2020.7070","The Colorectal Telephone Clinic: a new normal post-COVID-19?","In light of the COVID-19 recommendations from the Association of Coloproctology of Great Britain and Ireland, we aimed to study patient and clinician satisfaction with a newly established telephone (TP) colorectal clinic service in lieu of traditional face-to-face (FTF) appointments. Comparative outcomes included patient versus clinician satisfaction; patient versus clinician desire to continue TP clinics postpandemic; and views of Specialty Trainee 3+ (ST3+)/Specialty Associate Specialist (SAS)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Colorectal surgery; Outpatients; SARS-CoV-2; Telephone; Aftercare; COVID-19; Colorectal Neoplasms; Humans; Infection Control; Job Satisfaction; Medical Oncology; Patient Satisfaction; Prospective Studies; Remote Consultation; Surgeons; Surveys and Questionnaires; Telephone; United Kingdom","Divya","G S","Milton Keynes University Hospital, UK",NA
"1615","34192482","10.1308/rcsann.2020.7070","The Colorectal Telephone Clinic: a new normal post-COVID-19?","In light of the COVID-19 recommendations from the Association of Coloproctology of Great Britain and Ireland, we aimed to study patient and clinician satisfaction with a newly established telephone (TP) colorectal clinic service in lieu of traditional face-to-face (FTF) appointments. Comparative outcomes included patient versus clinician satisfaction; patient versus clinician desire to continue TP clinics postpandemic; and views of Specialty Trainee 3+ (ST3+)/Specialty Associate Specialist (SAS)","2021","07","05","Ann R Coll Surg Engl","Annals of the Royal College of Surgeons of England","COVID-19; Colorectal surgery; Outpatients; SARS-CoV-2; Telephone; Aftercare; COVID-19; Colorectal Neoplasms; Humans; Infection Control; Job Satisfaction; Medical Oncology; Patient Satisfaction; Prospective Studies; Remote Consultation; Surgeons; Surveys and Questionnaires; Telephone; United Kingdom","Singh","A","Milton Keynes University Hospital, UK",NA
"1616","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Chapman","Justin J","QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"1617","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Malacova","Eva","QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"1618","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Patterson","Sue","Metro North Mental Health Service, Brisbane, Queensland, Australia",NA
"1619","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Reavley","Nicola","University of Melbourne, Victoria, Australia",NA
"1620","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Wyder","Marianne","Metro South Addiction and Mental Health Service, Brisbane, Queensland, Australia",NA
"1621","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Brown","Wendy J","School of Human Movement and Nutrition Sciences, The University of Queensland, Brisbane, Queensland, Australia",NA
"1622","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Hielscher","Emily","QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"1623","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Childs","Sarah","Queensland Alliance for Mental health, Queensland, Australia",NA
"1624","34192474","10.1177/10398562211025040","Psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the COVID-19 pandemic.","People with mental illness may be vulnerable to psychological distress and reduced well-being during the COVID-19 pandemic. The aim of this study was to assess psychosocial and lifestyle predictors of distress and well-being in people with mental illness during the pandemic. People with mental illness who participated in an exercise programme prior to the pandemic were invited to complete surveys about mental health and lifestyle corresponding to before and during the pandemic. Social support re","2021","06","30","Australas Psychiatry","Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists","Social determinants; lifestyle behaviours; mental health; pandemic","Scott","James G","QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia",NA
"1625","34192471","10.1259/bjr.20201265","Low radiation dose to treat pneumonia and other inflammations.","Infection, the invasion of pathogenic microorganisms and viruses, causes reactive inflammation mediated by endogenous signals, with influx of leucocytes with distinct properties and capable of mounting a cellular or antibody response. Different forms of inflammation may also occur in response to tumours, in allergy and autoimmune disorders. Pneumonia, respiratory tract infection and septic shock for instance can arise as serious complications of the Covid-19 virus. While radiotherapy has been mo","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Chew","Ming Tsuey","Centre for Applied Physics and Radiation Technologies, School of Engineering and Technology, Sunway University, Selangor, Malaysia",NA
"1626","34192471","10.1259/bjr.20201265","Low radiation dose to treat pneumonia and other inflammations.","Infection, the invasion of pathogenic microorganisms and viruses, causes reactive inflammation mediated by endogenous signals, with influx of leucocytes with distinct properties and capable of mounting a cellular or antibody response. Different forms of inflammation may also occur in response to tumours, in allergy and autoimmune disorders. Pneumonia, respiratory tract infection and septic shock for instance can arise as serious complications of the Covid-19 virus. While radiotherapy has been mo","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Daar","Eman","Department of Physics, The University of Jordan, Amman, Jordan",NA
"1627","34192471","10.1259/bjr.20201265","Low radiation dose to treat pneumonia and other inflammations.","Infection, the invasion of pathogenic microorganisms and viruses, causes reactive inflammation mediated by endogenous signals, with influx of leucocytes with distinct properties and capable of mounting a cellular or antibody response. Different forms of inflammation may also occur in response to tumours, in allergy and autoimmune disorders. Pneumonia, respiratory tract infection and septic shock for instance can arise as serious complications of the Covid-19 virus. While radiotherapy has been mo","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Khandaker","Mayeen Uddin","Centre for Applied Physics and Radiation Technologies, School of Engineering and Technology, Sunway University, Selangor, Malaysia",NA
"1628","34192471","10.1259/bjr.20201265","Low radiation dose to treat pneumonia and other inflammations.","Infection, the invasion of pathogenic microorganisms and viruses, causes reactive inflammation mediated by endogenous signals, with influx of leucocytes with distinct properties and capable of mounting a cellular or antibody response. Different forms of inflammation may also occur in response to tumours, in allergy and autoimmune disorders. Pneumonia, respiratory tract infection and septic shock for instance can arise as serious complications of the Covid-19 virus. While radiotherapy has been mo","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Jones","Bleddyn","Gray Laboratory, CRUK/MRC Oxford Centre, Old Road Campus Research Building, Roosevelt Drive, University of Oxford, Oxford, UK",NA
"1629","34192471","10.1259/bjr.20201265","Low radiation dose to treat pneumonia and other inflammations.","Infection, the invasion of pathogenic microorganisms and viruses, causes reactive inflammation mediated by endogenous signals, with influx of leucocytes with distinct properties and capable of mounting a cellular or antibody response. Different forms of inflammation may also occur in response to tumours, in allergy and autoimmune disorders. Pneumonia, respiratory tract infection and septic shock for instance can arise as serious complications of the Covid-19 virus. While radiotherapy has been mo","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Nisbet","Andrew","Department of Medical Physics and Biomedical Engineering, University College London, Malet Place Engineering Building, London, UK",NA
"1630","34192471","10.1259/bjr.20201265","Low radiation dose to treat pneumonia and other inflammations.","Infection, the invasion of pathogenic microorganisms and viruses, causes reactive inflammation mediated by endogenous signals, with influx of leucocytes with distinct properties and capable of mounting a cellular or antibody response. Different forms of inflammation may also occur in response to tumours, in allergy and autoimmune disorders. Pneumonia, respiratory tract infection and septic shock for instance can arise as serious complications of the Covid-19 virus. While radiotherapy has been mo","2021","07","21","Br J Radiol","The British journal of radiology",NA,"Bradley","David A","Centre for Applied Physics and Radiation Technologies, School of Engineering and Technology, Sunway University, Selangor, Malaysia",NA
"1631","34192469","10.1080/14787210.2021.1949984","The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review.","Objective: We systematically reviewed the evidence of published original research to determine the role of remdesivir in the management of COVID-19 patients with a moderate-to-severe course of illness. Methods: A systematic search of articles was conducted in scientific databases, with the last update in May 2021. This paper systematically reviewed the clinical evidence available (randomized controlled trials, compassionate use studies, and case reports) on the use of remdesivir fo","2021","06","30","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Adverse events; SARS-CoV-2; critically ill; evidence-based medicine; remdesivir","Thiruchelvam","Kaeshaelya","The University of Newcastle, Callaghan, 2308 Australia",NA
"1632","34192469","10.1080/14787210.2021.1949984","The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review.","Objective: We systematically reviewed the evidence of published original research to determine the role of remdesivir in the management of COVID-19 patients with a moderate-to-severe course of illness. Methods: A systematic search of articles was conducted in scientific databases, with the last update in May 2021. This paper systematically reviewed the clinical evidence available (randomized controlled trials, compassionate use studies, and case reports) on the use of remdesivir fo","2021","06","30","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Adverse events; SARS-CoV-2; critically ill; evidence-based medicine; remdesivir","Kow","Chia Siang","International Medical University School of Medicine, Kuala Lumpur, 57000 Malaysia",NA
"1633","34192469","10.1080/14787210.2021.1949984","The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review.","Objective: We systematically reviewed the evidence of published original research to determine the role of remdesivir in the management of COVID-19 patients with a moderate-to-severe course of illness. Methods: A systematic search of articles was conducted in scientific databases, with the last update in May 2021. This paper systematically reviewed the clinical evidence available (randomized controlled trials, compassionate use studies, and case reports) on the use of remdesivir fo","2021","06","30","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Adverse events; SARS-CoV-2; critically ill; evidence-based medicine; remdesivir","Hadi","Muhammad","University of Birmingham, Birmingham, B15 2TT United Kingdom of Great Britain and Northern Ireland",NA
"1634","34192469","10.1080/14787210.2021.1949984","The use of remdesivir for the management of patients with moderate-to-severe COVID-19: A systematic review.","Objective: We systematically reviewed the evidence of published original research to determine the role of remdesivir in the management of COVID-19 patients with a moderate-to-severe course of illness. Methods: A systematic search of articles was conducted in scientific databases, with the last update in May 2021. This paper systematically reviewed the clinical evidence available (randomized controlled trials, compassionate use studies, and case reports) on the use of remdesivir fo","2021","06","30","Expert Rev Anti Infect Ther","Expert review of anti-infective therapy","Adverse events; SARS-CoV-2; critically ill; evidence-based medicine; remdesivir","Hasan","Syed Shahzad","University of Huddersfield, Huddersfield, HD1 3DH United Kingdom of Great Britain and Northern Ireland",NA
"1635","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Köksaldi","Ilkay Çisil","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1636","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Köse","Sila","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1637","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Ahan","Recep Erdem","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1638","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Haciosmanoglu","Nedim","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1639","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Sahin Kehribar","Ebru","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1640","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Güngen","Murat Alp","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1641","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Bastug","Aliye","Department of Infectious Diseases and Clinical Microbiology, Health Science University Turkey, Ankara City Hospital, 06800 Ankara, Turkey",NA
"1642","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Dinç","Bedia","Department of Infectious Diseases and Clinical Microbiology, Health Science University Turkey, Ankara City Hospital, 06800 Ankara, Turkey",NA
"1643","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Bodur","Hürrem","Department of Infectious Diseases and Clinical Microbiology, Health Science University Turkey, Ankara City Hospital, 06800 Ankara, Turkey",NA
"1644","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Özkul","Aykut","Faculty of Veterinary Medicine, Department of Virology, Ankara University, 06110 Ankara, Turkey",NA
"1645","34192453","10.1021/acs.analchem.1c00886","SARS-CoV-2 Detection with De Novo-Designed Synthetic Riboregulators.","SARS-CoV-2 is a human pathogen and the main cause of COVID-19 disease, announced as a global pandemic by the World Health Organization. COVID-19 is characterized by severe conditions, and early diagnosis can make dramatic changes for both personal and public health. Low-cost, easy-to-use diagnostic capabilities can have a very critical role in controlling the transmission of the disease. Here, we are reporting a state-of-the-art diagnostic tool developed with an in vitro synthetic biology approa","2021","07","23","Anal Chem","Analytical chemistry","COVID-19; Humans; Pandemics; Point-of-Care Systems; SARS-CoV-2","Seker","Urartu Özgür Safak","UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey",NA
"1646","34192438","10.1056/NEJMe2110939","Audio Interview: Another New Covid-19 Vaccine.",NA,"2021","07","02","N Engl J Med","The New England journal of medicine","Asymptomatic Diseases; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disaster Planning; Global Health; Humans; Immunogenicity, Vaccine; Observational Studies as Topic; Placebos; Public Health Surveillance; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Viral Load; Virus Replication","Rubin","Eric J",NA,NA
"1647","34192438","10.1056/NEJMe2110939","Audio Interview: Another New Covid-19 Vaccine.",NA,"2021","07","02","N Engl J Med","The New England journal of medicine","Asymptomatic Diseases; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disaster Planning; Global Health; Humans; Immunogenicity, Vaccine; Observational Studies as Topic; Placebos; Public Health Surveillance; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Viral Load; Virus Replication","Baden","Lindsey R",NA,NA
"1648","34192438","10.1056/NEJMe2110939","Audio Interview: Another New Covid-19 Vaccine.",NA,"2021","07","02","N Engl J Med","The New England journal of medicine","Asymptomatic Diseases; COVID-19; COVID-19 Vaccines; Communicable Disease Control; Disaster Planning; Global Health; Humans; Immunogenicity, Vaccine; Observational Studies as Topic; Placebos; Public Health Surveillance; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Viral Load; Virus Replication","Morrissey","Stephen",NA,NA
"1649","34192432","10.1056/NEJMra2106545","Cerebral Venous Thrombosis.",NA,"2021","07","13","N Engl J Med","The New England journal of medicine","Anticoagulants; Brain; COVID-19 Vaccines; Endovascular Procedures; Heparin; Humans; Intracranial Thrombosis; Magnetic Resonance Angiography; Practice Guidelines as Topic; Prognosis; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed","Ropper","Allan H","From the Department of Neurology, Brigham and Women's Hospital, Boston",NA
"1650","34192432","10.1056/NEJMra2106545","Cerebral Venous Thrombosis.",NA,"2021","07","13","N Engl J Med","The New England journal of medicine","Anticoagulants; Brain; COVID-19 Vaccines; Endovascular Procedures; Heparin; Humans; Intracranial Thrombosis; Magnetic Resonance Angiography; Practice Guidelines as Topic; Prognosis; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed","Klein","Joshua P","From the Department of Neurology, Brigham and Women's Hospital, Boston",NA
"1651","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Thompson","Mark G","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1652","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Burgess","Jefferey L","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1653","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Naleway","Allison L","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1654","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Tyner","Harmony","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1655","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Yoon","Sarang K","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1656","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Meece","Jennifer","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1657","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Olsho","Lauren E W","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1658","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Caban-Martinez","Alberto J","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1659","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Fowlkes","Ashley L","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1660","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Lutrick","Karen","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1661","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Groom","Holly C","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1662","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Dunnigan","Kayan","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1663","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Odean","Marilyn J","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1664","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Hegmann","Kurt","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1665","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Stefanski","Elisha","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1666","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Edwards","Laura J","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1667","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Schaefer-Solle","Natasha","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1668","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Grant","Lauren","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1669","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Ellingson","Katherine","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1670","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Kuntz","Jennifer L","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1671","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Zunie","Tnelda","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1672","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Thiese","Matthew S","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1673","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Ivacic","Lynn","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1674","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Wesley","Meredith G","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1675","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Mayo Lamberte","Julie","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1676","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Sun","Xiaoxiao","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1677","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Smith","Michael E","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1678","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Phillips","Andrew L","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1679","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Groover","Kimberly D","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1680","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Yoo","Young M","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1681","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Gerald","Joseph","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1682","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Brown","Rachel T","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1683","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Herring","Meghan K","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1684","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Joseph","Gregory","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1685","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Beitel","Shawn","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1686","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Morrill","Tyler C","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1687","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Mak","Josephine","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1688","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Rivers","Patrick","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1689","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Poe","Brandon P","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1690","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Lynch","Brian","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1691","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Zhou","Yingtao","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1692","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Zhang","Jing","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1693","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Kelleher","Anna","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1694","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Li","Yan","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1695","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Dickerson","Monica","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1696","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Hanson","Erika","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1697","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Guenther","Kyley","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1698","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Tong","Suxiang","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1699","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Bateman","Allen","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1700","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Reisdorf","Erik","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1701","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Barnes","John","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1702","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Azziz-Baumgartner","Eduardo","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1703","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Hunt","Danielle R","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1704","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Arvay","Melissa L","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1705","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Kutty","Preeta","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1706","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Fry","Alicia M","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1707","34192428","10.1056/NEJMoa2107058","Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.","Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. We conducted a prospective cohort study involving 3975 health care personnel, first responders, and other essential and frontline workers. From December 14, 2020, ","2021","07","22","N Engl J Med","The New England journal of medicine",NA,"Gaglani","Manjusha","From the Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta (M.G.T., A.L.F., L.G., J.M.L., Y.M.Y., G.J., J. Mak, B.L., Y.Z., J.Z., A.K., Y.L., M.D., S.T., J.B., E.A.-B., M.L.A., P.K., A.M.F.)",NA
"1708","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Heath","Paul T","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1709","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Galiza","Eva P","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1710","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Baxter","David N","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1711","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Boffito","Marta","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1712","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Browne","Duncan","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1713","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Burns","Fiona","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1714","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Chadwick","David R","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1715","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Clark","Rebecca","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1716","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Cosgrove","Catherine","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1717","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Galloway","James","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1718","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Goodman","Anna L","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1719","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Heer","Amardeep","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1720","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Higham","Andrew","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1721","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Iyengar","Shalini","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1722","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Jamal","Arham","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1723","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Jeanes","Christopher","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1724","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Kalra","Philip A","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1725","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Kyriakidou","Christina","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1726","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"McAuley","Daniel F","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1727","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Meyrick","Agnieszka","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1728","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Minassian","Angela M","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1729","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Minton","Jane","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1730","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Moore","Patrick","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1731","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Munsoor","Imrozia","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1732","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Nicholls","Helen","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1733","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Osanlou","Orod","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1734","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Packham","Jonathan","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1735","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Pretswell","Carol H","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1736","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"San Francisco Ramos","Alberto","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1737","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Saralaya","Dinesh","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1738","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Sheridan","Ray P","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1739","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Smith","Richard","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1740","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Soiza","Roy L","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1741","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Swift","Pauline A","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1742","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Thomson","Emma C","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1743","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Turner","Jeremy","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1744","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Viljoen","Marianne E","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1745","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Albert","Gary","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1746","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Cho","Iksung","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1747","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Dubovsky","Filip","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1748","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Glenn","Greg","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1749","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Rivers","Joy","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1750","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Robertson","Andreana","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1751","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Smith","Kathy","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1752","34192426","10.1056/NEJMoa2107659","Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.","Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototype strain plus Matrix-M adjuvant, showed that the vaccine was safe and associated with a robust immune response in healthy adult participants. Additional data were needed regarding the efficacy, immunogenicity, and safety of this vaccine in a larger population. ","2021","07","10","N Engl J Med","The New England journal of medicine",NA,"Toback","Seth","From the Vaccine Institute, St. George's, University of London, and St. George's University Hospitals NHS Foundation Trust (P.T.H., E.P.G., C.C., A.S.F.R.), Chelsea, Westminster Hospital NHS Foundation Trust and Imperial College London (M.B.), the Institute for Global Health, University College London, and Royal Free London NHS Foundation Trust (F.B.), the Centre for Rheumatic Disease, Kings College London (J.G.), the Department of Infectious Diseases, Guy's and St. Thomas' NHS Foundation Trust, MRC Clinical Trials Unit at University College London (A.L.G.), and Renal Services, Epsom and St. Helier University Hospitals NHS Trust (P.A.S.), London, Stockport NHS Foundation Trust, Stepping Hill Hospital, Stockport (D.N.B.), Royal Cornwall Hospitals NHS Trust, Truro (D.B.), Centre for Clinical Infection, South Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough (D.R.C.), Layton Medical Centre, Blackpool (R.C.), Lakeside Healthcare Research, Lakeside Surgeries, Corby (A. Heer), University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal (A. Higham), Accelerated Enrollment Solutions, Synexus Hexham Dedicated Research Site, Hexham General Hospital, Hexham (S.I.), Accelerated Enrollment Solutions, Synexus Thames Valley Dedicated Research Site, Reading (A.J.), Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich (C.J., J.T.), Salford Royal NHS Foundation Trust, Northern Care Alliance, Salford (P.A.K.), Accelerated Enrollment Solutions, Synexus Midlands Dedicated Research Site, Birmingham (C.K.), Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast and Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast (D.F.M.), Accelerated Enrollment Solutions, Synexus Merseyside Dedicated Research Site, Liverpool (A.M.), Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford (A.M.M.), St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds (J.M.), the Adam Practice, Poole (P.M.), University Hospital Southampton NHS Foundation Trust, Southampton (P.M.), Accelerated Enrollment Solutions, Synexus Glasgow Dedicated Research Site (I.M.), and MRC-University of Glasgow Centre for Virus Research and Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde (E.C.T.), Glasgow, Accelerated Enrollment Solutions, Synexus Wales Dedicated Research Site, Cardiff (H.N.), the School of Medical Sciences, Bangor University, and Betsi Cadwaladr University Health Board, Bangor (O.O.), the Division of Epidemiology and Public Health, University of Nottingham, Nottingham (J.P.), Haywood Hospital, Midlands Partnership NHS Foundation Trust, Stafford (J.P.), Accelerated Enrollment Solutions, Synexus Lancashire Dedicated Research Site, Chorley (C.H.P.), the National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust, Bradford (D.S.), Royal Devon and Exeter Hospital, Exeter (R.P.S.), East Suffolk, North Essex NHS Foundation Trust and University of Essex, Colchester (R.S.), Aberdeen Royal Infirmary, NHS Grampian, and Aging Clinical and Experimental Research Group, University of Aberdeen, Aberdeen (R.L.S.), and Accelerated Enrollment Solutions, Synexus Manchester Dedicated Research Site, Manchester (M.E.V.) - all in the United Kingdom",NA
"1753","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Nie","Lirong","Department of Hematology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China",NA
"1754","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Liu","Yan","Department of Transfusion Medicine, General Hospital of Central Theater Command of the PLA, Wuhan, China",NA
"1755","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Weng","Yijie","Department of Gastroenterology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China",NA
"1756","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Zheng","Yaqiong","Department of Transfusion Medicine, General Hospital of Central Theater Command of the PLA, Wuhan, China",NA
"1757","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Cai","Liping","Department of Transfusion Medicine, General Hospital of Central Theater Command of the PLA, Wuhan, China",NA
"1758","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Kou","Guomei","Department of Transfusion Medicine, General Hospital of Central Theater Command of the PLA, Wuhan, China",NA
"1759","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Xiong","Zhou","Department of Transfusion Medicine, General Hospital of Central Theater Command of the PLA, Wuhan, China",NA
"1760","34192413","10.1111/ijlh.13640","Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.","We aimed to identify the associations between the lymphocytes (LYM) absolute count on admission and clinical outcomes in COVID-19 patients. In this retrospective study, 224 COVID-19 patients who were admitted to General Hospital of Central Theater Command of the PLA from January 22 to April 4, 2020, were consecutively included. These patients were divided into the lymphopenia group and the nonlymphopenia group according to whether the LYM count on admission was below the normal range. During hos","2021","06","30","Int J Lab Hematol","International journal of laboratory hematology","COVID-19; clinical outcomes; lymphocytes","Liu","Lei","Department of Transfusion Medicine, General Hospital of Central Theater Command of the PLA, Wuhan, China",NA
"1761","34192408","10.1111/ajag.12976","Hospitalisation for lower respiratory viral infections in older people in residential aged care facilities.","To quantify incidence, trends and outcomes associated with lower respiratory viral infection (LRVI) hospitalisations in Australian residential aged care facilities (RACFs). A population-based cohort study of residents in RACFs aged =65 years from New South Wales (NSW), South Australia (SA) and Victoria (VIC) using data from the Registry of Senior Australians (2013-2016) was conducted. Age- and sex-standardised monthly and yearly LRVI hospitalisation incidences were calculated, and time trends an","2021","06","30","Australas J Ageing","Australasian journal on ageing","Respiratory Tract Infections I respiratory viral infection; health services for the aged; hospitalization; mortality","Caughey","Gillian E","Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, SA, Australia",NA
"1762","34192408","10.1111/ajag.12976","Hospitalisation for lower respiratory viral infections in older people in residential aged care facilities.","To quantify incidence, trends and outcomes associated with lower respiratory viral infection (LRVI) hospitalisations in Australian residential aged care facilities (RACFs). A population-based cohort study of residents in RACFs aged =65 years from New South Wales (NSW), South Australia (SA) and Victoria (VIC) using data from the Registry of Senior Australians (2013-2016) was conducted. Age- and sex-standardised monthly and yearly LRVI hospitalisation incidences were calculated, and time trends an","2021","06","30","Australas J Ageing","Australasian journal on ageing","Respiratory Tract Infections I respiratory viral infection; health services for the aged; hospitalization; mortality","Jorissen","Robert N","Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, SA, Australia",NA
"1763","34192408","10.1111/ajag.12976","Hospitalisation for lower respiratory viral infections in older people in residential aged care facilities.","To quantify incidence, trends and outcomes associated with lower respiratory viral infection (LRVI) hospitalisations in Australian residential aged care facilities (RACFs). A population-based cohort study of residents in RACFs aged =65 years from New South Wales (NSW), South Australia (SA) and Victoria (VIC) using data from the Registry of Senior Australians (2013-2016) was conducted. Age- and sex-standardised monthly and yearly LRVI hospitalisation incidences were calculated, and time trends an","2021","06","30","Australas J Ageing","Australasian journal on ageing","Respiratory Tract Infections I respiratory viral infection; health services for the aged; hospitalization; mortality","Lang","Catherine","Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, SA, Australia",NA
"1764","34192408","10.1111/ajag.12976","Hospitalisation for lower respiratory viral infections in older people in residential aged care facilities.","To quantify incidence, trends and outcomes associated with lower respiratory viral infection (LRVI) hospitalisations in Australian residential aged care facilities (RACFs). A population-based cohort study of residents in RACFs aged =65 years from New South Wales (NSW), South Australia (SA) and Victoria (VIC) using data from the Registry of Senior Australians (2013-2016) was conducted. Age- and sex-standardised monthly and yearly LRVI hospitalisation incidences were calculated, and time trends an","2021","06","30","Australas J Ageing","Australasian journal on ageing","Respiratory Tract Infections I respiratory viral infection; health services for the aged; hospitalization; mortality","Wesselingh","Steve L","Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, SA, Australia",NA
"1765","34192408","10.1111/ajag.12976","Hospitalisation for lower respiratory viral infections in older people in residential aged care facilities.","To quantify incidence, trends and outcomes associated with lower respiratory viral infection (LRVI) hospitalisations in Australian residential aged care facilities (RACFs). A population-based cohort study of residents in RACFs aged =65 years from New South Wales (NSW), South Australia (SA) and Victoria (VIC) using data from the Registry of Senior Australians (2013-2016) was conducted. Age- and sex-standardised monthly and yearly LRVI hospitalisation incidences were calculated, and time trends an","2021","06","30","Australas J Ageing","Australasian journal on ageing","Respiratory Tract Infections I respiratory viral infection; health services for the aged; hospitalization; mortality","Inacio","Maria C","Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, SA, Australia",NA
"1766","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","Lunn","Tamika J","Centre for Planetary Health and Food Security, Griffith University, Brisbane",NA
"1767","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","Peel","Alison J","Centre for Planetary Health and Food Security, Griffith University, Brisbane",NA
"1768","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","McCallum","Hamish","Centre for Planetary Health and Food Security, Griffith University, Brisbane",NA
"1769","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","Eby","Peggy","Centre for Planetary Health and Food Security, Griffith University, Brisbane",NA
"1770","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","Kessler","Maureen K","Department of Microbiology and Immunology, Montana State University, Bozeman, USA",NA
"1771","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","Plowright","Raina K","Department of Ecology, Montana State University, Bozeman, USA",NA
"1772","34192345","10.1111/1365-2656.13566","Spatial dynamics of pathogen transmission in communally roosting species: impacts of changing habitats on bat-virus dynamics.","The spatial organisation of populations determines their pathogen dynamics. This is particularly important for communally roosting species, whose aggregations are often driven by the spatial structure of their environment. We develop a spatially explicit model for virus transmission within roosts of Australian tree-dwelling bats (Pteropus spp.), parameterised to reflect Hendra virus. The spatial structure of roosts mirrors three study sites, and viral transmission between groups of bats in trees","2021","06","30","J Anim Ecol","The Journal of animal ecology","Henipavirus; aggregative behaviour; animal aggregation; communal roost; conspecific attraction; heterogeneous mixing; pathogen transmission; roost size","Restif","Olivier","Department of Veterinary Medicine, University of Cambridge, Cambridge, UK",NA
"1773","34192334","10.1093/infdis/jiab346","Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Beverland","Andrew","Immunology Department, Beaumont Hospital, Dublin, Ireland",NA
"1774","34192334","10.1093/infdis/jiab346","Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Keogan","Mary","Immunology Department, Beaumont Hospital, Dublin, Ireland",NA
"1775","34192334","10.1093/infdis/jiab346","Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Connell","Jeff","National Virus Reference Laboratory, University College Dublin, Belfield, Dublin, Ireland",NA
"1776","34192334","10.1093/infdis/jiab346","Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"De Gascun","Cillian","National Virus Reference Laboratory, University College Dublin, Belfield, Dublin, Ireland",NA
"1777","34192334","10.1093/infdis/jiab346","Longitudinal Serological Analysis following National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Igoe","Derval","Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland",NA
"1778","34192326","10.1093/infdis/jiab348","Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Tong","Ming","Department of Infectious Diseases, The First-affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, Hunan, China",NA
"1779","34192326","10.1093/infdis/jiab348","Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Zheng","Qing","Department of Geriatrics, The First-affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, Hunan, China",NA
"1780","34192326","10.1093/infdis/jiab348","Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Chen","Fang","Institute of Emergency Medicine, Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, The First-affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, Hunan, China",NA
"1781","34192326","10.1093/infdis/jiab348","Comment on: Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Zhu","Yimin","Institute of Emergency Medicine, Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, The First-affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, Hunan, China",NA
"1782","34192319","10.1093/infdis/jiab347","Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Kristensen","Markus K","Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre,Denmark",NA
"1783","34192319","10.1093/infdis/jiab347","Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Plovsing","Ronni R","Department of Anaesthesiology and Intensive Care, Hvidovre Hospital, University of Copenhagen, Hvidovre,Denmark",NA
"1784","34192319","10.1093/infdis/jiab347","Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Berg","Ronan M G","Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen,Denmark",NA
"1785","34192319","10.1093/infdis/jiab347","Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Madsen","Rikke Krogh","Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre,Denmark",NA
"1786","34192319","10.1093/infdis/jiab347","Cell adhesion molecules and vascular endothelial growth factor at the systemic and alveolar level in COVID-19 ARDS.",NA,"2021","06","30","J Infect Dis","The Journal of infectious diseases",NA,"Ronit","Andreas","Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Hvidovre,Denmark",NA
"1787","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Dhar","Chirag","Departments of Medicine and Cellular and Molecular Medicine, UC San Diego School of Medicine, La Jolla, CA",NA
"1788","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Sasmal","Aniruddha","Departments of Medicine and Cellular and Molecular Medicine, UC San Diego School of Medicine, La Jolla, CA",NA
"1789","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Diaz","Sandra","Departments of Medicine and Cellular and Molecular Medicine, UC San Diego School of Medicine, La Jolla, CA",NA
"1790","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Verhagen","Andrea","Departments of Medicine and Cellular and Molecular Medicine, UC San Diego School of Medicine, La Jolla, CA",NA
"1791","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Yu","Hai","Department of Chemistry, UC Davis, Davis, CA",NA
"1792","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Li","Wanqing","Department of Chemistry, UC Davis, Davis, CA",NA
"1793","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Chen","Xi","Department of Chemistry, UC Davis, Davis, CA",NA
"1794","34192318","10.1093/glycob/cwab063","Are sialic acids involved in COVID-19 pathogenesis?",NA,"2021","06","30","Glycobiology","Glycobiology",NA,"Varki","Ajit","Departments of Medicine and Cellular and Molecular Medicine, UC San Diego School of Medicine, La Jolla, CA",NA
"1795","34192311","10.1093/cid/ciab571","The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.",NA,"2021","06","30","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Darcis","Gilles","Department of infectious diseases, Liège university hospital, Belgium",NA
"1796","34192311","10.1093/cid/ciab571","The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.",NA,"2021","06","30","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Meuris","Christelle","Department of infectious diseases, Liège university hospital, Belgium",NA
"1797","34192311","10.1093/cid/ciab571","The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.",NA,"2021","06","30","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Kremer","Cécile","I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium",NA
"1798","34192311","10.1093/cid/ciab571","The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.",NA,"2021","06","30","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Faes","Christel","I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium",NA
"1799","34192311","10.1093/cid/ciab571","The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.",NA,"2021","06","30","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Hens","Niel","I-BioStat, Data Science Institute, Hasselt University, Hasselt, Belgium",NA
"1800","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Athiana","Ilektra","University Children's Hospital, Uppsala, Sweden",NA
"1801","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Légeret","Corinne","University Children's Hospital, Basel, Switzerland",NA
"1802","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Bontems","Patrick","Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium",NA
"1803","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Dall'Oglio","Luigi","Bambino Gesu Children's Hospital, Rome, Italy",NA
"1804","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","De Angelis","Paola","Bambino Gesu Children's Hospital, Rome, Italy",NA
"1805","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Dias","Jorge Amil","Centro Hospitalar Universitario S. Joao, Porto, Portugal",NA
"1806","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Hauser","Bruno","UZ Brussel KidZ Health Castle, Brussels, Belgium",NA
"1807","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Homan","Matja","Department of Gastroenterology, Hepatology and Nutrition, University Children's hospital, University Medical Center Ljubljana, Slovenia",NA
"1808","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Narula","Priya","Sheffield Children's Hospital, Sheffield, United Kingdom",NA
"1809","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Norsa","Lorenzo","Pediatric Hepatology, Gastroenterology and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"1810","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Oliva","Salvatore","Sapienza University of Rome, Rome, Italy",NA
"1811","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Papadopoulou","Alexandra","Children's Hospital Agia Sofia, Athens, Greece",NA
"1812","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Romano","Claudio","Pediatric Gastroenterology and Cystic Fibrosis Unit Department of Human Pathology and Pediatrics University of Messina, Italy",NA
"1813","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Thomson","Mike","Pediatric Hepatology, Gastroenterology and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy",NA
"1814","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Vila-Miravet","Victor","Hospital Sant Joan de Déu, Barcelona, Spain",NA
"1815","34192294","10.1097/PG9.0000000000000061","Significant variations across European centres in implementing recommended guidelines for the paediatric gastroenterology endoscopy suite during the COVID-19 pandemic.","The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) published recommendations regarding protection for the paediatric endoscopist during the coronavirus 2019 (COVID-19) pandemic.The aim of this survey was to investigate whether European paediatric gastroenterology centres applied the recommendations and how this extraordinary situation was handled by the different centres. Twelve paediatric European gastroenterology centres participated. Nine centres (75%) sc","2021","07","02","JPGN Rep","JPGN reports","COVID-19; ESPGHAN recommendations; children; endoscopy","Furlano","Raoul I","University Children's Hospital, Basel, Switzerland",NA
"1816","34192293","10.1097/PG9.0000000000000068","COVID-19 in a Pediatric Patient: Novel Presentation of Cardiac Failure resulting in Chylous Ascites and Abdominal Pain.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Phen","Claudia","Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Texas Southwestern/Children's Medical Center, Dallas, TX",NA
"1817","34192293","10.1097/PG9.0000000000000068","COVID-19 in a Pediatric Patient: Novel Presentation of Cardiac Failure resulting in Chylous Ascites and Abdominal Pain.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Woolley","Joseph","Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Texas Southwestern/Children's Medical Center, Dallas, TX",NA
"1818","34192293","10.1097/PG9.0000000000000068","COVID-19 in a Pediatric Patient: Novel Presentation of Cardiac Failure resulting in Chylous Ascites and Abdominal Pain.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Kelley","Shannon","Division of Pathology, Department of Pediatrics, University of Texas Southwestern/Children's Medical Center, Dallas, TX",NA
"1819","34192293","10.1097/PG9.0000000000000068","COVID-19 in a Pediatric Patient: Novel Presentation of Cardiac Failure resulting in Chylous Ascites and Abdominal Pain.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Garcia","Jessica","Division of Hematology, Department of Pediatrics, University of Texas Southwestern/Children's Medical Center, Dallas, TX",NA
"1820","34192293","10.1097/PG9.0000000000000068","COVID-19 in a Pediatric Patient: Novel Presentation of Cardiac Failure resulting in Chylous Ascites and Abdominal Pain.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Baez Hernandez","Nathanya","Division of Cardiology, Department of Pediatrics, University of Texas Southwestern/Children's Medical Center, Dallas, TX",NA
"1821","34192293","10.1097/PG9.0000000000000068","COVID-19 in a Pediatric Patient: Novel Presentation of Cardiac Failure resulting in Chylous Ascites and Abdominal Pain.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Aqul","Amal","Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Texas Southwestern/Children's Medical Center, Dallas, TX",NA
"1822","34192292","10.1097/PG9.0000000000000059","Initial Presentation of a Pediatric Intestinal Pseudo-Obstruction Episode After SARS-CoV-2 Virus (COVID-19) Infection.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Herdes","Rachel E","Department of Pediatrics, Division of Pediatric Gastroenterology, Stanford University School of Medicine, Palo Alto, CA",NA
"1823","34192292","10.1097/PG9.0000000000000059","Initial Presentation of a Pediatric Intestinal Pseudo-Obstruction Episode After SARS-CoV-2 Virus (COVID-19) Infection.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Cagil","Yasemin","Department of Pediatrics, Division of Pediatric Gastroenterology, Stanford University School of Medicine, Palo Alto, CA",NA
"1824","34192292","10.1097/PG9.0000000000000059","Initial Presentation of a Pediatric Intestinal Pseudo-Obstruction Episode After SARS-CoV-2 Virus (COVID-19) Infection.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Namjoshi","Shweta","Department of Pediatrics, Division of Pediatric Gastroenterology, Stanford University School of Medicine, Palo Alto, CA",NA
"1825","34192292","10.1097/PG9.0000000000000059","Initial Presentation of a Pediatric Intestinal Pseudo-Obstruction Episode After SARS-CoV-2 Virus (COVID-19) Infection.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Hassan","Maheen","Department of Pediatrics, Division of Pediatric Gastroenterology, Stanford University School of Medicine, Palo Alto, CA",NA
"1826","34192291","10.1097/PG9.0000000000000040","Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Shahein","Abdul R","Division of Pediatric Gastroenterology",NA
"1827","34192291","10.1097/PG9.0000000000000040","Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Young","Heather","Division of Pediatric Infectious Disease",NA
"1828","34192291","10.1097/PG9.0000000000000040","Phlegmonous Ileocolitis as a Presentation of Post SARS-CoV-2 (COVID-19) Multisystem Inflammatory Syndrome in Children.",NA,"2021","07","02","JPGN Rep","JPGN reports",NA,"Dalabih","Abdallah","Division of Pediatric Critical Care, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR",NA
"1829","34192290","10.1097/PG9.0000000000000011","Case Report: Acute Abdominal Pain as Presentation of Pneumonia and Acute Pancreatitis in a Pediatric Patient With COVID-19.","Abdominal pain, nausea, and vomiting are known gastrointestinal symptoms of symptomatic SARS-CoV-2 infection (COVID-19 disease) in pediatric patients.<sup>1</sup> There is little literature regarding pancreatitis in COVID-19. We describe a 16-year-old male diagnosed with acute pancreatitis in the setting of a SARS-COV-2 infection and associated fluid balance considerations.","2021","07","02","JPGN Rep","JPGN reports","SARS-CoV-2; acute pancreatitis; pediatrics","Sanchez","Raul E","Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH",NA
"1830","34192290","10.1097/PG9.0000000000000011","Case Report: Acute Abdominal Pain as Presentation of Pneumonia and Acute Pancreatitis in a Pediatric Patient With COVID-19.","Abdominal pain, nausea, and vomiting are known gastrointestinal symptoms of symptomatic SARS-CoV-2 infection (COVID-19 disease) in pediatric patients.<sup>1</sup> There is little literature regarding pancreatitis in COVID-19. We describe a 16-year-old male diagnosed with acute pancreatitis in the setting of a SARS-COV-2 infection and associated fluid balance considerations.","2021","07","02","JPGN Rep","JPGN reports","SARS-CoV-2; acute pancreatitis; pediatrics","Flahive","Colleen B","Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH",NA
"1831","34192290","10.1097/PG9.0000000000000011","Case Report: Acute Abdominal Pain as Presentation of Pneumonia and Acute Pancreatitis in a Pediatric Patient With COVID-19.","Abdominal pain, nausea, and vomiting are known gastrointestinal symptoms of symptomatic SARS-CoV-2 infection (COVID-19 disease) in pediatric patients.<sup>1</sup> There is little literature regarding pancreatitis in COVID-19. We describe a 16-year-old male diagnosed with acute pancreatitis in the setting of a SARS-COV-2 infection and associated fluid balance considerations.","2021","07","02","JPGN Rep","JPGN reports","SARS-CoV-2; acute pancreatitis; pediatrics","Mezoff","Ethan A","Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH",NA
"1832","34192290","10.1097/PG9.0000000000000011","Case Report: Acute Abdominal Pain as Presentation of Pneumonia and Acute Pancreatitis in a Pediatric Patient With COVID-19.","Abdominal pain, nausea, and vomiting are known gastrointestinal symptoms of symptomatic SARS-CoV-2 infection (COVID-19 disease) in pediatric patients.<sup>1</sup> There is little literature regarding pancreatitis in COVID-19. We describe a 16-year-old male diagnosed with acute pancreatitis in the setting of a SARS-COV-2 infection and associated fluid balance considerations.","2021","07","02","JPGN Rep","JPGN reports","SARS-CoV-2; acute pancreatitis; pediatrics","Gariepy","Cheryl","Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH",NA
"1833","34192290","10.1097/PG9.0000000000000011","Case Report: Acute Abdominal Pain as Presentation of Pneumonia and Acute Pancreatitis in a Pediatric Patient With COVID-19.","Abdominal pain, nausea, and vomiting are known gastrointestinal symptoms of symptomatic SARS-CoV-2 infection (COVID-19 disease) in pediatric patients.<sup>1</sup> There is little literature regarding pancreatitis in COVID-19. We describe a 16-year-old male diagnosed with acute pancreatitis in the setting of a SARS-COV-2 infection and associated fluid balance considerations.","2021","07","02","JPGN Rep","JPGN reports","SARS-CoV-2; acute pancreatitis; pediatrics","Hunt","W Garrett","Pediatric Infectious Disease, Nationwide Children's Hospital, Columbus, OH",NA
"1834","34192290","10.1097/PG9.0000000000000011","Case Report: Acute Abdominal Pain as Presentation of Pneumonia and Acute Pancreatitis in a Pediatric Patient With COVID-19.","Abdominal pain, nausea, and vomiting are known gastrointestinal symptoms of symptomatic SARS-CoV-2 infection (COVID-19 disease) in pediatric patients.<sup>1</sup> There is little literature regarding pancreatitis in COVID-19. We describe a 16-year-old male diagnosed with acute pancreatitis in the setting of a SARS-COV-2 infection and associated fluid balance considerations.","2021","07","02","JPGN Rep","JPGN reports","SARS-CoV-2; acute pancreatitis; pediatrics","Vaz","Karla K H","Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH",NA
"1835","34192289","10.1016/j.ahjo.2021.100025","Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?","Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms &gt;3-4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2","2021","07","15","Am Heart J Plus","American heart journal plus : cardiology research and practice","ACE2, angiotensin converting enzyme-2; AF/AFL, atrial fibrillation or flutter; CBT, cognitive behavioral therapy; CFS, Chronic Fatigue Syndrome; CMR, cardiac magnetic resonance imaging; CRP, C-reactive protein; CV, cardiovascular; Cardiology; Coronavirus Disease 2019; ECG, electrocardiography; ECV, extracellular volume; LGE, late gadolinium enhancement; Long COVID; Long-Haul COVID; MCAS, Mast Cell Activation Syndrome; MERS, Middle East Respiratory Syndrome; POTS, Post-Acute COVID-19 Syndrome; SARS-COV-1, Severe Acute Respiratory Syndrome Coronavirus-1; SARS-CoV-2; T1MI, type 1 myocardial infarction; T2MI, type 2 myocardial infarction; TTT, tilt table testing","Dixit","Neal M","Department of Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA",NA
"1836","34192289","10.1016/j.ahjo.2021.100025","Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?","Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms &gt;3-4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2","2021","07","15","Am Heart J Plus","American heart journal plus : cardiology research and practice","ACE2, angiotensin converting enzyme-2; AF/AFL, atrial fibrillation or flutter; CBT, cognitive behavioral therapy; CFS, Chronic Fatigue Syndrome; CMR, cardiac magnetic resonance imaging; CRP, C-reactive protein; CV, cardiovascular; Cardiology; Coronavirus Disease 2019; ECG, electrocardiography; ECV, extracellular volume; LGE, late gadolinium enhancement; Long COVID; Long-Haul COVID; MCAS, Mast Cell Activation Syndrome; MERS, Middle East Respiratory Syndrome; POTS, Post-Acute COVID-19 Syndrome; SARS-COV-1, Severe Acute Respiratory Syndrome Coronavirus-1; SARS-CoV-2; T1MI, type 1 myocardial infarction; T2MI, type 2 myocardial infarction; TTT, tilt table testing","Churchill","Austin","School of Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095, USA",NA
"1837","34192289","10.1016/j.ahjo.2021.100025","Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?","Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms &gt;3-4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2","2021","07","15","Am Heart J Plus","American heart journal plus : cardiology research and practice","ACE2, angiotensin converting enzyme-2; AF/AFL, atrial fibrillation or flutter; CBT, cognitive behavioral therapy; CFS, Chronic Fatigue Syndrome; CMR, cardiac magnetic resonance imaging; CRP, C-reactive protein; CV, cardiovascular; Cardiology; Coronavirus Disease 2019; ECG, electrocardiography; ECV, extracellular volume; LGE, late gadolinium enhancement; Long COVID; Long-Haul COVID; MCAS, Mast Cell Activation Syndrome; MERS, Middle East Respiratory Syndrome; POTS, Post-Acute COVID-19 Syndrome; SARS-COV-1, Severe Acute Respiratory Syndrome Coronavirus-1; SARS-CoV-2; T1MI, type 1 myocardial infarction; T2MI, type 2 myocardial infarction; TTT, tilt table testing","Nsair","Ali","Department of Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA",NA
"1838","34192289","10.1016/j.ahjo.2021.100025","Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?","Post-Acute COVID-19 Syndrome (PACS) is defined by persistent symptoms &gt;3-4 weeks after onset of COVID-19. The mechanism of these persistent symptoms is distinct from acute COVID-19 although not completely understood despite the high incidence of PACS. Cardiovascular symptoms such as chest pain and palpitations commonly occur in PACS, but the underlying cause of symptoms is infrequently known. While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2","2021","07","15","Am Heart J Plus","American heart journal plus : cardiology research and practice","ACE2, angiotensin converting enzyme-2; AF/AFL, atrial fibrillation or flutter; CBT, cognitive behavioral therapy; CFS, Chronic Fatigue Syndrome; CMR, cardiac magnetic resonance imaging; CRP, C-reactive protein; CV, cardiovascular; Cardiology; Coronavirus Disease 2019; ECG, electrocardiography; ECV, extracellular volume; LGE, late gadolinium enhancement; Long COVID; Long-Haul COVID; MCAS, Mast Cell Activation Syndrome; MERS, Middle East Respiratory Syndrome; POTS, Post-Acute COVID-19 Syndrome; SARS-COV-1, Severe Acute Respiratory Syndrome Coronavirus-1; SARS-CoV-2; T1MI, type 1 myocardial infarction; T2MI, type 2 myocardial infarction; TTT, tilt table testing","Hsu","Jeffrey J","Department of Medicine, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA",NA
"1839","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Walsh","Brian","Innova Group Alpharetta GA 30022 USA",NA
"1840","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Hosoi","Annette","School of EngineeringMassachusetts Institute of Technology Cambridge MA 02139 USA",NA
"1841","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Kingsley","Manuel","Innova Group Alpharetta GA 30022 USA",NA
"1842","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Moreira","Susan","Moreira Advisors Northborough MA USA",NA
"1843","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Ramakrishnan","Sreeram","RxCap Inc. Boston MA USA",NA
"1844","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Tessier","Paul","Consortia for Improving Medicine with Innovation and TechnologyMassachusetts General Hospital and Harvard Medical School Boston MA 02114 USA",NA
"1845","34192288","10.1109/OJEMB.2021.3070822","The RADx Tech Deployment Core: A Model for Academic/Government Based Support of Large-Scale Manufacturing and Implementation of Medical Technologies.","This paper explores how the approach, process, and learnings of the RADx<sup>SM</sup> Tech Deployment Core in its support of manufacturing, deployment, and implementation of medical technologies is creating a replicable model for the future. Initially, the key construct of the RADx Tech Deployment Core was helping companies manufacture, commercialize, and develop a digital infrastructure for the purpose of SARS-CoV-2 testing and reporting. However, the team and RADx Tech leadership soon realized","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; NIH; RADx; SARS-CoV-2; device testing","Gagliano","Nancy","Granite HealthCare Advisors Grantham NH USA",NA
"1846","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Gibson","Laura","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1847","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Fahey","Nisha","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1848","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Hafer","Nathaniel","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1849","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Buchholz","Bryan","University of Massachusetts Lowell Lowell MA 01854 USA",NA
"1850","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Dunlap","Denise","University of Massachusetts Lowell Lowell MA 01854 USA",NA
"1851","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Murphy","Robert","Northwestern University Feinberg School of Medicine Chicago IL 60611 USA",NA
"1852","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Achenbach","Chad","Northwestern University Feinberg School of Medicine Chicago IL 60611 USA",NA
"1853","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Stone","Cheryl","Children's Healthcare of Atlanta Inc Atlanta GA 30322 USA",NA
"1854","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Cleeton","Rebecca","Children's Healthcare of Atlanta Inc Atlanta GA 30322 USA",NA
"1855","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","O'Neal","Jared","Emory University School of Medicine Atlanta GA 30322 USA",NA
"1856","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Frediani","Jennifer","Emory University Nell Hodgson Woodruff School of Nursing Atlanta GA 30322 USA",NA
"1857","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Vos","Miriam","Emory University School of Medicine Atlanta GA 30322 USA",NA
"1858","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Brand","Oliver","Georgia Institute of Technology Atlanta GA 30332 USA",NA
"1859","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Nayee","Risha","Emory University School of Medicine Atlanta GA 30322 USA",NA
"1860","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Wells","Leona","Emory University School of Medicine Atlanta GA 30322 USA",NA
"1861","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Lam","Wilbur","Emory University School of Medicine Atlanta GA 30322 USA",NA
"1862","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Martin","Greg","Emory University School of Medicine Atlanta GA 30322 USA",NA
"1863","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Manabe","Yukari","Johns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1864","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Robinson","Matthew","Johns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1865","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Broach","John","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1866","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Olgin","Jeffrey","University of California San Francisco San Francisco CA 94158 USA",NA
"1867","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Barton","Bruce","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1868","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Lemon","Stephenie","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1869","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","Blodgett","Allison","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1870","34192287","10.1109/OJEMB.2021.3070830","The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies.","The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech initiative to support the development and commercialization of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) point-of-care test devices. The primary objective of the Clinical Studies Core (CSC) was to perform SARS-CoV-2 device studies involving diverse populations and settings. Within a few months, the infrastructure for clinical studies was developed, including a ","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; SARS-CoV-2; [Formula: see text] diagnostics; point-of-care testing; rapid acceleration of diagnostics","McManus","David","University of Massachusetts Medical School Worcester MA 01655 USA",NA
"1871","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Nehl","Eric","Behavioral, Social &amp",NA
"1872","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Heilman","Stacy","PediatricsEmory University Atlanta GA USA",NA
"1873","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Ku","David","School of Mechanical EngineeringGeorgia Institute of Technology Atlanta GA 30332-0405 USA",NA
"1874","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Gottfried","David","Institute for Electronics and NanotechnologyGeorgia Institute of Technology GA USA",NA
"1875","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Farmer","Sarah","Georgia Institute of Technology Atlanta GA USA",NA
"1876","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Mannino","Robert","Biomedical EngineeringGeorgia Institute of Technology Atlanta GA USA",NA
"1877","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Tyburski","Erika","The Atlanta Center for Microsystems-Engineered Point-of-Care TechnologiesGeorgia Institute of Technology Atlanta GA USA",NA
"1878","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Sullivan","Julie","PediatricsEmory University Atlanta GA USA",NA
"1879","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Suessmith","Allison","PediatricsEmory University Atlanta GA USA",NA
"1880","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Bassit","Leda","Laboratory of Biochemical PharmacologyEmory University Atlanta GA USA",NA
"1881","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Figueroa","Janet","PediatricsEmory University Atlanta GA USA",NA
"1882","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Wood","Anna","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1883","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Leong","Traci","StatisticsEmory University School of Public Health Atlanta GA USA",NA
"1884","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Rao","Anuradha","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1885","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Rogers","Beverly","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1886","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Jerris","Robert","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1887","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Park","Sunita","Childrens Healthcare of AtlantaEmory University School of Medicine Atlanta GA USA",NA
"1888","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Gonzalez","Mark","Childrens Healthcare of AtlantaEmory University School of Medicine Atlanta GA USA",NA
"1889","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Frediani","Jennifer","Emory University School of Public Health Atlanta GA USA",NA
"1890","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Morris","Claudia","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1891","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Levy","Joshua","Department of Otolaryngology-Head &amp",NA
"1892","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Schoof","Nils","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1893","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Mavigner","Maud","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1894","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Roback","John","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1895","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Herzegh","Kristen","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1896","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Saakadze","Natia","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1897","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Ingersoll","Jess","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1898","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Cheedarla","Narayana","Emory University School of Public Health Atlanta GA USA",NA
"1899","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Neish","Andrew","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1900","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Hanberry","Bradley","Childrens Healthcare of AtlantaEmory University School of Medicine Atlanta GA USA",NA
"1901","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Porter","Christopher","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1902","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Esper","Annette","MedicineEmory University School of Medicine Atlanta GA USA",NA
"1903","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Kempker","Russell","MedicineEmory University School of Medicine Atlanta GA USA",NA
"1904","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Rebolledo","Paulina","MedicineEmory University School of Medicine Atlanta GA USA",NA
"1905","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","McGuinness","Pamela","Medical Device ResearchUniversity of Massachusetts Lowell Lowell MA USA",NA
"1906","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Balagadde","Frederick","Biomedical EngineeringUniversity of Massachusetts Lowell Lowell MA USA",NA
"1907","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Gore","Rebecca","Biomedical EngineeringUniversity of Massachusetts Lowell Lowell MA USA",NA
"1908","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Koren","Ainat","School of NursingUniversity of Massachusetts Lowell Lowell MA USA",NA
"1909","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Pollock","Nira","Department of PathologyBoston Children's Hospital Boston MA 02115 USA",NA
"1910","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Rogers","Eugene","Biomedical and Nutritional SciencesUniversity of Massachusetts Lowell Lowell MA USA",NA
"1911","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Simin","Karl","Molecular, Cell, and Cancer BiologyUniversity of Massachusetts Medical School Worcester MA USA",NA
"1912","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Hafer","Nathaniel","University of Massachusetts Medical School Worcester MA USA",NA
"1913","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Picard","Mary Ann","Medical Device ResearchUniversity of Massachusetts Lowell Lowell MA USA",NA
"1914","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Ghezzi","Chiara","Biomedical EngineeringUniversity of Massachusetts Lowell Lowell MA USA",NA
"1915","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","McManus","David","Medicine, UMass Medical School Worcester MA USA",NA
"1916","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Buchholz","Bryan","University of Massachusetts Lowell Lowell MA USA",NA
"1917","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Rostad","Christina","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1918","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Claveria","Viviana","School of Mechanical EngineeringGeorgia Institute of Technology Atlanta GA 30332-0405 USA",NA
"1919","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Ramachandra","Thanuja","MedicineEmory University School of Medicine Atlanta GA USA",NA
"1920","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Wang","Yun F","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1921","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Washington","CaDeidre","MedicineEmory University School of Medicine Atlanta GA USA",NA
"1922","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Stone","Cheryl","Children's Healthcare of Atlanta Inc Atlanta GA USA",NA
"1923","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Griffiths","Mark","Pediatric Emergency MedicineEmory University School of Medicine Atlanta GA USA",NA
"1924","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Schinazi","Ray","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1925","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Chahroudi","Ann","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1926","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Vos","Miriam","PediatricsEmory University School of Medicine Atlanta GA USA",NA
"1927","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Brand","Oliver","Electrical and Computer EngineeringGeorgia Institute of Technology Atlanta GA USA",NA
"1928","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Martin","Greg","MedicineEmory University School of Medicine Atlanta GA USA",NA
"1929","34192286","10.1109/OJEMB.2021.3070825","The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change.","Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the ""RADx<sup>SM</sup> Tech Test Verification Core"" and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to prese","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Device Testing; RADx","Lam","Wilbur","Pathology and Laboratory MedicineEmory University School of Medicine Atlanta GA USA",NA
"1930","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Robinson","Matthew","Division of Infectious DiseasesJohns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1931","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Gaydos","Charlotte","Division of Infectious DiseasesJohns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1932","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Van Der Pol","Barbara","Division of Infectious DiseasesThe University of Alabama at Birmingham School of Medicine Birmingham AL 35233 USA",NA
"1933","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","McFall","Sally","Center for Innovation in Point-of-Care Technology for HIV/AIDSNorthwestern University Evanston IL 60208 USA",NA
"1934","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Hsieh","Yu-Hsiang","Department of Emergency MedicineJohns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1935","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Clarke","William","Department of PathologyJohns Hopkins School of Medicine Baltimore MD 21205 USA",NA
"1936","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Murphy","Robert L","Division of Infectious Diseases and Institute for Global HealthNorthwestern University Feinberg School of Medicine Chicago IL 60611 USA",NA
"1937","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Widdice","Lea E","Department of Pediatrics, Cincinnati Children's Hospital Medical CenterUniversity of Cincinnati College of Medicine Cincinnati OH 45229 USA",NA
"1938","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Hirschhorn","Lisa R","Department of Medical Social SciencesNorthwestern University Feinberg School of Medicine Chicago IL 60611 USA",NA
"1939","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Rothman","Richard","Department of Emergency MedicineJohns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1940","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Achenbach","Chad","Division of Infectious DiseasesNorthwestern University Feinberg School of Medicine Chicago IL 60611 USA",NA
"1941","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Hawkins","Claudia","Division of Infectious DiseasesNorthwestern University Feinberg School of Medicine Chicago IL 60611 USA",NA
"1942","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Samuta","Adam","RADx Tech Bethesda MD 20892 USA",NA
"1943","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Gibson","Laura","Division of Infectious DiseaseUniversity of Massachusetts Medical School Worcester MA 01655 USA",NA
"1944","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","McManus","David","Department of MedicineUniversity of Massachusetts Medical School Worcester MA 01655 USA",NA
"1945","34192285","10.1109/OJEMB.2021.3070818","The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech.","The NIH Rapid Acceleration of Diagnostics (RADx<sup>SM</sup>) Tech Program was created to speed the development, validation, and commercialization of innovative point-of-care (POC) and home-based tests, and to improve clinical laboratory tests, that can directly detect SARS-CoV-2. Leveraging the experience of the Point-of-Care Technologies Research Network, a Clinical Review Committee (CRC) composed of clinicians, bioengineers, regulatory experts, and laboratorians was created to provide structu","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; Rapid Acceleration of Diagnostics program; SARS-CoV-2; in vitro diagnostics; point-of-care testing","Manabe","Yukari C","Division of Infectious DiseasesJohns Hopkins University School of Medicine Baltimore MD 21205 USA",NA
"1946","34192284","10.1109/OJEMB.2021.3070827","The RADx Tech Deep Dive and Work Package 1 Process.","The RADx<sup>SM</sup> Tech program was a unique funding and support mechanism to accelerate the market introduction of diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. In addition to providing funding, the RADx Tech program provided unprecedented levels of non- monetary support. Applications were evaluated using a deep dive process which involved a 1- to 2-week intensive collaboration between the applicant and a team of experts from RADx Tech. The result of this deep dive was a v","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","RADx; SBIR; commercialization; funding; translational research","Dempsey","Michael","Consortia for Improving Medicine with Innovation and Technology (CIMIT)Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA",NA
"1947","34192284","10.1109/OJEMB.2021.3070827","The RADx Tech Deep Dive and Work Package 1 Process.","The RADx<sup>SM</sup> Tech program was a unique funding and support mechanism to accelerate the market introduction of diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. In addition to providing funding, the RADx Tech program provided unprecedented levels of non- monetary support. Applications were evaluated using a deep dive process which involved a 1- to 2-week intensive collaboration between the applicant and a team of experts from RADx Tech. The result of this deep dive was a v","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","RADx; SBIR; commercialization; funding; translational research","Tessier","Paul","Consortia for Improving Medicine with Innovation and Technology (CIMIT)Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA",NA
"1948","34192284","10.1109/OJEMB.2021.3070827","The RADx Tech Deep Dive and Work Package 1 Process.","The RADx<sup>SM</sup> Tech program was a unique funding and support mechanism to accelerate the market introduction of diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. In addition to providing funding, the RADx Tech program provided unprecedented levels of non- monetary support. Applications were evaluated using a deep dive process which involved a 1- to 2-week intensive collaboration between the applicant and a team of experts from RADx Tech. The result of this deep dive was a v","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","RADx; SBIR; commercialization; funding; translational research","Collins","John","Biocomx Dana Point CA 92629 USA",NA
"1949","34192284","10.1109/OJEMB.2021.3070827","The RADx Tech Deep Dive and Work Package 1 Process.","The RADx<sup>SM</sup> Tech program was a unique funding and support mechanism to accelerate the market introduction of diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. In addition to providing funding, the RADx Tech program provided unprecedented levels of non- monetary support. Applications were evaluated using a deep dive process which involved a 1- to 2-week intensive collaboration between the applicant and a team of experts from RADx Tech. The result of this deep dive was a v","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","RADx; SBIR; commercialization; funding; translational research","Caro","Elias","Consortia for Improving Medicine with Innovation and Technology (CIMIT)Harvard University Cambridge MA 02138 USA",NA
"1950","34192283","10.1109/OJEMB.2021.3070829","The Role of CoLab and GAITS in Enabling the RADx Tech Program.","The RADx<sup>SM</sup> Tech initiative required a massive mobilization of the biomedical community. It was chartered with the extremely ambitious goal of rapidly developing and deploying innovative tests to detect people infected with the SARS-CoV-2 virus. It needed to do so at a scale and with urgency to get the country back to daily activities such as school and work as soon as possible. It required forming and supporting a diversity of teams with members from around the country and beyond. The","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","CoLab; GAITS; RADx Tech; commercialization; healthcare innovation","Collins","John M","Center for the Integration of Medicine and Innovative Technology (CIMIT)Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA",NA
"1951","34192283","10.1109/OJEMB.2021.3070829","The Role of CoLab and GAITS in Enabling the RADx Tech Program.","The RADx<sup>SM</sup> Tech initiative required a massive mobilization of the biomedical community. It was chartered with the extremely ambitious goal of rapidly developing and deploying innovative tests to detect people infected with the SARS-CoV-2 virus. It needed to do so at a scale and with urgency to get the country back to daily activities such as school and work as soon as possible. It required forming and supporting a diversity of teams with members from around the country and beyond. The","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","CoLab; GAITS; RADx Tech; commercialization; healthcare innovation","Collins","Marshall R","Center for the Integration of Medicine and Innovative Technology (CIMIT)Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA",NA
"1952","34192283","10.1109/OJEMB.2021.3070829","The Role of CoLab and GAITS in Enabling the RADx Tech Program.","The RADx<sup>SM</sup> Tech initiative required a massive mobilization of the biomedical community. It was chartered with the extremely ambitious goal of rapidly developing and deploying innovative tests to detect people infected with the SARS-CoV-2 virus. It needed to do so at a scale and with urgency to get the country back to daily activities such as school and work as soon as possible. It required forming and supporting a diversity of teams with members from around the country and beyond. The","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","CoLab; GAITS; RADx Tech; commercialization; healthcare innovation","McKenzie","Tamara","BiocomX Dana Point CA 92629 USA",NA
"1953","34192283","10.1109/OJEMB.2021.3070829","The Role of CoLab and GAITS in Enabling the RADx Tech Program.","The RADx<sup>SM</sup> Tech initiative required a massive mobilization of the biomedical community. It was chartered with the extremely ambitious goal of rapidly developing and deploying innovative tests to detect people infected with the SARS-CoV-2 virus. It needed to do so at a scale and with urgency to get the country back to daily activities such as school and work as soon as possible. It required forming and supporting a diversity of teams with members from around the country and beyond. The","2021","06","30","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","CoLab; GAITS; RADx Tech; commercialization; healthcare innovation","Marino","Mark","VentureWell Hadley MA 02114 USA",NA
"1954","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Adans-Dester","Catherine P","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1955","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Bamberg","Stacy","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1956","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Bertacchi","Francesco P","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1957","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Caulfield","Brian","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1958","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Chappie","Kara","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1959","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Demarchi","Danilo","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1960","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Erb","M Kelley","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1961","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Estrada","Juan","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1962","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Fabara","Eric E","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1963","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Freni","Michael","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1964","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Friedl","Karl E","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1965","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Ghaffari","Roozbeh","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1966","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Gill","Geoffrey","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1967","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Greenberg","Mark S","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1968","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Hoyt","Reed W","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1969","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Jovanov","Emil","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1970","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Kanzler","Christoph M","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1971","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Katabi","Dina","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1972","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Kernan","Meredith","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1973","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Kigin","Colleen","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1974","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Lee","Sunghoon I","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1975","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Leonhardt","Steffen","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1976","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Lovell","Nigel H","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1977","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Mantilla","Jose","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1978","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","McCoy","Thomas H","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1979","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Luo","Nell Meosky","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1980","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Miller","Glenn A","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1981","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Moore","John","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1982","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","O'Keeffe","Derek","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1983","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Palmer","Jeffrey","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1984","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Parisi","Federico","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1985","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Patel","Shyamal","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1986","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Po","Jack","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1987","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Pugliese","Benito L","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1988","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Quatieri","Thomas","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1989","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Rahman","Tauhidur","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1990","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Ramasarma","Nathan","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1991","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Rogers","John A","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1992","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Ruiz-Esparza","Guillermo U","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1993","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Sapienza","Stefano","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1994","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Schiurring","Gregory","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1995","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Schwamm","Lee","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1996","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Shafiee","Hadi","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1997","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Kelly Silacci","Sara","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1998","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Sims","Nathaniel M","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"1999","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Talkar","Tanya","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2000","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Tharion","William J","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2001","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Toombs","James A","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2002","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Uschnig","Christopher","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2003","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Vergara-Diaz","Gloria P","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2004","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Wacnik","Paul","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2005","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Wang","May D","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2006","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Welch","James","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2007","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Williamson","Lina","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2008","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Zafonte","Ross","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2009","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Zai","Adrian","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2010","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Zhang","Yuan-Ting","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2011","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Tearney","Guillermo J","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2012","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Ahmad","Rushdy","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2013","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Walt","David R","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2014","34192282","10.1109/OJEMB.2020.3015141","Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?","Goal: The aim of the study herein reported was to review mobile health (mHealth) technologies and explore their use to monitor and mitigate the effects of the COVID-19 pandemic. Methods: A Task Force was assembled by recruiting individuals with expertise in electronic Patient-Reported Outcomes (ePRO), wearable sensors, and digital contact tracing technologies. Its members collected and discussed available information and summarized it in a series of reports. Results: The Tas","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; digital contact tracing; electronic patient reported outcomes (ePRO); mHealth technology; wearable sensors","Bonato","Paolo","Paolo Bonato is with the Department of Physical Medicine and RehabilitationHarvard Medical School at Spaulding Rehabilitation HospitalBostonMA02129USA",NA
"2015","34192281","10.1109/OJEMB.2020.3002447","Detecting Regions At Risk for Spreading COVID-19 Using Existing Cellular Wireless Network Functionalities.","Goal: The purpose of this article is to introduce a new strategy to identify areas with high human density and mobility, which are at risk for spreading COVID-19. Crowded regions with actively moving people (called at-risk regions) are susceptible to spreading the disease, especially if they contain asymptomatic infected people together with healthy people. Methods: Our scheme identifies at-risk regions using existing cellular network functionalities-handover a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; infectious diseases; tracking","Alsaeedy","Alaa A R","Department of Electrical and Computer EngineeringColorado State UniversityFort CollinsCO80523USA",NA
"2016","34192281","10.1109/OJEMB.2020.3002447","Detecting Regions At Risk for Spreading COVID-19 Using Existing Cellular Wireless Network Functionalities.","Goal: The purpose of this article is to introduce a new strategy to identify areas with high human density and mobility, which are at risk for spreading COVID-19. Crowded regions with actively moving people (called at-risk regions) are susceptible to spreading the disease, especially if they contain asymptomatic infected people together with healthy people. Methods: Our scheme identifies at-risk regions using existing cellular network functionalities-handover a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","COVID-19; infectious diseases; tracking","Chong","Edwin K P","Department of Electrical and Computer EngineeringColorado State UniversityFort CollinsCO80523USA",NA
"2017","34192280","10.1109/OJEMB.2020.2999214","COVID-19 Antibody Test/Vaccination Certification: There's an App for That.","Goal: As the Coronavirus Pandemic of 2019/2020 unfolds, a COVID-19 'Immunity Passport' has been mooted as a way to enable individuals to return back to work. While the quality of antibody testing, the availability of vaccines, and the likelihood of even attaining COVID-19 immunity continue to be researched, we address the issues involved in providing tamper-proof and privacy-preserving certification for test results and vaccinations. Methods: We developed a prototype mobile phone a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","Blockchain; COVID-19; coronavirus; decentralized; immunity certification","Eisenstadt","Marc","Knowledge Media InstituteThe Open UniversityMiltonKeynesMK7 6AAU",NA
"2018","34192280","10.1109/OJEMB.2020.2999214","COVID-19 Antibody Test/Vaccination Certification: There's an App for That.","Goal: As the Coronavirus Pandemic of 2019/2020 unfolds, a COVID-19 'Immunity Passport' has been mooted as a way to enable individuals to return back to work. While the quality of antibody testing, the availability of vaccines, and the likelihood of even attaining COVID-19 immunity continue to be researched, we address the issues involved in providing tamper-proof and privacy-preserving certification for test results and vaccinations. Methods: We developed a prototype mobile phone a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","Blockchain; COVID-19; coronavirus; decentralized; immunity certification","Ramachandran","Manoharan","Knowledge Media InstituteThe Open UniversityMiltonKeynesMK7 6AAU",NA
"2019","34192280","10.1109/OJEMB.2020.2999214","COVID-19 Antibody Test/Vaccination Certification: There's an App for That.","Goal: As the Coronavirus Pandemic of 2019/2020 unfolds, a COVID-19 'Immunity Passport' has been mooted as a way to enable individuals to return back to work. While the quality of antibody testing, the availability of vaccines, and the likelihood of even attaining COVID-19 immunity continue to be researched, we address the issues involved in providing tamper-proof and privacy-preserving certification for test results and vaccinations. Methods: We developed a prototype mobile phone a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","Blockchain; COVID-19; coronavirus; decentralized; immunity certification","Chowdhury","Niaz","Knowledge Media InstituteThe Open UniversityMiltonKeynesMK7 6AAU",NA
"2020","34192280","10.1109/OJEMB.2020.2999214","COVID-19 Antibody Test/Vaccination Certification: There's an App for That.","Goal: As the Coronavirus Pandemic of 2019/2020 unfolds, a COVID-19 'Immunity Passport' has been mooted as a way to enable individuals to return back to work. While the quality of antibody testing, the availability of vaccines, and the likelihood of even attaining COVID-19 immunity continue to be researched, we address the issues involved in providing tamper-proof and privacy-preserving certification for test results and vaccinations. Methods: We developed a prototype mobile phone a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","Blockchain; COVID-19; coronavirus; decentralized; immunity certification","Third","Allan","Knowledge Media InstituteThe Open UniversityMiltonKeynesMK7 6AAU",NA
"2021","34192280","10.1109/OJEMB.2020.2999214","COVID-19 Antibody Test/Vaccination Certification: There's an App for That.","Goal: As the Coronavirus Pandemic of 2019/2020 unfolds, a COVID-19 'Immunity Passport' has been mooted as a way to enable individuals to return back to work. While the quality of antibody testing, the availability of vaccines, and the likelihood of even attaining COVID-19 immunity continue to be researched, we address the issues involved in providing tamper-proof and privacy-preserving certification for test results and vaccinations. Methods: We developed a prototype mobile phone a","2021","07","02","IEEE Open J Eng Med Biol","IEEE open journal of engineering in medicine and biology","Blockchain; COVID-19; coronavirus; decentralized; immunity certification","Domingue","John","Knowledge Media InstituteThe Open UniversityMiltonKeynesMK7 6AAU",NA
"2022","34192279","10.1097/FM9.0000000000000071","Human Coronavirus Infections and Pregnancy.","Human coronavirus (HCoV) causes potentially fatal respiratory disease. Pregnancy is a physiological state that predisposes women to viral infection. In this review, we aim to present advances in the pathogenesis, clinical features, diagnosis, and treatment in HCoV in pregnancy. We retrieved information from the Pubmed database up to June 2020, using various search terms and relevant words, including coronaviruses, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome co","2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","COVID-19; Coronavirus; MERS-CoV; Pregnancy; SARS-CoV; SARS-CoV-2","Fan","Shangrong","Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China",NA
"2023","34192279","10.1097/FM9.0000000000000071","Human Coronavirus Infections and Pregnancy.","Human coronavirus (HCoV) causes potentially fatal respiratory disease. Pregnancy is a physiological state that predisposes women to viral infection. In this review, we aim to present advances in the pathogenesis, clinical features, diagnosis, and treatment in HCoV in pregnancy. We retrieved information from the Pubmed database up to June 2020, using various search terms and relevant words, including coronaviruses, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome co","2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","COVID-19; Coronavirus; MERS-CoV; Pregnancy; SARS-CoV; SARS-CoV-2","Yan","Shaomei","Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China",NA
"2024","34192279","10.1097/FM9.0000000000000071","Human Coronavirus Infections and Pregnancy.","Human coronavirus (HCoV) causes potentially fatal respiratory disease. Pregnancy is a physiological state that predisposes women to viral infection. In this review, we aim to present advances in the pathogenesis, clinical features, diagnosis, and treatment in HCoV in pregnancy. We retrieved information from the Pubmed database up to June 2020, using various search terms and relevant words, including coronaviruses, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome co","2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","COVID-19; Coronavirus; MERS-CoV; Pregnancy; SARS-CoV; SARS-CoV-2","Liu","Xiaoping","Department of Laboratory Science, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China",NA
"2025","34192279","10.1097/FM9.0000000000000071","Human Coronavirus Infections and Pregnancy.","Human coronavirus (HCoV) causes potentially fatal respiratory disease. Pregnancy is a physiological state that predisposes women to viral infection. In this review, we aim to present advances in the pathogenesis, clinical features, diagnosis, and treatment in HCoV in pregnancy. We retrieved information from the Pubmed database up to June 2020, using various search terms and relevant words, including coronaviruses, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome co","2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","COVID-19; Coronavirus; MERS-CoV; Pregnancy; SARS-CoV; SARS-CoV-2","Liu","Ping","Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China",NA
"2026","34192279","10.1097/FM9.0000000000000071","Human Coronavirus Infections and Pregnancy.","Human coronavirus (HCoV) causes potentially fatal respiratory disease. Pregnancy is a physiological state that predisposes women to viral infection. In this review, we aim to present advances in the pathogenesis, clinical features, diagnosis, and treatment in HCoV in pregnancy. We retrieved information from the Pubmed database up to June 2020, using various search terms and relevant words, including coronaviruses, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome co","2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","COVID-19; Coronavirus; MERS-CoV; Pregnancy; SARS-CoV; SARS-CoV-2","Huang","Lei","Department of Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China",NA
"2027","34192279","10.1097/FM9.0000000000000071","Human Coronavirus Infections and Pregnancy.","Human coronavirus (HCoV) causes potentially fatal respiratory disease. Pregnancy is a physiological state that predisposes women to viral infection. In this review, we aim to present advances in the pathogenesis, clinical features, diagnosis, and treatment in HCoV in pregnancy. We retrieved information from the Pubmed database up to June 2020, using various search terms and relevant words, including coronaviruses, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome co","2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","COVID-19; Coronavirus; MERS-CoV; Pregnancy; SARS-CoV; SARS-CoV-2","Wang","Suhua","Department of Obstetrics and Gynecology, Third People's Hospital of Shenzhen, Shenzhen, Guangdong 518020, China",NA
"2028","34192278","10.1097/FM9.0000000000000072","Keeping Pregnant Patients Safe During COVID-19 Pandemic.",NA,"2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)",NA,"Hess","Philip E","Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA",NA
"2029","34192278","10.1097/FM9.0000000000000072","Keeping Pregnant Patients Safe During COVID-19 Pandemic.",NA,"2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)",NA,"Wylie","Blair J","Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA",NA
"2030","34192278","10.1097/FM9.0000000000000072","Keeping Pregnant Patients Safe During COVID-19 Pandemic.",NA,"2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)",NA,"Golen","Toni","Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA",NA
"2031","34192278","10.1097/FM9.0000000000000072","Keeping Pregnant Patients Safe During COVID-19 Pandemic.",NA,"2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)",NA,"Shainker","Scott A","Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA",NA
"2032","34192278","10.1097/FM9.0000000000000072","Keeping Pregnant Patients Safe During COVID-19 Pandemic.",NA,"2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)",NA,"Zera","Chloe","Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA",NA
"2033","34192278","10.1097/FM9.0000000000000072","Keeping Pregnant Patients Safe During COVID-19 Pandemic.",NA,"2021","07","02","Matern Fetal Med","Maternal-fetal medicine (Wolters Kluwer Health, Inc.)",NA,"Li","Yunping","Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA",NA
"2034","34192276","10.1097/OR9.0000000000000036","COVID-19 pandemic and clinical psychology placements: a provisional psychologist's perspective.",NA,"2021","07","02","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice",NA,"Whittall","Hannah","Flinders University, Adelaide, South Australia",NA
"2035","34192276","10.1097/OR9.0000000000000036","COVID-19 pandemic and clinical psychology placements: a provisional psychologist's perspective.",NA,"2021","07","02","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice",NA,"Shaw","Joanne","Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, New South Wales",NA
"2036","34192276","10.1097/OR9.0000000000000036","COVID-19 pandemic and clinical psychology placements: a provisional psychologist's perspective.",NA,"2021","07","02","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice",NA,"Beatty","Lisa","Flinders University, Adelaide, South Australia",NA
"2037","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Liu","Xiaohong","Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2038","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Liu","Feng","Department of Radiation Oncology, Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2039","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Tong","Fei","Psychological Clinic, Hunan Cancer Hospital The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2040","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Peng","Wanglian","Department of Hospice Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2041","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Wen","Minni","Department of Clinical Spiritual Care, Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2042","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Zou","Ran","Department of Hospice Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2043","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Zhang","Lemeng","Thoracic Medicine Department, Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2044","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Jiang","Ling","Department of Clinical Spiritual Care, Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2045","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Yang","Hui","Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2046","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Yi","Lili","Thoracic Medicine Department, Hunan Cancer Hospital/ The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2047","34192275","10.1097/OR9.0000000000000035","Psychological reactions and interventions to help Cancer patients cope during the COVID-19 pandemic in China.","During COVID-19 pandemic, how can cancer patients adjust their psychological status? In this article, some questions and suggestions are given to share. I listed some of negative emotions could happen on cancer patients and showed their harm and gave suggestions accordingly, especially in how to keep cancer patients in a healthy attitude during the difficult time.","2021","06","30","J Psychosoc Oncol Res Pract","Journal of psychosocial oncology research and practice","COVID-19 pandemic; Cancer patient; Psychological crisis; Psychosocial reactions","Huang","Xufen","Department of Hospice Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, P.R. China",NA
"2048","34192273","10.1093/ehjdh/ztaa007","COVID-19 pandemic: practical considerations on rapid initiation of remote care in chronic cardiac patients.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Schuuring","Mark J","Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands",NA
"2049","34192273","10.1093/ehjdh/ztaa007","COVID-19 pandemic: practical considerations on rapid initiation of remote care in chronic cardiac patients.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Kauw","Dirkjan","Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands",NA
"2050","34192273","10.1093/ehjdh/ztaa007","COVID-19 pandemic: practical considerations on rapid initiation of remote care in chronic cardiac patients.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Bouma","Berto J","Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands",NA
"2051","34192272","10.1093/ehjdh/ztaa003","Insights from Twitter about novel COVID-19 symptoms.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Krittanawong","Chayakrit","The Michael E. DeBakey VA Medical Center, Section of Cardiology, Baylor College of Medicine, Houston, TX, USA",NA
"2052","34192272","10.1093/ehjdh/ztaa003","Insights from Twitter about novel COVID-19 symptoms.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Narasimhan","Bharat","Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"2053","34192272","10.1093/ehjdh/ztaa003","Insights from Twitter about novel COVID-19 symptoms.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Virk","Hafeez Ul Hassan","Department of Cardiovascular Diseases, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA",NA
"2054","34192272","10.1093/ehjdh/ztaa003","Insights from Twitter about novel COVID-19 symptoms.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Narasimhan","Harish","Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA",NA
"2055","34192272","10.1093/ehjdh/ztaa003","Insights from Twitter about novel COVID-19 symptoms.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Wang","Zhen","Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA",NA
"2056","34192272","10.1093/ehjdh/ztaa003","Insights from Twitter about novel COVID-19 symptoms.",NA,"2021","07","02","Eur Heart J Digit Health","European heart journal. Digital health",NA,"Tang","W H Wilson","Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA",NA
"2057","34192271","10.1093/oxfimm/iqab004","What can neuroimmunology teach us about the symptoms of long-COVID?","Long-Coronavirus Disease (Long-COVID) is becoming increasingly recognized due to the persistence of symptoms such as profound fatigue, neurocognitive difficulties, muscle pains and weaknesses and depression, which would last beyond 3-12 weeks following infection with SARS-CoV-2. These particular symptoms have been extensively observed and studied in the context of previous psychoneuroimmunology research. In this short commentary, we discuss how previous neuroimmunology studies could help us to b","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; depression; fatigue; long-COVID; microglia; neuroimmunology","Mondelli","Valeria","Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"2058","34192271","10.1093/oxfimm/iqab004","What can neuroimmunology teach us about the symptoms of long-COVID?","Long-Coronavirus Disease (Long-COVID) is becoming increasingly recognized due to the persistence of symptoms such as profound fatigue, neurocognitive difficulties, muscle pains and weaknesses and depression, which would last beyond 3-12 weeks following infection with SARS-CoV-2. These particular symptoms have been extensively observed and studied in the context of previous psychoneuroimmunology research. In this short commentary, we discuss how previous neuroimmunology studies could help us to b","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; depression; fatigue; long-COVID; microglia; neuroimmunology","Pariante","Carmine M","Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK",NA
"2059","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Scourfield","D Oliver","Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK",NA
"2060","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Reed","Sophie G","Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK",NA
"2061","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Quastel","Max","Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK",NA
"2062","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Alderson","Jennifer","Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, OX3 FTY, UK",NA
"2063","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Bart","Valentina M T","Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK",NA
"2064","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Teijeira Crespo","Alicia","Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN UK",NA
"2065","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Jones","Ruth","Dementia Research Institute, Cardiff University, Cardiff, CF24 4HQ, UK",NA
"2066","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Pring","Ellie","Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK",NA
"2067","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Richter","Felix Clemens","Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, OX3 FTY, UK",NA
"2068","34192270","10.1093/oxfimm/iqab003","The role and uses of antibodies in COVID-19 infections: a living review.","Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various ","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; antibodies; convalescent plasma; long-term immunity; nanobodies; vaccines","Burnell","Stephanie E A","Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK",NA
"2069","34192269","10.1093/oxfimm/iqab001","Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.","The role of obesity in the pathophysiology of respiratory virus infections has become particularly apparent during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, where obese patients are twice as likely to suffer from severe coronavirus disease 2019 (COVID-19) than healthy weight individuals. Obesity results in disruption of systemic lipid metabolism promoting a state of chronic low-grade inflammation. However, it remains unclear how these underlying metabolic","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; immune response; inflammation; influenza; metabolism; obesity; virus","Richter","Felix Clemens","Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK",NA
"2070","34192269","10.1093/oxfimm/iqab001","Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.","The role of obesity in the pathophysiology of respiratory virus infections has become particularly apparent during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, where obese patients are twice as likely to suffer from severe coronavirus disease 2019 (COVID-19) than healthy weight individuals. Obesity results in disruption of systemic lipid metabolism promoting a state of chronic low-grade inflammation. However, it remains unclear how these underlying metabolic","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; immune response; inflammation; influenza; metabolism; obesity; virus","Alrubayyi","Aljawharah","Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK",NA
"2071","34192269","10.1093/oxfimm/iqab001","Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.","The role of obesity in the pathophysiology of respiratory virus infections has become particularly apparent during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, where obese patients are twice as likely to suffer from severe coronavirus disease 2019 (COVID-19) than healthy weight individuals. Obesity results in disruption of systemic lipid metabolism promoting a state of chronic low-grade inflammation. However, it remains unclear how these underlying metabolic","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; immune response; inflammation; influenza; metabolism; obesity; virus","Teijeira Crespo","Alicia","Division of Cancer and Genetics, Henry Wellcome Building, Cardiff University, Cardiff, UK",NA
"2072","34192269","10.1093/oxfimm/iqab001","Impact of obesity and SARS-CoV-2 infection: implications for host defence - a living review.","The role of obesity in the pathophysiology of respiratory virus infections has become particularly apparent during the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, where obese patients are twice as likely to suffer from severe coronavirus disease 2019 (COVID-19) than healthy weight individuals. Obesity results in disruption of systemic lipid metabolism promoting a state of chronic low-grade inflammation. However, it remains unclear how these underlying metabolic","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; immune response; inflammation; influenza; metabolism; obesity; virus","Hulin-Curtis","Sarah","Division of Infection and Immunity, Henry Wellcome Building, Cardiff University, Cardiff, UK",NA
"2073","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Rodrigues","Patrícia R S","Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK",NA
"2074","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Alrubayyi","Aljawharah","Nuffield Department of Medicine, Viral Immunology Unit, University of Oxford, Oxford, UK",NA
"2075","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Pring","Ellie","Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK",NA
"2076","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Bart","Valentina M T","Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK",NA
"2077","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Jones","Ruth","Dementia Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2078","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Coveney","Clarissa","Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK",NA
"2079","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Lu","Fangfang","Sir William Dunn School of Pathology, University of Oxford, Oxford, UK",NA
"2080","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Tellier","Michael","Sir William Dunn School of Pathology, University of Oxford, Oxford, UK",NA
"2081","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Maleki-Toyserkani","Shayda","Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK",NA
"2082","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Richter","Felix C","Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK",NA
"2083","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Scourfield","D Oliver","Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK",NA
"2084","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Gea-Mallorquí","Ester","Nuffield Department of Medicine, Viral Immunology Unit, University of Oxford, Oxford, UK",NA
"2085","34192268","10.1093/oxfimm/iqaa005","Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.","The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; Innate immunology; Macrophages; Monocytes; NK cells; Neutrophils","Davies","Luke C","Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK",NA
"2086","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Coveney","Clarissa","Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK",NA
"2087","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Tellier","Michel","Sir William Dunn School of Pathology, University of Oxford, Oxford, UK",NA
"2088","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Lu","Fangfang","Sir William Dunn School of Pathology, University of Oxford, Oxford, UK",NA
"2089","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Maleki-Toyserkani","Shayda","Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2090","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Jones","Ruth","Dementia Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2091","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Bart","Valentina M T","Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2092","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Pring","Ellie","Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2093","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Alrubayyi","Aljawharah","Viral Immunology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"2094","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Richter","Felix C","Sir William Dunn School of Pathology, University of Oxford, Oxford, UK",NA
"2095","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Scourfield","D Oliver","Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2096","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Rehwinkel","Jan","Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK",NA
"2097","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Rodrigues","Patrícia R S","Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2098","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Davies","Luke C","Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK",NA
"2099","34192267","10.1093/oxfimm/iqaa004","Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.","The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral ent","2021","07","02","Oxf Open Immunol","Oxford open immunology","COVID-19; SARS-CoV-2; host response; interferon; viral entry; viral evasion","Gea-Mallorquí","Ester","Viral Immunology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK",NA
"2100","34192265","10.1177/2633489520949151","Implementation researchers can improve the responses of services to the COVID-19 pandemic.","This article describes a rapid implementation research project with the Stockholm health care system to assist the system to respond to the COVID-19 pandemic. It uses this example to illustrate some ways in which implementation research and knowledge can contribute to improving service responses to the pandemic and its consequences as these evolve over the coming months. A sub-specialty of rapid implementation science is proposed to provide practical assistance and as one way to develop implemen","2021","07","02","Implement Res Pract","Implementation research and practice","COVID-19; Emergency management; implementing organization changes","Øvretveit","John","Medical Management Center (LIME), Karolinska Institutet, Stockholm, Sweden",NA
"2101","34192264","10.1017/qrd.2021.2","Ultrafast enzymatic digestion of deoxyribonucleic acid in aqueous microdroplets for sequence discrimination and identification.","We report the use of aqueous microdroplets to accelerate deoxyribonucleic acid (DNA) fragmentation by deoxyribonuclease I (DNase I), and we present a simple, ultrafast approach named DNA fragment mass fingerprinting to discriminate different DNA sequences by comparing their fragment mass patterns. DNA fragmentation in tiny microdroplets, which was produced by electrosonically spraying (+3 kV) a room temperature aqueous solution containing 10 µM DNA and 10 µg ml<sup>-1</sup> DNase I from a homema","2021","07","02","QRB Discov","QRB discovery","DNA; Deoxyribonuclease; Microdroplet chemistry; Reaction Rate Acceleration; SARS-CoV-2Orf1ab","Zhong","Xiaoqin","Department of Chemistry, Fudan University, Shanghai, China",NA
"2102","34192264","10.1017/qrd.2021.2","Ultrafast enzymatic digestion of deoxyribonucleic acid in aqueous microdroplets for sequence discrimination and identification.","We report the use of aqueous microdroplets to accelerate deoxyribonucleic acid (DNA) fragmentation by deoxyribonuclease I (DNase I), and we present a simple, ultrafast approach named DNA fragment mass fingerprinting to discriminate different DNA sequences by comparing their fragment mass patterns. DNA fragmentation in tiny microdroplets, which was produced by electrosonically spraying (+3 kV) a room temperature aqueous solution containing 10 µM DNA and 10 µg ml<sup>-1</sup> DNase I from a homema","2021","07","02","QRB Discov","QRB discovery","DNA; Deoxyribonuclease; Microdroplet chemistry; Reaction Rate Acceleration; SARS-CoV-2Orf1ab","Chen","Hao","Department of Chemistry &amp",NA
"2103","34192264","10.1017/qrd.2021.2","Ultrafast enzymatic digestion of deoxyribonucleic acid in aqueous microdroplets for sequence discrimination and identification.","We report the use of aqueous microdroplets to accelerate deoxyribonucleic acid (DNA) fragmentation by deoxyribonuclease I (DNase I), and we present a simple, ultrafast approach named DNA fragment mass fingerprinting to discriminate different DNA sequences by comparing their fragment mass patterns. DNA fragmentation in tiny microdroplets, which was produced by electrosonically spraying (+3 kV) a room temperature aqueous solution containing 10 µM DNA and 10 µg ml<sup>-1</sup> DNase I from a homema","2021","07","02","QRB Discov","QRB discovery","DNA; Deoxyribonuclease; Microdroplet chemistry; Reaction Rate Acceleration; SARS-CoV-2Orf1ab","Zare","Richard N","Department of Chemistry, Fudan University, Shanghai, China",NA
"2104","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Zhang","Kaiming","Department of Bioengineering and James H. Clark Center, Stanford University, Stanford, CA 94305, USA",NA
"2105","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Li","Shanshan","Department of Bioengineering and James H. Clark Center, Stanford University, Stanford, CA 94305, USA",NA
"2106","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Pintilie","Grigore","Department of Bioengineering and James H. Clark Center, Stanford University, Stanford, CA 94305, USA",NA
"2107","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Chmielewski","David","Graduate Program in Biophysics, Stanford University, Stanford, CA 94305, USA",NA
"2108","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Schmid","Michael F","Division of CryoEM and Bioimaging, SSRL, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA",NA
"2109","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Simmons","Graham","Vitalant Research Institute, San Francisco, CA 94030, USA",NA
"2110","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Jin","Jing","Vitalant Research Institute, San Francisco, CA 94030, USA",NA
"2111","34192263","10.1017/qrd.2020.16","A 3.4-Å cryo-electron microscopy structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles.","Human coronavirus NL63 (HCoV-NL63) is an enveloped pathogen of the family Coronaviridae that spreads worldwide and causes up to 10% of all annual respiratory diseases. HCoV-NL63 is typically associated with mild upper respiratory symptoms in children, elderly and immunocompromised individuals. It has also been shown to cause severe lower respiratory illness. NL63 shares ACE2 as a receptor for viral entry with SARS-CoV-1 and SARS-CoV-2. Here, we present the in situ structure of HCoV","2021","07","02","QRB Discov","QRB discovery","Cryo-EM; human coronavirus NL63; spike trimer","Chiu","Wah","Department of Bioengineering and James H. Clark Center, Stanford University, Stanford, CA 94305, USA",NA
"2112","34192262","10.1017/qrd.2020.8","Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.","This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19's method of operation is upon nonhuman-like (NHL) epitopes in 21.6% of the composition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s spike protein, which displays distinct distributed","2021","07","02","QRB Discov","QRB discovery","Charge; Co-receptor; Epitope; Peptide; SARS-CoV-2; Vaccine","Sørensen","Birger","Immunor AS, Oslo, Norway",NA
"2113","34192262","10.1017/qrd.2020.8","Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.","This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19's method of operation is upon nonhuman-like (NHL) epitopes in 21.6% of the composition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s spike protein, which displays distinct distributed","2021","07","02","QRB Discov","QRB discovery","Charge; Co-receptor; Epitope; Peptide; SARS-CoV-2; Vaccine","Susrud","Andres","Immunor AS, Oslo, Norway",NA
"2114","34192262","10.1017/qrd.2020.8","Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.","This study presents the background, rationale and method of action of Biovacc-19, a candidate vaccine for corona virus disease 2019 (Covid-19), now in advanced preclinical development, which has already passed the first acute toxicity testing. Unlike conventionally developed vaccines, Biovacc-19's method of operation is upon nonhuman-like (NHL) epitopes in 21.6% of the composition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)'s spike protein, which displays distinct distributed","2021","07","02","QRB Discov","QRB discovery","Charge; Co-receptor; Epitope; Peptide; SARS-CoV-2; Vaccine","Dalgleish","Angus George","Immunor AS, Oslo, Norway",NA
"2115","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Edwards","David","Harvard John A. Paulson School of Engineering &amp",NA
"2116","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Hickey","Anthony","RTI International, Research Triangle Park, NC, USA",NA
"2117","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Batycky","Richard","Nocion Therapeutics, Waltham, MA, USA",NA
"2118","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Griel","Lester","Department of Veterinary and Biomedical Sciences, Penn State University, State College, PA, USA",NA
"2119","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Lipp","Michael","Nocion Therapeutics, Waltham, MA, USA",NA
"2120","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Dehaan","Wes","Selecta Biosciences, Watertown, MA, USA",NA
"2121","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Clarke","Robert","Pulmatrix Inc., Lexington, MA, USA",NA
"2122","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Hava","David","Pulmatrix Inc., Lexington, MA, USA",NA
"2123","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Perry","Jason","Pulmatrix Inc., Lexington, MA, USA",NA
"2124","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Laurenzi","Brendan","Pulmatrix Inc., Lexington, MA, USA",NA
"2125","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Curran","Aidan K","Pulmatrix Inc., Lexington, MA, USA",NA
"2126","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Beddingfield","Brandon J","Department of Microbiology and Immunology, Tulane School of Medicine, New Orleans, LA, USA",NA
"2127","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Roy","Chad J","Department of Microbiology and Immunology, Tulane School of Medicine, New Orleans, LA, USA",NA
"2128","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Devlin","Tom","Sensory Cloud Inc., Boston, MA, USA",NA
"2129","34192261","10.1017/qrd.2020.9","A New Natural Defense Against Airborne Pathogens.","We propose the nasal administration of calcium-enriched physiological salts as a new hygienic intervention with possible therapeutic application as a response to the rapid and tenacious spread of COVID-19. We test the effectiveness of these salts against viral and bacterial pathogens in animals and humans. We find that aerosol administration of these salts to the airways diminishes the exhalation of the small particles that face masks fail to filter and, in the case of an influenza swine model, ","2021","07","02","QRB Discov","QRB discovery","Aerosols; Covid-19; Exhaled Particles; Hygiene; Nasal Delivery; Saline","Langer","Robert","Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA",NA
"2130","34192259","10.1136/bmjno-2021-000140","COVID-19 lockdown impact on the physical activity of adults with progressive muscle diseases.","This short article summarises findings about reduced physical activity of adults with progressive muscle disease as a result of COVID-19 lockdown. As part of an ongoing longitudinal cohort study, we prospectively and objectively measured physical activity using accelerometry at baseline in 2019 and follow-up in 2020. A subset of 85 participants incidentally had follow-up data collected during the first UK COVID-19 lockdown from 23 March to 4 July 2020. Thus, for this cohort we had activity data ","2021","07","02","BMJ Neurol Open","BMJ neurology open","COVID-19; muscle disease; muscular dystrophy; physiotherapy; rehabilitation","Roberts-Lewis","Sarah F","School of Population Health and Environmental Sciences, King's College London, London, UK",NA
"2131","34192259","10.1136/bmjno-2021-000140","COVID-19 lockdown impact on the physical activity of adults with progressive muscle diseases.","This short article summarises findings about reduced physical activity of adults with progressive muscle disease as a result of COVID-19 lockdown. As part of an ongoing longitudinal cohort study, we prospectively and objectively measured physical activity using accelerometry at baseline in 2019 and follow-up in 2020. A subset of 85 participants incidentally had follow-up data collected during the first UK COVID-19 lockdown from 23 March to 4 July 2020. Thus, for this cohort we had activity data ","2021","07","02","BMJ Neurol Open","BMJ neurology open","COVID-19; muscle disease; muscular dystrophy; physiotherapy; rehabilitation","Ashworth","Mark","School of Population Health and Environmental Sciences, King's College London, London, UK",NA
"2132","34192259","10.1136/bmjno-2021-000140","COVID-19 lockdown impact on the physical activity of adults with progressive muscle diseases.","This short article summarises findings about reduced physical activity of adults with progressive muscle disease as a result of COVID-19 lockdown. As part of an ongoing longitudinal cohort study, we prospectively and objectively measured physical activity using accelerometry at baseline in 2019 and follow-up in 2020. A subset of 85 participants incidentally had follow-up data collected during the first UK COVID-19 lockdown from 23 March to 4 July 2020. Thus, for this cohort we had activity data ","2021","07","02","BMJ Neurol Open","BMJ neurology open","COVID-19; muscle disease; muscular dystrophy; physiotherapy; rehabilitation","White","Claire M","School of Population Health and Environmental Sciences, King's College London, London, UK",NA
"2133","34192259","10.1136/bmjno-2021-000140","COVID-19 lockdown impact on the physical activity of adults with progressive muscle diseases.","This short article summarises findings about reduced physical activity of adults with progressive muscle disease as a result of COVID-19 lockdown. As part of an ongoing longitudinal cohort study, we prospectively and objectively measured physical activity using accelerometry at baseline in 2019 and follow-up in 2020. A subset of 85 participants incidentally had follow-up data collected during the first UK COVID-19 lockdown from 23 March to 4 July 2020. Thus, for this cohort we had activity data ","2021","07","02","BMJ Neurol Open","BMJ neurology open","COVID-19; muscle disease; muscular dystrophy; physiotherapy; rehabilitation","Rose","Michael R","Neurology, King s College Hospital, London, UK",NA
"2134","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Ansari","Shamshul","Department of Microbiology, Chitwan Medical College and Teaching Hospital, Bharatpur, 44200 Chitwan, Nepal",NA
"2135","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Hays","John P","Department of Medical Microbiology &amp",NA
"2136","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Kemp","Andrew","Scientific Advisory Board of the British Institute of Cleaning Sciences, Northampton, UK",NA
"2137","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Okechukwu","Raymond","Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Agulu Campus, Nigeria",NA
"2138","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Murugaiyan","Jayaseelan","Department of Biology, SRM University AP, Andhra Pradesh 522502, India",NA
"2139","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Ekwanzala","Mutshiene Deogratias","Department of Environmental, Water and Earth Sciences, Tshwane University of Technology, Pretoria, South Africa",NA
"2140","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Ruiz Alvarez","Maria Josefina","Research Coordination and Support Service, Istituto Superiore di Sanità, Rome, Italy",NA
"2141","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Paul-Satyaseela","Maneesh","Acharya Institute of Technology, Bengaluru, India",NA
"2142","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Iwu","Chidozie Declan","School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa",NA
"2143","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Balleste-Delpierre","Clara","ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain",NA
"2144","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Septimus","Ed","Department of Population Medicine, Harvard Medical School &amp",NA
"2145","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Mugisha","Lawrence","College of Veterinary Medicine, Animal Resources &amp",NA
"2146","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Fadare","Joseph","Department of Pharmacology and Therapeutics, College of Medicine, Ekiti State University, Ado-Ekiti, Nigeria",NA
"2147","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Chaudhuri","Susmita","Translational Health Science and Technology Institute, Faridabad 121001, India",NA
"2148","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Chibabhai","Vindana","Department of Clinical Microbiology and Infectious Diseases, University of the Witwatersrand, and Clinical Microbiology Laboratory, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service, Johannesburg, South Africa",NA
"2149","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Wadanamby","J M Rohini W W","Department of Microbiology, Lanka Hospital Diagnostics, Lanka Hospital 578, Elvitigala Mw, Colombo 05, Sri Lanka",NA
"2150","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Daoud","Ziad","Department of Clinical Microbiology &amp",NA
"2151","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Xiao","Yonghong","State Key Laboratory for Diagnosis &amp",NA
"2152","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Parkunan","Thulasiraman","Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary and Animal Sciences, Institute of Agricultural Sciences, Rajiv Gandhi South Campus, Banaras Hindu University, Mirzapur, Uttar Pradesh, India",NA
"2153","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Khalaf","Yara","Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt",NA
"2154","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"M'Ikanatha","Nkuchia M","Division of Infectious Disease Epidemiology, Pennsylvania Department of Health, Harrisburg, PA, USA",NA
"2155","34192258","10.1093/jacamr/dlab038","The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.","The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pat","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"van Dongen","Maarten B M","AMR Insights, Amsterdam, The Netherlands",NA
"2156","34192257","10.1093/jacamr/dlab031","<i>Educational Resource Review</i>: Vaccine development: finding a vaccine for COVID-19 and future pandemics.",NA,"2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,NA,NA,NA,NA
"2157","34192256","10.1093/jacamr/dlab030","Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective.","While the use of antibiotics for secondary infections in COVID-19 has been described in scientific literature and guidelines have been issued for their appropriate use, the importance of listening to patients in a systematic manner has often been overlooked. To highlight this issue, we spoke with patients about their experiences with antibiotics as treatment for COVID-19 and their understanding of antimicrobial resistance (AMR). We found that there is a general lack of awareness of the risks of ","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Dahal","Deepa","DKI Health, 228 Park Ave Suite 28653, New York, NY 10003, USA",NA
"2158","34192256","10.1093/jacamr/dlab030","Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective.","While the use of antibiotics for secondary infections in COVID-19 has been described in scientific literature and guidelines have been issued for their appropriate use, the importance of listening to patients in a systematic manner has often been overlooked. To highlight this issue, we spoke with patients about their experiences with antibiotics as treatment for COVID-19 and their understanding of antimicrobial resistance (AMR). We found that there is a general lack of awareness of the risks of ","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Sundar","Swarna","DKI Health India Private Limited, 1st Floor Gopala Krishna Complex, Residency Road, Bangalore, Karnataka 560025, India",NA
"2159","34192256","10.1093/jacamr/dlab030","Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective.","While the use of antibiotics for secondary infections in COVID-19 has been described in scientific literature and guidelines have been issued for their appropriate use, the importance of listening to patients in a systematic manner has often been overlooked. To highlight this issue, we spoke with patients about their experiences with antibiotics as treatment for COVID-19 and their understanding of antimicrobial resistance (AMR). We found that there is a general lack of awareness of the risks of ","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Kullar","Ravina","Expert Stewardship, Inc, 320 Superior Ave, Newport Beach, CA 92663, USA",NA
"2160","34192256","10.1093/jacamr/dlab030","Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective.","While the use of antibiotics for secondary infections in COVID-19 has been described in scientific literature and guidelines have been issued for their appropriate use, the importance of listening to patients in a systematic manner has often been overlooked. To highlight this issue, we spoke with patients about their experiences with antibiotics as treatment for COVID-19 and their understanding of antimicrobial resistance (AMR). We found that there is a general lack of awareness of the risks of ","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Milevska-Kostova","Neda","International Alliance of Patients Organisations, 49-51 East Road, London N1 6AH, UK",NA
"2161","34192256","10.1093/jacamr/dlab030","Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective.","While the use of antibiotics for secondary infections in COVID-19 has been described in scientific literature and guidelines have been issued for their appropriate use, the importance of listening to patients in a systematic manner has often been overlooked. To highlight this issue, we spoke with patients about their experiences with antibiotics as treatment for COVID-19 and their understanding of antimicrobial resistance (AMR). We found that there is a general lack of awareness of the risks of ","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Dindial","Karen","DKI Health, 228 Park Ave Suite 28653, New York, NY 10003, USA",NA
"2162","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Rawson","Timothy M","National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK",NA
"2163","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Hernandez","Bernard","Centre for Bio-inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK",NA
"2164","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Wilson","Richard C","National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK",NA
"2165","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Ming","Damien","National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK",NA
"2166","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Herrero","Pau","Centre for Bio-inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK",NA
"2167","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Ranganathan","Nisha","Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK",NA
"2168","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Skolimowska","Keira","Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK",NA
"2169","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Gilchrist","Mark","National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK",NA
"2170","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Satta","Giovanni","Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK",NA
"2171","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Georgiou","Pantelis","Centre for Bio-inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, UK",NA
"2172","34192255","10.1093/jacamr/dlab002","Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19.","Bacterial infection has been challenging to diagnose in patients with COVID-19. We developed and evaluated supervised machine learning algorithms to support the diagnosis of secondary bacterial infection in hospitalized patients during the COVID-19 pandemic. Inpatient data at three London hospitals for the first COVD-19 wave in March and April 2020 were extracted. Demographic, blood test and microbiology data for individuals with and without SARS-CoV-2-positive PCR were obtained. A Gaussian Naiv","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Holmes","Alison H","National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK",NA
"2173","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Malcolm","William","NHS National Services Scotland, Glasgow, UK",NA
"2174","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Seaton","Ronald A","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK",NA
"2175","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Haddock","Gail","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK",NA
"2176","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Baxter","Linsey","Public Health Scotland, Edinburgh, UK",NA
"2177","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Thirlwell","Sarah","Public Health Scotland, Edinburgh, UK",NA
"2178","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Russell","Polly","Public Health Scotland, Edinburgh, UK",NA
"2179","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Cooper","Lesley","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK",NA
"2180","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Thomson","Anne","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK",NA
"2181","34192254","10.1093/jacamr/dlaa105","Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland.","Following concerns about increased antibiotic use during the COVID-19 pandemic, trends in community antibiotic prescriptions in Scotland were evaluated. The primary care prescription electronic messaging system used in GP practices with NHS contracts provided near real-time data analysis of national data. The main outcome measures were the weekly number of prescriptions for antibiotics generated by prescribers in GP practices in 2020 compared with 2019. At end of Week 12 2020 (22 March), after a","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Sneddon","Jacqueline","Scottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, Glasgow, UK",NA
"2182","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Townsend","Liam",NA,NA
"2183","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Hughes","Gerry",NA,NA
"2184","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Kerr","Colm",NA,NA
"2185","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Kelly","Mary",NA,NA
"2186","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"O'Connor","Roisin",NA,NA
"2187","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Sweeney","Eileen",NA,NA
"2188","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Doyle","Catriona",NA,NA
"2189","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"O'Riordan","Ruth",NA,NA
"2190","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Martin-Loeches","Ignacio",NA,NA
"2191","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Bergin","Colm",NA,NA
"2192","34192253","10.1093/jacamr/dlaa095","Erratum to: Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection.","[This corrects the article DOI: 10.1093/jacamr/dlaa071.].","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Bannan","Ciaran",NA,NA
"2193","34192252","10.1093/jacamr/dlaa067","<i>Nomen est omen</i>: why we need to rename 'antimicrobial resistance'.","The naming of diseases is a critical aspect of public health communication. In light of the recent renaming of the 'Wuhan novel coronavirus' to COVID-19, the names of other health threats must be reviewed. In particular, a new name is urgently needed for the global challenge typically referred to as 'antimicrobial resistance'. The current name is inconsistently used, difficult to pronounce and lacks meaning for lay audiences. It also fails to express the magnitude of the phenomenon's potential c","2021","07","04","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Krockow","Eva M","Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester LE1 7RH, UK",NA
"2194","34192251","10.1093/jacamr/dlaa055","Emerging respiratory viruses, including COVID-19: methods for detection, prevention, response and control.","Graphical Abstract.","2021","06","30","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,NA,NA,NA,NA
"2195","34192250","10.1093/jacamr/dlaa053","The impact of the COVID-19 pandemic on antimicrobial resistance: a debate.","The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial ","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"van Duin","David","Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA",NA
"2196","34192250","10.1093/jacamr/dlaa053","The impact of the COVID-19 pandemic on antimicrobial resistance: a debate.","The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial ","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Barlow","Gavin","Department of Infection, Hull University Teaching Hospitals NHS Trust, Hull, UK and Hull York Medical School, University of York, Heslington, UK",NA
"2197","34192250","10.1093/jacamr/dlaa053","The impact of the COVID-19 pandemic on antimicrobial resistance: a debate.","The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial ","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Nathwani","Dilip","Emeritus Honorary Professor of Infection, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK",NA
"2198","34192249","10.1093/jacamr/dlaa051","CON: COVID-19 will not result in increased antimicrobial resistance prevalence.","Antimicrobial resistance (AMR) is affected by many factors, but too much of our focus has been on antimicrobial usage. The major factor that drives resistance rates globally is spread. The COVID-19 pandemic should lead to improved infection prevention and control practices, both in healthcare facilities and the community. COVID-19 will also have ongoing and profound effects on local, national and international travel. All these factors should lead to a decrease in the spread of resistant bacteri","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Collignon","Peter","Australian Capital Territory Pathology, Canberra Hospital, Garran, Australian Capital Territory, Australia",NA
"2199","34192249","10.1093/jacamr/dlaa051","CON: COVID-19 will not result in increased antimicrobial resistance prevalence.","Antimicrobial resistance (AMR) is affected by many factors, but too much of our focus has been on antimicrobial usage. The major factor that drives resistance rates globally is spread. The COVID-19 pandemic should lead to improved infection prevention and control practices, both in healthcare facilities and the community. COVID-19 will also have ongoing and profound effects on local, national and international travel. All these factors should lead to a decrease in the spread of resistant bacteri","2021","07","02","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Beggs","John J","Monarch Institute, 10 Queen St, Melbourne, Australia",NA
"2200","34192248","10.1093/jacamr/dlaa049","PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates.","We argue that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR). Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients and in excess of reported secondary infection rates, suggesting unnecessary prescribing. Selection pressure is likely to be particularly intense in COVID-19 epicentres and within non-epicentre hospital units dedicated to COVID-19 care. Risk factors that increase the likelihood of hospitalization or poor outcomes among COVID-19 p","2021","07","05","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Clancy","Cornelius J","University of Pittsburgh, Department of Medicine, Pittsburgh, PA, USA",NA
"2201","34192248","10.1093/jacamr/dlaa049","PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates.","We argue that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR). Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients and in excess of reported secondary infection rates, suggesting unnecessary prescribing. Selection pressure is likely to be particularly intense in COVID-19 epicentres and within non-epicentre hospital units dedicated to COVID-19 care. Risk factors that increase the likelihood of hospitalization or poor outcomes among COVID-19 p","2021","07","05","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Buehrle","Deanna J","VA Pittsburgh Healthcare System, Pittsburgh, PA, USA",NA
"2202","34192248","10.1093/jacamr/dlaa049","PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates.","We argue that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR). Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients and in excess of reported secondary infection rates, suggesting unnecessary prescribing. Selection pressure is likely to be particularly intense in COVID-19 epicentres and within non-epicentre hospital units dedicated to COVID-19 care. Risk factors that increase the likelihood of hospitalization or poor outcomes among COVID-19 p","2021","07","05","JAC Antimicrob Resist","JAC-antimicrobial resistance",NA,"Nguyen","M Hong","University of Pittsburgh, Department of Medicine, Pittsburgh, PA, USA",NA
"2203","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Kakimoto","Kazuki","nd Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan",NA
"2204","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Matsuura","Minoru","Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan",NA
"2205","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Fukuchi","Takumi","Department of Gastroenterology and Hepatology, Iseikai Hospital, Osaka, Osaka, Japan",NA
"2206","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Hongo","Hitoshi","Department of Gastroenterology, Fujita Gastroenterological Hospital, Takatsuki, Osaka, Japan",NA
"2207","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Kimura","Tsuguhiro","Department of Gastroenterology, Fujita Gastroenterological Hospital, Takatsuki, Osaka, Japan",NA
"2208","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Aoyama","Nobuo","Department of Gastroenterology, Gastrointestinal Endoscopy and IBD Center, Aoyama Medical Clinic, Kobe, Hyogo, Japan",NA
"2209","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Okuda","Yorihide","Department of Gastroenterology, Otemae Hospital, Osaka, Osaka, Japan",NA
"2210","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Aomatsu","Kazuki","Department of Gastroenterology, Izumiotsu Municipal Hospital, Izumiotsu, Osaka, Japan",NA
"2211","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Kamata","Noriko","Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Osaka, Japan",NA
"2212","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Yokoyama","Yoko","Department of Intestinal Inflammation Research, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan",NA
"2213","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Mizuno","Chiemi","Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Osaka, Japan",NA
"2214","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Inoue","Takuya","nd Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan",NA
"2215","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Miyazaki","Takako","nd Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan",NA
"2216","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Nakamura","Shiro","nd Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan",NA
"2217","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Higuchi","Kazuhide","nd Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan",NA
"2218","34192247","10.1093/crocol/otaa073","Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.","Granulocyte and monocyte adsorptive apheresis (GMA) has been used for therapy of steroid-dependent/refractory ulcerative colitis (UC). The aim of this study was to investigate the effectiveness of GMA in UC patients not receiving steroids. We conducted a single-arm, open-label, and multicenter prospective clinical trial. UC patients who had insufficient responses to 5-aminosalicylic acid received GMA twice a week for 5 weeks. The response rate of all patients was 58.2% (39/67). Of the 39 patient","2021","07","02","Crohns Colitis 360","Crohn's &amp; colitis 360","COVID-19; granulocyte and monocyte adsorptive apheresis; inflammatory bowel disease; steroid naive","Nakase","Hiroshi","Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan",NA
"2219","34192246","10.1136/bmjsit-2020-000046","COVID-19 has no effect on gravity.",NA,"2021","07","02","BMJ Surg Interv Health Technol","BMJ surgery, interventions, &amp; health technologies","health policy; methodology; real world evidence","McCulloch","Peter","Nuffield Department of Surgical Science, University of Oxford, Oxford, Oxfordshire, UK",NA
"2220","34192246","10.1136/bmjsit-2020-000046","COVID-19 has no effect on gravity.",NA,"2021","07","02","BMJ Surg Interv Health Technol","BMJ surgery, interventions, &amp; health technologies","health policy; methodology; real world evidence","Sedrakyan","Art","Healthcare Policy and Research, Weill Cornell Medical College, New York, New York, USA",NA
"2221","34192245","10.1016/j.hest.2021.06.001","Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine.","Though rare, neurological side effects of SARS-CoV-2 vaccinations are increasingly reported. Even if the first dosage goes uncomplicated, the second dose may be complicated by severe adverse reactions as in the following case. A 52yo male developed sudden-onset reading difficulty and aphasia 7d after the second dose of an mRNA-based SARS-CoV-2 vaccine. He had a previous history of myocardial infarction, arterial hypertension, hyperlipidemia, and nephrolithiasis. Blood pressure was slightly eleva","2021","07","02","Brain Hemorrhages","Brain hemorrhages","Adverse reaction; Aphasia; COVID-19; Intracerebral bleeding; SARS-CoV-2; Side effect; Vaccination","Finsterer","Josef","Klinik Landstrasse, Messerli Institute, Vienna, Austria",NA
"2222","34192245","10.1016/j.hest.2021.06.001","Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine.","Though rare, neurological side effects of SARS-CoV-2 vaccinations are increasingly reported. Even if the first dosage goes uncomplicated, the second dose may be complicated by severe adverse reactions as in the following case. A 52yo male developed sudden-onset reading difficulty and aphasia 7d after the second dose of an mRNA-based SARS-CoV-2 vaccine. He had a previous history of myocardial infarction, arterial hypertension, hyperlipidemia, and nephrolithiasis. Blood pressure was slightly eleva","2021","07","02","Brain Hemorrhages","Brain hemorrhages","Adverse reaction; Aphasia; COVID-19; Intracerebral bleeding; SARS-CoV-2; Side effect; Vaccination","Korn","Maria","Klinik Landstrasse, Messerli Institute, Vienna, Austria",NA
"2223","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Shetti","Nagaraj P","Center for Electrochemical Science and Materials, Department of Chemistry, K.L.E. Institute of Technology, Hubballi 580 027, Karnataka, India",NA
"2224","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Mishra","Amit","Department of Chemical Engineering, Inha University, Incheon 22212,South Korea",NA
"2225","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Bukkitgar","Shikandar D","Center for Electrochemical Science and Materials, Department of Chemistry, K.L.E. Institute of Technology, Hubballi 580 027, Karnataka, India",NA
"2226","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Basu","Soumen","School of Chemistry and Biochemistry, Thapar Institute of Engineering &amp",NA
"2227","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Narang","Jagriti","Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India",NA
"2228","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Raghava Reddy","Kakarla","School of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, New South Wales 2006, Australia",NA
"2229","34192244","10.1021/acsabm.0c01545","Conventional and Nanotechnology-Based Sensing Methods for SARS Coronavirus (2019-nCoV).","Ongoing pandemic coronavirus (COVID-19) has affected over 218 countries and infected 88,512,243 and 1,906,853 deaths reported by Jan. 8, 2021. At present, vaccines are being developed in Europe, Russia, USA, and China, although some of these are in phase III of trials, which are waiting to be available for the general public. The only option available now is by vigorous testing, isolation of the infected cases, and maintaining physical and social distances. Numerous methods are now available or ","2021","07","02","ACS Appl Bio Mater","ACS applied bio materials",NA,"Aminabhavi","Tejraj M","Department of Pharmaceutical Engineering, SET's College of Pharmacy, Dharwad, Karnataka 580 002, India",NA
"2230","34192243","10.1021/acsanm.0c03319","Hydration of Hydrophilic Cloth Face Masks Enhances the Filtration of Nanoparticles.","Under high humidity conditions that mimic respiration, the filtration efficiency (FE) of hydrophilic fabrics increases when challenged with hygroscopic nanoparticles, for example, respiratory droplets containing SARS-CoV-2. The FE and differential pressure (<U+0394>P) of natural, synthetic, and blended fabrics were measured as a function of relative humidity (RH) for particles with mobility diameters between 50 and 825 nm. Fabrics were equilibrated at 99% RH, mimicking conditions experienced whe","2021","07","02","ACS Appl Nano Mater","ACS applied nano materials",NA,"Zangmeister","Christopher D","Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States",NA
"2231","34192243","10.1021/acsanm.0c03319","Hydration of Hydrophilic Cloth Face Masks Enhances the Filtration of Nanoparticles.","Under high humidity conditions that mimic respiration, the filtration efficiency (FE) of hydrophilic fabrics increases when challenged with hygroscopic nanoparticles, for example, respiratory droplets containing SARS-CoV-2. The FE and differential pressure (<U+0394>P) of natural, synthetic, and blended fabrics were measured as a function of relative humidity (RH) for particles with mobility diameters between 50 and 825 nm. Fabrics were equilibrated at 99% RH, mimicking conditions experienced whe","2021","07","02","ACS Appl Nano Mater","ACS applied nano materials",NA,"Radney","James G","Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States",NA
"2232","34192243","10.1021/acsanm.0c03319","Hydration of Hydrophilic Cloth Face Masks Enhances the Filtration of Nanoparticles.","Under high humidity conditions that mimic respiration, the filtration efficiency (FE) of hydrophilic fabrics increases when challenged with hygroscopic nanoparticles, for example, respiratory droplets containing SARS-CoV-2. The FE and differential pressure (<U+0394>P) of natural, synthetic, and blended fabrics were measured as a function of relative humidity (RH) for particles with mobility diameters between 50 and 825 nm. Fabrics were equilibrated at 99% RH, mimicking conditions experienced whe","2021","07","02","ACS Appl Nano Mater","ACS applied nano materials",NA,"Staymates","Matthew E","Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States",NA
"2233","34192243","10.1021/acsanm.0c03319","Hydration of Hydrophilic Cloth Face Masks Enhances the Filtration of Nanoparticles.","Under high humidity conditions that mimic respiration, the filtration efficiency (FE) of hydrophilic fabrics increases when challenged with hygroscopic nanoparticles, for example, respiratory droplets containing SARS-CoV-2. The FE and differential pressure (<U+0394>P) of natural, synthetic, and blended fabrics were measured as a function of relative humidity (RH) for particles with mobility diameters between 50 and 825 nm. Fabrics were equilibrated at 99% RH, mimicking conditions experienced whe","2021","07","02","ACS Appl Nano Mater","ACS applied nano materials",NA,"Vicenzi","Edward P","Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States",NA
"2234","34192243","10.1021/acsanm.0c03319","Hydration of Hydrophilic Cloth Face Masks Enhances the Filtration of Nanoparticles.","Under high humidity conditions that mimic respiration, the filtration efficiency (FE) of hydrophilic fabrics increases when challenged with hygroscopic nanoparticles, for example, respiratory droplets containing SARS-CoV-2. The FE and differential pressure (<U+0394>P) of natural, synthetic, and blended fabrics were measured as a function of relative humidity (RH) for particles with mobility diameters between 50 and 825 nm. Fabrics were equilibrated at 99% RH, mimicking conditions experienced whe","2021","07","02","ACS Appl Nano Mater","ACS applied nano materials",NA,"Weaver","Jamie L","Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States",NA
"2235","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Zhang","Huijuan","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2236","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Li","Wei","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2237","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Li","Hui","Clinical Research Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2238","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Zhang","Caidi","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2239","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Luo","Jinjing","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2240","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Zhu","Yikang","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2241","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Wu","Hui","Department of Medical Psychology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China",NA
"2242","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Zhu","Zhuoying","Institute of Psychology and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China",NA
"2243","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Xu","Yifeng","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2244","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Wang","Jijun","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2245","34192242","10.1136/gpsych-2020-100344","Prevalence and dynamic features of psychological issues among Chinese healthcare workers during the COVID-19 pandemic: a systematic review and cumulative meta-analysis.","The COVID-19 pandemic has placed tremendous pressure on healthcare workers who are at the frontline in the battle against it, causing various forms of psychological distress. To outline the prevalence and dynamic changing features of medical workers' psychological issues and to review the related national policies during the COVID-19 pandemic in China. We systematically searched for studies on the psychological states of Chinese medical staff from 1 January 2020 to 8 May 2020. The aggregate prev","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; mental health; prevalence","Li","Chunbo","Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2246","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","Ike","Ikenna David","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2247","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","Durand-Hill","Matthieu","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2248","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","Elmusharaf","Eiman","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2249","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","Asemota","Nicole","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2250","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","Silva","Elizabeth","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2251","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","White","Elliott","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2252","34192241","10.1136/gpsych-2020-100368","NHS staff mental health status in the active phase of the COVID-19 era: a staff survey in a large London hospital.","Experiencing a pandemic can be very unsettling and may have a negative impact on the mental health of frontline healthcare workers (HCWs). This may have serious consequences for the overall well-being of HCWs, which in turn may adversely affect patient safety and the productivity of the institution. We designed a study to assess the prevalence of generalised anxiety disorder (GAD), depression and work-related stress experienced by the National Health Service staff in a large tertiary London hosp","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; post-traumatic; stress disorders","Awad","Wael I","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, UK",NA
"2253","34192240","10.1136/gpsych-2020-100343","Case series associated with COVID-19 pandemic in causing psychiatric morbidity.","The COVID-19 has emerged as a public health emergency across the globe. Countries all over the world have been forced to enforce nationwide lockdowns to curb the transmission of this illness, affecting millions of people. The disorder and the lockdowns enforced have resulted in a complex set of psychosocial stressors in the lives of people, affecting their resilience and causing psychological stress and mental health issues. In this case series, we aim to highlight the role of such psychosocial ","2021","07","02","Gen Psychiatr","General psychiatry","adolescent psychiatry; behavioural symptoms; conflict; psychological; psychological trauma","Mahapatra","Ananya","Deaprtment of Psychiatry, Dr Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research, New Delhi, India",NA
"2254","34192240","10.1136/gpsych-2020-100343","Case series associated with COVID-19 pandemic in causing psychiatric morbidity.","The COVID-19 has emerged as a public health emergency across the globe. Countries all over the world have been forced to enforce nationwide lockdowns to curb the transmission of this illness, affecting millions of people. The disorder and the lockdowns enforced have resulted in a complex set of psychosocial stressors in the lives of people, affecting their resilience and causing psychological stress and mental health issues. In this case series, we aim to highlight the role of such psychosocial ","2021","07","02","Gen Psychiatr","General psychiatry","adolescent psychiatry; behavioural symptoms; conflict; psychological; psychological trauma","Sharma","Prerna","Department of Clinical Psychology, Dr Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research, New Delhi, India",NA
"2255","34192239","10.1136/gpsych-2020-100349","Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.","Lockdowns were implemented to limit the spread of COVID-19. Peritraumatic distress (PD) and post-traumatic stress disorder have been reported after traumatic events, but the specific effect of the pandemic is not well known. The aim of this study was to assess PD in France, a country where COVID-19 had such a dramatic impact that it required a country-wide lockdown. We recruited patients in four groups of chatbot users followed for breast cancer, asthma, depression and migraine. We used the Psyc","2021","07","02","Gen Psychiatr","General psychiatry","mental health; post-traumatic; psychological trauma; stress disorders","Chaix","Benjamin","ENT Department, Hôpital Gui de Chauliac, Montpellier, France",NA
"2256","34192239","10.1136/gpsych-2020-100349","Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.","Lockdowns were implemented to limit the spread of COVID-19. Peritraumatic distress (PD) and post-traumatic stress disorder have been reported after traumatic events, but the specific effect of the pandemic is not well known. The aim of this study was to assess PD in France, a country where COVID-19 had such a dramatic impact that it required a country-wide lockdown. We recruited patients in four groups of chatbot users followed for breast cancer, asthma, depression and migraine. We used the Psyc","2021","07","02","Gen Psychiatr","General psychiatry","mental health; post-traumatic; psychological trauma; stress disorders","Delamon","Guillaume","Hôpital Pité-Salpêtrière, Wefight, Brain &amp",NA
"2257","34192239","10.1136/gpsych-2020-100349","Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.","Lockdowns were implemented to limit the spread of COVID-19. Peritraumatic distress (PD) and post-traumatic stress disorder have been reported after traumatic events, but the specific effect of the pandemic is not well known. The aim of this study was to assess PD in France, a country where COVID-19 had such a dramatic impact that it required a country-wide lockdown. We recruited patients in four groups of chatbot users followed for breast cancer, asthma, depression and migraine. We used the Psyc","2021","07","02","Gen Psychiatr","General psychiatry","mental health; post-traumatic; psychological trauma; stress disorders","Guillemassé","Arthur","Hôpital Pité-Salpêtrière, Wefight, Brain &amp",NA
"2258","34192239","10.1136/gpsych-2020-100349","Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.","Lockdowns were implemented to limit the spread of COVID-19. Peritraumatic distress (PD) and post-traumatic stress disorder have been reported after traumatic events, but the specific effect of the pandemic is not well known. The aim of this study was to assess PD in France, a country where COVID-19 had such a dramatic impact that it required a country-wide lockdown. We recruited patients in four groups of chatbot users followed for breast cancer, asthma, depression and migraine. We used the Psyc","2021","07","02","Gen Psychiatr","General psychiatry","mental health; post-traumatic; psychological trauma; stress disorders","Brouard","Benoît","Hôpital Pité-Salpêtrière, Wefight, Brain &amp",NA
"2259","34192239","10.1136/gpsych-2020-100349","Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations.","Lockdowns were implemented to limit the spread of COVID-19. Peritraumatic distress (PD) and post-traumatic stress disorder have been reported after traumatic events, but the specific effect of the pandemic is not well known. The aim of this study was to assess PD in France, a country where COVID-19 had such a dramatic impact that it required a country-wide lockdown. We recruited patients in four groups of chatbot users followed for breast cancer, asthma, depression and migraine. We used the Psyc","2021","07","02","Gen Psychiatr","General psychiatry","mental health; post-traumatic; psychological trauma; stress disorders","Bibault","Jean-Emmanuel","Department of Radiation Oncology, Hôpital Européen Georges Pompidou Cancérologie, Paris, France",NA
"2261","34192237","10.1136/gpsych-2020-100294","Unmet needs for mental care services for older people in Bangladesh during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","mental health services; panic disorder; psychiatry","Rahman","Md Sazedur","Statistics Discipline, Khulna University, Khulna, Bangladesh",NA
"2262","34192237","10.1136/gpsych-2020-100294","Unmet needs for mental care services for older people in Bangladesh during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","mental health services; panic disorder; psychiatry","Rahman","Md Ashfikur","Development Studies Discipline, Khulna University, Khulna, Bangladesh",NA
"2263","34192237","10.1136/gpsych-2020-100294","Unmet needs for mental care services for older people in Bangladesh during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","mental health services; panic disorder; psychiatry","Afroze","Laila","Statistics Discipline, Khulna University, Khulna, Bangladesh",NA
"2264","34192237","10.1136/gpsych-2020-100294","Unmet needs for mental care services for older people in Bangladesh during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","mental health services; panic disorder; psychiatry","Islam","Sheikh Mohammed Shariful","Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Faculty of Health, Deakin University, Burwood, Victoria, Australia",NA
"2265","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Cheng","Wenhong","Department of Psychiatry, Shanghai Mental Health Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2266","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Zhang","Fang","Department of Psychiatry, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2267","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Liu","Zhen","Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2268","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Zhang","Hao","Department of Psychiatry, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2269","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Lyu","Yifan","Department of Psychiatry, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2270","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Xu","Hao","Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2271","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Hua","Yingqi","Department of Scientific Research Administration, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2272","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Gu","Jiarong","Department of Administration, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2273","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Yang","Zhi","Laboratory of Psychological Health and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2274","34192236","10.1136/gpsych-2020-100288","A psychological health support scheme for medical teams in COVID-19 outbreak and its effectiveness.","Medical staff fighting the COVID-19 pandemic are experiencing stress from high occupational risk, panic in the community and the extreme workload. Maintaining the psychological health of a medical team is essential for efficient functioning, but psychological intervention models for emergency medical teams are rare. To design a systematic, full-coverage psychological health support scheme for medical teams serving large-scale emergent situations, and demonstrate its effectiveness in a real-world","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; global burden of disease; psychology, medical","Liu","Jun","Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2276","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Yue","Ling","Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Affiliated Shanghai Mental Health Center, Shanghai, China",NA
"2277","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Wang","Jingyi","Department of Social Medicine, School of Public Health, Fudan University, Shanghai, China",NA
"2278","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Ju","Mingliang","Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Affiliated Shanghai Mental Health Center, Shanghai, China",NA
"2279","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Zhu","Yi","Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Affiliated Shanghai Mental Health Center, Shanghai, China",NA
"2280","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Chen","Lianghu","Department of Psychiatry, Nanhui Mental Health Center of Pudong New Area, Shanghai, China",NA
"2281","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Shi","Lin","Department of General Adult Psychiatry, Xuhui District Mental Health Center, Shanghai, China",NA
"2282","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Shi","Bohai","Department of Psychiatry, Hongkou District Mental Health Center, Shanghai, China",NA
"2283","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Chen","Jun","Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Affiliated Shanghai Mental Health Center, Shanghai, China",NA
"2284","34192234","10.1136/gpsych-2020-100272","How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China.","Patients with COVID-19 are at high risk of developing mental health problems; however, the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear. We aimed to investigate the mental health problems of patients infected with COVID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic. We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai, China. We analysed data fr","2021","07","02","Gen Psychiatr","General psychiatry","crisis intervention; mental health services","Shen","Yifeng","Department of Psychiatry, Shanghai Jiao Tong University School of Medicine, Affiliated Shanghai Mental Health Center, Shanghai, China",NA
"2285","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Du","Jiang","Drug Abuse Treatment Department, Shanghai Mental Health Center, Shanghai, China",NA
"2286","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Fan","Ni","Drug Abuse Treatment Department, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",NA
"2287","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Zhao","Min","Shanghai Mental Health Center, Shanghai, China",NA
"2288","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Hao","Wei","Mental Health Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan, China",NA
"2289","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Liu","Tieqiao","Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China",NA
"2290","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Lu","Lin","Peking University Sixth Hospital, Beijing, China",NA
"2291","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Shi","Jie","Peking University School of Basic Medical Sciences, Beijing, China",NA
"2292","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Jiang","Haifeng","Drug Abuse Treatment Department, Shanghai Mental Health Center, Shanghai, China",NA
"2293","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Zhong","Na","Drug Abuse Treatment Department, Shanghai Mental Health Center, Shanghai, China",NA
"2294","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Lan","Xiaochang","Drug Abuse Treatment Department, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",NA
"2295","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Xu","Shichao","Drug Abuse Treatment Department, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",NA
"2296","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Chen","Hongxian","Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China",NA
"2297","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Xiang","Xiaojun","Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China",NA
"2298","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Wang","Xuyi","Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China",NA
"2299","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Sun","Hongqiang","Peking University Sixth Hospital, Beijing, China",NA
"2300","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Li","Bing","Peking University Sixth Hospital, Beijing, China",NA
"2301","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Ning","Yu-Ping","The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China",NA
"2302","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Li","Jing","Mental Health Institute, Sichuan University West China Hospital, Chengdu, Sichuan, China",NA
"2303","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Guo","Wanjun","Mental Health Institute, Sichuan University West China Hospital, Chengdu, Sichuan, China",NA
"2304","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Niu","Yajuan","Drug Abuse Treatment Department, Beijing Huilongguan Hospital, Beijing, China",NA
"2305","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Sheng","Lixia","Drug Abuse Treatment Department, Beijing An Ding Hospital, Beijing, China",NA
"2306","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Li","Yi","Drug Abuse Treatment Department, Wuhan Mental Health Center, Wuhan, Hubei, China",NA
"2307","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Liu","Xuebin","Drug Abuse Treatment Department, Wuhan Mental Health Center, Wuhan, Hubei, China",NA
"2308","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Zhou","Xuhui","Drug Abuse Treatment Department, Brain Hospital of Hunan Province, Changsha, China",NA
"2309","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Qian","Mincai","Huzhou Third People's Hospital, Huzhou, Zhejiang, China",NA
"2310","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Zhou","Wenhua","Drug Abuse Treatment Department, Ningbo University Medical School, Ningbo, Zhejiang, China",NA
"2311","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Zhang","Ruiling","Drug Abuse Treatment Department, Xinxiang Medical University Affiliated Second Hospital, Xinxiang, Henan, China",NA
"2312","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Hu","Hongxing","Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China",NA
"2313","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Xia","Yan","Mental Health Department, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China",NA
"2314","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Su","Zhonghua","Mental Health Department, Shandong Province Ankang Hospital, Jining, Shandong, China",NA
"2315","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Zhang","Ruimin","Huayou Health Care Center, Beijing, China",NA
"2316","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Yang","Mei","Drug Abuse Treatment Department, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China",NA
"2317","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Liu","Fen","Drug Abuse Treatment Department, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China",NA
"2318","34192233","10.1136/gpsych-2020-100252","Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","psychotic disorders; public health administration","Yuan","Wei","Drug Abuse Treatment Department, Shandong Mental Health Center, Jinan, China",NA
"2319","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Wu","Mengting","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2320","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Xu","Wenyan","School of Social Development and Public Policy, Fudan University, Shanghai, China",NA
"2321","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Yao","Yuhong","Mental Health Education and Counseling Center, Tongji University, Shanghai, China",NA
"2322","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Zhang","Lei","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2323","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Guo","Lei","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2324","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Fan","Juan","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2325","34192232","10.1136/gpsych-2020-100250","Mental health status of students' parents during COVID-19 pandemic and its influence factors.","During the outbreak of COVID-19, the national policy of home quarantine may affect the mental health of parents. However, few studies have investigated the mental health of parents during the COVID-19 pandemic. To investigate the depression, anxiety and stress of the students' parents during the COVID-19 pandemic, and to explore the influence factors, especially the influence of social support and family-related factors. The Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, Perceiv","2021","07","02","Gen Psychiatr","General psychiatry","anxiety; depression; mental health; parents","Chen","Jue","Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China",NA
"2326","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Presti","Giovambattista","Faculty of Human and Social Sciences, University of Enna 'Kore', Enna, Italy",NA
"2327","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Dal Lago","Barbara","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"2328","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Fattori","Alice","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"2329","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Mioli","Giuliana","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"2330","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Moderato","Paolo","IULM University, Milano, Lombardia, Italy",NA
"2331","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Sciaretta","Lucia","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"2332","34192231","10.1136/gpsych-2020-100244","Mental health support to staff in a major hospital in Milan (Italy) during the COVID-19 pandemic: a framework of actions.",NA,"2021","07","02","Gen Psychiatr","General psychiatry","adaptation, psychological; health behaviour; mental health; psychology, medical; resilience, psychological","Costantino","Maria Antonella","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy",NA
"2333","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Nevels","Michael","University of St Andrews, Biomolecular Sciences Building, Fife, United Kingdom of Great Britain and Northern Ireland, KY16 9ST",NA
"2334","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Si","Xiaohan","School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Queensland, Australia",NA
"2335","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Bambrick","Hilary","School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Queensland, Australia",NA
"2336","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Zhang","Yuzhou","School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Queensland, Australia",NA
"2337","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Cheng","Jian","School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Queensland, Australia",NA
"2338","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","McClymont","Hannah","School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Queensland, Australia",NA
"2339","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Bonsall","Michael B","Mathematical Ecology Research Group, Department of Zoology, University of Oxford, Oxford, OX1 3SZ, UK",NA
"2340","34192228","10.1017/exp.2021.4","Weather variability and transmissibility of COVID-19: a time series analysis based on effective reproductive number.","COVID-19 is causing a significant burden on medical and healthcare resources globally due to high numbers of hospitalisations and deaths recorded as the pandemic continues. This research aims to assess the effects of climate factors (i.e., daily average temperature and average relative humidity) on effective reproductive number of COVID-19 outbreak in Wuhan, China during the early stage of the outbreak. Our research showed that effective reproductive number of COVID-19 will increase by 7.6% (95%","2021","07","02","Exp Results","Experimental results","COVID-19; effective reproductive number; time series regression model; weather factors","Hu","Wenbiao","School of Public Health and Social Work, Queensland University of Technology, Brisbane, 4059, Queensland, Australia",NA
"2341","34192227","10.1017/exp.2020.73","Rapid shortening of survival duration in early fatal cases of COVID-19, Wuhan, China.","Severe COVID-19 cases place immediate pressure on hospital resources. To assess this, we analysed survival duration in the first 39 fatal cases in Wuhan, China. Time from onset and hospitalization to death declined rapidly, from ~40 to 7 days, and ~25 to 4 days, respectively, in the outbreak's first month.","2021","07","02","Exp Results","Experimental results","COVID-19; Wuhan; fatal cases; survival duration","Nevels","Michael","University of St Andrews, Biomolecular Sciences Building, Fife, United Kingdom of Great Britain and Northern Ireland, KY16 9ST",NA
"2342","34192227","10.1017/exp.2020.73","Rapid shortening of survival duration in early fatal cases of COVID-19, Wuhan, China.","Severe COVID-19 cases place immediate pressure on hospital resources. To assess this, we analysed survival duration in the first 39 fatal cases in Wuhan, China. Time from onset and hospitalization to death declined rapidly, from ~40 to 7 days, and ~25 to 4 days, respectively, in the outbreak's first month.","2021","07","02","Exp Results","Experimental results","COVID-19; Wuhan; fatal cases; survival duration","Zhang","Yuzhou","School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane 4059, Queensland, Australia",NA
"2343","34192227","10.1017/exp.2020.73","Rapid shortening of survival duration in early fatal cases of COVID-19, Wuhan, China.","Severe COVID-19 cases place immediate pressure on hospital resources. To assess this, we analysed survival duration in the first 39 fatal cases in Wuhan, China. Time from onset and hospitalization to death declined rapidly, from ~40 to 7 days, and ~25 to 4 days, respectively, in the outbreak's first month.","2021","07","02","Exp Results","Experimental results","COVID-19; Wuhan; fatal cases; survival duration","Bambrick","Hilary","School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane 4059, Queensland, Australia",NA
"2344","34192227","10.1017/exp.2020.73","Rapid shortening of survival duration in early fatal cases of COVID-19, Wuhan, China.","Severe COVID-19 cases place immediate pressure on hospital resources. To assess this, we analysed survival duration in the first 39 fatal cases in Wuhan, China. Time from onset and hospitalization to death declined rapidly, from ~40 to 7 days, and ~25 to 4 days, respectively, in the outbreak's first month.","2021","07","02","Exp Results","Experimental results","COVID-19; Wuhan; fatal cases; survival duration","Tong","Shilu","School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane 4059, Queensland, Australia",NA
"2345","34192227","10.1017/exp.2020.73","Rapid shortening of survival duration in early fatal cases of COVID-19, Wuhan, China.","Severe COVID-19 cases place immediate pressure on hospital resources. To assess this, we analysed survival duration in the first 39 fatal cases in Wuhan, China. Time from onset and hospitalization to death declined rapidly, from ~40 to 7 days, and ~25 to 4 days, respectively, in the outbreak's first month.","2021","07","02","Exp Results","Experimental results","COVID-19; Wuhan; fatal cases; survival duration","Lambert","Stephen B","National Centre for Epidemiology and Population Health, The Australian National University, Canberra0200, Australian Capital Territory, Australia",NA
"2346","34192227","10.1017/exp.2020.73","Rapid shortening of survival duration in early fatal cases of COVID-19, Wuhan, China.","Severe COVID-19 cases place immediate pressure on hospital resources. To assess this, we analysed survival duration in the first 39 fatal cases in Wuhan, China. Time from onset and hospitalization to death declined rapidly, from ~40 to 7 days, and ~25 to 4 days, respectively, in the outbreak's first month.","2021","07","02","Exp Results","Experimental results","COVID-19; Wuhan; fatal cases; survival duration","Hu","Wenbiao","School of Public Health and Social Work, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane 4059, Queensland, Australia",NA
"2347","34192226","10.1017/exp.2020.69","Simplifying the Measurement of College Students' Career Planning: the Development of Career Student Planning Scale during the COVID-19 Pandemic.","We created a new, 8-item scale called ""Career Student Planning Scale (CSPS)"" for a valid and reliable measure regarding college students' career planning during a traumatic event, such as a pandemic. CSPS is conceptually similar to the career decision-making difficulty questionnaire (CDDQ) and the career decision self-efficacy (CDSE) scale. CSPS leans towards questions about college students' perceptions about career planning, rather than intuitions about career decision-making; it also inquires","2021","07","02","Exp Results","Experimental results","COVID-19 anxiety; career decision self-efficacy (CDSE); career student planning scale (CSPS); procrastination","Wang","Xiaoping","Second Xiangya Hospital, Department of psychiatry, 139 Renmin Middle Road, Changsha, Hunan, China, 410011",NA
"2348","34192226","10.1017/exp.2020.69","Simplifying the Measurement of College Students' Career Planning: the Development of Career Student Planning Scale during the COVID-19 Pandemic.","We created a new, 8-item scale called ""Career Student Planning Scale (CSPS)"" for a valid and reliable measure regarding college students' career planning during a traumatic event, such as a pandemic. CSPS is conceptually similar to the career decision-making difficulty questionnaire (CDDQ) and the career decision self-efficacy (CDSE) scale. CSPS leans towards questions about college students' perceptions about career planning, rather than intuitions about career decision-making; it also inquires","2021","07","02","Exp Results","Experimental results","COVID-19 anxiety; career decision self-efficacy (CDSE); career student planning scale (CSPS); procrastination","Gray","Magnus A","School of Social &amp",NA
"2349","34192226","10.1017/exp.2020.69","Simplifying the Measurement of College Students' Career Planning: the Development of Career Student Planning Scale during the COVID-19 Pandemic.","We created a new, 8-item scale called ""Career Student Planning Scale (CSPS)"" for a valid and reliable measure regarding college students' career planning during a traumatic event, such as a pandemic. CSPS is conceptually similar to the career decision-making difficulty questionnaire (CDDQ) and the career decision self-efficacy (CDSE) scale. CSPS leans towards questions about college students' perceptions about career planning, rather than intuitions about career decision-making; it also inquires","2021","07","02","Exp Results","Experimental results","COVID-19 anxiety; career decision self-efficacy (CDSE); career student planning scale (CSPS); procrastination","Kim","Minsung","Defense Language Institute Foreign Language Center, Presidio of Monterey, Monterey, CA93944, USA",NA
"2350","34192226","10.1017/exp.2020.69","Simplifying the Measurement of College Students' Career Planning: the Development of Career Student Planning Scale during the COVID-19 Pandemic.","We created a new, 8-item scale called ""Career Student Planning Scale (CSPS)"" for a valid and reliable measure regarding college students' career planning during a traumatic event, such as a pandemic. CSPS is conceptually similar to the career decision-making difficulty questionnaire (CDDQ) and the career decision self-efficacy (CDSE) scale. CSPS leans towards questions about college students' perceptions about career planning, rather than intuitions about career decision-making; it also inquires","2021","07","02","Exp Results","Experimental results","COVID-19 anxiety; career decision self-efficacy (CDSE); career student planning scale (CSPS); procrastination","Lee","Seungyeon","School of Social &amp",NA
"2351","34192225","10.1017/exp.2020.45","A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions.","The ongoing coronavirus disease 2019 (COVID-19) pandemic is of global concern and has recently emerged in the US. In this paper, we construct a stochastic variant of the SEIR model to estimate a quasi-worst-case scenario prediction of the COVID-19 outbreak in the US West and East Coast population regions by considering the different phases of response implemented by the US as well as transmission dynamics of COVID-19 in countries that were most affected. The model is then fitted to current data ","2021","07","02","Exp Results","Experimental results","COVID-19; SARS-CoV-2; computational model; coronavirus; viral transmission","Henrion","Marc","Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Statistical Support Unit, Queen Elizabeth Central Hospital, PO Box 30096, Blantyre, Malawi",NA
"2352","34192225","10.1017/exp.2020.45","A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions.","The ongoing coronavirus disease 2019 (COVID-19) pandemic is of global concern and has recently emerged in the US. In this paper, we construct a stochastic variant of the SEIR model to estimate a quasi-worst-case scenario prediction of the COVID-19 outbreak in the US West and East Coast population regions by considering the different phases of response implemented by the US as well as transmission dynamics of COVID-19 in countries that were most affected. The model is then fitted to current data ","2021","07","02","Exp Results","Experimental results","COVID-19; SARS-CoV-2; computational model; coronavirus; viral transmission","Yeo","Yao-Yu","Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14850, USA",NA
"2353","34192225","10.1017/exp.2020.45","A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions.","The ongoing coronavirus disease 2019 (COVID-19) pandemic is of global concern and has recently emerged in the US. In this paper, we construct a stochastic variant of the SEIR model to estimate a quasi-worst-case scenario prediction of the COVID-19 outbreak in the US West and East Coast population regions by considering the different phases of response implemented by the US as well as transmission dynamics of COVID-19 in countries that were most affected. The model is then fitted to current data ","2021","07","02","Exp Results","Experimental results","COVID-19; SARS-CoV-2; computational model; coronavirus; viral transmission","Yeo","Yao-Rui","Department of Mathematics, University of Pennsylvania, Philadelphia, PA 19104, USA",NA
"2354","34192225","10.1017/exp.2020.45","A Computational Model for Estimating the Progression of COVID-19 Cases in the US West and East Coast Population Regions.","The ongoing coronavirus disease 2019 (COVID-19) pandemic is of global concern and has recently emerged in the US. In this paper, we construct a stochastic variant of the SEIR model to estimate a quasi-worst-case scenario prediction of the COVID-19 outbreak in the US West and East Coast population regions by considering the different phases of response implemented by the US as well as transmission dynamics of COVID-19 in countries that were most affected. The model is then fitted to current data ","2021","07","02","Exp Results","Experimental results","COVID-19; SARS-CoV-2; computational model; coronavirus; viral transmission","Yeo","Wan-Jin","Department of Physics, University of Washington, Seattle, WA 98195, USA",NA
"2355","34192224","10.1177/25158414211003368","COVID-19 and conjunctivitis: a meta-analysis.","COVID-19 is a disease first identified in Wuhan City, Hubei Province, China, in December 2019, causes by a SARS-COV-2 virus infection. By 27 October 2020, 43,921,473 confirmed cases were reported worldwide, with 1,166,389 COVID-19 deaths. Conjunctivitis has been reported in adults and pediatric patients with COVID-19. The aim of this meta-analysis is to estimate the odd Ratio (ORs) of conjunctivitis in patients with COVID-19. A systematic review and meta-analysis have been performed using the Pu","2021","07","02","Ther Adv Ophthalmol","Therapeutic advances in ophthalmology","COVID-19; SARS-CoV-2; meta-analysis; viral conjunctivitis","Al-Namaeh","Mashael","School of Health and Social Care, Oulu University of Applied Sciences, Kiviharjuntie 8, 90220 Oulu Teuvo, Pakkalan Katu 19, 90100 Oulu, 90220, Finland",NA
"2356","34192223","10.1093/ehjcr/ytab086","Tension posterior pneumomediastinum in acute respiratory distress syndrome due to COVID-19.",NA,"2021","06","30","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Lo Presti","Saberio","Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J1, Cleveland, OH 44195, USA",NA
"2357","34192223","10.1093/ehjcr/ytab086","Tension posterior pneumomediastinum in acute respiratory distress syndrome due to COVID-19.",NA,"2021","06","30","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Mauro","Joshua","Pulmonary and Critical Care Department, Cleveland Clinic, Cleveland, OH 44195, USA",NA
"2358","34192223","10.1093/ehjcr/ytab086","Tension posterior pneumomediastinum in acute respiratory distress syndrome due to COVID-19.",NA,"2021","06","30","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Mireles-Cabodevila","Eduardo","Pulmonary and Critical Care Department, Cleveland Clinic, Cleveland, OH 44195, USA",NA
"2359","34192223","10.1093/ehjcr/ytab086","Tension posterior pneumomediastinum in acute respiratory distress syndrome due to COVID-19.",NA,"2021","06","30","Eur Heart J Case Rep","European heart journal. Case reports",NA,"Collier","Patrick","Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J1, Cleveland, OH 44195, USA",NA
"2360","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Calvi","Emiliano","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2361","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Bernardi","Nicola","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2362","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Cimino","Giuliana","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2363","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Pascariello","Greta","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2364","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Faggiano","Pompilio","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2365","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Gavazzi","Emanuele","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Radiology, University of Brescia, Brescia,Italy",NA
"2366","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Vizzardi","Enrico","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2367","34192222","10.1093/ehjcr/ytaa518","Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series.","COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed ev","2021","07","02","Eur Heart J Case Rep","European heart journal. Case reports","Anticoagulant; Case series; Coagulation; Thrombus; Transthoracic echocardiography","Metra","Marco","Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Institute of Cardiology, University of Brescia, Brescia,Italy",NA
"2368","34192221","10.1097/GRH.0000000000000040","Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE, and IFFS.",NA,"2021","06","30","Glob Reprod Health","Global reproductive health",NA,"Veiga","Anna","ESHRE, Madrid, Spain",NA
"2369","34192221","10.1097/GRH.0000000000000040","Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE, and IFFS.",NA,"2021","06","30","Glob Reprod Health","Global reproductive health",NA,"Gianaroli","Luca","ESHRE, Milan, Italy",NA
"2370","34192221","10.1097/GRH.0000000000000040","Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE, and IFFS.",NA,"2021","06","30","Glob Reprod Health","Global reproductive health",NA,"Ory","Steve","IFFS, Mount Royal, NJ",NA
"2371","34192221","10.1097/GRH.0000000000000040","Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE, and IFFS.",NA,"2021","06","30","Glob Reprod Health","Global reproductive health",NA,"Horton","Marcos","IFFS, Buenos Aires, Argentina",NA
"2372","34192221","10.1097/GRH.0000000000000040","Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE, and IFFS.",NA,"2021","06","30","Glob Reprod Health","Global reproductive health",NA,"Feinberg","Eve","ASRM, Washington, DC",NA
"2373","34192221","10.1097/GRH.0000000000000040","Assisted reproduction and COVID-19: a joint statement of ASRM, ESHRE, and IFFS.",NA,"2021","06","30","Glob Reprod Health","Global reproductive health",NA,"Penzias","Alan","ASRM, Washington, DC",NA
"2374","34192220","10.1097/GRH.0000000000000047","COVID-19 in pregnancy.","Evidence continues to emerge on the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) in pregnancy. Compared with previous coronavirus outbreaks (severe acute respiratory syndrome and Middle East respiratory syndrome), recent reports suggest that pregnant women who contract SARS-CoV-2 have lower rates of maternal and fetal complications; however, the incidence of preterm birth remains elevated. The potential for vertical transmission is still under investigation. U","2021","07","02","Glob Reprod Health","Global reproductive health","COVID-19; Coronavirus; Fetal complications; Maternal complications; Pregnancy; SARS-CoV2","Martini","Anne E","Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD",NA
"2375","34192219","10.1097/GRH.0000000000000045","COVID-19 antibody testing: future directions.","The novel coronavirus disease 2019 (COVID-19) has rapidly spread around the world, impacting every aspect of life. Valuable research is currently being conducted to understand disease transmission, detection, and treatment. As countries begin to relax policies aimed to reduce disease transmission, contact tracing and antibody testing will likely be incorporated to slow the spread of COVID-19. However, future research is needed to determine if the presence of COVID-19 antibodies offers immunity.","2021","07","02","Glob Reprod Health","Global reproductive health","Antibodies; COVID-19; Coronavirus; Immunity; Pandemic","Zolton","Jessica R","Program in Reproductive Endocrinology and Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD",NA
"2376","34192218","10.1097/GRH.0000000000000044","SARS-CoV-2 found in semen.","With a novel coronavirus comes novel unknowns. One such unknown was whether or not the SARS-CoV-2 virus could be detected in semen. A recent report demonstrated the presence of the virus in semen, which raises additional questions.","2021","07","02","Glob Reprod Health","Global reproductive health","COVID; Coronavirus; Semen","Carpinello","Olivia J","Program in Reproductive Endocrinology and Gynecology, Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD",NA
"2377","34192217","10.1097/GRH.0000000000000042","SARS-CoV-2 Vaccine.","With the SARS-CoV-2 pandemic creating such a wide-reaching health crisis, it is imperative that a safe and effective vaccine be developed promptly for global availability. As such, there are several vaccine development projects currently underway aiming to meet this critical demand. However, COVID vaccine development is not immune to the inherent limitations and challenges that are encountered during vaccine clinical trials.","2021","07","02","Glob Reprod Health","Global reproductive health","COVID vaccine; Coronavirus vaccine; SARS-CoV-2 vaccine","Walker","Karrie","National Institute of Child Health and Human Development, Rockville, MD",NA
"2378","34192216","10.1097/GRH.0000000000000043","The global impact of COVID-19 on infertility services.","The COVID-19 pandemic has posed unique concerns and potential risks to women now pregnant or considering childbearing. Although no professional societies have issued recommendations that women avoid conception at this time, several professional organizations recommended a moratorium on infertility services including both medically assisted reproduction and assisted reproductive technology shortly after the World Health Organization declared COVID-19 infection to be a pandemic. Reasons cited for ","2021","07","02","Glob Reprod Health","Global reproductive health","ART; Covid-19 pandemic; Infertility services; MART","Ory","Steven J","IVF Florida Reproductive Associates, Margate",NA
"2379","34192216","10.1097/GRH.0000000000000043","The global impact of COVID-19 on infertility services.","The COVID-19 pandemic has posed unique concerns and potential risks to women now pregnant or considering childbearing. Although no professional societies have issued recommendations that women avoid conception at this time, several professional organizations recommended a moratorium on infertility services including both medically assisted reproduction and assisted reproductive technology shortly after the World Health Organization declared COVID-19 infection to be a pandemic. Reasons cited for ","2021","07","02","Glob Reprod Health","Global reproductive health","ART; Covid-19 pandemic; Infertility services; MART","Miller","Kathleen A","IVF Florida Reproductive Associates, Margate",NA
"2380","34192216","10.1097/GRH.0000000000000043","The global impact of COVID-19 on infertility services.","The COVID-19 pandemic has posed unique concerns and potential risks to women now pregnant or considering childbearing. Although no professional societies have issued recommendations that women avoid conception at this time, several professional organizations recommended a moratorium on infertility services including both medically assisted reproduction and assisted reproductive technology shortly after the World Health Organization declared COVID-19 infection to be a pandemic. Reasons cited for ","2021","07","02","Glob Reprod Health","Global reproductive health","ART; Covid-19 pandemic; Infertility services; MART","Horton","Marcos","Pregna Medicina Reproductiva",NA
"2381","34192216","10.1097/GRH.0000000000000043","The global impact of COVID-19 on infertility services.","The COVID-19 pandemic has posed unique concerns and potential risks to women now pregnant or considering childbearing. Although no professional societies have issued recommendations that women avoid conception at this time, several professional organizations recommended a moratorium on infertility services including both medically assisted reproduction and assisted reproductive technology shortly after the World Health Organization declared COVID-19 infection to be a pandemic. Reasons cited for ","2021","07","02","Glob Reprod Health","Global reproductive health","ART; Covid-19 pandemic; Infertility services; MART","Giudice","Linda","International Federation of Fertility Societies",NA
"2382","34192215","10.1097/GRH.0000000000000041","SARS CoV-2: a review of current treatment regimens.","SARS CoV-2, otherwise known as Corona virus 2019 (COVID-19) has left &gt;300,000 dead without a definitive cure in sight. Significant research has been conducted regarding the use of currently available pharmacotherapies and multiple clinical trials are underway to bring new treatments to market. While supportive treatment remains the standard of care, additional therapeutic regimens including antivirals, monoclonal antibodies, antibiotics, anti-inflammatories, immunoenhancers, vitamins, systemi","2021","07","02","Glob Reprod Health","Global reproductive health","COVID-19; Corona virus; SARS CoV-2; Therapy; Treatment","Combs","Joshua C","Eunice Kennedy Shriver National Institute of Child Health and Human Development",NA
"2383","34192214","10.1109/TRPMS.2020.3002658","Gas Plasma Technology-An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?","The COVID-19 crisis profoundly disguised the vulnerability of human societies and healthcare systems in the situation of a pandemic. In many instances, it became evident that the quick and safe reduction of viral load and spread is the foremost principle in the successful management of such a pandemic. However, it became also clear that many of the established routines in healthcare are not always sufficient to cope with the increased demand for decontamination procedures of items, healthcare pr","2021","07","02","IEEE Trans Radiat Plasma Med Sci","IEEE transactions on radiation and plasma medical sciences","Airborne virus; DBD; cold atmospheric pressure plasma; decontamination; plasma jet; transmission","Bekeschus","Sander","ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP)17489GreifswaldGermany",NA
"2384","34192214","10.1109/TRPMS.2020.3002658","Gas Plasma Technology-An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?","The COVID-19 crisis profoundly disguised the vulnerability of human societies and healthcare systems in the situation of a pandemic. In many instances, it became evident that the quick and safe reduction of viral load and spread is the foremost principle in the successful management of such a pandemic. However, it became also clear that many of the established routines in healthcare are not always sufficient to cope with the increased demand for decontamination procedures of items, healthcare pr","2021","07","02","IEEE Trans Radiat Plasma Med Sci","IEEE transactions on radiation and plasma medical sciences","Airborne virus; DBD; cold atmospheric pressure plasma; decontamination; plasma jet; transmission","Kramer","Axel","Institute for Hygiene and Environmental Medicine, Greifswald University Medical Center17489GreifswaldGermany",NA
"2385","34192214","10.1109/TRPMS.2020.3002658","Gas Plasma Technology-An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?","The COVID-19 crisis profoundly disguised the vulnerability of human societies and healthcare systems in the situation of a pandemic. In many instances, it became evident that the quick and safe reduction of viral load and spread is the foremost principle in the successful management of such a pandemic. However, it became also clear that many of the established routines in healthcare are not always sufficient to cope with the increased demand for decontamination procedures of items, healthcare pr","2021","07","02","IEEE Trans Radiat Plasma Med Sci","IEEE transactions on radiation and plasma medical sciences","Airborne virus; DBD; cold atmospheric pressure plasma; decontamination; plasma jet; transmission","Suffredini","Elisabetta","Department of Food Safety, Nutrition and Veterinary Public HealthIstituto Superiore di Sanità00161RomeItaly",NA
"2386","34192214","10.1109/TRPMS.2020.3002658","Gas Plasma Technology-An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?","The COVID-19 crisis profoundly disguised the vulnerability of human societies and healthcare systems in the situation of a pandemic. In many instances, it became evident that the quick and safe reduction of viral load and spread is the foremost principle in the successful management of such a pandemic. However, it became also clear that many of the established routines in healthcare are not always sufficient to cope with the increased demand for decontamination procedures of items, healthcare pr","2021","07","02","IEEE Trans Radiat Plasma Med Sci","IEEE transactions on radiation and plasma medical sciences","Airborne virus; DBD; cold atmospheric pressure plasma; decontamination; plasma jet; transmission","von Woedtke","Thomas","ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP)17489GreifswaldGermany",NA
"2387","34192214","10.1109/TRPMS.2020.3002658","Gas Plasma Technology-An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?","The COVID-19 crisis profoundly disguised the vulnerability of human societies and healthcare systems in the situation of a pandemic. In many instances, it became evident that the quick and safe reduction of viral load and spread is the foremost principle in the successful management of such a pandemic. However, it became also clear that many of the established routines in healthcare are not always sufficient to cope with the increased demand for decontamination procedures of items, healthcare pr","2021","07","02","IEEE Trans Radiat Plasma Med Sci","IEEE transactions on radiation and plasma medical sciences","Airborne virus; DBD; cold atmospheric pressure plasma; decontamination; plasma jet; transmission","Colombo","Vittorio","Department of Industrial Engineering, Interdepartmental Center for Agri-food Industrial Research, Interdepartmental Center for Industrial Research on Advanced Applications in Mechanical Engineering and Materials TechnologyAlma Mater Studiorum-Università di Bologna40136BolognaItaly",NA
"2388","34192211","10.4102/sajp.v77i1.1544","Blended teaching versus traditional teaching for undergraduate physiotherapy students at the University of the Witwatersrand.","Shifting from face-to-face teaching to incorporating technology may prepare students better for future work as health professionals. Evidence of blended teaching's effect on the academic performance of undergraduate physiotherapy students' performance is scarce. The purpose of our study was to determine students' theoretical and clinical performance in a blended teaching module compared to their own performance in two knowledge areas taught face to face, and student perceptions of blended teachi","2021","07","02","S Afr J Physiother","The South African journal of physiotherapy","COVID-19; blended learning; feasibility; higher education; physiotherapy; teaching; undergraduate learning","Ravat","Sadiya","Department of Physiotherapy, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"2389","34192211","10.4102/sajp.v77i1.1544","Blended teaching versus traditional teaching for undergraduate physiotherapy students at the University of the Witwatersrand.","Shifting from face-to-face teaching to incorporating technology may prepare students better for future work as health professionals. Evidence of blended teaching's effect on the academic performance of undergraduate physiotherapy students' performance is scarce. The purpose of our study was to determine students' theoretical and clinical performance in a blended teaching module compared to their own performance in two knowledge areas taught face to face, and student perceptions of blended teachi","2021","07","02","S Afr J Physiother","The South African journal of physiotherapy","COVID-19; blended learning; feasibility; higher education; physiotherapy; teaching; undergraduate learning","Barnard-Ashton","Paula","eFundanathi, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"2390","34192211","10.4102/sajp.v77i1.1544","Blended teaching versus traditional teaching for undergraduate physiotherapy students at the University of the Witwatersrand.","Shifting from face-to-face teaching to incorporating technology may prepare students better for future work as health professionals. Evidence of blended teaching's effect on the academic performance of undergraduate physiotherapy students' performance is scarce. The purpose of our study was to determine students' theoretical and clinical performance in a blended teaching module compared to their own performance in two knowledge areas taught face to face, and student perceptions of blended teachi","2021","07","02","S Afr J Physiother","The South African journal of physiotherapy","COVID-19; blended learning; feasibility; higher education; physiotherapy; teaching; undergraduate learning","Keller","Monique M","Department of Physiotherapy, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa",NA
"2391","34192205","10.1136/bmjpo-2021-001089","Cuba: Solidarity, Ebola and COVID-19.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; health services research; mortality","Escobedo","Angel A","Department of Epidemiology, Institute of Gastroenterology, Havana, Cuba",NA
"2392","34192205","10.1136/bmjpo-2021-001089","Cuba: Solidarity, Ebola and COVID-19.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; health services research; mortality","Auza-Santiváñez","Cristians","Universidad Mayor de San Andrés. Psychopedagogical and Research Center in Higher Education, La Paz, Bolivia",NA
"2393","34192205","10.1136/bmjpo-2021-001089","Cuba: Solidarity, Ebola and COVID-19.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; health services research; mortality","Rumbaut","Raisa","Department of Communicable Diseases, Ministry of Public Health, Havana, Cuba",NA
"2394","34192205","10.1136/bmjpo-2021-001089","Cuba: Solidarity, Ebola and COVID-19.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; health services research; mortality","Bonati","Maurizio","Department of Public Health, Laboratory for Mother and Child Health, Mario Negri Institute for Pharmacological Research, Milan, Italy",NA
"2395","34192205","10.1136/bmjpo-2021-001089","Cuba: Solidarity, Ebola and COVID-19.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; health services research; mortality","Choonara","Imti","Academic Division of Child Health, University of Nottingham School of Medicine, Derby, UK",NA
"2396","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","Prasad","Arun","Department of Pediatrics, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2397","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","N","Yankappa","Department of Pediatrics, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2398","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","Kumar","Pradeep","Department of Pediatrics, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2399","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","Chaudhary","Bhavesh Kant","Department of Pediatrics, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2400","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","Pati","Binod Kumar","Department of Microbiology, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2401","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","Anant","Monika","Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2402","34192204","10.1136/bmjpo-2021-001087","Excretion of SARS-CoV-2 in breast milk: a single-centre observational study.","Breast feeding by SARS-CoV-2-infected mothers has been a concern because of the possibility of excretion of virus in breast milk. To detect SARS-CoV-2 in expressed breast milk (EBM) of mothers infected with SARS-CoV-2 and clinical outcome of neonates delivered and breast fed by them. A single-centre, prospective observational study involving 50 SARS-CoV-2-infected mothers and their 51 neonates. A tertiary care hospital in Eastern India. SARS-CoV-2-infected mothers and neonates delivered by them.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; neonatology","Tiwari","Lokesh Kumar","Department of Pediatrics, All India Institute of Medical Sciences, Patna, Bihar, India",NA
"2403","34192203","10.1136/bmjpo-2021-001077","COVID-19 pandemic experiences of parents caring for children with oesophageal atresia/tracheo-oesophageal fistula.","The COVID-19 pandemic has resulted in a global health crisis of unparalleled magnitude. The direct risk to the health of children is low. However, disease-containment measures have society-wide impacts. This study explored the pandemic experiences of parents of children with oesophageal atresia/tracheo-oesophageal fistula (OA/TOF) in the UK. A phenomenological approach underpinned use of an asynchronous online forum method, in collaboration with a patient support group. Data were evaluated using","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; qualitative research","Stewart","Alexandra","Department of Speech and Language Therapy, Great Ormond Street Hospital For Children NHS Trust, London, UK",NA
"2404","34192203","10.1136/bmjpo-2021-001077","COVID-19 pandemic experiences of parents caring for children with oesophageal atresia/tracheo-oesophageal fistula.","The COVID-19 pandemic has resulted in a global health crisis of unparalleled magnitude. The direct risk to the health of children is low. However, disease-containment measures have society-wide impacts. This study explored the pandemic experiences of parents of children with oesophageal atresia/tracheo-oesophageal fistula (OA/TOF) in the UK. A phenomenological approach underpinned use of an asynchronous online forum method, in collaboration with a patient support group. Data were evaluated using","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; qualitative research","Smith","Christina H","Department of Language and Cognition, University College London, London, UK",NA
"2405","34192203","10.1136/bmjpo-2021-001077","COVID-19 pandemic experiences of parents caring for children with oesophageal atresia/tracheo-oesophageal fistula.","The COVID-19 pandemic has resulted in a global health crisis of unparalleled magnitude. The direct risk to the health of children is low. However, disease-containment measures have society-wide impacts. This study explored the pandemic experiences of parents of children with oesophageal atresia/tracheo-oesophageal fistula (OA/TOF) in the UK. A phenomenological approach underpinned use of an asynchronous online forum method, in collaboration with a patient support group. Data were evaluated using","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; qualitative research","Eaton","Simon","Stem Cells and Regenerative Medicine Section, University College London Institute of Child Health, London, UK",NA
"2406","34192203","10.1136/bmjpo-2021-001077","COVID-19 pandemic experiences of parents caring for children with oesophageal atresia/tracheo-oesophageal fistula.","The COVID-19 pandemic has resulted in a global health crisis of unparalleled magnitude. The direct risk to the health of children is low. However, disease-containment measures have society-wide impacts. This study explored the pandemic experiences of parents of children with oesophageal atresia/tracheo-oesophageal fistula (OA/TOF) in the UK. A phenomenological approach underpinned use of an asynchronous online forum method, in collaboration with a patient support group. Data were evaluated using","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; qualitative research","De Coppi","Paolo","Stem Cells and Regenerative Medicine Section, University College London Institute of Child Health, London, UK",NA
"2407","34192203","10.1136/bmjpo-2021-001077","COVID-19 pandemic experiences of parents caring for children with oesophageal atresia/tracheo-oesophageal fistula.","The COVID-19 pandemic has resulted in a global health crisis of unparalleled magnitude. The direct risk to the health of children is low. However, disease-containment measures have society-wide impacts. This study explored the pandemic experiences of parents of children with oesophageal atresia/tracheo-oesophageal fistula (OA/TOF) in the UK. A phenomenological approach underpinned use of an asynchronous online forum method, in collaboration with a patient support group. Data were evaluated using","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; qualitative research","Wray","Jo","Centre for Outcomes and Experience Research in Children's Health, Illness and Disability (ORCHID), Great Ormond Street Hospital For Children NHS Trust, London, UK",NA
"2408","34192202","10.1136/bmjpo-2021-001066","Changes in children's surgical services during the COVID-19 pandemic at a tertiary-level government hospital in a lower middle-income country.","The aim of this study was to quantify the changes that occurred in the surgical services of children during the COVID-19 pandemic from the perspective of a low/middle-income country. A case-control study was conducted at a large referral centre in Bangladesh among patients aged =12 years. Comparisons were made between cases admitted during a period of 'April to September 2020' (Pandemic period) and controls during a similar period in 2019 (Reference period). The number of admissions and outpatie","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; health services research; neonatology","Farooq","Md Abdullah Al","Department of Paediatric Surgery, Chittagong Medical College, Chattogram, Bangladesh",NA
"2409","34192202","10.1136/bmjpo-2021-001066","Changes in children's surgical services during the COVID-19 pandemic at a tertiary-level government hospital in a lower middle-income country.","The aim of this study was to quantify the changes that occurred in the surgical services of children during the COVID-19 pandemic from the perspective of a low/middle-income country. A case-control study was conducted at a large referral centre in Bangladesh among patients aged =12 years. Comparisons were made between cases admitted during a period of 'April to September 2020' (Pandemic period) and controls during a similar period in 2019 (Reference period). The number of admissions and outpatie","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; health services research; neonatology","Kabir","S M Humayun","Director, Chattogram Medical College Hospital, Chattogram, Bangladesh",NA
"2410","34192202","10.1136/bmjpo-2021-001066","Changes in children's surgical services during the COVID-19 pandemic at a tertiary-level government hospital in a lower middle-income country.","The aim of this study was to quantify the changes that occurred in the surgical services of children during the COVID-19 pandemic from the perspective of a low/middle-income country. A case-control study was conducted at a large referral centre in Bangladesh among patients aged =12 years. Comparisons were made between cases admitted during a period of 'April to September 2020' (Pandemic period) and controls during a similar period in 2019 (Reference period). The number of admissions and outpatie","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; health services research; neonatology","Chowdhury","Tanvir Kabir","Department of Paediatric Surgery, Chittagong Medical College, Chattogram, Bangladesh",NA
"2411","34192202","10.1136/bmjpo-2021-001066","Changes in children's surgical services during the COVID-19 pandemic at a tertiary-level government hospital in a lower middle-income country.","The aim of this study was to quantify the changes that occurred in the surgical services of children during the COVID-19 pandemic from the perspective of a low/middle-income country. A case-control study was conducted at a large referral centre in Bangladesh among patients aged =12 years. Comparisons were made between cases admitted during a period of 'April to September 2020' (Pandemic period) and controls during a similar period in 2019 (Reference period). The number of admissions and outpatie","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; health services research; neonatology","Sadia","Ayesha","Department of Paediatric Surgery, Chittagong Medical College, Chattogram, Bangladesh",NA
"2412","34192202","10.1136/bmjpo-2021-001066","Changes in children's surgical services during the COVID-19 pandemic at a tertiary-level government hospital in a lower middle-income country.","The aim of this study was to quantify the changes that occurred in the surgical services of children during the COVID-19 pandemic from the perspective of a low/middle-income country. A case-control study was conducted at a large referral centre in Bangladesh among patients aged =12 years. Comparisons were made between cases admitted during a period of 'April to September 2020' (Pandemic period) and controls during a similar period in 2019 (Reference period). The number of admissions and outpatie","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; health services research; neonatology","Alam","Md Afruzul","Department of Paediatric Surgery, Chittagong Medical College, Chattogram, Bangladesh",NA
"2413","34192202","10.1136/bmjpo-2021-001066","Changes in children's surgical services during the COVID-19 pandemic at a tertiary-level government hospital in a lower middle-income country.","The aim of this study was to quantify the changes that occurred in the surgical services of children during the COVID-19 pandemic from the perspective of a low/middle-income country. A case-control study was conducted at a large referral centre in Bangladesh among patients aged =12 years. Comparisons were made between cases admitted during a period of 'April to September 2020' (Pandemic period) and controls during a similar period in 2019 (Reference period). The number of admissions and outpatie","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; health services research; neonatology","Farhad","Tanzil","Department of Paediatric Surgery, Chittagong Medical College, Chattogram, Bangladesh",NA
"2414","34192201","10.1136/bmjpo-2021-001063","Understanding COVID-19: are children the key?","The devastating impact of the COVID-19 pandemic on global health and economic stability is immeasurable. The situation is dynamic and fast-evolving, with the world facing new variants of concern which may have immune escape potential. With threatened treatment and preventative strategies at stake, and the prospect of reinfection prolonging the pandemic, it is more crucial than ever to understand the pathogenesis of SARS-CoV-2 infection, which intriguingly disproportionately affects adults and th","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; cell biology; epidemiology; microbiology; virology","Warner","Suz","Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK",NA
"2415","34192201","10.1136/bmjpo-2021-001063","Understanding COVID-19: are children the key?","The devastating impact of the COVID-19 pandemic on global health and economic stability is immeasurable. The situation is dynamic and fast-evolving, with the world facing new variants of concern which may have immune escape potential. With threatened treatment and preventative strategies at stake, and the prospect of reinfection prolonging the pandemic, it is more crucial than ever to understand the pathogenesis of SARS-CoV-2 infection, which intriguingly disproportionately affects adults and th","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; cell biology; epidemiology; microbiology; virology","Richter","Alex","Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK",NA
"2416","34192201","10.1136/bmjpo-2021-001063","Understanding COVID-19: are children the key?","The devastating impact of the COVID-19 pandemic on global health and economic stability is immeasurable. The situation is dynamic and fast-evolving, with the world facing new variants of concern which may have immune escape potential. With threatened treatment and preventative strategies at stake, and the prospect of reinfection prolonging the pandemic, it is more crucial than ever to understand the pathogenesis of SARS-CoV-2 infection, which intriguingly disproportionately affects adults and th","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; cell biology; epidemiology; microbiology; virology","Stamataki","Zania","Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK",NA
"2417","34192201","10.1136/bmjpo-2021-001063","Understanding COVID-19: are children the key?","The devastating impact of the COVID-19 pandemic on global health and economic stability is immeasurable. The situation is dynamic and fast-evolving, with the world facing new variants of concern which may have immune escape potential. With threatened treatment and preventative strategies at stake, and the prospect of reinfection prolonging the pandemic, it is more crucial than ever to understand the pathogenesis of SARS-CoV-2 infection, which intriguingly disproportionately affects adults and th","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; cell biology; epidemiology; microbiology; virology","Kelly","Deirdre","The Liver Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK",NA
"2418","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Shet","Anita","International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA",NA
"2419","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Dhaliwal","Baldeep","International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA",NA
"2420","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Banerjee","Preetika","International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA",NA
"2421","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Carr","Kelly","International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA",NA
"2422","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","DeLuca","Andrea","Amputee Coalition of America, Knoxville, Tennessee, USA",NA
"2423","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Britto","Carl","Infectious Disease Resaerch Unit, St John's National Academy of Health Sciences, Bangalore, Karnataka, India",NA
"2424","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Seth","Rajeev","Bal Umang Drishya Sanstha (BUDS), New Delhi, India",NA
"2425","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Parekh","Bakul","Indian Academy of Pediatrics, Navi Mumbai, Maharashtra, India",NA
"2426","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Basavaraj","Gangasamudra V","Indian Academy of Pediatrics, Navi Mumbai, Maharashtra, India",NA
"2427","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Shastri","Digant","Indian Academy of Pediatrics, Navi Mumbai, Maharashtra, India",NA
"2428","34192200","10.1136/bmjpo-2021-001060","COVID-19-related disruptions to routine vaccination services in India: a survey of paediatric providers.","The COVID-19 pandemic has led to disruptions in essential health services globally. We surveyed Indian paediatric providers on their perceptions of the impact of the pandemic on routine vaccination. Among 424 (survey 1) and 141 (survey 2) respondents representing 26 of 36 Indian states and union territories, complete suspension of vaccination services was reported by 33.4% and 7.8%, respectively. In April-June 2020, 83.1% perceived that vaccination services dropped by half, followed by 32.6% in ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; data collection; epidemiology","Gupta","Piyush","Indian Academy of Pediatrics, Navi Mumbai, Maharashtra, India",NA
"2429","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Thompson","Daniel A","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2430","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Abbasizanjani","Hoda","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2431","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Fry","Richard","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2432","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Marchant","Emily","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2433","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Griffiths","Lucy","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2434","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Akbari","Ashley","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2435","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Hollinghurst","Joe","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2436","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","North","Laura","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2437","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Lyons","Jane","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2438","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Torabi","Fatemeh","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2439","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Davies","Gareth","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2440","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Gravenor","Mike B","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2441","34192199","10.1136/bmjpo-2021-001049","Staff-pupil SARS-CoV-2 infection pathways in schools in Wales: a population-level linked data approach.","Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection while minimising disruption to children's education and well-being. Our national e-cohort (n=464531) study used anonymised linked data for pupils, staff and associated households linked via educational settings in Wales. We estimated the odds of testing positive for SARS-CoV-2 infection for staff and pupils over the period August","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","SARS-CoV-2; disease transmission; public health; schools","Lyons","Ronan A","Swansea University Medical School, Swansea University, Swansea, UK",NA
"2442","34192198","10.1136/bmjpo-2021-001043","Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.","In the context of containment measures against the COVID-19 pandemic, the aims were to examine the impact of lockdown and school closures on childs' and adolescents' health and well-being and social inequalities in health. Literature review by searching five databases until November 2020. We included quantitative peer-reviewed studies reporting health and well-being outcomes in children (0-18 years) related to closure measures' impact due to COVID-19. A pair of authors assessed the risk of bias ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescents; children health; lockdown; school closure, social inequalities","Rajmil","Luis","Pediatric and Public Health Specialist, Retired, Barcelona, Spain",NA
"2443","34192198","10.1136/bmjpo-2021-001043","Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.","In the context of containment measures against the COVID-19 pandemic, the aims were to examine the impact of lockdown and school closures on childs' and adolescents' health and well-being and social inequalities in health. Literature review by searching five databases until November 2020. We included quantitative peer-reviewed studies reporting health and well-being outcomes in children (0-18 years) related to closure measures' impact due to COVID-19. A pair of authors assessed the risk of bias ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescents; children health; lockdown; school closure, social inequalities","Hjern","Anders","Centre for Health Equity Studies, Stockholm University/Karolinska Institutet, Stockholm, Sweden",NA
"2444","34192198","10.1136/bmjpo-2021-001043","Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.","In the context of containment measures against the COVID-19 pandemic, the aims were to examine the impact of lockdown and school closures on childs' and adolescents' health and well-being and social inequalities in health. Literature review by searching five databases until November 2020. We included quantitative peer-reviewed studies reporting health and well-being outcomes in children (0-18 years) related to closure measures' impact due to COVID-19. A pair of authors assessed the risk of bias ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescents; children health; lockdown; school closure, social inequalities","Boran","Perran","Department of Pediatrics, Marmara University School of Medicine, Istanbul, Turkey",NA
"2445","34192198","10.1136/bmjpo-2021-001043","Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.","In the context of containment measures against the COVID-19 pandemic, the aims were to examine the impact of lockdown and school closures on childs' and adolescents' health and well-being and social inequalities in health. Literature review by searching five databases until November 2020. We included quantitative peer-reviewed studies reporting health and well-being outcomes in children (0-18 years) related to closure measures' impact due to COVID-19. A pair of authors assessed the risk of bias ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescents; children health; lockdown; school closure, social inequalities","Gunnlaugsson","Geir","Faculty of Social and Human Sciences, University of Iceland, Reykjavík, Iceland",NA
"2446","34192198","10.1136/bmjpo-2021-001043","Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.","In the context of containment measures against the COVID-19 pandemic, the aims were to examine the impact of lockdown and school closures on childs' and adolescents' health and well-being and social inequalities in health. Literature review by searching five databases until November 2020. We included quantitative peer-reviewed studies reporting health and well-being outcomes in children (0-18 years) related to closure measures' impact due to COVID-19. A pair of authors assessed the risk of bias ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescents; children health; lockdown; school closure, social inequalities","Kraus de Camargo","Olaf","Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada",NA
"2447","34192198","10.1136/bmjpo-2021-001043","Impact of lockdown and school closure on children's health and well-being during the first wave of COVID-19: a narrative review.","In the context of containment measures against the COVID-19 pandemic, the aims were to examine the impact of lockdown and school closures on childs' and adolescents' health and well-being and social inequalities in health. Literature review by searching five databases until November 2020. We included quantitative peer-reviewed studies reporting health and well-being outcomes in children (0-18 years) related to closure measures' impact due to COVID-19. A pair of authors assessed the risk of bias ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescents; children health; lockdown; school closure, social inequalities","Raman","Shanti","Department of Community Paediatrics, South Western Sydney Local Health District, Liverpool, New South Wales, Australia",NA
"2448","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Armann","Jakob Peter","Department of Paediatrics, University Hospital and Medical Faculty Carl Gustav, Dresden University of Technology, Dresden, Germany",NA
"2449","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Kirsten","Carolin","Department of Paediatrics, University Hospital and Medical Faculty Carl Gustav, Dresden University of Technology, Dresden, Germany",NA
"2450","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Galow","Lukas","Department of Paediatrics, University Hospital and Medical Faculty Carl Gustav, Dresden University of Technology, Dresden, Germany",NA
"2451","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Kahre","Elisabeth","Department of Paediatrics, University Hospital and Medical Faculty Carl Gustav, Dresden University of Technology, Dresden, Germany",NA
"2452","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Haag","Luise","Department of Paediatrics, University Hospital and Medical Faculty Carl Gustav, Dresden University of Technology, Dresden, Germany",NA
"2453","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Dalpke","Alexander","Institute of Medical Microbiology and Hygiene, Institute of Virology, TU Dresden, Dresden, Sachsen, Germany",NA
"2454","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Lück","Christian","Institute of Medical Microbiology and Hygiene, Institute of Virology, TU Dresden, Dresden, Sachsen, Germany",NA
"2455","34192197","10.1136/bmjpo-2021-001036","SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020.","To quantify the number of undetected SARS-CoV-2 infections in educational settings. Serial SARS-CoV-2 seroprevalence study before and during the second wave of the COVID-19 pandemic. Secondary school in Dresden, Germany. Grade 8-12 students and their teachers were invited to participate in serial blood sampling and SARS-CoV-2 IgG antibody assessment. Seroprevalence of SARS-CoV-2 antibodies in study population. 247 students and 55 teachers participated in the initial study visit and 197 students ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology","Berner","Reinhard","Department of Paediatrics, University Hospital and Medical Faculty Carl Gustav, Dresden University of Technology, Dresden, Germany",NA
"2456","34192196","10.1136/bmjpo-2021-001029","Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria.","We assessed the effect of COVID-19 lockdown on deliveries and neonatal admissions according to gestation in Lagos, Nigeria. During lockdown (April-June 2020), there was a marked fall of about 50% in in-hospital deliveries and admissions to the neonatal wards for both in and outborn infants compared with prelockdown (January-March 2020) and a comparison period (April-June 2019). However, the proportion of preterm infants was broadly similar in each period. Lockdown markedly reduced hospital deliv","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; neonatology","Ezenwa","Beatrice Nkolika","Department of Paediatrics, University of Lagos College of Medicine, Lagos, Nigeria",NA
"2457","34192196","10.1136/bmjpo-2021-001029","Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria.","We assessed the effect of COVID-19 lockdown on deliveries and neonatal admissions according to gestation in Lagos, Nigeria. During lockdown (April-June 2020), there was a marked fall of about 50% in in-hospital deliveries and admissions to the neonatal wards for both in and outborn infants compared with prelockdown (January-March 2020) and a comparison period (April-June 2019). However, the proportion of preterm infants was broadly similar in each period. Lockdown markedly reduced hospital deliv","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; neonatology","Fajolu","Iretiola B","Department of Paediatrics, University of Lagos College of Medicine, Lagos, Nigeria",NA
"2458","34192196","10.1136/bmjpo-2021-001029","Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria.","We assessed the effect of COVID-19 lockdown on deliveries and neonatal admissions according to gestation in Lagos, Nigeria. During lockdown (April-June 2020), there was a marked fall of about 50% in in-hospital deliveries and admissions to the neonatal wards for both in and outborn infants compared with prelockdown (January-March 2020) and a comparison period (April-June 2019). However, the proportion of preterm infants was broadly similar in each period. Lockdown markedly reduced hospital deliv","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; neonatology","Nabwera","Helen","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK",NA
"2459","34192196","10.1136/bmjpo-2021-001029","Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria.","We assessed the effect of COVID-19 lockdown on deliveries and neonatal admissions according to gestation in Lagos, Nigeria. During lockdown (April-June 2020), there was a marked fall of about 50% in in-hospital deliveries and admissions to the neonatal wards for both in and outborn infants compared with prelockdown (January-March 2020) and a comparison period (April-June 2019). However, the proportion of preterm infants was broadly similar in each period. Lockdown markedly reduced hospital deliv","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; neonatology","Wang","Duolao","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK",NA
"2460","34192196","10.1136/bmjpo-2021-001029","Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria.","We assessed the effect of COVID-19 lockdown on deliveries and neonatal admissions according to gestation in Lagos, Nigeria. During lockdown (April-June 2020), there was a marked fall of about 50% in in-hospital deliveries and admissions to the neonatal wards for both in and outborn infants compared with prelockdown (January-March 2020) and a comparison period (April-June 2019). However, the proportion of preterm infants was broadly similar in each period. Lockdown markedly reduced hospital deliv","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; neonatology","Ezeaka","Chinyere V","Department of Paediatrics, University of Lagos College of Medicine, Lagos, Nigeria",NA
"2461","34192196","10.1136/bmjpo-2021-001029","Impact of COVID-19 lockdown measures on institutional delivery, neonatal admissions and prematurity: a reflection from Lagos, Nigeria.","We assessed the effect of COVID-19 lockdown on deliveries and neonatal admissions according to gestation in Lagos, Nigeria. During lockdown (April-June 2020), there was a marked fall of about 50% in in-hospital deliveries and admissions to the neonatal wards for both in and outborn infants compared with prelockdown (January-March 2020) and a comparison period (April-June 2019). However, the proportion of preterm infants was broadly similar in each period. Lockdown markedly reduced hospital deliv","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; neonatology","Allen","Stephen","Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK",NA
"2462","34192195","10.1136/bmjpo-2020-001013","Large decrease in paediatric hospitalisations during the COVID-19 outbreak in Japan.","We evaluated the nationwide trends in paediatric hospitalisations including non-emergency hospitalisations during the COVID-19 pandemic in Japan. Using inpatient data from 272 acute-care hospitals covering 12.4% of total hospitalisations of all ages, we analysed the number of hospitalisations of children (aged 1-17 years) for weeks 9-21 of 2020 (during the outbreak) versus 2017-2019. Hospitalisation decreased during the outbreak by 38.4% (adjusted incidence rate ratio, 0.60; 95% CI, 0.53 to 0.69","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Sano","Kazuaki","Department of Public Health, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan",NA
"2463","34192195","10.1136/bmjpo-2020-001013","Large decrease in paediatric hospitalisations during the COVID-19 outbreak in Japan.","We evaluated the nationwide trends in paediatric hospitalisations including non-emergency hospitalisations during the COVID-19 pandemic in Japan. Using inpatient data from 272 acute-care hospitals covering 12.4% of total hospitalisations of all ages, we analysed the number of hospitalisations of children (aged 1-17 years) for weeks 9-21 of 2020 (during the outbreak) versus 2017-2019. Hospitalisation decreased during the outbreak by 38.4% (adjusted incidence rate ratio, 0.60; 95% CI, 0.53 to 0.69","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Nakamura","Masaki","Medical Data Vision Co., Ltd, Chiyoda-ku, Tokyo, Japan",NA
"2464","34192195","10.1136/bmjpo-2020-001013","Large decrease in paediatric hospitalisations during the COVID-19 outbreak in Japan.","We evaluated the nationwide trends in paediatric hospitalisations including non-emergency hospitalisations during the COVID-19 pandemic in Japan. Using inpatient data from 272 acute-care hospitals covering 12.4% of total hospitalisations of all ages, we analysed the number of hospitalisations of children (aged 1-17 years) for weeks 9-21 of 2020 (during the outbreak) versus 2017-2019. Hospitalisation decreased during the outbreak by 38.4% (adjusted incidence rate ratio, 0.60; 95% CI, 0.53 to 0.69","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Ninomiya","Hideki","Department of Health Policy and Management, Keio University, Minato-ku, Tokyo, Japan",NA
"2465","34192195","10.1136/bmjpo-2020-001013","Large decrease in paediatric hospitalisations during the COVID-19 outbreak in Japan.","We evaluated the nationwide trends in paediatric hospitalisations including non-emergency hospitalisations during the COVID-19 pandemic in Japan. Using inpatient data from 272 acute-care hospitals covering 12.4% of total hospitalisations of all ages, we analysed the number of hospitalisations of children (aged 1-17 years) for weeks 9-21 of 2020 (during the outbreak) versus 2017-2019. Hospitalisation decreased during the outbreak by 38.4% (adjusted incidence rate ratio, 0.60; 95% CI, 0.53 to 0.69","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Kobayashi","Yasuki","Department of Public Health, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan",NA
"2466","34192195","10.1136/bmjpo-2020-001013","Large decrease in paediatric hospitalisations during the COVID-19 outbreak in Japan.","We evaluated the nationwide trends in paediatric hospitalisations including non-emergency hospitalisations during the COVID-19 pandemic in Japan. Using inpatient data from 272 acute-care hospitals covering 12.4% of total hospitalisations of all ages, we analysed the number of hospitalisations of children (aged 1-17 years) for weeks 9-21 of 2020 (during the outbreak) versus 2017-2019. Hospitalisation decreased during the outbreak by 38.4% (adjusted incidence rate ratio, 0.60; 95% CI, 0.53 to 0.69","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Miyawaki","Atsushi","Department of Public Health, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan",NA
"2468","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Bekkering","Geertruida","Academic Center for General Practice, KU Leuven, Leuven, Flanders, Belgium",NA
"2469","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Delvaux","Nicolas","Academic Center for General Practice, KU Leuven, Leuven, Flanders, Belgium",NA
"2470","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Vankrunkelsven","Patrik","Academic Center for General Practice, KU Leuven, Leuven, Flanders, Belgium",NA
"2471","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Toelen","Jaan","Pediatrics, UZ Leuven, Leuven, Belgium",NA
"2472","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Aertgeerts","Sigrid","Primary School Heilig Hart, Leuven, Belgium",NA
"2473","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Crommen","Sofie","Practice for Child Psychiatry, Zutendaal, Belgium",NA
"2474","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Bruyckere","Pedro De","Teacher Training Department, Artevelde University College, Gent, Belgium",NA
"2475","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Devisch","Ignaas","Department of Public Health and Primary Care, UGent, Gent, Belgium",NA
"2476","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Lernout","Tinne","Sciensano, Brussels, Belgium",NA
"2477","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Masschalck","Katrien","Laakdal, Belgium",NA
"2478","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Milissen","Nore","Heverlee, Belgium",NA
"2479","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Molenberghs","Geert","Data Science Institute, UHasselt BIOMED, Diepenbeek, Limburg, Belgium",NA
"2480","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Pascal","Annelies","Hotelschool Ter Groene Poorte, Secondary School, Brugge, Belgium",NA
"2481","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Plomteux","Oscar","Geel, Belgium",NA
"2482","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Raes","Marc","Pediatrics, Jessa Hospital VZW, Hasselt, Belgium",NA
"2483","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Rans","Lise","Heverlee, Belgium",NA
"2484","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Seghers","Alexandra","Vrij CLB, Leuven, Belgium",NA
"2485","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Sweldens","Lode","De Olm, Special Primary Education, Herk-de-Stad, Belgium",NA
"2486","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Vandenbussche","Jeroen","Primary Education Boven-Lo, Kessel-Lo, Belgium",NA
"2487","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Vanham","Guido","Institute of Tropical Medicine, Antwerpen, Belgium",NA
"2488","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Wollants","Elke","Clinical and Epidemiological Virology, KU Leuven, Leuven, Belgium",NA
"2489","34192193","10.1136/bmjpo-2020-000971","Closing schools for SARS-CoV-2: a pragmatic rapid recommendation.","In Belgium, schools closed during the first lockdown in March 2020, with a partial reopening in May. They fully reopened in September. During the summer, infections started to increase in the general population, speeding up in September. Some measures were taken to limit social contacts but those were insufficient to mitigate the exponential rise of infections in October. Children were still receiving all lessons at school at that time and it was questioned whether this position was tenable. We ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; adolescent health; epidemiology","Aertgeerts","Bert","Academic Center for General Practice, KU Leuven, Leuven, Flanders, Belgium",NA
"2490","34192192","10.1136/bmjpo-2020-000967","Changing patterns of emergency paediatric presentations during the first wave of COVID-19: learning for the second wave from a UK tertiary emergency department.","The SARS-CoV-2 pandemic and initial public health response led to significant changes in health service delivery, access and utilisation. However, SARS-CoV-2 illness burden in children and young people (CYP) is low. To inform effective child public health interventions, we aimed to compare patterns of paediatric emergency department presentation during the initial pandemic response with a previous non-pandemic period. Retrospective review of attendances (0-18 years) over the initial pandemic (2 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Shanmugavadivel","Dhurgshaarna","Division of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham, Nottingham, UK",NA
"2491","34192192","10.1136/bmjpo-2020-000967","Changing patterns of emergency paediatric presentations during the first wave of COVID-19: learning for the second wave from a UK tertiary emergency department.","The SARS-CoV-2 pandemic and initial public health response led to significant changes in health service delivery, access and utilisation. However, SARS-CoV-2 illness burden in children and young people (CYP) is low. To inform effective child public health interventions, we aimed to compare patterns of paediatric emergency department presentation during the initial pandemic response with a previous non-pandemic period. Retrospective review of attendances (0-18 years) over the initial pandemic (2 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Liu","Jo-Fen","Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK",NA
"2492","34192192","10.1136/bmjpo-2020-000967","Changing patterns of emergency paediatric presentations during the first wave of COVID-19: learning for the second wave from a UK tertiary emergency department.","The SARS-CoV-2 pandemic and initial public health response led to significant changes in health service delivery, access and utilisation. However, SARS-CoV-2 illness burden in children and young people (CYP) is low. To inform effective child public health interventions, we aimed to compare patterns of paediatric emergency department presentation during the initial pandemic response with a previous non-pandemic period. Retrospective review of attendances (0-18 years) over the initial pandemic (2 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Gilhooley","Colin","DREEAM: Department of Research and Education in Emergency Medicine, Acute Medicine and Major Trauma, Nottingham University Hospitals NHS Trust, Nottingham, UK",NA
"2493","34192192","10.1136/bmjpo-2020-000967","Changing patterns of emergency paediatric presentations during the first wave of COVID-19: learning for the second wave from a UK tertiary emergency department.","The SARS-CoV-2 pandemic and initial public health response led to significant changes in health service delivery, access and utilisation. However, SARS-CoV-2 illness burden in children and young people (CYP) is low. To inform effective child public health interventions, we aimed to compare patterns of paediatric emergency department presentation during the initial pandemic response with a previous non-pandemic period. Retrospective review of attendances (0-18 years) over the initial pandemic (2 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Elsaadany","Loai","Nottingham Children's Hospital, Queen's Medical Centre Nottingham University Hospital NHS Trust, Nottingham, UK",NA
"2494","34192192","10.1136/bmjpo-2020-000967","Changing patterns of emergency paediatric presentations during the first wave of COVID-19: learning for the second wave from a UK tertiary emergency department.","The SARS-CoV-2 pandemic and initial public health response led to significant changes in health service delivery, access and utilisation. However, SARS-CoV-2 illness burden in children and young people (CYP) is low. To inform effective child public health interventions, we aimed to compare patterns of paediatric emergency department presentation during the initial pandemic response with a previous non-pandemic period. Retrospective review of attendances (0-18 years) over the initial pandemic (2 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; epidemiology; health services research","Wood","Damian","Nottingham Children's Hospital, Queen's Medical Centre Nottingham University Hospital NHS Trust, Nottingham, UK",NA
"2495","34192191","10.1136/bmjpo-2020-000956","Supporting marginalised children with school problems in the COVID-19 pandemic.",NA,"2021","06","30","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; child psychiatry; psychology","Minhas","Ripudaman Singh","Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"2496","34192191","10.1136/bmjpo-2020-000956","Supporting marginalised children with school problems in the COVID-19 pandemic.",NA,"2021","06","30","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; child psychiatry; psychology","Freeman","Sloane J","Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada",NA
"2497","34192190","10.1136/bmjpo-2020-000942","Survey of young people in one region of the UK on accessing COVID-19 information (SOCIAL).","COVID-19 has significantly impacted young people's lives yet little is known about the COVID-19 related sources of information they access. We performed a cross-sectional survey of pupils (11-16 years) in North Staffordshire, UK. 408 (23%) pupils responded to an online survey emailed to them by their school. Descriptive statistics were used to summarise the data. Social media, accessed by 68%, played a significant role in the provision of information, despite it not being considered trustworthy.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; technology","Lawton","Oliver G P","St Joseph's Catholic College, Stoke on Trent, UK",NA
"2498","34192190","10.1136/bmjpo-2020-000942","Survey of young people in one region of the UK on accessing COVID-19 information (SOCIAL).","COVID-19 has significantly impacted young people's lives yet little is known about the COVID-19 related sources of information they access. We performed a cross-sectional survey of pupils (11-16 years) in North Staffordshire, UK. 408 (23%) pupils responded to an online survey emailed to them by their school. Descriptive statistics were used to summarise the data. Social media, accessed by 68%, played a significant role in the provision of information, despite it not being considered trustworthy.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; technology","Lawton","Sarah A","Keele CTU, Faculty of Medicine and Health Sciences, Keele University, Keele, UK",NA
"2499","34192190","10.1136/bmjpo-2020-000942","Survey of young people in one region of the UK on accessing COVID-19 information (SOCIAL).","COVID-19 has significantly impacted young people's lives yet little is known about the COVID-19 related sources of information they access. We performed a cross-sectional survey of pupils (11-16 years) in North Staffordshire, UK. 408 (23%) pupils responded to an online survey emailed to them by their school. Descriptive statistics were used to summarise the data. Social media, accessed by 68%, played a significant role in the provision of information, despite it not being considered trustworthy.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; technology","Dikomitis","Lisa","Faculty of Medicine and Health Sciences, Keele University, Keele, UK",NA
"2500","34192190","10.1136/bmjpo-2020-000942","Survey of young people in one region of the UK on accessing COVID-19 information (SOCIAL).","COVID-19 has significantly impacted young people's lives yet little is known about the COVID-19 related sources of information they access. We performed a cross-sectional survey of pupils (11-16 years) in North Staffordshire, UK. 408 (23%) pupils responded to an online survey emailed to them by their school. Descriptive statistics were used to summarise the data. Social media, accessed by 68%, played a significant role in the provision of information, despite it not being considered trustworthy.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; technology","Protheroe","Joanne","Faculty of Medicine and Health Sciences, Keele University, Keele, UK",NA
"2501","34192190","10.1136/bmjpo-2020-000942","Survey of young people in one region of the UK on accessing COVID-19 information (SOCIAL).","COVID-19 has significantly impacted young people's lives yet little is known about the COVID-19 related sources of information they access. We performed a cross-sectional survey of pupils (11-16 years) in North Staffordshire, UK. 408 (23%) pupils responded to an online survey emailed to them by their school. Descriptive statistics were used to summarise the data. Social media, accessed by 68%, played a significant role in the provision of information, despite it not being considered trustworthy.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; technology","Smith","Joanne","Keele CTU, Faculty of Medicine and Health Sciences, Keele University, Keele, UK",NA
"2502","34192190","10.1136/bmjpo-2020-000942","Survey of young people in one region of the UK on accessing COVID-19 information (SOCIAL).","COVID-19 has significantly impacted young people's lives yet little is known about the COVID-19 related sources of information they access. We performed a cross-sectional survey of pupils (11-16 years) in North Staffordshire, UK. 408 (23%) pupils responded to an online survey emailed to them by their school. Descriptive statistics were used to summarise the data. Social media, accessed by 68%, played a significant role in the provision of information, despite it not being considered trustworthy.","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; technology","Mallen","Christian D","Faculty of Medicine and Health Sciences, Keele University, Keele, UK",NA
"2503","34192189","10.1136/bmjpo-2020-000926","Scoping exercise to develop a storybook to support children's education during the COVID-19 pandemic.","In June 2020, as COVID-19 lockdown measures were eased in the UK, this scoping exercise aimed to rapidly identify topics to cover within a children's online storybook 'My Back to School Bubble', designed to support the return to school. An email invitation was sent to 71 known contacts within networks across Public Health England, local authorities, health protection teams and contacts within the Department for Education. Following online publication of 'My Back to School Bubble', users were ask","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; qualitative research","Syeda","Rowshonara","Primary Care and Interventions Unit, Public Health England, Gloucester, UK",NA
"2504","34192189","10.1136/bmjpo-2020-000926","Scoping exercise to develop a storybook to support children's education during the COVID-19 pandemic.","In June 2020, as COVID-19 lockdown measures were eased in the UK, this scoping exercise aimed to rapidly identify topics to cover within a children's online storybook 'My Back to School Bubble', designed to support the return to school. An email invitation was sent to 71 known contacts within networks across Public Health England, local authorities, health protection teams and contacts within the Department for Education. Following online publication of 'My Back to School Bubble', users were ask","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; qualitative research","Hann","Magdalena","Primary Care and Interventions Unit, Public Health England, Gloucester, UK",NA
"2505","34192189","10.1136/bmjpo-2020-000926","Scoping exercise to develop a storybook to support children's education during the COVID-19 pandemic.","In June 2020, as COVID-19 lockdown measures were eased in the UK, this scoping exercise aimed to rapidly identify topics to cover within a children's online storybook 'My Back to School Bubble', designed to support the return to school. An email invitation was sent to 71 known contacts within networks across Public Health England, local authorities, health protection teams and contacts within the Department for Education. Following online publication of 'My Back to School Bubble', users were ask","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; qualitative research","Allison","Rosalie","Primary Care and Interventions Unit, Public Health England, Gloucester, UK",NA
"2506","34192189","10.1136/bmjpo-2020-000926","Scoping exercise to develop a storybook to support children's education during the COVID-19 pandemic.","In June 2020, as COVID-19 lockdown measures were eased in the UK, this scoping exercise aimed to rapidly identify topics to cover within a children's online storybook 'My Back to School Bubble', designed to support the return to school. An email invitation was sent to 71 known contacts within networks across Public Health England, local authorities, health protection teams and contacts within the Department for Education. Following online publication of 'My Back to School Bubble', users were ask","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; qualitative research","Demirjian","Alicia","Primary Care and Interventions Unit, Public Health England, Gloucester, UK",NA
"2507","34192188","10.1136/bmjpo-2020-000894","Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.","In this review, we discuss some important aspects of paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), a new syndrome that is temporally related to previous exposure to SARS-CoV-2 infection. This virus has a broad spectrum of presentation that may overlap with Kawasaki disease in terms of presenting symptoms and laboratory and cardiac findings. Our objective was to review and summarise published evidence regarding the most important aspects of PIMS-TS, w","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","mortality; pathology; syndrome; therapeutics; virology","Fernández-Sarmiento","Jaime","Department of Critical Care Medicine and Pediatrics Fundación Cardioinfantil - Instituto de Cardiología, Universidad de la Sabana, CES Graduate School, Sepsis Committee Latin American Society of Pediatric Intensive Care (SLACIP), Bogotá, Colombia",NA
"2508","34192188","10.1136/bmjpo-2020-000894","Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.","In this review, we discuss some important aspects of paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), a new syndrome that is temporally related to previous exposure to SARS-CoV-2 infection. This virus has a broad spectrum of presentation that may overlap with Kawasaki disease in terms of presenting symptoms and laboratory and cardiac findings. Our objective was to review and summarise published evidence regarding the most important aspects of PIMS-TS, w","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","mortality; pathology; syndrome; therapeutics; virology","De Souza","Daniela","Pediatric Intensive Care Unit and Department of Pediatrics, Hospital Universitario da Universidad de São Paulo and Hospital Sírio Libanês, Sepsis Committee Latin American Society of Pediatric Intensive Care (SLACIP), Sao Paulo, Brazil",NA
"2509","34192188","10.1136/bmjpo-2020-000894","Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.","In this review, we discuss some important aspects of paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), a new syndrome that is temporally related to previous exposure to SARS-CoV-2 infection. This virus has a broad spectrum of presentation that may overlap with Kawasaki disease in terms of presenting symptoms and laboratory and cardiac findings. Our objective was to review and summarise published evidence regarding the most important aspects of PIMS-TS, w","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","mortality; pathology; syndrome; therapeutics; virology","Jabornisky","Roberto","Department of Pediatrics Facultad de Medicina Universidad Nacional del Nordeste, Sepsis Committee Latin American Society of Pediatric Intensive Care (SLACIP), Corrientes, Argentina",NA
"2510","34192188","10.1136/bmjpo-2020-000894","Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.","In this review, we discuss some important aspects of paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), a new syndrome that is temporally related to previous exposure to SARS-CoV-2 infection. This virus has a broad spectrum of presentation that may overlap with Kawasaki disease in terms of presenting symptoms and laboratory and cardiac findings. Our objective was to review and summarise published evidence regarding the most important aspects of PIMS-TS, w","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","mortality; pathology; syndrome; therapeutics; virology","Gonzalez","Gustavo Ariel","Pediatric Intensive Care Unit. Hospital Churruca - Visca Medical Complex, Ricardo Gutiérrez Children's Hospital, Sepsis Committee. Latin American Society of Pediatric Intensive Care (SLACIP), Buenos Aires, Argentina",NA
"2511","34192188","10.1136/bmjpo-2020-000894","Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.","In this review, we discuss some important aspects of paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), a new syndrome that is temporally related to previous exposure to SARS-CoV-2 infection. This virus has a broad spectrum of presentation that may overlap with Kawasaki disease in terms of presenting symptoms and laboratory and cardiac findings. Our objective was to review and summarise published evidence regarding the most important aspects of PIMS-TS, w","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","mortality; pathology; syndrome; therapeutics; virology","Arias López","Maria Del Pilar","Pediatric Intensive Care Unit Ricardo Gutiérrez Children's Hospital, Sepsis Committee Latin American Society of Pediatric Intensive Care (SLACIP), Buenos Aires, Argentina",NA
"2512","34192188","10.1136/bmjpo-2020-000894","Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee.","In this review, we discuss some important aspects of paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS), a new syndrome that is temporally related to previous exposure to SARS-CoV-2 infection. This virus has a broad spectrum of presentation that may overlap with Kawasaki disease in terms of presenting symptoms and laboratory and cardiac findings. Our objective was to review and summarise published evidence regarding the most important aspects of PIMS-TS, w","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","mortality; pathology; syndrome; therapeutics; virology","Palacio","Gladys","Pediatric Intensive Care Unit Ricardo Gutiérrez Children's Hospital, Sepsis Committee. Latin American Society of Pediatric Intensive Care (SLACIP), Buenos Aires, Argentina",NA
"2513","34192186","10.1136/bmjpo-2020-000853","COVID-19 and the impact on child dental services in the UK.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; dentistry; epidemiology; obesity","Okike","Ifeanyichukwu","Paediatrics, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK",NA
"2514","34192186","10.1136/bmjpo-2020-000853","COVID-19 and the impact on child dental services in the UK.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; dentistry; epidemiology; obesity","Reid","Allan","Public Health Improvement Team, Public Health England, Midlands, Nottingham, UK",NA
"2515","34192186","10.1136/bmjpo-2020-000853","COVID-19 and the impact on child dental services in the UK.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; dentistry; epidemiology; obesity","Woonsam","Katherine","Paediatrics, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK",NA
"2516","34192186","10.1136/bmjpo-2020-000853","COVID-19 and the impact on child dental services in the UK.",NA,"2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","COVID-19; dentistry; epidemiology; obesity","Dickenson","Andrew","Regional Postgraduate Dental Dean Midlands and East, Health Education England, Leicester, UK",NA
"2518","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Muniraman","Hemananda","Department of Pediatrics, Creighton University School of Medicine, Omaha, Nebraska, USA",NA
"2519","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Ali","Mahmoud","Division of Neonatology, Department of Pediatrics, Baylor Scott and White McLane Children's Medical Center, Temple, Texas, USA",NA
"2520","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Cawley","Paul","Division of Neonatology, Department of Paediatrics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2521","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Hillyer","Jessica","Division of Neonatology, Department of Pediatrics, Baylor Scott and White McLane Children's Medical Center, Temple, Texas, USA",NA
"2522","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Heathcote","Adam","Neonatal Intensive Care Unit, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK",NA
"2523","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Ponnusamy","Vennila","Neonatal Intensive Care Unit, Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, Surrey, UK",NA
"2524","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Coleman","Zoe","Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, USA",NA
"2525","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Hammonds","Kendall","Baylor Scott and White Research Institute, Temple, Texas, USA",NA
"2526","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Raiyani","Chandni","Baylor Scott and White Research Institute, Temple, Texas, USA",NA
"2527","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Gait-Carr","Eleanor","Neonatal Intensive Care Unit, University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK",NA
"2528","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Myers","Sarah","Neonatal Intensive Care Unit, University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK",NA
"2529","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Hunt","Katie","Division of Neonatology, Department of Paediatrics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2530","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Govande","Vinayak","Division of Neonatology, Department of Pediatrics, Baylor Scott and White McLane Children's Medical Center, Temple, Texas, USA",NA
"2531","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Jain","Anoo","Division of Neonatology, Department of Paediatrics, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"2532","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Clark","Reese","MEDNAX Inc, Sunrise, Florida, USA",NA
"2533","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Doherty","Cora","Neonatal Intensive Care Unit, University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK",NA
"2534","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Raju","Venkata","Division of Neonatology, Department of Pediatrics, Baylor Scott and White McLane Children's Medical Center, Temple, Texas, USA",NA
"2535","34192184","10.1136/bmjpo-2020-000899","Parental perceptions of the impact of neonatal unit visitation policies during COVID-19 pandemic.","To ascertain parental perceptions of the impact of restricted visiting policies to neonatal intensive care units during the current COVID-19 pandemic. Cross-sectional survey of parents impacted by visitation policies. Six tertiary level neonatal units, four from the UK and two from the USA, participated in the study. Parents and families of infants hospitalised in the participating centres between 1 May 2020 and 21 August 2020. Online-based and/or paper-based survey, querying the visitation poli","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; neonatology","Clarke","Paul","Neonatal Intensive Care Unit, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK",NA
"2536","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Ng","Sze May","Department of Paediatrics, Southport and Ormskirk Hospital NHS Trust, Ormskirk, UK",NA
"2537","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Woodger","Katherine","Department of Paediatrics, Southport and Ormskirk Hospital NHS Trust, Ormskirk, UK",NA
"2538","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Regan","Fiona","Department of Paediatrics, Wexham Park Hospital, Slough, UK",NA
"2539","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Soni","Astha","Department of General Medicine, Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK",NA
"2540","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Wright","Neil","Department of Paediatric Endocrinology &amp",NA
"2541","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Agwu","Juliana Chizo","Department of Paediatrics, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK",NA
"2542","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Williams","Eleri","Department of Paediatrics, Hampshire Hospitals NHS Foundation Trust, Winchester, Hampshire, UK",NA
"2543","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Timmis","Alison","Department of Paediatrics, Countess of Chester Hospital NHS Foundation Trust, Chester, Cheshire West and Chester, UK",NA
"2544","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Kershaw","Melanie","Department of Paediatrics, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK",NA
"2545","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Moudiotis","Christopher","Department of Paediatrics, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK",NA
"2546","34192183","10.1136/bmjpo-2020-000884","Presentation of newly diagnosed type 1 diabetes in children and young people during COVID-19: a national UK survey.","In the UK, there have been reports of significant reductions in paediatric emergency attendances and visits to the general practitioners due to COVID-19. A national survey undertaken by the UK Association of Children's Diabetes Clinicians found that the proportion of new-onset type 1 diabetes (T1D) presenting with diabetes ketoacidosis (DKA) during this COVID-19 pandemic was higher than previously reported, and there has been an increase in presentation of severe DKA at diagnosis in children and","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","endocrinology; epidemiology; health services research","Drew","Josephine","Department of Paediatrics, Nottingham University Hospitals NHS Trust, Nottingham, UK",NA
"2547","34192182","10.1136/bmjpo-2020-000859","COVID-19 in pregnancy: the foetal perspective-a systematic review.","We aimed to conduct a systematic review of the available literature to determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity. Data sources: eligible studies between 1 November 2019 and 10 August 2020 were retrieved from PubMed, Embase, LitCovid, Google Scholar, EBSCO MEDLINE, CENTRAL, CINAHL, MedRXiv, BioRXiv and Scopus collection databases. English language c","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; microbiology; mortality; neonatology; virology","Dube","Rajani","Obstetrics and Gynaecology, RAK Medical and Health Sciences University, Ras Al Khaimah, UAE",NA
"2548","34192182","10.1136/bmjpo-2020-000859","COVID-19 in pregnancy: the foetal perspective-a systematic review.","We aimed to conduct a systematic review of the available literature to determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity. Data sources: eligible studies between 1 November 2019 and 10 August 2020 were retrieved from PubMed, Embase, LitCovid, Google Scholar, EBSCO MEDLINE, CENTRAL, CINAHL, MedRXiv, BioRXiv and Scopus collection databases. English language c","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; microbiology; mortality; neonatology; virology","Kar","Subhranshu Sekhar","Paediatrics, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, UAE",NA
"2549","34192181","10.1136/bmjpo-2020-000854","Infection and transmission of COVID-19 among students and teachers in schools in Japan after the reopening in June 2020.","We aimed to investigate the confirmed COVID-19 cases among students and teachers in elementary schools (ages 6-12 years) and junior high schools (ages 13-15 years) in Japan between 1 June and 31 July 2020. We requested all schools to provide reports when students or teachers tested positive for COVID-19. A total of 207 cases were reported among students. Household transmission was identified as the dominant transmission route, confirmed in 71.4% of elementary schools and 60.3% of junior high sch","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; virology","Wada","Koji","Department of Public Health, Faculty of Medicine, International University of Health and Welfare, Tokyo, Japan",NA
"2550","34192181","10.1136/bmjpo-2020-000854","Infection and transmission of COVID-19 among students and teachers in schools in Japan after the reopening in June 2020.","We aimed to investigate the confirmed COVID-19 cases among students and teachers in elementary schools (ages 6-12 years) and junior high schools (ages 13-15 years) in Japan between 1 June and 31 July 2020. We requested all schools to provide reports when students or teachers tested positive for COVID-19. A total of 207 cases were reported among students. Household transmission was identified as the dominant transmission route, confirmed in 71.4% of elementary schools and 60.3% of junior high sch","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; virology","Okabe","Nobuhiko","Expert Committee on Infection Control and Prevention in Schools, Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan",NA
"2551","34192181","10.1136/bmjpo-2020-000854","Infection and transmission of COVID-19 among students and teachers in schools in Japan after the reopening in June 2020.","We aimed to investigate the confirmed COVID-19 cases among students and teachers in elementary schools (ages 6-12 years) and junior high schools (ages 13-15 years) in Japan between 1 June and 31 July 2020. We requested all schools to provide reports when students or teachers tested positive for COVID-19. A total of 207 cases were reported among students. Household transmission was identified as the dominant transmission route, confirmed in 71.4% of elementary schools and 60.3% of junior high sch","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; virology","Shobugawa","Yugo","Expert Committee on Infection Control and Prevention in Schools, Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan",NA
"2553","34192179","10.1136/bmjpo-2020-000826","Initial impact of COVID-19 on paediatric spinal services in Scotland.","COVID-19 has affected many National Health Service Scotland services. Our aim is to describe this impact on the Scottish National Spine Deformity Service (SNSDS). All referrals to the SNSDS from 1 January 2020 to 30 June 2020 were analysed and compared with the same period in 2019. There was a 64.3% decline in referrals during the pandemic to the SNSDS. The mean waiting time to be seen in first clinical appointment for a new referral was 6.5 weeks in 2020 compared with 10.9 in 2019. There were 6","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; health services research","Newman","Matthew","Scottish National Spine Deformity Service, RHSC, Edinburgh, UK",NA
"2554","34192179","10.1136/bmjpo-2020-000826","Initial impact of COVID-19 on paediatric spinal services in Scotland.","COVID-19 has affected many National Health Service Scotland services. Our aim is to describe this impact on the Scottish National Spine Deformity Service (SNSDS). All referrals to the SNSDS from 1 January 2020 to 30 June 2020 were analysed and compared with the same period in 2019. There was a 64.3% decline in referrals during the pandemic to the SNSDS. The mean waiting time to be seen in first clinical appointment for a new referral was 6.5 weeks in 2020 compared with 10.9 in 2019. There were 6","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; health services research","Garrido","Enrique","Scottish National Spine Deformity Service, RHSC, Edinburgh, UK",NA
"2555","34192179","10.1136/bmjpo-2020-000826","Initial impact of COVID-19 on paediatric spinal services in Scotland.","COVID-19 has affected many National Health Service Scotland services. Our aim is to describe this impact on the Scottish National Spine Deformity Service (SNSDS). All referrals to the SNSDS from 1 January 2020 to 30 June 2020 were analysed and compared with the same period in 2019. There was a 64.3% decline in referrals during the pandemic to the SNSDS. The mean waiting time to be seen in first clinical appointment for a new referral was 6.5 weeks in 2020 compared with 10.9 in 2019. There were 6","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; health services research","Tsirikos","Athanasios I","Scottish National Spine Deformity Service, RHSC, Edinburgh, UK",NA
"2556","34192178","10.1136/bmjpo-2020-000825","A cross-sectional survey of parental perceptions of COVID-19 related hygiene measures within schools and adherence to social distancing in journeys to and from school.","During the early stages of the COVID-19 pandemic, schools in England were only kept open to children of 'key workers' and, from 1 June, to children in reception, year 1 and year 6. Our cross-sectional survey of parents found low rates of attendance (&lt;50%) in both groups. Many parents whose children attended school reported low adherence to hygiene measures (eg, not maintaining distance from others during school drop-off) and doubted that their school was adhering to COVID-19 guidelines. This ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent Health; psychology","Smith","Louise E","Department of Psychological Medicine, King's College London, London, UK",NA
"2557","34192178","10.1136/bmjpo-2020-000825","A cross-sectional survey of parental perceptions of COVID-19 related hygiene measures within schools and adherence to social distancing in journeys to and from school.","During the early stages of the COVID-19 pandemic, schools in England were only kept open to children of 'key workers' and, from 1 June, to children in reception, year 1 and year 6. Our cross-sectional survey of parents found low rates of attendance (&lt;50%) in both groups. Many parents whose children attended school reported low adherence to hygiene measures (eg, not maintaining distance from others during school drop-off) and doubted that their school was adhering to COVID-19 guidelines. This ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent Health; psychology","Woodland","Lisa","Department of Psychological Medicine, King's College London, London, UK",NA
"2558","34192178","10.1136/bmjpo-2020-000825","A cross-sectional survey of parental perceptions of COVID-19 related hygiene measures within schools and adherence to social distancing in journeys to and from school.","During the early stages of the COVID-19 pandemic, schools in England were only kept open to children of 'key workers' and, from 1 June, to children in reception, year 1 and year 6. Our cross-sectional survey of parents found low rates of attendance (&lt;50%) in both groups. Many parents whose children attended school reported low adherence to hygiene measures (eg, not maintaining distance from others during school drop-off) and doubted that their school was adhering to COVID-19 guidelines. This ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent Health; psychology","Amlôt","Richard","Emergency Response Department, Public Health England, Salisbury, UK",NA
"2559","34192178","10.1136/bmjpo-2020-000825","A cross-sectional survey of parental perceptions of COVID-19 related hygiene measures within schools and adherence to social distancing in journeys to and from school.","During the early stages of the COVID-19 pandemic, schools in England were only kept open to children of 'key workers' and, from 1 June, to children in reception, year 1 and year 6. Our cross-sectional survey of parents found low rates of attendance (&lt;50%) in both groups. Many parents whose children attended school reported low adherence to hygiene measures (eg, not maintaining distance from others during school drop-off) and doubted that their school was adhering to COVID-19 guidelines. This ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent Health; psychology","Rubin","Antonia","Weald of Kent Grammar School, Tonbridge, UK",NA
"2560","34192178","10.1136/bmjpo-2020-000825","A cross-sectional survey of parental perceptions of COVID-19 related hygiene measures within schools and adherence to social distancing in journeys to and from school.","During the early stages of the COVID-19 pandemic, schools in England were only kept open to children of 'key workers' and, from 1 June, to children in reception, year 1 and year 6. Our cross-sectional survey of parents found low rates of attendance (&lt;50%) in both groups. Many parents whose children attended school reported low adherence to hygiene measures (eg, not maintaining distance from others during school drop-off) and doubted that their school was adhering to COVID-19 guidelines. This ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent Health; psychology","Rubin","G James","Department of Psychological Medicine, King's College London, London, UK",NA
"2561","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Ibrahim","Chokkiyil Ponnambath Hafis","Neonatal Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2562","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Lobko","Fatma Oleks","Neonatal Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2563","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Alchamat","Ghalia Abou","Neonatal Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2564","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Swilam","Waleed Gamal","Neonatal Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2565","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Wani","Saleema Rasool","Obstetric Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2566","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Said","Soha Tohamy","Obstetric Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2567","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Weber","Stefan","Reference Laboratory for Infectious Diseases, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates",NA
"2568","34192177","10.1136/bmjpo-2020-000824","Management of infants born to mothers with SARS-CoV2 infection: a prospective observational study.","To assess the clinical risk of mother-to-infant transmission of SARS-CoV2 and transmission during rooming in and breast feeding in infants born to mothers with COVID-19. Prospective observational study. A large tertiary maternal and neonatal care centre based in the UAE. Infants born to mothers diagnosed to have COVID-19 at the time of delivery, born between 1 April and 15 June 2020. Rate of transmission of SARS-CoV2 from mother to infant (vertical or horizontal) while rooming in and breast feed","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; neonatology","Bosio","Paul","Obstetric Division, Corniche Hospital, Abu Dhabi, United Arab Emirates",NA
"2569","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Stellato","Pio","Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2570","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Granata","Annalisa","Healthcare Management, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2571","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","De Matteo","Antonia","Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2572","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Capelli","Carlo","Healthcare Management, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2573","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Paparo","Matteo","Clinical Pathology Unit, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2574","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Parasole","Rosanna","Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2575","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Ricciardi","Immacolata","Clinical Pathology Unit, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2576","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Tambaro","Francesco Paolo","Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2577","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Leone","Ornella","Clinical Pathology Unit, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2578","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Quaglietta","Lucia","Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2579","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Menna","Giuseppe","Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2580","34192176","10.1136/bmjpo-2020-000818","Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.","COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","data collection; epidemiology; health services research","Silvestri","Nicola","Healthcare Management, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy",NA
"2581","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Oulasvirta","Jelena","Division of Anaesthesiology, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2582","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Pirneskoski","Jussi","Department of Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2583","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Harve-Rytsälä","Heini","Department of Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2584","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Lääperi","Mitja","Department of Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2585","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Kuitunen","Mikael","New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2586","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Kuisma","Markku","Department of Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2587","34192175","10.1136/bmjpo-2020-000808","Paediatric prehospital emergencies and restrictions during the COVID-19 pandemic: a population-based study.","Children are less vulnerable to serious forms of the COVID-19 disease. However, concerns have been raised about children being the second victims of the pandemic and its control measures. Therefore, we wanted to study if the pandemic, the infection control measures and their consequences to the society projected to paediatric prehospital emergency medical services (EMS) contacts. We conducted a population-based cohort study concerning all children aged 0-15 years with EMS contacts in the Helsink","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Salmi","Heli","Division of Anaesthesiology, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland",NA
"2588","34192174","10.1136/bmjpo-2020-000801","Cross-sectional study of paediatric case mix presenting to an emergency centre in Cape Town, South Africa, during COVID-19.","To describe and compare the effect of level 5 lockdown measures on the workload and case mix of paediatric patients presenting to a district-level emergency centre in Cape Town, South Africa. Paediatric patients (&lt;13 years) presenting to Mitchells Plain Hospital were included. The level 5 lockdown period (27 March 2020-30 April 2020) was compared with similar 5-week periods immediately before (21 February 2020-26 March 2020) and after the lockdown (1 May 2020-4 June 2020), and to similar time","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Akuaake","Lembi Magano","Division of Emergency Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa",NA
"2589","34192174","10.1136/bmjpo-2020-000801","Cross-sectional study of paediatric case mix presenting to an emergency centre in Cape Town, South Africa, during COVID-19.","To describe and compare the effect of level 5 lockdown measures on the workload and case mix of paediatric patients presenting to a district-level emergency centre in Cape Town, South Africa. Paediatric patients (&lt;13 years) presenting to Mitchells Plain Hospital were included. The level 5 lockdown period (27 March 2020-30 April 2020) was compared with similar 5-week periods immediately before (21 February 2020-26 March 2020) and after the lockdown (1 May 2020-4 June 2020), and to similar time","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Hendrikse","Clint","Division of Emergency Medicine, University of Cape Town, Cape Town, Western Cape, South Africa",NA
"2590","34192174","10.1136/bmjpo-2020-000801","Cross-sectional study of paediatric case mix presenting to an emergency centre in Cape Town, South Africa, during COVID-19.","To describe and compare the effect of level 5 lockdown measures on the workload and case mix of paediatric patients presenting to a district-level emergency centre in Cape Town, South Africa. Paediatric patients (&lt;13 years) presenting to Mitchells Plain Hospital were included. The level 5 lockdown period (27 March 2020-30 April 2020) was compared with similar 5-week periods immediately before (21 February 2020-26 March 2020) and after the lockdown (1 May 2020-4 June 2020), and to similar time","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Spittal","Graeme","Paediatric Department, Mitchells Plain Hospital, Cape Town, South Africa",NA
"2591","34192174","10.1136/bmjpo-2020-000801","Cross-sectional study of paediatric case mix presenting to an emergency centre in Cape Town, South Africa, during COVID-19.","To describe and compare the effect of level 5 lockdown measures on the workload and case mix of paediatric patients presenting to a district-level emergency centre in Cape Town, South Africa. Paediatric patients (&lt;13 years) presenting to Mitchells Plain Hospital were included. The level 5 lockdown period (27 March 2020-30 April 2020) was compared with similar 5-week periods immediately before (21 February 2020-26 March 2020) and after the lockdown (1 May 2020-4 June 2020), and to similar time","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Evans","Katya","Division of Emergency Medicine, University of Cape Town, Cape Town, Western Cape, South Africa",NA
"2592","34192174","10.1136/bmjpo-2020-000801","Cross-sectional study of paediatric case mix presenting to an emergency centre in Cape Town, South Africa, during COVID-19.","To describe and compare the effect of level 5 lockdown measures on the workload and case mix of paediatric patients presenting to a district-level emergency centre in Cape Town, South Africa. Paediatric patients (&lt;13 years) presenting to Mitchells Plain Hospital were included. The level 5 lockdown period (27 March 2020-30 April 2020) was compared with similar 5-week periods immediately before (21 February 2020-26 March 2020) and after the lockdown (1 May 2020-4 June 2020), and to similar time","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","van Hoving","Daniël Jacobus","Division of Emergency Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa",NA
"2594","34192172","10.1136/bmjpo-2020-000763","Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?","We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms. There were four emergency medical services (EMS) responses concerning children (age 0-15 years) leading to death on-scene in 2 months during the pandemic, and eight during the previous 12 months in the Helsinki University Hospital area, although the number of EMS missions decreased by 18%. The prevalence of COVID-19 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","ethics; health services research; mortality","Harve-Rytsälä","Heini","Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Uusimaa, Finland",NA
"2595","34192172","10.1136/bmjpo-2020-000763","Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?","We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms. There were four emergency medical services (EMS) responses concerning children (age 0-15 years) leading to death on-scene in 2 months during the pandemic, and eight during the previous 12 months in the Helsinki University Hospital area, although the number of EMS missions decreased by 18%. The prevalence of COVID-19 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","ethics; health services research; mortality","Puhakka","Laura","New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Uusimaa, Finland",NA
"2596","34192172","10.1136/bmjpo-2020-000763","Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?","We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms. There were four emergency medical services (EMS) responses concerning children (age 0-15 years) leading to death on-scene in 2 months during the pandemic, and eight during the previous 12 months in the Helsinki University Hospital area, although the number of EMS missions decreased by 18%. The prevalence of COVID-19 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","ethics; health services research; mortality","Kuisma","Markku","Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Uusimaa, Finland",NA
"2597","34192172","10.1136/bmjpo-2020-000763","Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?","We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms. There were four emergency medical services (EMS) responses concerning children (age 0-15 years) leading to death on-scene in 2 months during the pandemic, and eight during the previous 12 months in the Helsinki University Hospital area, although the number of EMS missions decreased by 18%. The prevalence of COVID-19 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","ethics; health services research; mortality","Kuitunen","Mikael","New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Uusimaa, Finland",NA
"2598","34192172","10.1136/bmjpo-2020-000763","Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?","We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms. There were four emergency medical services (EMS) responses concerning children (age 0-15 years) leading to death on-scene in 2 months during the pandemic, and eight during the previous 12 months in the Helsinki University Hospital area, although the number of EMS missions decreased by 18%. The prevalence of COVID-19 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","ethics; health services research; mortality","Oulasvirta","Jelena","Helsingin ja Uudenmaan Sairaanhoitopiiri, Helsinki, Uusimaa, Finland",NA
"2599","34192172","10.1136/bmjpo-2020-000763","Out-of-hospital deaths among children during COVID-19 pandemic: indicator of collateral damage?","We aimed to investigate the out-of-hospital mortality, and the actual prevalence of COVID-19 in children requiring paediatric emergency department (ED) care for infectious symptoms. There were four emergency medical services (EMS) responses concerning children (age 0-15 years) leading to death on-scene in 2 months during the pandemic, and eight during the previous 12 months in the Helsinki University Hospital area, although the number of EMS missions decreased by 18%. The prevalence of COVID-19 ","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","ethics; health services research; mortality","Salmi","Heli","New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Uusimaa, Finland",NA
"2600","34192171","10.1136/bmjpo-2020-000757","Impact of COVID-19 on training: a single-centre survey of trainees.","To review the impact of COVID-19 on postgraduate paediatric training, a 10-question online survey was designed to evaluate trainees' training opportunities. 56 trainees working at a single centre, Alder Hey Children's Hospital, completed the survey. The majority of trainees felt that COVID-19 had affected their training. Trainees wanted to become involved in Quality Improvement Programs. Face-to-face teaching was still favourable but web-based teaching methods were preferred. Novel online, Worke","2021","06","30","BMJ Paediatr Open","BMJ paediatrics open","health services research; qualitative research; statistics","Whitby","Thomas","General Paediatrics, Alder Hey Children's Hospital, Liverpool, UK",NA
"2601","34192171","10.1136/bmjpo-2020-000757","Impact of COVID-19 on training: a single-centre survey of trainees.","To review the impact of COVID-19 on postgraduate paediatric training, a 10-question online survey was designed to evaluate trainees' training opportunities. 56 trainees working at a single centre, Alder Hey Children's Hospital, completed the survey. The majority of trainees felt that COVID-19 had affected their training. Trainees wanted to become involved in Quality Improvement Programs. Face-to-face teaching was still favourable but web-based teaching methods were preferred. Novel online, Worke","2021","06","30","BMJ Paediatr Open","BMJ paediatrics open","health services research; qualitative research; statistics","Cleary","Gavin","Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK",NA
"2602","34192171","10.1136/bmjpo-2020-000757","Impact of COVID-19 on training: a single-centre survey of trainees.","To review the impact of COVID-19 on postgraduate paediatric training, a 10-question online survey was designed to evaluate trainees' training opportunities. 56 trainees working at a single centre, Alder Hey Children's Hospital, completed the survey. The majority of trainees felt that COVID-19 had affected their training. Trainees wanted to become involved in Quality Improvement Programs. Face-to-face teaching was still favourable but web-based teaching methods were preferred. Novel online, Worke","2021","06","30","BMJ Paediatr Open","BMJ paediatrics open","health services research; qualitative research; statistics","Halfhide","Clare P","Respiratory Unit, Alder Hey Children's Hospital, Liverpool, UK",NA
"2603","34192170","10.1136/bmjpo-2020-000748","Presentations to the emergency department in Bologna, Italy, during COVID-19 outbreak.","The Emilia Romagna (ER) region, Italy, in March 2020 has seen one of the largest and most serious clusters of COVID-19 in the world. In the period of 30 January to 31 May 2020, the number of paediatric emergency department presentations in Bologna, ER, decreased by 50% compared with the same period of 2019. Visits declined for every age group, with a decrease of 35%, 55% and 46% for the three age groups 0-2, 2-10 and 10-14 years, respectively. The admission rate increased from 5% to 13%. Fewer n","2021","07","13","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Masetti","Riccardo","Unit of Peadiatrics, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy",NA
"2604","34192170","10.1136/bmjpo-2020-000748","Presentations to the emergency department in Bologna, Italy, during COVID-19 outbreak.","The Emilia Romagna (ER) region, Italy, in March 2020 has seen one of the largest and most serious clusters of COVID-19 in the world. In the period of 30 January to 31 May 2020, the number of paediatric emergency department presentations in Bologna, ER, decreased by 50% compared with the same period of 2019. Visits declined for every age group, with a decrease of 35%, 55% and 46% for the three age groups 0-2, 2-10 and 10-14 years, respectively. The admission rate increased from 5% to 13%. Fewer n","2021","07","13","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Corsini","Ilaria","Unit of Peadiatrics Emergency, Sant'Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy",NA
"2605","34192170","10.1136/bmjpo-2020-000748","Presentations to the emergency department in Bologna, Italy, during COVID-19 outbreak.","The Emilia Romagna (ER) region, Italy, in March 2020 has seen one of the largest and most serious clusters of COVID-19 in the world. In the period of 30 January to 31 May 2020, the number of paediatric emergency department presentations in Bologna, ER, decreased by 50% compared with the same period of 2019. Visits declined for every age group, with a decrease of 35%, 55% and 46% for the three age groups 0-2, 2-10 and 10-14 years, respectively. The admission rate increased from 5% to 13%. Fewer n","2021","07","13","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Leardini","Davide","Unit of Peadiatrics, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy",NA
"2606","34192170","10.1136/bmjpo-2020-000748","Presentations to the emergency department in Bologna, Italy, during COVID-19 outbreak.","The Emilia Romagna (ER) region, Italy, in March 2020 has seen one of the largest and most serious clusters of COVID-19 in the world. In the period of 30 January to 31 May 2020, the number of paediatric emergency department presentations in Bologna, ER, decreased by 50% compared with the same period of 2019. Visits declined for every age group, with a decrease of 35%, 55% and 46% for the three age groups 0-2, 2-10 and 10-14 years, respectively. The admission rate increased from 5% to 13%. Fewer n","2021","07","13","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Lanari","Marcello","Unit of Peadiatrics Emergency, Sant'Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy",NA
"2607","34192170","10.1136/bmjpo-2020-000748","Presentations to the emergency department in Bologna, Italy, during COVID-19 outbreak.","The Emilia Romagna (ER) region, Italy, in March 2020 has seen one of the largest and most serious clusters of COVID-19 in the world. In the period of 30 January to 31 May 2020, the number of paediatric emergency department presentations in Bologna, ER, decreased by 50% compared with the same period of 2019. Visits declined for every age group, with a decrease of 35%, 55% and 46% for the three age groups 0-2, 2-10 and 10-14 years, respectively. The admission rate increased from 5% to 13%. Fewer n","2021","07","13","BMJ Paediatr Open","BMJ paediatrics open","epidemiology; health services research","Pession","Andrea","Unit of Peadiatrics, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy",NA
"2608","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Cella","Andrea","Paediatric Emergency Unit, Guglielmo da Saliceto City Hospital, Piacenza, Italy",NA
"2609","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Marchetti","Federico","Paediatrics &amp",NA
"2610","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Iughetti","Lorenzo","Paediatrics Unit, AOU Policlinico di Modena, Modena, Italy",NA
"2611","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Di Biase","Anna Rita","Paediatrics Unit, AOU Policlinico di Modena, Modena, Italy",NA
"2612","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Graziani","Giulia","Paediatrics &amp",NA
"2613","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","De Fanti","Alessandro","Paediatrics Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy",NA
"2614","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Valletta","Enrico","Paediatrics Unit, GB Morgagni- L. Pierantoni Hospital, Forlì, Italy",NA
"2615","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Vaienti","Francesca","Paediatrics Unit, GB Morgagni- L. Pierantoni Hospital, Forlì, Italy",NA
"2616","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Vergine","Gianluca","Paediatrics Unit, Infermi Hospital, Rimini, Italy",NA
"2617","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Viola","Laura","Paediatrics Unit, Infermi Hospital, Rimini, Italy",NA
"2618","34192169","10.1136/bmjpo-2020-000742","Italian COVID-19 epidemic: effects on paediatric emergency attendance-a survey in the Emilia Romagna region.","To evaluate the effect of the COVID-19 epidemic on paediatric emergency department (ED) attendance in a region of Northern Italy. A survey was proposed to six out of nine paediatric EDs in the Emilia Romagna region to evaluate attendance data, distribution by age and gender, triage code score, outcome of clinical course, number of hospitalisations and the distribution of patients by disease. Data were collected during March 2020 and compared with that of March 2019. A drop in paediatric ED atten","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","adolescent health; data collection; epidemiology; health services research","Biasucci","Giacomo","Paediatrics &amp",NA
"2619","34192168","10.1136/bmjpo-2020-000715","Clinical presentation of paediatric patients with COVID-19 admitted to a single paediatric intensive care unit (PICU) in Iran.","To describe the clinical characteristics of paediatric patients admitted to a single paediatric intensive care unit (PICU) in Iran with COVID-19. A cross-sectional study of paediatric patients who were admitted to a COVID-19-dedicated PICU from 16 March 2020 to 21 April 2020 with COVID-19. Six children had confirmed COVID-19 and four had suspected COVID-19. Six had pre-existing chronic medical conditions. Nine had respiratory failure and needed ventilation. Five children, of whom four had chroni","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; mortality; virology","Saeed","Amir","Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"2620","34192168","10.1136/bmjpo-2020-000715","Clinical presentation of paediatric patients with COVID-19 admitted to a single paediatric intensive care unit (PICU) in Iran.","To describe the clinical characteristics of paediatric patients admitted to a single paediatric intensive care unit (PICU) in Iran with COVID-19. A cross-sectional study of paediatric patients who were admitted to a COVID-19-dedicated PICU from 16 March 2020 to 21 April 2020 with COVID-19. Six children had confirmed COVID-19 and four had suspected COVID-19. Six had pre-existing chronic medical conditions. Nine had respiratory failure and needed ventilation. Five children, of whom four had chroni","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; mortality; virology","Shorafa","Eslam","department of pediatrics, division of intensive care unit, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"2621","34192168","10.1136/bmjpo-2020-000715","Clinical presentation of paediatric patients with COVID-19 admitted to a single paediatric intensive care unit (PICU) in Iran.","To describe the clinical characteristics of paediatric patients admitted to a single paediatric intensive care unit (PICU) in Iran with COVID-19. A cross-sectional study of paediatric patients who were admitted to a COVID-19-dedicated PICU from 16 March 2020 to 21 April 2020 with COVID-19. Six children had confirmed COVID-19 and four had suspected COVID-19. Six had pre-existing chronic medical conditions. Nine had respiratory failure and needed ventilation. Five children, of whom four had chroni","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; mortality; virology","Sanaeidashti","Anahita","Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"2622","34192168","10.1136/bmjpo-2020-000715","Clinical presentation of paediatric patients with COVID-19 admitted to a single paediatric intensive care unit (PICU) in Iran.","To describe the clinical characteristics of paediatric patients admitted to a single paediatric intensive care unit (PICU) in Iran with COVID-19. A cross-sectional study of paediatric patients who were admitted to a COVID-19-dedicated PICU from 16 March 2020 to 21 April 2020 with COVID-19. Six children had confirmed COVID-19 and four had suspected COVID-19. Six had pre-existing chronic medical conditions. Nine had respiratory failure and needed ventilation. Five children, of whom four had chroni","2021","07","02","BMJ Paediatr Open","BMJ paediatrics open","health services research; mortality; virology","Kadivar","Mohammad Rahim","Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran",NA
"2624","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Madayag","Robert M","Trauma Services Department, St Anthony Hospital &amp",NA
"2625","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Sercy","Erica","Trauma Research Department, Swedish Medical Center, Englewood, Colorado, USA",NA
"2626","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Berg","Gina M","Trauma Services Department, Wesley Medical Center, Wichita, Kansas, USA",NA
"2627","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Banton","Kaysie L","Trauma Services Department, Swedish Medical Center, Englewood, Colorado, USA",NA
"2628","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Carrick","Matthew","Trauma Services Department, Medical Center of Plano, Plano, Texas, USA",NA
"2629","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Lieser","Mark","Trauma Services Department, Research Medical Center, Kansas City, Missouri, USA",NA
"2630","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Tanner","Allen","Trauma Services Department, Penrose Hospital, Colorado Springs, Colorado, USA",NA
"2631","34192166","10.1136/tsaco-2021-000692","Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements.","The COVID-19 pandemic has had major effects on hospitals' ability to perform scientific research while providing patient care and minimizing virus exposure and spread. Many non-COVID-19 research has been halted, and funding has been diverted to COVID-19 research and away from other areas. A 28-question survey was administered to all level 1 trauma centers in the USA that included questions about how the pandemic affected the trauma centers' ability to fulfill the volume and research requirements","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; survey","Bar-Or","David","Trauma Research Department, Swedish Medical Center, Englewood, Colorado, USA",NA
"2632","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Greenberg","Anya L","School of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"2633","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Schwartz","Hope","School of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"2634","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Collins","Caitlin R","Department of Surgery, University of California San Francisco, San Francisco, California, USA",NA
"2635","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Kelly","Yvonne M","Department of Surgery, University of California San Francisco, San Francisco, California, USA",NA
"2636","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Mackersie","Robert","Department of Surgery, University of California San Francisco, San Francisco, California, USA",NA
"2637","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Mourad","Michelle","Department of Medicine, University of California San Francisco, San Francisco, California, USA",NA
"2638","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Roberts","John P","Department of Surgery, University of California San Francisco, San Francisco, California, USA",NA
"2639","34192165","10.1136/tsaco-2021-000679","Emergency general surgery utilization and disparities during COVID-19: an interrupted time-series analysis.","We aimed to compare general surgery emergency (GSE) volume, demographics and disease severity before and during COVID-19. Presentations to the emergency department (ED) for GSEs fell during the early COVID-19 pandemic. Barriers to accessing care may be heightened, especially for vulnerable populations, and patients delaying care raises public health concerns. We included adult patients with ED presentations for potential GSEs at a single quaternary-care hospital from January 2018 to August 2020.","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; emergency medical services; emergency treatment; general surgery","Bongiovanni","Tasce","Department of Surgery, University of California San Francisco, San Francisco, California, USA",NA
"2640","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Chodos","Marc","Orthopedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA",NA
"2641","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Sarani","Babak","Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA",NA
"2642","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Sparks","Andrew","Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA",NA
"2643","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Bruns","Brandon","Surgery, University of Maryland Medical System, Baltimore, Maryland, USA",NA
"2644","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Gupta","Shailvi","Surgery, University of Maryland Medical System, Baltimore, Maryland, USA",NA
"2645","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Michetti","Christopher P","Surgery, Inova Fairfax Hospital, Falls Church, Virginia, USA",NA
"2646","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Crane","Joshua","Surgery, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2647","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Hall","Erin","Department of Surgery, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2648","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Trankiem","Christine T","Surgery, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2649","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Abouassaly","Chadi","Surgery, MedStar Washington Hospital Center, Washington, DC, USA",NA
"2650","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Haut","Elliott R","Surgery, Johns Hopkins Medicine School of Medicine, Baltimore, Maryland, USA",NA
"2651","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Etchill","Eric","Surgery, Johns Hopkins Medicine, Baltimore, Maryland, USA",NA
"2652","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Kovler","Mark L","Surgery, Johns Hopkins Medicine, Baltimore, Maryland, USA",NA
"2653","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Williams","Mallory","Surgery, Howard University Hospital, Washington, DC, USA",NA
"2654","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Zeineddin","Ahmad","Surgery, Howard University Hospital, Washington, DC, USA",NA
"2655","34192164","10.1136/tsaco-2020-000659","Impact of COVID-19 pandemic on injury prevalence and pattern in the Washington, DC Metropolitan Region: a multicenter study by the American College of Surgeons Committee on Trauma, Washington, DC.","The COVID-19 pandemic has had far-reaching effects on healthcare systems and society with resultant impact on trauma systems worldwide. This study evaluates the impact the pandemic has had in the Washington, DC Metropolitan Region as compared with similar months in 2019. A retrospective multicenter study of all adult trauma centers in the Washington, DC region was conducted using trauma registry data between January 1, 2019 and May 31, 2020. March 1, 2020 through May 31, 2020 was defined as COVI","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; injury","Estroff","Jordan","Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA",NA
"2656","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Pelzl","Casey E","ION Research, Englewood, Colorado, USA",NA
"2657","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Salottolo","Kristin","ION Research, Englewood, Colorado, USA",NA
"2658","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Banton","Kaysie","Department of Trauma Surgery, Swedish Medical Center, Englewood, Colorado, USA",NA
"2659","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Madayag","Robert M","Trauma Services Department, St Anthony Hospital &amp",NA
"2660","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Hamilton","David","Trauma Services Department, Penrose-St Francis Health Services, Colorado Springs, Colorado, USA",NA
"2661","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Duane","Therese M","Trauma Services Department, Medical Center of Plano, Plano, Texas, USA",NA
"2662","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Carrick","Matthew","Trauma Services Department, Medical Center of Plano, Plano, Texas, USA",NA
"2663","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Lieser","Mark","Department of Trauma Services, Research Medical Center, Kansas City, Missouri, USA",NA
"2664","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Berg","Gina","Department of Trauma Services, Wesley Medical Center, Wichita, Kansas, USA",NA
"2665","34192163","10.1136/tsaco-2020-000645","COVID-19 and trauma: how social distancing orders altered the patient population using trauma services during the 2020 pandemic.","Recent studies have reported changes in trauma volumes resulting from the COVID-19 pandemic and social distancing orders (SDOs) implemented by federal and state governments. However, literature is lacking on demographic, injury and outcome patterns. This retrospective, cross-sectional study included patients aged =18 years at six US level 1 trauma centers. Patients not discharged by the date of data acquisition were excluded. Demographic, injury and outcome variables were assessed across four ti","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","COVID-19; epidemiology; observational study","Bar-Or","David","ION Research, Englewood, Colorado, USA",NA
"2666","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Carmichael","Heather","Department of Surgery, University of Colorado, Aurora, Colorado, USA",NA
"2667","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Wright","Franklin L","Department of Surgery, Division of Gastrointestinal, Trauma and Endocrine Surgery (GITES), University of Colorado, Aurora, Colorado, USA",NA
"2668","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","McIntyre","Robert C","Department of Surgery, Division of Gastrointestinal, Trauma and Endocrine Surgery (GITES), University of Colorado, Aurora, Colorado, USA",NA
"2669","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Vogler","Thomas","Department of Surgery, University of Colorado, Aurora, Colorado, USA",NA
"2670","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Urban","Shane","Trauma Program, University of Colorado Health, Aurora, Colorado, USA",NA
"2671","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Jolley","Sarah E","Division of Pulmonary and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA",NA
"2672","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Burnham","Ellen L","Division of Pulmonary and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA",NA
"2673","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Firth","Whitney","Surgical/Trauma ICU, University of Colorado Health, Aurora, Colorado, USA",NA
"2674","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Velopulos","Catherine G","Department of Surgery, Division of Gastrointestinal, Trauma and Endocrine Surgery (GITES), University of Colorado, Aurora, Colorado, USA",NA
"2675","34192162","10.1136/tsaco-2020-000591","Early ventilator liberation and decreased sedation needs after tracheostomy in patients with COVID-19 infection.","Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, published tracheostomy guidelines have generally recommended deferral of the procedure beyond the initial weeks of intubation given high mortality as well as concerns about transmission of the infection to providers. It is unclear whether tracheostomy in patients with COVID-19 infection facilitates ventilator weaning, and long-term outcomes are not yet reported in the literature. This is a retrospective study of tracheostomy o","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical care; pneumonia; respiratory distress syndrome; tracheostomy","Idrovo","Juan Pablo","Department of Surgery, Division of Gastrointestinal, Trauma and Endocrine Surgery (GITES), University of Colorado, Aurora, Colorado, USA",NA
"2676","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Sun","Beatrice J","Department of Surgery, Stanford University, Stanford, California, USA",NA
"2677","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Wolff","Christopher J","Department of Surgery, Stanford University, Stanford, California, USA",NA
"2678","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Bechtold","Hannah M","Anesthesiology, Stanford University, Stanford, California, USA",NA
"2679","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Free","Dwayne","Bronchoscopy and Respiratory Care Services, Stanford University, Stanford, California, USA",NA
"2680","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Lorenzo","Javier","Anesthesiology, Stanford University, Stanford, California, USA",NA
"2681","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Minot","Patrick R","Anesthesiology, Stanford University, Stanford, California, USA",NA
"2682","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Maggio","Paul G","Department of Surgery, Stanford University, Stanford, California, USA",NA
"2683","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Spain","David A","Department of Surgery, Stanford University, Stanford, California, USA",NA
"2684","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Weiser","Thomas G","Department of Surgery, Stanford University, Stanford, California, USA",NA
"2685","34192161","10.1136/tsaco-2020-000625","Modified percutaneous tracheostomy in patients with COVID-19.","Patients hospitalized with COVID-19 are at risk of developing hypoxic respiratory failure and often require prolonged mechanical ventilation. Indication and timing to perform tracheostomy is controversial in patients with COVID-19. This was a single-institution retrospective review of tracheostomies performed on patients admitted for COVID-19 between April 8, 2020 and August 1, 2020 using a modified percutaneous tracheostomy technique to minimize hypoxia and aerosolization. Twelve tracheostomies","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","critical care; infections; respiratory insufficiency; tracheostomy","Forrester","Joseph D","Department of Surgery, Stanford University, Stanford, California, USA",NA
"2686","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Choron","Rachel Leah","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2687","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Butts","Christopher A","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2688","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Bargoud","Christopher","Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2689","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Krumrei","Nicole","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2690","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Teichman","Amanda L","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2691","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Schroeder","Mary","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2692","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Bover Manderski","Michelle T","Department of Biostatistics and Epidemiology, Rutgers School of Public Health New Brunswick Campus, Piscataway, New Jersey, USA",NA
"2693","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","To","Jennifer","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2694","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Moffa","Salvatore M","Chief Medical Officer, Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey, USA",NA
"2695","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Rodricks","Michael B","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2696","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Lissauer","Matthew","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2697","34192160","10.1136/tsaco-2020-000557","Surgeons in surge - the versatility of the acute care surgeon: outcomes of COVID-19 ICU patients in a community hospital where all ICU patients are managed by surgical intensivists.","Reported characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit (ICU) are widely disparate with varying mortality rates. No literature describes outcomes in ICU patients with COVID-19 managed by an acute care surgery (ACS) division. Our ACS division manages all ICU patients at a community hospital in New Jersey. When that hospital was overwhelmed and in crisis secondary to COVID-19, we sought to describe outcomes for all patients with COVID-19 a","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","adult; critical illness; intensive care units; mortality; respiratory distress syndrome","Gupta","Rajan","Division of Acute Care Surgery, Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA",NA
"2698","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Issa","Nabil","Departments of Surgery and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA",NA
"2699","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Liddy","Whitney E","Department of Ear, Nose and Throat, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA",NA
"2700","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Samant","Sandeep","Department of Ear, Nose and Throat, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA",NA
"2701","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Conley","David B","Department of Ear, Nose and Throat, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA",NA
"2702","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Kern","Robert C","Department of Ear, Nose and Throat, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA",NA
"2703","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Hungness","Eric S","Departments of Surgery and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA",NA
"2704","34192159","10.1136/tsaco-2020-000542","Emergency cricothyrotomy during the COVID-19 pandemic: how to suppress aerosolization.","Cricothyrotomy is associated with significant aerosolization that increases the potential risk of infection among healthcare providers. It is important to identify simple yet effective methods to suppress aerosolization and improve the safety of healthcare providers. 5 ear, nose and throat and general surgeons used a locally developed hybrid cricothyrotomy simulator with a porcine trachea to test three draping methods to suppress aerosolization during the procedure: an X-ray cassette drape, dry ","2021","07","02","Trauma Surg Acute Care Open","Trauma surgery &amp; acute care open","airway management; critical care; emergency treatment; intubation","Barsuk","Jeffrey H","Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2705","34192157","10.1136/bmjophth-2021-000765","In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; experimental &amp; laboratory; infection; public health; tears","Felfeli","Tina","Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada",NA
"2706","34192157","10.1136/bmjophth-2021-000765","In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; experimental &amp; laboratory; infection; public health; tears","Kasloff","Samantha B","J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, Canada",NA
"2707","34192157","10.1136/bmjophth-2021-000765","In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; experimental &amp; laboratory; infection; public health; tears","Krishnan","Jay","J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, Canada",NA
"2708","34192157","10.1136/bmjophth-2021-000765","In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; experimental &amp; laboratory; infection; public health; tears","El-Defrawy","Sherif R","Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada",NA
"2709","34192157","10.1136/bmjophth-2021-000765","In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; experimental &amp; laboratory; infection; public health; tears","Mazzulli","Tony","Department of Microbiology, Mount Sinai Hospital, University Health Network, Toronto, Ontario, Canada",NA
"2710","34192157","10.1136/bmjophth-2021-000765","In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; experimental &amp; laboratory; infection; public health; tears","Cutts","Todd A","J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, Canada",NA
"2711","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Muyldermans","Astrid","Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2712","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Bjerke","Maria","Laboratory of Neurochemistry, Department of Clinical Biology and Center for Neurosciences, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2713","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Demuyser","Thomas","Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2714","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","De Geyter","Deborah","Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2715","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Wybo","Ingrid","Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2716","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Soetens","Oriane","Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2717","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Weets","Ilse","Laboratory of Neurochemistry, Department of Clinical Biology and Center for Neurosciences, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2718","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Kuijpers","Robert","Department of Ophthalmology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2719","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Allard","Sabine D","Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2720","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Piérard","Denis","Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2721","34192156","10.1136/bmjophth-2021-000733","SARS-CoV-2 RNA and antibodies in tear fluid.","SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients w","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; diagnostic tests/investigation; immunology; microbiology; tears","Raus","Peter P M","Department of Ophthalmology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium",NA
"2722","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Downey","Louise","Department of Ophthalmology, Hull Royal Infirmary, Hull, Kingston upon Hull, UK",NA
"2723","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Acharya","Nachiketa","Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, UK",NA
"2724","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Devonport","Helen","Department of Ophthalmology, Bradford Royal Infirmary, Bradford, UK",NA
"2725","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Gale","Richard","Department of Ophthalmology, York Hospital, York, UK",NA
"2726","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Habib","Maged","Department of Ophthalmology, Sunderland Eye Infirmary, Sunderland, UK",NA
"2727","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Manjunath","Vina","Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK",NA
"2728","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Mukherjee","Rajarshi","Department of Ophthalmology, St James's University Hospital, Leeds, UK",NA
"2729","34192155","10.1136/bmjophth-2020-000696","Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era.","First-line treatment of centrally involved diabetic macular oedema (CI-DMO) is often with an anti-vascular endothelial growth factor (anti-VEGF) agent. Although this can provide efficacy in the majority of eyes, a sizeable proportion do not respond sufficiently and many continue to receive anti-VEGF therapy after it may be optimal. This imposes a treatment burden on both patients and clinicians and, most importantly of all, can be sight threatening. Changing treatment to an intravitreal corticos","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; drugs; inflammation; intraocular pressure; macula; retina; treatment medical; vision","Severn","Philip","Department of Ophthalmology, James Cook University Hospital, Middlesbrough, UK",NA
"2730","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Ziemssen","Focke","Center for Ophthalmology, Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2731","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Feng","You-Shan","Institute for Clinical Epidemiology and applied Biostatistics (IKEaB), Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2732","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Schnichels","Sven","Center for Ophthalmology, Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2733","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Bayyoud","Tarek","Center for Ophthalmology, Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2734","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Ueffing","Marius","Center for Ophthalmology, Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2735","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Bartz-Schmidt","Karl Ulrich","Center for Ophthalmology, Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2736","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Martus","Peter","Institute for Clinical Epidemiology and applied Biostatistics (IKEaB), Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2737","34192154","10.1136/bmjophth-2020-000688","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre.","The actual prevalence of a SARS-CoV-2 infection and the individual assessment of being or having been infected may differ. Facing the great uncertainty-especially at the beginning of the pandemic-and the possibility of asymptomatic or mildly symptomatic, subclinical infections, we evaluate the experience of SARS-CoV-2 antibody screening at a tertiary clinical setting. All employees of a tertiary eye centre and a research institute of ophthalmology were offered antibody testing in May 2020, using","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","COVID-19; infection; public health","Peter","Andreas","Institute of Clinical Chemistry and Pathobichemistry, Department of Internal Medicine, Eberhard Karls Universitat Tubingen, Tubingen, Germany",NA
"2738","34192153","10.1136/bmjophth-2020-000632","Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states.","Conjunctivitis has been reported in people suffering from COVID-19. However, many ocular symptoms are associated with the term 'conjunctivitis' which may be misleading. It is also unknown whether ocular symptoms were different in chronic sufferers of anterior eye diseases, when they were experienced or how long they lasted for compared with other COVID-19 symptoms. An online structured questionnaire obtained self-report data from people who had a confirmed diagnosis of COVID-19. Data for the typ","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","conjunctiva; eye (globe); ocular surface","Pardhan","Shahina","Vision and Eye Research Institute, School of Medicine, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Cambridge, UK",NA
"2739","34192153","10.1136/bmjophth-2020-000632","Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states.","Conjunctivitis has been reported in people suffering from COVID-19. However, many ocular symptoms are associated with the term 'conjunctivitis' which may be misleading. It is also unknown whether ocular symptoms were different in chronic sufferers of anterior eye diseases, when they were experienced or how long they lasted for compared with other COVID-19 symptoms. An online structured questionnaire obtained self-report data from people who had a confirmed diagnosis of COVID-19. Data for the typ","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","conjunctiva; eye (globe); ocular surface","Vaughan","Megan","Vision and Eye Research Institute, School of Medicine, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Cambridge, UK",NA
"2740","34192153","10.1136/bmjophth-2020-000632","Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states.","Conjunctivitis has been reported in people suffering from COVID-19. However, many ocular symptoms are associated with the term 'conjunctivitis' which may be misleading. It is also unknown whether ocular symptoms were different in chronic sufferers of anterior eye diseases, when they were experienced or how long they lasted for compared with other COVID-19 symptoms. An online structured questionnaire obtained self-report data from people who had a confirmed diagnosis of COVID-19. Data for the typ","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","conjunctiva; eye (globe); ocular surface","Zhang","Jufen","Clinical Trial Unit, School of Medicine, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Cambridge, UK",NA
"2741","34192153","10.1136/bmjophth-2020-000632","Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states.","Conjunctivitis has been reported in people suffering from COVID-19. However, many ocular symptoms are associated with the term 'conjunctivitis' which may be misleading. It is also unknown whether ocular symptoms were different in chronic sufferers of anterior eye diseases, when they were experienced or how long they lasted for compared with other COVID-19 symptoms. An online structured questionnaire obtained self-report data from people who had a confirmed diagnosis of COVID-19. Data for the typ","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","conjunctiva; eye (globe); ocular surface","Smith","Lee","The Cambridge Centre for Sport and Exercise Sciences, Faculty of Science and Engineering, Anglia Ruskin University, Cambridge, UK",NA
"2742","34192153","10.1136/bmjophth-2020-000632","Sore eyes as the most significant ocular symptom experienced by people with COVID-19: a comparison between pre-COVID-19 and during COVID-19 states.","Conjunctivitis has been reported in people suffering from COVID-19. However, many ocular symptoms are associated with the term 'conjunctivitis' which may be misleading. It is also unknown whether ocular symptoms were different in chronic sufferers of anterior eye diseases, when they were experienced or how long they lasted for compared with other COVID-19 symptoms. An online structured questionnaire obtained self-report data from people who had a confirmed diagnosis of COVID-19. Data for the typ","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","conjunctiva; eye (globe); ocular surface","Chichger","Havovi","Biomedical Research Group, School of Life Sciences, Faculty of Science and Engineering, Anglia Ruskin University, Cambridge, Cambridgeshire, UK",NA
"2743","34192152","10.1136/bmjophth-2020-000563","Are eyes the windows to COVID-19? Systematic review and meta-analysis.","To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were rel","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","infection; microbiology; ocular surface; tears","La Distia Nora","Rina","Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia",NA
"2744","34192152","10.1136/bmjophth-2020-000563","Are eyes the windows to COVID-19? Systematic review and meta-analysis.","To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were rel","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","infection; microbiology; ocular surface; tears","Putera","Ikhwanuliman","Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia",NA
"2745","34192152","10.1136/bmjophth-2020-000563","Are eyes the windows to COVID-19? Systematic review and meta-analysis.","To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were rel","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","infection; microbiology; ocular surface; tears","Khalisha","Dhiya Farah","Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia",NA
"2746","34192152","10.1136/bmjophth-2020-000563","Are eyes the windows to COVID-19? Systematic review and meta-analysis.","To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were rel","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","infection; microbiology; ocular surface; tears","Septiana","Indah","Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia",NA
"2747","34192152","10.1136/bmjophth-2020-000563","Are eyes the windows to COVID-19? Systematic review and meta-analysis.","To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were rel","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","infection; microbiology; ocular surface; tears","Ridwan","Asri Salima","Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia",NA
"2748","34192152","10.1136/bmjophth-2020-000563","Are eyes the windows to COVID-19? Systematic review and meta-analysis.","To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19. A systematic literature search from PubMed, ScienceDirect and Google Scholar databases was performed using standardised Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Selected keywords were rel","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","infection; microbiology; ocular surface; tears","Sitompul","Ratna","Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia",NA
"2749","34192151","10.1136/bmjophth-2020-000560","Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown.","To analyse the remodelling and recovery of a relocated intravitreal injection (IVI) service with an adapted treatment regimen in a tertiary referral centre during a nationwide lockdown with initial cancellation of all non-emergency treatments caused by the COVID-19 pandemic. For this retrospective observational study at Hanusch Hospital, Vienna, between 16 March 2020 and 5 May 2020, we conducted an analysis of an appointment booking system based on prioritisation incorporating disease class, sev","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","degeneration; macula; neovascularisation; retina","Huemer","Josef","Department of Ophthalmology, Hanusch Hospital, Vienna, Austria",NA
"2750","34192151","10.1136/bmjophth-2020-000560","Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown.","To analyse the remodelling and recovery of a relocated intravitreal injection (IVI) service with an adapted treatment regimen in a tertiary referral centre during a nationwide lockdown with initial cancellation of all non-emergency treatments caused by the COVID-19 pandemic. For this retrospective observational study at Hanusch Hospital, Vienna, between 16 March 2020 and 5 May 2020, we conducted an analysis of an appointment booking system based on prioritisation incorporating disease class, sev","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","degeneration; macula; neovascularisation; retina","Hienert","Julius","Department of Ophthalmology, Hanusch Hospital, Vienna, Austria",NA
"2751","34192151","10.1136/bmjophth-2020-000560","Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown.","To analyse the remodelling and recovery of a relocated intravitreal injection (IVI) service with an adapted treatment regimen in a tertiary referral centre during a nationwide lockdown with initial cancellation of all non-emergency treatments caused by the COVID-19 pandemic. For this retrospective observational study at Hanusch Hospital, Vienna, between 16 March 2020 and 5 May 2020, we conducted an analysis of an appointment booking system based on prioritisation incorporating disease class, sev","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","degeneration; macula; neovascularisation; retina","Hirn","Cornelia","Department of Ophthalmology, Hanusch Hospital, Vienna, Austria",NA
"2752","34192151","10.1136/bmjophth-2020-000560","Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown.","To analyse the remodelling and recovery of a relocated intravitreal injection (IVI) service with an adapted treatment regimen in a tertiary referral centre during a nationwide lockdown with initial cancellation of all non-emergency treatments caused by the COVID-19 pandemic. For this retrospective observational study at Hanusch Hospital, Vienna, between 16 March 2020 and 5 May 2020, we conducted an analysis of an appointment booking system based on prioritisation incorporating disease class, sev","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","degeneration; macula; neovascularisation; retina","Hackl","Christoph","Department of Ophthalmology, Hanusch Hospital, Vienna, Austria",NA
"2753","34192151","10.1136/bmjophth-2020-000560","Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown.","To analyse the remodelling and recovery of a relocated intravitreal injection (IVI) service with an adapted treatment regimen in a tertiary referral centre during a nationwide lockdown with initial cancellation of all non-emergency treatments caused by the COVID-19 pandemic. For this retrospective observational study at Hanusch Hospital, Vienna, between 16 March 2020 and 5 May 2020, we conducted an analysis of an appointment booking system based on prioritisation incorporating disease class, sev","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","degeneration; macula; neovascularisation; retina","Radda","Stephan M","Department of Ophthalmology, Hanusch Hospital, Vienna, Austria",NA
"2754","34192151","10.1136/bmjophth-2020-000560","Remodelling intravitreal therapy pathways for macular disease during the COVID-19 pandemic and an Austrian national lockdown.","To analyse the remodelling and recovery of a relocated intravitreal injection (IVI) service with an adapted treatment regimen in a tertiary referral centre during a nationwide lockdown with initial cancellation of all non-emergency treatments caused by the COVID-19 pandemic. For this retrospective observational study at Hanusch Hospital, Vienna, between 16 March 2020 and 5 May 2020, we conducted an analysis of an appointment booking system based on prioritisation incorporating disease class, sev","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","degeneration; macula; neovascularisation; retina","Findl","Oliver","Department of Ophthalmology, Hanusch Hospital, Vienna, Austria",NA
"2755","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Shah","Vishal","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2756","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Naderi","Khayam","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2757","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Maubon","Laura","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2758","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Jameel","Ashmal","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2759","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Patel","Darshak S","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2760","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Gormley","Jack","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2761","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Heemraz","Sanjeev","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2762","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Azan","Elodie","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2763","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Verma","Seema","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2764","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","Low","Sancy","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2765","34192150","10.1136/bmjophth-2020-000554","Acceptability of immediate sequential bilateral cataract surgery (ISBCS) in a public health care setting before and after COVID-19: a prospective patient questionnaire survey.","To ascertain patient acceptance of immediate sequential bilateral cataract surgery (ISBCS) in the National Health Service (NHS). A survey was devised using a 5-point Likert scale for questions related to ISBCS, which patients undertook during their cataract outpatient appointment pre-COVID-19 lockdown and by telephone during the lockdown. Questionnaires were completed for 267 patients. Most respondents were aged over 71 (51%) and were female individuals (60%). Forty-five per cent agreed/strongly","2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","public health; treatment surgery; vision","O'Brart","David","Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK",NA
"2766","34192149","10.1136/bmjophth-2020-000495","Coronavirus: good or bad news for ocular diseases?",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","cornea; epidemiology; infection; microbiology; ocular surface","Navel","Valentin","Ophthalmology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, Auvergne Rhône Alpes, France",NA
"2767","34192149","10.1136/bmjophth-2020-000495","Coronavirus: good or bad news for ocular diseases?",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","cornea; epidemiology; infection; microbiology; ocular surface","Chiambaretta","Frédéric","Ophthalmology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, Auvergne Rhône Alpes, France",NA
"2768","34192149","10.1136/bmjophth-2020-000495","Coronavirus: good or bad news for ocular diseases?",NA,"2021","07","02","BMJ Open Ophthalmol","BMJ open ophthalmology","cornea; epidemiology; infection; microbiology; ocular surface","Dutheil","Frédéric","Preventive and Occupational Medicine, University Hospital of Clermont-Ferrand, Clermont-Ferrand, Auvergne-Rhône-Alpes, France",NA
"2769","34192147","10.1177/23780231211000171","Visualizing the Network Structure of COVID-19 in Singapore.","Many infectious diseases such as coronavirus disease 2019 spread through preexisting social networks. Although network models consider the implications of micro-level interaction patterns for disease transmission, epidemiologists and social scientists know little about the meso-structure of disease transmission. Meso-structure refers to the pattern of disease spread at a higher level of aggregation, that is, among infection clusters corresponding to organizations, locales, and events. The","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; epidemics; health; networks","Van Gunten","Tod","University of Edinburgh, Edinburgh, UK",NA
"2770","34192146","10.1177/2378023121992607","U.S. Children ""Learning Online"" during COVID-19 without the Internet or a Computer: Visualizing the Gradient by Race/Ethnicity and Parental Educational Attainment.","The coronavirus disease 2019 pandemic has caused unprecedented disruptions to education in the United States, with a large proportion of schooling moving to online formats, which has the potential to exacerbate existing racial/ethnic and socioeconomic disparities in learning. The authors visualize access to online learning technologies using data from the Household Pulse Survey from the early fall 2020 school period (August 19 to October 26). The authors find that 10.1 percent of children partic","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; educational inequality; online learning; racial/ethnic disparities","Friedman","Joseph","University of California, Los Angeles, Los Angeles, CA, USA",NA
"2771","34192146","10.1177/2378023121992607","U.S. Children ""Learning Online"" during COVID-19 without the Internet or a Computer: Visualizing the Gradient by Race/Ethnicity and Parental Educational Attainment.","The coronavirus disease 2019 pandemic has caused unprecedented disruptions to education in the United States, with a large proportion of schooling moving to online formats, which has the potential to exacerbate existing racial/ethnic and socioeconomic disparities in learning. The authors visualize access to online learning technologies using data from the Household Pulse Survey from the early fall 2020 school period (August 19 to October 26). The authors find that 10.1 percent of children partic","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; educational inequality; online learning; racial/ethnic disparities","York","Hunter","Princeton University, Princeton, NJ, USA",NA
"2772","34192146","10.1177/2378023121992607","U.S. Children ""Learning Online"" during COVID-19 without the Internet or a Computer: Visualizing the Gradient by Race/Ethnicity and Parental Educational Attainment.","The coronavirus disease 2019 pandemic has caused unprecedented disruptions to education in the United States, with a large proportion of schooling moving to online formats, which has the potential to exacerbate existing racial/ethnic and socioeconomic disparities in learning. The authors visualize access to online learning technologies using data from the Household Pulse Survey from the early fall 2020 school period (August 19 to October 26). The authors find that 10.1 percent of children partic","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; educational inequality; online learning; racial/ethnic disparities","Mokdad","Ali H","University of Washington, Seattle, WA, USA",NA
"2773","34192146","10.1177/2378023121992607","U.S. Children ""Learning Online"" during COVID-19 without the Internet or a Computer: Visualizing the Gradient by Race/Ethnicity and Parental Educational Attainment.","The coronavirus disease 2019 pandemic has caused unprecedented disruptions to education in the United States, with a large proportion of schooling moving to online formats, which has the potential to exacerbate existing racial/ethnic and socioeconomic disparities in learning. The authors visualize access to online learning technologies using data from the Household Pulse Survey from the early fall 2020 school period (August 19 to October 26). The authors find that 10.1 percent of children partic","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; educational inequality; online learning; racial/ethnic disparities","Gakidou","Emmanuela","University of Washington, Seattle, WA, USA",NA
"2774","34192145","10.1177/2378023121992601","Firm Size and Employment during the Pandemic.","Previous studies have established that firm size is associated with a wage premium, but the wage premium has declined in recent decades. The authors examine the risk for unemployment by firm size during the initial outbreak of coronavirus disease 2019 in the United States. Using both yearly and state-month variation, the authors find greater excess unemployment among workers in small enterprises than among those in larger firms. The gaps cannot be entirely attributed to the sorting of workers or","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; firm size; remotability","Lin","Ken-Hou","The University of Texas, Austin, TX, USA",NA
"2775","34192145","10.1177/2378023121992601","Firm Size and Employment during the Pandemic.","Previous studies have established that firm size is associated with a wage premium, but the wage premium has declined in recent decades. The authors examine the risk for unemployment by firm size during the initial outbreak of coronavirus disease 2019 in the United States. Using both yearly and state-month variation, the authors find greater excess unemployment among workers in small enterprises than among those in larger firms. The gaps cannot be entirely attributed to the sorting of workers or","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; firm size; remotability","Aragão","Carolina","The University of Texas, Austin, TX, USA",NA
"2776","34192145","10.1177/2378023121992601","Firm Size and Employment during the Pandemic.","Previous studies have established that firm size is associated with a wage premium, but the wage premium has declined in recent decades. The authors examine the risk for unemployment by firm size during the initial outbreak of coronavirus disease 2019 in the United States. Using both yearly and state-month variation, the authors find greater excess unemployment among workers in small enterprises than among those in larger firms. The gaps cannot be entirely attributed to the sorting of workers or","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; firm size; remotability","Dominguez","Guillermo","The University of Texas, Austin, TX, USA",NA
"2777","34192144","10.1177/2378023120988397","The Racial Gap in Employment and Layoffs during COVID-19 in the United States: A Visualization.","A large body of sociological research has shown that racial minorities and women experience significant disadvantages in the labor market. In this visualization, the author presents evidence from the Current Population Survey examining the effects of the coronavirus disease 2019 crisis on racial and gender inequalities in employment in the United States among prime-age workers. The author shows that the white-nonwhite gap in employment increased significantly during the post-outbreak period. Res","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; United States; employment; race","Dias","Felipe A","Tufts University, Medford, MA, USA",NA
"2778","34192143","10.1177/2378023120988203","Online or in Person? Examining College Decisions to Reopen during the COVID-19 Pandemic in Fall 2020.","When coronavirus disease 2019 (COVID-19) became a major impediment to face-to-face college instruction in spring 2020, most teaching went online. Over the summer, colleges had to make difficult decisions about whether to return to in-person instruction. Although opening campuses could pose a major health risk, keeping instruction online could dissuade students from enrolling. Taking an ecological approach, the authors use mixed modeling techniques and data from 87 percent of two- and four-year p","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID; contextual effects; education; policy; politics","Felson","Jacob","William Paterson University, Wayne, NJ, USA",NA
"2779","34192143","10.1177/2378023120988203","Online or in Person? Examining College Decisions to Reopen during the COVID-19 Pandemic in Fall 2020.","When coronavirus disease 2019 (COVID-19) became a major impediment to face-to-face college instruction in spring 2020, most teaching went online. Over the summer, colleges had to make difficult decisions about whether to return to in-person instruction. Although opening campuses could pose a major health risk, keeping instruction online could dissuade students from enrolling. Taking an ecological approach, the authors use mixed modeling techniques and data from 87 percent of two- and four-year p","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID; contextual effects; education; policy; politics","Adamczyk","Amy","John Jay College of Criminal Justice and The Graduate Center, City University of New York, NY, USA",NA
"2780","34192142","10.1177/2378023120987710","Who Stays Physically Active during COVID-19? Inequality and Exercise Patterns in the United States.","Exercising is crucial to keeping up physical and mental health during the coronavirus disease 2019 (COVID-19) pandemic. In this visualization, the authors consider how existing social inequalities may create unequal physical exercise patterns during COVID-19 in the United States. Analyzing data from a nationally representative Internet panel of the University of Southern California Center for Economic and Social Research Understanding Coronavirus in America project (March to December), the autho","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; SES; exercise inequality; gender; race","Sher","Chloe","University of Toronto, Toronto, ON, Canada",NA
"2781","34192142","10.1177/2378023120987710","Who Stays Physically Active during COVID-19? Inequality and Exercise Patterns in the United States.","Exercising is crucial to keeping up physical and mental health during the coronavirus disease 2019 (COVID-19) pandemic. In this visualization, the authors consider how existing social inequalities may create unequal physical exercise patterns during COVID-19 in the United States. Analyzing data from a nationally representative Internet panel of the University of Southern California Center for Economic and Social Research Understanding Coronavirus in America project (March to December), the autho","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; SES; exercise inequality; gender; race","Wu","Cary","York University, Toronto, ON, Canada",NA
"2782","34192141","10.1177/2378023120980918","Racial Disparities in COVID-19 and Excess Mortality in Minnesota.","The coronavirus disease 2019 (COVID-19) pandemic has produced vastly disproportionate deaths for communities of color in the United States. Minnesota seemingly stands out as an exception to this national pattern, with white Minnesotans accounting for 80 percent of the population and 82 percent of COVID-19 deaths. The authors examine confirmed COVID-19 mortality alongside deaths indirectly attributable to the pandemic-""excess mortality""-in Minnesota. This analysis reveals profound racial disparit","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; excess mortality; racial disparities","Wrigley-Field","Elizabeth","University of Minnesota, Twin Cities, Minneapolis, MN, USA",NA
"2783","34192141","10.1177/2378023120980918","Racial Disparities in COVID-19 and Excess Mortality in Minnesota.","The coronavirus disease 2019 (COVID-19) pandemic has produced vastly disproportionate deaths for communities of color in the United States. Minnesota seemingly stands out as an exception to this national pattern, with white Minnesotans accounting for 80 percent of the population and 82 percent of COVID-19 deaths. The authors examine confirmed COVID-19 mortality alongside deaths indirectly attributable to the pandemic-""excess mortality""-in Minnesota. This analysis reveals profound racial disparit","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; excess mortality; racial disparities","Garcia","Sarah","University of Minnesota, Twin Cities, Minneapolis, MN, USA",NA
"2784","34192141","10.1177/2378023120980918","Racial Disparities in COVID-19 and Excess Mortality in Minnesota.","The coronavirus disease 2019 (COVID-19) pandemic has produced vastly disproportionate deaths for communities of color in the United States. Minnesota seemingly stands out as an exception to this national pattern, with white Minnesotans accounting for 80 percent of the population and 82 percent of COVID-19 deaths. The authors examine confirmed COVID-19 mortality alongside deaths indirectly attributable to the pandemic-""excess mortality""-in Minnesota. This analysis reveals profound racial disparit","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; excess mortality; racial disparities","Leider","Jonathon P","University of Minnesota, Twin Cities, Minneapolis, MN, USA",NA
"2785","34192141","10.1177/2378023120980918","Racial Disparities in COVID-19 and Excess Mortality in Minnesota.","The coronavirus disease 2019 (COVID-19) pandemic has produced vastly disproportionate deaths for communities of color in the United States. Minnesota seemingly stands out as an exception to this national pattern, with white Minnesotans accounting for 80 percent of the population and 82 percent of COVID-19 deaths. The authors examine confirmed COVID-19 mortality alongside deaths indirectly attributable to the pandemic-""excess mortality""-in Minnesota. This analysis reveals profound racial disparit","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; excess mortality; racial disparities","Robertson","Christopher","University of Minnesota, Twin Cities, Minneapolis, MN, USA",NA
"2786","34192141","10.1177/2378023120980918","Racial Disparities in COVID-19 and Excess Mortality in Minnesota.","The coronavirus disease 2019 (COVID-19) pandemic has produced vastly disproportionate deaths for communities of color in the United States. Minnesota seemingly stands out as an exception to this national pattern, with white Minnesotans accounting for 80 percent of the population and 82 percent of COVID-19 deaths. The authors examine confirmed COVID-19 mortality alongside deaths indirectly attributable to the pandemic-""excess mortality""-in Minnesota. This analysis reveals profound racial disparit","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; excess mortality; racial disparities","Wurtz","Rebecca","University of Minnesota, Twin Cities, Minneapolis, MN, USA",NA
"2787","34192140","10.1177/2378023120980328","Decline in Marriage Associated with the COVID-19 Pandemic in the United States.","In the social upheaval arising from the coronavirus disease 2019 (COVID-19) pandemic, we do not yet know how union formation, particularly marriage, has been affected. Using administration records-marriage certificates and applications-gathered from settings representing a variety of COVID-19 experiences in the United States, the authors compare counts of recorded marriages in 2020 against those from the same period in 2019. There is a dramatic decrease in year-to-date cumulative marriages in 20","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; administrative data; marriage","Wagner","Brandon G","Texas Tech University, Lubbock, TX, USA",NA
"2788","34192140","10.1177/2378023120980328","Decline in Marriage Associated with the COVID-19 Pandemic in the United States.","In the social upheaval arising from the coronavirus disease 2019 (COVID-19) pandemic, we do not yet know how union formation, particularly marriage, has been affected. Using administration records-marriage certificates and applications-gathered from settings representing a variety of COVID-19 experiences in the United States, the authors compare counts of recorded marriages in 2020 against those from the same period in 2019. There is a dramatic decrease in year-to-date cumulative marriages in 20","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; administrative data; marriage","Choi","Kate H","University of Western Ontario, London, ON, Canada",NA
"2789","34192140","10.1177/2378023120980328","Decline in Marriage Associated with the COVID-19 Pandemic in the United States.","In the social upheaval arising from the coronavirus disease 2019 (COVID-19) pandemic, we do not yet know how union formation, particularly marriage, has been affected. Using administration records-marriage certificates and applications-gathered from settings representing a variety of COVID-19 experiences in the United States, the authors compare counts of recorded marriages in 2020 against those from the same period in 2019. There is a dramatic decrease in year-to-date cumulative marriages in 20","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; administrative data; marriage","Cohen","Philip N","University of Maryland, College Park, MD, USA",NA
"2790","34192139","10.1177/2378023120950190","Staying Informed and Bridging ""Social Distance"": Smartphone News Use and Mobile Messaging Behaviors of Flemish Adults during the First Weeks of the COVID-19 Pandemic.","The authors explore patterns of smartphone use during the first weeks following the outbreak of the coronavirus disease 2019 pandemic in Belgium, focusing on citizens' use of smartphones to consume news and to communicate and interact with others. Unique smartphone tracking data from 2,778 Flemish adults reveal that at the height of the outbreak, people used their smartphone on average 45 minutes (28 percent) more than before the outbreak. The number of smartphone pickups remained fairly stable ","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; coronavirus; mobile messaging; mobile news; smartphone use","Ohme","Jakob","University of Amsterdam, Amsterdam, the Netherlands",NA
"2791","34192139","10.1177/2378023120950190","Staying Informed and Bridging ""Social Distance"": Smartphone News Use and Mobile Messaging Behaviors of Flemish Adults during the First Weeks of the COVID-19 Pandemic.","The authors explore patterns of smartphone use during the first weeks following the outbreak of the coronavirus disease 2019 pandemic in Belgium, focusing on citizens' use of smartphones to consume news and to communicate and interact with others. Unique smartphone tracking data from 2,778 Flemish adults reveal that at the height of the outbreak, people used their smartphone on average 45 minutes (28 percent) more than before the outbreak. The number of smartphone pickups remained fairly stable ","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; coronavirus; mobile messaging; mobile news; smartphone use","Vanden Abeele","Mariek M P","Tilburg University, Tilburg, the Netherlands",NA
"2792","34192139","10.1177/2378023120950190","Staying Informed and Bridging ""Social Distance"": Smartphone News Use and Mobile Messaging Behaviors of Flemish Adults during the First Weeks of the COVID-19 Pandemic.","The authors explore patterns of smartphone use during the first weeks following the outbreak of the coronavirus disease 2019 pandemic in Belgium, focusing on citizens' use of smartphones to consume news and to communicate and interact with others. Unique smartphone tracking data from 2,778 Flemish adults reveal that at the height of the outbreak, people used their smartphone on average 45 minutes (28 percent) more than before the outbreak. The number of smartphone pickups remained fairly stable ","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; coronavirus; mobile messaging; mobile news; smartphone use","Van Gaeveren","Kyle","Ghent University, Ghent, Belgium",NA
"2793","34192139","10.1177/2378023120950190","Staying Informed and Bridging ""Social Distance"": Smartphone News Use and Mobile Messaging Behaviors of Flemish Adults during the First Weeks of the COVID-19 Pandemic.","The authors explore patterns of smartphone use during the first weeks following the outbreak of the coronavirus disease 2019 pandemic in Belgium, focusing on citizens' use of smartphones to consume news and to communicate and interact with others. Unique smartphone tracking data from 2,778 Flemish adults reveal that at the height of the outbreak, people used their smartphone on average 45 minutes (28 percent) more than before the outbreak. The number of smartphone pickups remained fairly stable ","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; coronavirus; mobile messaging; mobile news; smartphone use","Durnez","Wouter","Ghent University, Ghent, Belgium",NA
"2794","34192139","10.1177/2378023120950190","Staying Informed and Bridging ""Social Distance"": Smartphone News Use and Mobile Messaging Behaviors of Flemish Adults during the First Weeks of the COVID-19 Pandemic.","The authors explore patterns of smartphone use during the first weeks following the outbreak of the coronavirus disease 2019 pandemic in Belgium, focusing on citizens' use of smartphones to consume news and to communicate and interact with others. Unique smartphone tracking data from 2,778 Flemish adults reveal that at the height of the outbreak, people used their smartphone on average 45 minutes (28 percent) more than before the outbreak. The number of smartphone pickups remained fairly stable ","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; coronavirus; mobile messaging; mobile news; smartphone use","De Marez","Lieven","Ghent University, Ghent, Belgium",NA
"2795","34192138","10.1177/2378023120947997","Early Signs Indicate That COVID-19 Is Exacerbating Gender Inequality in the Labor Force.","In this data visualization, the authors examine how the coronavirus disease 2019 (COVID-19) crisis in the United States has affected labor force participation, unemployment, and work hours across gender and parental status. Using data from the Current Population Survey, the authors compare estimates between February and April 2020 to examine the period of time before the COVID-19 outbreak in the United States to the height of the first wave, when stay-at-home orders were issued across the countr","2021","06","30","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; family; gender; work hours","Landivar","Liana Christin","Maryland Population Research Center, College Park, MD, USA",NA
"2796","34192138","10.1177/2378023120947997","Early Signs Indicate That COVID-19 Is Exacerbating Gender Inequality in the Labor Force.","In this data visualization, the authors examine how the coronavirus disease 2019 (COVID-19) crisis in the United States has affected labor force participation, unemployment, and work hours across gender and parental status. Using data from the Current Population Survey, the authors compare estimates between February and April 2020 to examine the period of time before the COVID-19 outbreak in the United States to the height of the first wave, when stay-at-home orders were issued across the countr","2021","06","30","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; family; gender; work hours","Ruppanner","Leah","University of Melbourne, Melbourne, Australia",NA
"2797","34192138","10.1177/2378023120947997","Early Signs Indicate That COVID-19 Is Exacerbating Gender Inequality in the Labor Force.","In this data visualization, the authors examine how the coronavirus disease 2019 (COVID-19) crisis in the United States has affected labor force participation, unemployment, and work hours across gender and parental status. Using data from the Current Population Survey, the authors compare estimates between February and April 2020 to examine the period of time before the COVID-19 outbreak in the United States to the height of the first wave, when stay-at-home orders were issued across the countr","2021","06","30","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; family; gender; work hours","Scarborough","William J","University of North Texas, Denton, TX, USA",NA
"2798","34192138","10.1177/2378023120947997","Early Signs Indicate That COVID-19 Is Exacerbating Gender Inequality in the Labor Force.","In this data visualization, the authors examine how the coronavirus disease 2019 (COVID-19) crisis in the United States has affected labor force participation, unemployment, and work hours across gender and parental status. Using data from the Current Population Survey, the authors compare estimates between February and April 2020 to examine the period of time before the COVID-19 outbreak in the United States to the height of the first wave, when stay-at-home orders were issued across the countr","2021","06","30","Socius","Socius : sociological research for a dynamic world","COVID-19; employment; family; gender; work hours","Collins","Caitlyn","Washington University in St. Louis, St. Louis, MO, USA",NA
"2799","34192137","10.1177/2378023120944358","The Status Dynamics of Role Blurring in the Time of COVID-19.","Has the coronavirus disease 2019 pandemic altered the status dynamics of role blurring? Although researchers typically investigate its conflictual aspects, the authors assess if the work-home interface might also be a source of status-and the relevance of schedule control in these processes. Analyzing data from nationally representative samples of workers in September 2019 and March 2020, the authors find that role blurring is associated with elevated status, but the onset of coronavirus disease","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; pandemic; role blurring; schedule control; subjective social status; work-family interface","Schieman","Scott","University of Toronto, Toronto, ON, Canada",NA
"2800","34192137","10.1177/2378023120944358","The Status Dynamics of Role Blurring in the Time of COVID-19.","Has the coronavirus disease 2019 pandemic altered the status dynamics of role blurring? Although researchers typically investigate its conflictual aspects, the authors assess if the work-home interface might also be a source of status-and the relevance of schedule control in these processes. Analyzing data from nationally representative samples of workers in September 2019 and March 2020, the authors find that role blurring is associated with elevated status, but the onset of coronavirus disease","2021","07","02","Socius","Socius : sociological research for a dynamic world","COVID-19; pandemic; role blurring; schedule control; subjective social status; work-family interface","Badawy","Philip J","University of Toronto, Toronto, ON, Canada",NA
"2801","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Miseikis","Justinas","F&amp",NA
"2802","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Caroni","Pietro","F&amp",NA
"2803","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Duchamp","Patricia","F&amp",NA
"2804","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Gasser","Alina","F&amp",NA
"2805","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Marko","Rastislav","F&amp",NA
"2806","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Miseikiene","Nelija","F&amp",NA
"2807","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Zwilling","Frederik","F&amp",NA
"2808","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","de Castelbajac","Charles","F&amp",NA
"2809","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Eicher","Lucas","F&amp",NA
"2810","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Fruh","Michael","F&amp",NA
"2811","34192136","10.1109/LRA.2020.3007462","Lio-A Personal Robot Assistant for Human-Robot Interaction and Care Applications.","Lio is a mobile robot platform with a multi-functional arm explicitly designed for human-robot interaction and personal care assistant tasks. The robot has already been deployed in several health care facilities, where it is functioning autonomously, assisting staff and patients on an everyday basis. Lio is intrinsically safe by having full coverage in soft artificial-leather material as well as collision detection, limited speed and forces. Furthermore, the robot has a compliant motion controll","2021","07","02","IEEE Robot Autom Lett","IEEE robotics and automation letters","Service robotics; automation in life sciences: biotechnology; autonomous agents; human-centered robotics; pharmaceutical and health care; physical human-robot interaction","Fruh","Hansruedi","F&amp",NA
"2812","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Fu","Lucy","Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2813","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Swete","Michael","Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2814","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Selgrade","Daniel","Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2815","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Chan","Clarence W","Department of Pathology, University of Chicago, Chicago, IL, USA",NA
"2816","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Rodriguez","Raven","Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2817","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Wolniak","Kristy","Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2818","34192135","10.1177/23742895211010275","Virtual Pathology Elective Provides Uninterrupted Medical Education and Impactful Pathology Education During the COVID-19 Pandemic.","As students do not qualify as essential health care workers, medical education faced severe disruptions during the COVID-19 pandemic including initial suspension of all in-person lectures and on-site rotations. Our Pathology Department was among the first at Northwestern to offer a completely virtual rotation with the goals of: (1) providing a comprehensive introduction to the practice of anatomic and clinical pathology, (2) emphasizing uninterrupted and continued excellence in education, and (3","2021","07","02","Acad Pathol","Academic pathology","COVID-19; curriculum; education; pathology; remote; rotation; student; virtual","Blanco","Luis Z","Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA",NA
"2819","34192134","10.1177/23742895211002843","Engage in Exploration: Pathology Gross Laboratory in the COVID-Era.","The outbreak of Covid-19 has changed education, including the mechanism of delivery of gross pathology laboratories. Herein, we describe how we revised our preclinical gross pathology lab to a flipped model to fit with COVID-19 regulations. A series of short, session objective-driven videos are made available online. Students are expected to watch the videos before coming to the hands-on lab. Groups of 2 students enter the gross lab on a timed basis and rotate through a series of stations. At ea","2021","07","02","Acad Pathol","Academic pathology","active learning; flipped; gross pathology; lab; teaching","Bryant","Ronald J","Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at the University of Vermont, Burlington, VT, USA",NA
"2820","34192134","10.1177/23742895211002843","Engage in Exploration: Pathology Gross Laboratory in the COVID-Era.","The outbreak of Covid-19 has changed education, including the mechanism of delivery of gross pathology laboratories. Herein, we describe how we revised our preclinical gross pathology lab to a flipped model to fit with COVID-19 regulations. A series of short, session objective-driven videos are made available online. Students are expected to watch the videos before coming to the hands-on lab. Groups of 2 students enter the gross lab on a timed basis and rotate through a series of stations. At ea","2021","07","02","Acad Pathol","Academic pathology","active learning; flipped; gross pathology; lab; teaching","Wilcox","Rebecca","Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at the University of Vermont, Burlington, VT, USA",NA
"2821","34192134","10.1177/23742895211002843","Engage in Exploration: Pathology Gross Laboratory in the COVID-Era.","The outbreak of Covid-19 has changed education, including the mechanism of delivery of gross pathology laboratories. Herein, we describe how we revised our preclinical gross pathology lab to a flipped model to fit with COVID-19 regulations. A series of short, session objective-driven videos are made available online. Students are expected to watch the videos before coming to the hands-on lab. Groups of 2 students enter the gross lab on a timed basis and rotate through a series of stations. At ea","2021","07","02","Acad Pathol","Academic pathology","active learning; flipped; gross pathology; lab; teaching","Zhang","Bei","Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at the University of Vermont, Burlington, VT, USA",NA
"2822","34192133","10.1177/23742895211002783","The #Path2Path Virtual Landscape During the COVID-19 Pandemic: Preparing for the 2020 Pathology Residency Recruitment Season.","On May 11, 2020, the Association of American Medical Colleges released recommendations discouraging in-person activities for away rotations and mandating virtual-only residency recruitment interviews. This paper focuses on how residency programs have attempted to adjust to this vastly different application cycle by using social media to reach their applicants. A total of 138 programs were identified through the Electronic Residency Application Services. The presence of Departmental/Residency pro","2021","06","30","Acad Pathol","Academic pathology","#path2path; COVID-19; education; pathology; residency recruitment; social media","Cutshall","Hannah","School of Medicine, University of Alabama, Birmingham, AL, USA",NA
"2823","34192133","10.1177/23742895211002783","The #Path2Path Virtual Landscape During the COVID-19 Pandemic: Preparing for the 2020 Pathology Residency Recruitment Season.","On May 11, 2020, the Association of American Medical Colleges released recommendations discouraging in-person activities for away rotations and mandating virtual-only residency recruitment interviews. This paper focuses on how residency programs have attempted to adjust to this vastly different application cycle by using social media to reach their applicants. A total of 138 programs were identified through the Electronic Residency Application Services. The presence of Departmental/Residency pro","2021","06","30","Acad Pathol","Academic pathology","#path2path; COVID-19; education; pathology; residency recruitment; social media","Hattaway","Reagan","School of Medicine, University of Alabama, Birmingham, AL, USA",NA
"2824","34192133","10.1177/23742895211002783","The #Path2Path Virtual Landscape During the COVID-19 Pandemic: Preparing for the 2020 Pathology Residency Recruitment Season.","On May 11, 2020, the Association of American Medical Colleges released recommendations discouraging in-person activities for away rotations and mandating virtual-only residency recruitment interviews. This paper focuses on how residency programs have attempted to adjust to this vastly different application cycle by using social media to reach their applicants. A total of 138 programs were identified through the Electronic Residency Application Services. The presence of Departmental/Residency pro","2021","06","30","Acad Pathol","Academic pathology","#path2path; COVID-19; education; pathology; residency recruitment; social media","Singh","Nikhi P","School of Medicine, University of Alabama, Birmingham, AL, USA",NA
"2825","34192133","10.1177/23742895211002783","The #Path2Path Virtual Landscape During the COVID-19 Pandemic: Preparing for the 2020 Pathology Residency Recruitment Season.","On May 11, 2020, the Association of American Medical Colleges released recommendations discouraging in-person activities for away rotations and mandating virtual-only residency recruitment interviews. This paper focuses on how residency programs have attempted to adjust to this vastly different application cycle by using social media to reach their applicants. A total of 138 programs were identified through the Electronic Residency Application Services. The presence of Departmental/Residency pro","2021","06","30","Acad Pathol","Academic pathology","#path2path; COVID-19; education; pathology; residency recruitment; social media","Rais-Bahrami","Soroush","Department of Urology, University of Alabama, Birmingham, AL, USA",NA
"2826","34192133","10.1177/23742895211002783","The #Path2Path Virtual Landscape During the COVID-19 Pandemic: Preparing for the 2020 Pathology Residency Recruitment Season.","On May 11, 2020, the Association of American Medical Colleges released recommendations discouraging in-person activities for away rotations and mandating virtual-only residency recruitment interviews. This paper focuses on how residency programs have attempted to adjust to this vastly different application cycle by using social media to reach their applicants. A total of 138 programs were identified through the Electronic Residency Application Services. The presence of Departmental/Residency pro","2021","06","30","Acad Pathol","Academic pathology","#path2path; COVID-19; education; pathology; residency recruitment; social media","McCleskey","Brandi","Department of Pathology, University of Alabama, Birmingham, AL, USA",NA
"2827","34192132","10.1097/CXA.0000000000000092","COVID-19 and the Seeds of Unrest.",NA,"2021","06","30","Can J Addict","The Canadian journal of addiction",NA,"El-Guebaly","Nady","Editor-in-Chief, CJA-JCA",NA
"2828","34192130","10.1097/CXA.0000000000000084","The COVID-19 pandemic and its impact on addiction treatment.",NA,"2021","07","02","Can J Addict","The Canadian journal of addiction",NA,"Crockford","David",NA,NA
"2829","34192129","10.1097/CXA.0000000000000081","COVID-19 and social distancing.",NA,"2021","07","02","Can J Addict","The Canadian journal of addiction",NA,NA,NA,NA,NA
"2830","34192128","10.1159/000514784","Digestive Oncology in the COVID-19 Pandemic Era.","Since the rise of the COVID-19 pandemic there has been widespread concern regarding the possible delay in the diagnosis/treatment of cancer patients. We aimed to assess the impact of the COVID-19 pandemic on the diagnosis, treatment, and outcome of patients with digestive cancer. This was a retrospective study including patients with an inaugural digestive cancer diagnosis discussed for the first time at our center during the weekly digestive oncology reunion (DOR) meeting. The study group was e","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Colorectal cancer; Digestive cancer; Digestive oncology; Pandemic","Brito","Mariana","Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal",NA
"2831","34192128","10.1159/000514784","Digestive Oncology in the COVID-19 Pandemic Era.","Since the rise of the COVID-19 pandemic there has been widespread concern regarding the possible delay in the diagnosis/treatment of cancer patients. We aimed to assess the impact of the COVID-19 pandemic on the diagnosis, treatment, and outcome of patients with digestive cancer. This was a retrospective study including patients with an inaugural digestive cancer diagnosis discussed for the first time at our center during the weekly digestive oncology reunion (DOR) meeting. The study group was e","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Colorectal cancer; Digestive cancer; Digestive oncology; Pandemic","Laranjo","Ana","Department of Gastroenterology, Hospital do Espírito Santo de Évora, Évora, Portugal",NA
"2832","34192128","10.1159/000514784","Digestive Oncology in the COVID-19 Pandemic Era.","Since the rise of the COVID-19 pandemic there has been widespread concern regarding the possible delay in the diagnosis/treatment of cancer patients. We aimed to assess the impact of the COVID-19 pandemic on the diagnosis, treatment, and outcome of patients with digestive cancer. This was a retrospective study including patients with an inaugural digestive cancer diagnosis discussed for the first time at our center during the weekly digestive oncology reunion (DOR) meeting. The study group was e","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Colorectal cancer; Digestive cancer; Digestive oncology; Pandemic","Sabino","Júlia","Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal",NA
"2833","34192128","10.1159/000514784","Digestive Oncology in the COVID-19 Pandemic Era.","Since the rise of the COVID-19 pandemic there has been widespread concern regarding the possible delay in the diagnosis/treatment of cancer patients. We aimed to assess the impact of the COVID-19 pandemic on the diagnosis, treatment, and outcome of patients with digestive cancer. This was a retrospective study including patients with an inaugural digestive cancer diagnosis discussed for the first time at our center during the weekly digestive oncology reunion (DOR) meeting. The study group was e","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Colorectal cancer; Digestive cancer; Digestive oncology; Pandemic","Oliveira","Carla","Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal",NA
"2834","34192128","10.1159/000514784","Digestive Oncology in the COVID-19 Pandemic Era.","Since the rise of the COVID-19 pandemic there has been widespread concern regarding the possible delay in the diagnosis/treatment of cancer patients. We aimed to assess the impact of the COVID-19 pandemic on the diagnosis, treatment, and outcome of patients with digestive cancer. This was a retrospective study including patients with an inaugural digestive cancer diagnosis discussed for the first time at our center during the weekly digestive oncology reunion (DOR) meeting. The study group was e","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Colorectal cancer; Digestive cancer; Digestive oncology; Pandemic","Mocanu","Irina","Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal",NA
"2835","34192128","10.1159/000514784","Digestive Oncology in the COVID-19 Pandemic Era.","Since the rise of the COVID-19 pandemic there has been widespread concern regarding the possible delay in the diagnosis/treatment of cancer patients. We aimed to assess the impact of the COVID-19 pandemic on the diagnosis, treatment, and outcome of patients with digestive cancer. This was a retrospective study including patients with an inaugural digestive cancer diagnosis discussed for the first time at our center during the weekly digestive oncology reunion (DOR) meeting. The study group was e","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Colorectal cancer; Digestive cancer; Digestive oncology; Pandemic","Fonseca","Jorge","Department of Gastroenterology, Hospital Garcia de Orta, Almada, Portugal",NA
"2836","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Garrido","Mónica","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2837","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Pereira Guedes","Tiago","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2838","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Alves Silva","Joana","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2839","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Falcão","Daniela","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2840","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Novo","Inês","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2841","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Archer","Sara","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2842","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Rocha","Marta","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2843","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Maia","Luís","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2844","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Sarmento-Castro","Rui","Department of Infectious Diseases, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
"2845","34192127","10.1159/000513593","Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.","The impact of SARS-CoV-2 infection on the liver and the possibility of chronic liver disease (CLD) as a risk factor for COVID-19 severity is not fully understood. Our goal was to describe clinical outcomes of COVID-19 inpatients regarding the presence of abnormal liver tests and CLD. A retrospective analysis of patients with SARS-CoV-2 infection, hospitalized in a tertiary center in Portugal, was performed. Studied outcomes were disease and hospitalization length, COVID-19 severity, admission to","2021","07","02","GE Port J Gastroenterol","GE Portuguese journal of gastroenterology","COVID-19; Chronic liver disease; Cirrhosis; Liver; SARS-CoV-2","Pedroto","Isabel","Department of Gastroenterology, Centro Hospitalar Universitário do Porto, Porto, Portugal",NA
